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Abstract 
 
Kenneth F. Stensrud, Ph.D. 
Department of Chemistry, April 2008 
University of Kansas 
 
 
The p-hydroxyphenacyl chromophore (pHP) is a versatile phototrigger for an 
assortment of biological nucleofuges, such as γ-aminobutyric acid (GABA).  The 
photochemistry is trenchant; irradiation discharges the nucleofuge and induces 
rearrangement of pHP, analogous to the ground state Favorskii rearrangement.   
Structure-reactivity relationships were explored with pHP GABA’s.  Electron 
donating groups lowered the release efficiency, Φdis, relative to the unsubstituted 
analog.  Electron withdrawing carbonyl groups attenuated Φdis. Fluoro moieties 
modulated the pKa of pHP; protonated pHP manifested higher Φdis than their 
conjugate base counterparts. The reactive excited states were determined as triplets by 
Stern-Volmer quenching and laser flash photolysis studies.  The triplet lifetimes were 
~ 10-9 s with release rate constants of 107 to 108 s-1. Auxochrome substitutions 
lengthened the λmax of pHP but lowered Φdis.  Added perchlorate salts markedly 
improved Φdis for pHP GABA’s, imputing intermediate ion-radical pairs.   
Comprehensive photo-Favorskii mechanisms were posited for protonated and 
conjugate base forms of pHP GABA.   
  
 
 
 
 
 iv 
Acknowledgements 
 
 There have been frequent comments regarding my use of flowery, poetic 
words instead of those deemed appropriate for scientific writing.  Though I have 
learned to distinguish one from the other while composing this dissertation, I find it 
truly risible that, at this time, words fail me when appositely expressing my gratitude 
to my advisor, Professor Richard Givens.  Dr. Givens equanimity in dealing with my 
oft hair-brained ideas and digressions cannot be understated.  My motivations to work 
long hours at solving our research problems originated from his encouragements and 
well considered proposals.  Honestly, I shouldn’t continue to indite a synopsis of his 
qualities, as they will present as mere platitudes.  I can only state with certainty that 
Dr. Givens will always remain close to my heart for everything he has passed on to 
me both as a scientist and a man of utmost integrity. 
 My parents, Ken and Donna, have sacrificed more than I can fathom to ensure 
that their son, the opsimath, would succeed in his endeavors. I am grateful for your 
closeness and support.  Mom and dad, my love for you will transcend this life.  My 
brother Dan has always been there for me irrespective of the difficulty of the times.  
Dan, I look forward to growing old with you as both my brother and best friend. 
 My wife, Beth Stensrud, was the linchpin in my success as a graduate student.  
The single greatest event in my life was meeting you my first semester at KU.  You 
were my foundation, my stimulus to endure time of tumult.  I am dubious that I would 
 v 
have persevered without you.  Beth, from you I have recognized the existence of 
angels.   
 I owe a debt of gratitude to Dr. Todd Williams for his willingness to instruct 
me on the applications of the QQQ and furthermore permit me to utilize the 
instrument without restrictions over the past two years.  I can honestly state that I 
would have completed a tenth of the amount of work if I did not have access to 
instrument and your exhortations.  Todd, your succor will always be remembered and 
revered. 
  Professor Abraham Yousef was my antecedent in the laboratory.  Your 
forbearance and willingness to instruct when I was maladroit will never be forgotten.  
Abraham, I owe much of my success in the laboratory to you, your mundane 
disposition was appreciated more than you can know.  I hope we can stay in touch 
throughout the years. 
 To Dr. Elizabeth Cope, you were a friend and lab colleague.  Beth, I will 
never forget the long hours and weekends we spent in the laboratory, imbued with 
successes, failures, and insightful talks.  I appreciated this.  It is eerie now when I 
come into lab on the weekends and I don’t see you.  
 To Dr. Gerry Lushington, Professor Jakob Wirz, Dr. Dominik Heger and 
Professor Karl Kandler, thank you for your collaborative efforts. The information that 
you gleaned facilitated the solution of my research problems. 
 vi 
 John Hershberger - we came in together and we will go out together.  Through 
good and bad times, times of confusion and consumption, our experiences will never 
be forgotten. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
Table of Contents 
 
page 
Abstract          iii 
Acknowledgements         iv 
List of Figures          xi 
List of Schemes                   xvii 
List of Tables                    xxi 
List of Equations                  xxiv 
Glossary of Chemical Compounds Studied                xxv 
Introduction          1 
 I.  Early Investigations of The Favorskii Rearrangement   1 
 II. Bordwell’s Contributions       5 
  A.  Rate, Isotope and Nucleofuge Studies    6 
  B.  Substituent, LFER, Salt, Media Studies    11 
  C.  Ramberg-Backland Analogy-Role of Orbital Overlap  17 
  D.  Influence of α-Substituents     21 
  E.  Evidence for a Dipolar Intermediate    29 
  F.  Studies in Stereochemistry     32 
 III.  Computational Investigations      37   
 IV.  Variations to the Classical Favorskii Rearrangement   44     
 viii 
V.  The Photochemical Version of the Favorskii Rearrangement   46       
Statement of Problem         92 
Results          94 
 I.  Synthetic Methodologies       94 
  A.  pHP GABA Series and 4-Fluorophenacyl GABA  94 
  B.  pHP Glu Series       101 
  C.  Other pHP Caged Amino Acids     102 
  D.  pHP Deoxycholic Acid      104
  E.  pHP Diethyl Phosphonate      106
  F.  pHP F        106     
  G.  5-Acetylsalicylic Acid and Salicylamide GABA Series  107    
  H.  5-Acetylsalicylic Acid Alkanoyl Compounds   113   
  I.  α-alkyl-pHP diaseteromers     114   
  J.  FITC-DOC        116 
 II.  Exploratory Photochemistry      117 
  A.  1H NMR Analysis, pHP GABA Series    119 
  B.  1H NMR Analysis, α-Alkyl-pHP GABA Series   125 
  C.  1H NMR Analysis, pHP Glu Series    128    
  D.  1H NMR Analysis, Other pHP-Caged Amino Acids  130   
  E.  1H NMR Analysis, pHP Deoxycholic Acid   131  
  F.  1H NMR Analysis, pHP Diethyl Phosphonate   133   
  G.  1H NMR Analysis, pHP F      133    
 ix 
  H.  1H NMR Analysis, 5-Acetylsalicylic acid GABA Series  135   
  I.  1H NMR Analysis, 5-Acetylsalicylic Acid Alkanoyls  137 
  J.  1H NMR Analysis, α-Alkyl pHP Diastereomers   140 
  K.  19F NMR Analysis, pHP and 5-Acetylsalicylic Acid GABA’s 142 
 III.  UV-Vis Spectroscopic Studies      145 
  A.  pHP GABA Series and 4-Fluorophenacyl GABA  145 
  B.  pHP Glu Series       153 
  C.  Other pHP-Caged Amino Acids, DOC and Fluoride  154 
  D.  5-Acetylsalicylic Acid GABA Series and Alkanoyls  154 
  E.  α-Alkyl-pHP Diastereomers     156 
 IV.  Fluorescence Spectroscopic Studies     156 
 V.  Time Correlated Single Photon Counting Studies   158 
 VI. Quantitative Photochemical Analysis     159 
  A.  pHP GABA Series at 300 nm     160 
  B.  pHP GABA Series at 350 nm     168 
  C.  pHP Glu Series        169 
  D.  Other pHP-Caged Amino Acids     170 
  E.  pHP DOC and Fluoride      171 
  F.  5-Acetylsalicylic Acid GABA Series and Alkanoyls  171 
  G.  α-Alkyl-pHP Diastereomers     173 
 VII.  Stern-Volmer Quenching Studies     174 
 VIII.  Computational Studies       176 
 x 
  A.  ClogP Calculations      177 
  B.  Energies and Geometries of Triplet Biradicals   179 
  C.  Spin and Charge Density Calculations    181 
 IX.  Laser Flash Photolysis Studies      183 
Discussion          198 
 A.  Synthetic Strategies       198 
 B.  General Photochemistry       201 
 C.  Preliminary Mechanistic Studies      203 
 D.  Substituent Effects on the Photo-Favorskii Rearrangement  209 
 E.  Miscellaneous Substituent Effects on pHP GABA Photochemistry 216 
 F.  Substituent Effects on 5-acetylsalicylic acid GABA derivatives  221 
 G.  Nucleofuge Effects on the Photo-Favorskii Rearrangement  221 
 H.  Nucleofuge Effects - Linear Free Energy Relationships   223 
 I.  Media Effects on the Photo-Favorskii Rearrangement   226 
 J.  Salt and Ionic Strength Effects      231 
 K.  Rationalized Mechanism of the Photo-Favorskii Rearrangement 240 
 L.  Biological Studies        244 
 M.  Future Studies        248 
Conclusion          251 
Experimental           255 
 
 
 
 xi 
List of Figures 
 
Figure 1.  Diphenylcyclohexanones examined in the Favorskii reaction.  6 
Figure 2.  A potential energy illustration of the semibenzilic rearrangement  
                 process, revealing relative energies (in kcal/mol) of stationary points  
                 on the reactive surface that were calculated at the HF/6-31G* level.   40 
 
Figure 3.  A potential energy surface diagram of the cyclopropanone 
                  rearrangement mechanism, revealing relative energies  
                 (in kcal/mol) of stationary points on the reactive surface  
                  that were calculated at the HF/6-31G* level.    43 
 
Figure 4.  Left:  Time dependent decay profile of pHP diethyl phosphate  
                          (3114) band ~1600 cm-1 with ns 3TR.  Right: Time dependent  
                 decay profile of 3114 band ~1600 cm-1 with ns 3TR.   70 
 
Figure 5.  Time dependent decay profile of 3110 at ~1600 cm-1 in  
                 ns-3TR spectra.  Circles indicate degassed, triangles open air,  
                 and squares oxygen.         72 
 
Figure 6.  Left:  1) Bottom - psTR3 spectrum of 115 in water.   
                 2) Top - psTR3 spectrum of 115 in water.   
                 Right:  1) Bottom - psTR3 spectrum of 115 in buffer, pH = 9.00.   
                 2) Top - psTR3 spectrum of 115 in buffer, pH = 9.00.   75 
 
Figure 7.  DFT determined, optimized geometry and bond distances (Ǻ)  
                 of 3115 in water.        77 
 
Figure 8.  Stern Volmer  analysis of  3114 lifetimes as a function  
                 of water concentration, in percentage.       81 
 
Figure 9.  Phillips’ proposed structure of unknown, M, as a solvation/contact 
                 ion pair complex.        84 
 
Figure 10.  Step-scan FTIR of 121 in CD3CN (2% D2O) at 50 ns (red) and  
                   1µs (blue) delay.        89 
 
Figure 11.  Plot of kobs of 3114 vs. mole fraction of deuterium in degassed,  
                   10% aq. CH3CN at 25oC.       90 
 
 xii 
Figure 12.  Novel pHP GABA esters.      94 
Figure 13.  α-methyl and ethyl-pHP GABA enantiomers, (R,S)-140 and  
                   (R,S)-141 respectively.       99 
 
Figure 14.  pHP Glu derivatives, 143-145.      101 
Figure 15.  Other pHP caged amino acids, 146-149.     103 
Figure 16.  5-acetylsalicylic acid and salicylate GABA derivatives,  
                  153, 154, 157-165.       108 
 
Figure 17.  5-acetylsalicylate GABA compounds where the standard 
                   Pd/C protocol for debenzylation wasn’t effective.   112 
 
Figure 18.  Two 5-acetylsalicylic acid alkanoyl derivatives (155 and 156).  113 
Figure 19.  1H NMR spectrum of m-OCF3-pHP GABA (131) in D2O.  120 
Figure 20.  1H NMR spectrum after 2 h photolysis of (131) in D2O.  121 
Figure 21.  Spiking experiment with p-hydroxy-m-trifluoromethoxybenzyl 
                   alcohol (1312).        122 
 
Figure 22.  Pre-photolysis 1H NMR spectrum of m-OCH3-pHP GABA,  
                   (134), in D2O.        123 
 
Figure 23.  1H NMR spectrum of the photolysis mixture of 134 at 300 nm  
                    in D2O.         125 
 
Figure 24.  1H NMR spectrum of α-methyl-pHP GABA enantiomers  
                   (R,S)-140 in D2O prior to irradiation.     126 
 
Figure 25.  1H NMR spectrum of the product mixture after 1 h irradiation 
                   of (R,S-140) at 300 nm, in D2O.      127 
 
Figure 26.  1H NMR spectrum of photolysis mixture with added 
                   2-(4-hydroxyphenyl)propanoic acid.       128 
 
Figure 27.  Pre photolysis 1H NMR spectrum of m-CF3-pHP Glu (145) in  
                   1:1 D2O: CD3OD.         129 
 
 
 
 xiii 
Figure 28.  1H NMR analysis of products from photolysis of  
                    m-CF3-pHP Glu (145) at 300 nm in 1:1 CD3OD:D2O.   130 
 
Figure 29.  1H NMR spectrum of 150 in 1:9 D2O:CD3OD prior to photolysis. 131 
Figure 30.  1H NMR spectrum of the product mixture after irradiation of 150  
                   for 4 h at 300 nm in 1:9 D2O:CD3OD.     132 
 
Figure 31.  1H NMR analysis of 152 in 1:3 D2O:CD3OD prior to irradiation. 133 
Figure 32.  1H NMR assessment of the product mixture after 1 h photolysis of 
                   152 at 300 nm in 1:3 D2O:CD3OD.     134 
 
Figure 33.  1H NMR spectrum of 153 in D2O prior to photolysis.   135 
Figure 34.  1H NMR analysis of the product mixture from 1 h photolysis  
                   of 153 at 300 nm in D2O.       136 
 
Figure 35.  1H NMR analysis of 156 in d6-DMSO prior to irradiation.  138 
Figure 36.  1H NMR spectrum of the product mixture after irradiation of  
                   156 in 1:9 D2O:CD3OD.       139 
 
Figure 37.  1H NMR spectrum of a mixture of 166 and 167 in  
                    1:1 D2O:CD3OD.       140 
 
Figure 38.  1H NMR spectrum of the product mixture from irradiation of  
                   166 and 167 at 300 nm in 1:1 CD3OD:D2O.    142 
 
Figure 39.  19F NMR spectrum of 129 in D2O prior to photolysis.   143 
Figure 40.  19F NMR spectrum of the product mixture from photolysis of  
                   129 at 300 nm in D2O.       144 
 
Figure 41.  Comparison of UV-Vis spectra of 123 in water (red) and  
                    pH = 8.2 buffer (pink).        148 
 
Figure 42.  UV-Vis spectroscopic analysis of 1 mM solution of 123 in 
                   unbuffered aqueous solution.      149 
 
Figure 43.  UV-Vis spectroscopic analysis of 5 mM 123 in 0.01 M HEPES, 
                   0.1 M LiClO4, pH = 8.2.        150 
 
 
 xiv 
Figure 44.  UV-Vis probe of the photolysis of 129, predominantly the  
                   conjugate base in water, monitored at 3 minute intervals.  152 
 
Figure 45.  Fluorescence spectrum of 130 in 0.01 M HEPES, 0.1 M LiClO4 
                   pH = 8.2, λex = 325 nm.       157 
 
Figure 46.  TCSPC decay profile for m-CF3-pHP GABA (130) in 0.1 M LiOH. 159 
Figure 47.  Stern-Volmer relationship from the photolysis of 124 in  
                   water with potassium sorbate as the quencher, Q.    175 
  
Figure 48.  Out of plane orientation of the carbonyl constituent of  
                    tetraF 117 relative to the aryl plane.     181 
 
Figure 49.  Predicted radical positions for the tetraF 117, from MP2  
                   calculations at the B3LYP level using the 6-31G* basis set.  183 
 
Figure 50.  Three dimensional, time resolved absorption contour of 122  
                    in aqueous CH3CN.       185 
 
Figure 51.  Three dimensional triplet decay contour of 122 in aq. CH3CN.  186 
Figure 52.  Cross section of the three dimensional, time resolved absorption 
                   contour of 122 in aqueous CH3CN.       187 
 
Figure 53.  Three dimensional, time resolved triplet decay contour of 101  
                    in aqueous CH3CN.       188 
 
Figure 54.  Triplet decay profile of 101 at 400 nm in aqueous CH3CN.  189 
Figure 55.  Triplet decay profile of 101 at 500 nm in aqueous CH3CN.  189 
Figure 56.  Three dimensional, time resolved triplet decay contour of 128 
                    in aqueous CH3CN.       190 
 
Figure 57.  A cross section of the three dimensional absorption contour of  
                   128 in aqueous CH3CN.       191 
 
Figure 58.  Triplet decay plot for 128 in aqueous CH3CN.    192 
Figure 59.  Cross section of the three dimensional absorption profile of  
                    153 in water.        193 
 
Figure 60.  Triplet decay profile for 153 in water.     194 
 xv 
Figure 61.  Cross section of the three dimensional absorption contour  
                   of 154 in aqueous CH3CN.      195 
 
Figure 62.  Cross section of the three dimensional absorption profile of  
                   154 in aqueous CH3CN.       196 
 
Figure 63.  Triplet decay profile of 154 at 416 nm in aqueous CH3CN.  197 
Figure 64.  Photoproducts of 134 a) m,m’-diOCH3-115,  
                   b) m,m’-diOCH3-α-OH-115 and 133 c) m-OCH3-115,  
                   d) m-OCH3-α-OH-115.       207 
 
Figure 65.  Plot of pKa of fluoro pHP GABA’s vs. Φdis in water  
                   (blue diamonds) and buffer pH 7.3 (pink squares).     211 
 
Figure 66.  A. Plot of rate constants for release, kr, of pHP GABA’s  
                   vs. pKa’s in water.  B.  Plot of rate constants for  
                   release, kr, of pHP GABA’s vs. pKa’s in pH 7.3 buffer.   213 
 
Figure 67.  Proposed H-bonding between the o-OH and  
                   ketone carbonyl of 135.       217 
 
Figure 68.  H-bonding between meta and para-OH moieties of 136.  218 
Figure 69.  Lowest energy conformations of decaged 139 and 115 by  
                    low level MM2 calculations.         219 
 
Figure 70.  A plot of rates of disappearance, (Φdis/3τ) vs. the pKa  
                   of pHP esters, establishing a Brønsted linear free energy relationship. 226 
 
Figure 71.  Titration curves obtained from 1H NMR analysis  
                   depicting the dependence of quantum yields for acetate  
                   appearance, Φapp (Φp in plot) on pH for photolysis of  
                   pHP acetate 114 in 1:1 CH3CN (circles).    228 
 
Figure 72.  Observed enhancements of kobsd of trifluoroacetolysis of 172 
                  (R = CH3) as a function of [LiClO4].          234 
 
Figure 73.  Plot of Φdis vs. [LiClO4] for pHP GABA (101).    235 
Figure 74.  Plot of Φdis vs. [LiClO4] for o-F-pHP GABA (123).   236 
Figure 75.  Plot of Φdis vs. [LiClO4] for 2,5-diF-pHP GABA (125).  237 
 xvi 
Figure 76.  Plot of Φdis vs. [Mg(ClO4)2] for 2,3-diF-pHP GABA (124).  238 
Figure 77.  Proposed coordination between Mg2+ and  
                   2,3-diF-pHP GABA (124).      239 
 
Figure 78.  Amplified current as a function of photoreleased GABA  
                   from m-OCF3-pHP GABA (131).      244 
 
Figure 79.  Population data of peak currents normalized to the  
                   maximum peak response and fitted to Hill’s equation to  
                   derive EC50 values for 130, 131, and 134.    245 
 
Figure 80.  Membrane currents elicited from photolysis of 131 are  
                   completely obstructed by Garbazine, indicating origin  
                   activation as the GABAA receptor.     246 
 
Figure 81.  Reverse potential educed from the photolysis of 131.   246 
Figure 82.  Probing the effect of 131 on the holding currents or 
                    membrane input resistance.      247 
 
     
 
 
 
 
 
 
 
 
 
 
 
 xvii 
List of Schemes 
 
Scheme 1.  Richard’s asserted mechanism of the Favorskii rearrangement.  3 
Scheme 2.  McPhee’s mechanism of the Favorskii reaction.    3 
Scheme 3.  Loftfield’s mechanism of the Favorskii rearrangement.   4 
Scheme 4.  Dewar’s proposed mechanism of the Favorskii reaction.  5 
Scheme 5.  The reaction of 2-bromo-4,4’-diphenylcyclohexanone (25) with  
                   CH3O- to corresponding intermediates.     7 
 
Scheme 6.  Disparate reaction pathways for α-chlorobenzyl methyl 
                   ketone derivatives in CH3O-/CH3OH.     12 
 
Scheme 7.  A depiction of the Ramberg-Backland reaction.    17 
Scheme 8.  Delocalized (sp2) vs. localized (sp3) electron models.   18 
Scheme 9.  Anchimeric π assistance in establishing a cyclopropanone  
                   intermediate.        19 
 
Scheme 10.  Rates of bromide release from anionic α-bromo substrates.  20 
Scheme 11.  Reactions of α-chloro analogs in CH3O-/CH3OH.                                21 
 
Scheme 12.  Discrete mechanistic pathways for α-chlorobenzylpropiophenone  
                     (51) to the rearranged ester (44) and α-methoxyketone (45).  24 
 
Scheme 13.  Reaction courses of isomers 53 and 43 to rearranged 44  
                     and α-methoxy ketone (45).      26 
 
Scheme 14.  Reactions of alkyl substituted α-chloro ketones with CH3O-.  27 
Scheme 15.  Product distributions from the reaction of α-chloro ketones  
                     with low concentrations of CH3O-.     29 
 
Scheme 16.  Proposed mechanism for the reaction of α-chloroketone,  
                     (56) with low [CH3O-] to form the methyl ester (59).   30 
 
 xviii 
Scheme 17.  Suggested dipolar (oxyallyl) mechanism to indanone (61).   31 
Scheme 18.  Stork-Borowitz proposal for stereochemical inversion  
                     of precursors to Favorskii products.     32 
 
Scheme 19.  Reactions of α-bromo ketones (63) and cis/trans  
                     diastereomers (66) with CH3O- in CH3OH.    33 
 
Scheme 20.  Bordwell’s suggested reaction pathways of 63 to diastereomers 
                     (64 and 65) in CH3O-, directed by the oxyallyl intermediate (69).   35 
 
Scheme 21.  The proposed semibenzilic mechanism of conversion 
                     of α-chlorocyclobutanone to cyclopropane carboxylic acid  
                     through calculated stationary points.     38 
 
Scheme 22.  The Favorskii rearrangement mechanism of  
                     α-chlorocyclobutanone to cyclopropane carboxylic acid  
                     through calculated stationary points.       41 
 
Scheme 23.  Proposed mechanism of the homo-Favorskii reaction.   45 
Scheme 24.  Posited mechanism to account for the formation of  
                     chlorobenzene from α-chloroacetophenone derivatives.    49 
  
Scheme 25.  Posited mechanism of benzoic acid release from 
                     the p-methoxyacetophenone chromophore.    51 
 
Scheme 26.  Product compositions from photolysis of  
                     corresponding α-chloroketones.     53 
 
Scheme 27.  Results from photolysis of pHP ATP and pHP  
                     diethyl phosphate in aqueous media.     57 
 
Scheme 28.  Proposed mechanism for phosphate release from the  
                     pHP chromophore.       58 
 
Scheme 29.  Radical pair mechanism for the formation of  
                    dibenzyl (107) from phenacyl caged phenylacetic acid.   61 
 
Scheme 30.  Hydrogen atom transfer mechanism for substrate release.  62 
 
Scheme 31.  Singlet excited state proton transfer mechanism for acetate release. 64 
 xix 
Scheme 32.  Concerted mechanism for acetate release from pHP.   66 
Scheme 33.  Proposed thermodynamic cycle of p-hydroxyacetophenone (115).   68 
Scheme 34.  Phillips proposed mechanism for excited state  
                     processes of p-hydroxyacetophenone (115).    78 
 
Scheme 35.  Proposed intermediate precursor to rearranged product.  83 
 
Scheme 36.  Posited mechanism for phosphate release from the pHP  
                     chromophore.        86 
 
Scheme 37.  Proposed mechanism for diethyl phosphate release from pHP. 87 
 
Scheme 38.  The synthesis of m-F-pHP GABA (122).    96     
Scheme 39.  Synthesis of the o-OH derivative of pHP GABA (135).  98  
Scheme 40.  Synthesis of α-methyl-pHP-GABA enantiomers ((R,S)-140).  100 
Scheme 41.  Synthesis of 4-fluorophenacyl GABA (142).    101 
Scheme 42.  Synthesis of m-F-pHP Glu (144).     102 
Scheme 43.  Synthesis of pHP Gly (146).      104 
Scheme 44.  Synthesis of pHP DOC (150).      105 
Scheme 45.  Synthesis of pHP diethyl phosphonate (151).    106 
Scheme 46.  Synthesis of pHP F (152).      107 
Scheme 47.  Synthesis of 5-acetylsalicylic acid GABA (153).   109 
Scheme 48.  5-acetyl salicylamide benzophenone GABA (157).   110 
Scheme 49.  Synthesis of 5-acetylsalicylic acid dodecanoate (155).   114 
Scheme 50.  Synthesis of α-methyl-pHP diaseteromers (166 and 167).  115 
Scheme 51.  Synthesis of FITC-DOC (168).      117 
Scheme 52.  Preliminary mechanism of the photo-Favorskii rearrangement,  
                     with 153         205 
 xx 
Scheme 53.  Modified version of Yousef’s discrete mechanistic pathways 
                     to m,m’-diOCH3-115 and m,m’-diOCH3-α-OH-115.   208 
 
Scheme 54.  Proposed mechanism of GABA photorelease from the  
                     conjugate base of 101.         215 
 
Scheme 55.  Winstein’s ion-pair, solvolysis mechanism with added LiClO4. 232 
Scheme 56.  Proposed photo-Favorskii mechanism for protonated  
                     pHP GABA esters          242 
 
Scheme 57.  Proposed photo-Favorskii mechanism for the conjugate base 
                    of pHP GABA esters.       243 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xxi 
List of Tables 
 
Table 1.  Summary of rates of halide release, k; isotope exchange ratios,  
                kH/kD, and rate comparisons, kBr/kCl for reactions of 23-26 under  
                Favorskii conditions.         7 
 
Table 2.  Summary of hydrogen-deuterium exchange with 24, 26, and the 
                rearranged Favorskii esters over one half life (~3 h) at 0oC with  
                0.05 M CH3O-.        9 
 
Table 3.  Results of the reactions of 28 at various [CH3O-] and [LiClO4]  
                in CH3OH at various temperatures.       12 
 
Table 4.  Effect of water composition on the reaction rate, k2, of  
                PhCH2COCH2Cl (40) in 0.05 M CH3O-/CH3OH at 0oC.   14 
 
Table 5.  Summary of observed and Favorskii rate constants and product  
                yields in CH3O-/CH3OH at 0o for substituted 28 as a function of  
                substituent.         15 
 
Table 6.  Results from the reaction of 40, 43, and 46 in varying [CH3O-]  
                in CH3OH at 0oC.        22 
 
Table 7.  Summary of product yields and rates of reaction for 46, 49  
                and 53 as a function of CH3O- in CH3OH.     28 
 
Table 8.  Results of reactions of 63 and 66 with various [CH3O-] in  
                CH3OH at 00C.          33 
 
Table 9.  Relative energies (kcal/mol) of stationary points associated with  
                the semibenzilic rearrangement mechanism, in the gas and aqueous 
                phases, as determined by various computational methods.  39 
 
Table 10.  Relative energies (kcal/mol) of stationary points associated 
                  with the cyclopropanone rearrangement mechanism, in the gas  
                  and aqueous phases, as determined by the connoted computational 
                  methods.         42 
 
Table 11.  Substituent effects on the photoproduct distributions from photolysis 
                  of substituted α-chloroacetophenones in ethanol, irradiated at 300 nm 
      for 1-2 h.           50 
 xxii 
Table 12.  Photoproduct % compositions from photolysis of 3% solutions 
                 of 82 a-d in degassed CH3OH.      52 
 
Table 13.  Time constants for triplet decays of 116, 114, and 110  
                   in mixed CH3CN/H2O solvents and corresponding pKa’s of  
                   the nucleofuge.        80 
 
Table 14.  Rate constants, kobs, for decay of triplet pHP acetate (3114) as a  
                  function of the D/H mole fraction, n, using ns-LFP in 10% aq.  
                  CH3CN at 25oC.        89 
 
Table 15.  UV-Vis properties of 122-142 with corresponding pKa values.  146 
Table 16.  Times for 100% conversion to photoproducts of 1 mM  
                  concentrations of 122-141 in water.     151 
 
Table 17.  UV-Vis parameters and estimated times for 100% conversion to 
                  photoproducts from irradiation at 300 nm and associated pKa’s  
                  for 143-145.        153 
 
Table 18.  UV-Vis parameters and 100% conversion times for 146-152,  
                  from irradiation at 300 nm.        154 
 
Table 19.  UV-Vis parameters, 100% conversion times from irradiation 
                  at 300 nm, and % conversion after 24 h from irradiation at  
                  350 nm for 153-165.        155 
 
Table 20.  Fluorescence of 122-131 in 0.01 M HEPES,  
                  0.1 M LiClO4 at pH  8.2.       157 
 
Table 21.  TCSPC derived fluorescence decay profiles of 101, 122-131 in  
                  aq. 0.1 M LiOH.        158 
 
Table 22.  Quantum yields for 122-141 and the unsubstituted parent (101)  
                  in water and 0.01 M ammonium acetate buffer, pH 5.0 to 9.0  161 
 
Table 23.  Quantum yields for 122-141 and the unsubstituted parent (101)  
                  from photolysis in buffers pH 7.0 to 9.0, with and without  
                  adjusted ionic strengths       163 
 
Table 24.  Quantum yields for 122-131, 133-134 and the unsubstituted parent  
                  (101) from photolysis in organic media and degassed aq. solution  
                  adjusted ionic strengths.       165 
 xxiii 
Table 25.  Quantum yields for 122-141 and the unsubstituted parent (101)  
                  from photolysis in water with  adjusted ionic strengths from  
                  0.008 to 1.0 M LiClO4.       167 
 
Table 26.  Quantum yields for 122-124 and the unsubstituted parent (101)  
                  from photolysis in water with adjusted ionic strengths and added  
                  GABA at 300 nm.        168 
 
Table 27.  Quantum yields for 122-131 in 0.01 M TRIS, 0.1 M LiClO4 at 
                  pH 9.0 at 350 nm.        169 
 
Table 28.  Quantum yields of 143-145 and unsubstituted parent (102) from  
                  photolysis in water, pH 7.0, pH 7.3 and pH 8.2 buffers at 300 nm. 170 
 
Table 29.  Quantum yields of 146-149 in water, pH 7.3 buffer, and water  
                  with adjusted ionic strengths.      171 
 
Table 30.  Φdis of 153 in various media from photolysis at 300 nm.   172 
Table 31.  The values for Φdis and Φapp of 154 from photolyses at 300 nm  
                  in a variety of media.        172 
 
Table 32.  Φdis and Φapp for 157-165 in 3:1 H2O:CH3OH at 300 nm.  173 
 
Table 33.  Parameters derived from Stern-Volmer quenching analysis for  
                  122-131, 137-139, and 153 in water and 0.01 M HEPES,  
                  0.1 M LiClO4 at pH = 7.3.      176 
 
Table 34.  ClogP values for GABA derivatives (unsubstituted parent (101),  
                  122-131, 133-134), Glu derivatives (unsubstituted parent (102)  
                  and 143-145) and the conjugate bases of 122-131.      178 
 
Table 35.  The out of plane (OOP) contortion angles and relative energies  
                  of the oxyallyl-phenoxy triplet biradicals (117) of 122-131.  180 
 
Table 36.  Calculated spin and charge densities for tetraF 117.   182 
Table 37.  Pump probe spectroscopy results from 101, 122, 125, 128-131,  
                  and 153 in water and mixed media.     184 
 
Table 38.  Parameters of 168-171 and other pHP derivatives.   225 
 
 xxiv 
List of Equations 
 
Equation 1          1 
Equation 2          2 
Equation 3          36 
Equation 4          45 
Equation 5          47 
Equation 6          47 
Equation 7          48 
Equation 8          50 
Equation 9          52 
Equation 10          56 
Equation 11          59 
Equation 12          60 
Equation 13          83 
Equation 14          84 
Equation 15          90 
Equation 16          219 
Equation 17          224 
Equation 18          233 
                      
           
            
            
 xxv 
Glossary of Chemical Compounds Studied 
 
OH
O
O
O
+
H3N
-
O
O
CF3
OH
O
O
O
+
H3N
-O
O
CF3
OH
O
O
O
+H3N
-
O
O
CF3
F
F
OH
O
O
O
+
H3N
-O
O
CF3
OH
O
O
O
+
H3N
-O
O
CF3
OH
O
O
O
+H3N
-
O
O
CF3
F
F
F
F
F F
OH
O
O
O
+H3N
-
O
O
CF3
OH
O
O
O
+H3N
-
O
O
CF3
OH
O
O
O
+
H3N
-O
O
CF3
F F
F
F
F
F
F
F
F
OH
O
O
O
+H3N
-
O
O
CF3
OH
O
O
O
+H3N
-
O
O
CF3
OH
O
O
O
+
H3N
-O
O
CF3
CF3
O CF3
NO 2
OH
O
O
O
+
H3N
-O
O
CF3
OH
O
O
O
+
H3N
-O
O
CF3
OH
O
O
O
+H3N
-
O
O
CF3
OCH3H3CO OCH3
O H
pHP GABA (101) m -F-pHP GABA (122) o-F -pHP GABA (123)
2,3- diF-pHP GABA ( 124) 2,5- diF-pHP GABA ( 125)
3,5- diF-pHP GABA ( 126)
2,6-diF-pHP GABA (127)
2,3,6-tr iF-pHP GABA ( 128) 2,3,5,6-t et raF-pHP GABA (129)
m -CF3-pHP GABA ( 130)
m -OCF3-pHP GABA (131)
m -NO2-pHP GABA ( 132)
m ,m '-diOCH3-pHP GABA ( 133) m
- OCH3-pHP G ABA (134)
o-OH-pHP G ABA (135)
 
 xxvi 
OH
O
O
O
+
H3N
-O
O
CF3
m -OH-pHP GABA (136)
O H
OH
O
O
O
+
H3N
-O
O
CF3
m -CH3-pHP GABA (137)
OH
O
O
O
+
H3N
-
O
O
CF3
m,m'-d iCH3-pHP GABA ( 138)
OH
O
O
O
+
H3N
-
O
O
CF3
o -CH3-pHP G ABA (139)
OH
O
O
O
+
H3N
-
O
O
CF3
(R ,S) -!-methyl-pHP GABA ( 140)
F
O
O
O
+
H3N
-
O
O
CF3
4-f luorop henacyl GABA (142)
OH
O
O
O
+
H3N
-O
O
CF3
(R ,S )-!- et hyl-pHP G ABA (141)
OH
O
O
O
+
H3N
o-F- pHP Glu (143)
F
O OH
CF3CO2
-
OH
O
O
O
+
H3N
m-F- pHP Glu (144)
O O H
CF3CO2
-
F
OH
O
O
O
+
H3N
m-CF3-pHP G lu (145)
O O H
CF3CO2
-
CF3
OH
O
O
O
+
H3N
pHP Gly (146)
CF3CO2
-
O H
O
O
O
+H3N
pHP Val (147)
CF3CO2
-
 
 
 
 xxvii 
CF3CO 2
-
OH
O
O
O
+
H3N
pHP Trp (148)
HN
CF3CO2
-
OH
O
O
O
+H3N
pHP Phe (149)
OH
O
pHP DOC ( 150)
HO H
HO
O
O
H
H
H
OH
O
F
pHP F (151)
OH
O
P
p HP diethyl phosphonate ( 152)
O
O
O
OH
O
O
5-acetylsalicylic acid GABA (153)
OH
O
O
+
H3N
CF3CO2
-
OH
O
O
methyl-5-acetylsalicylic acid GABA (154)
O
O
O
+H3N
CF3CO2
-
OH
O
O
5-acetylsalicylic acid do decanoate (155)
HO
O
C11H23
O
OH
O
O
5-acetylsalicylic acid tetradecan oat e (156)
HO
O
C13H27
O
OH
O
O
N
H
O
O
+
H3N
CF3CO2
-
O
157  
 
 xxviii 
OH
O
O
O
O
O
+
H3N
CF
3
CO
2
-
158
F
F
O H
O
O
O
O
O
+
H3N
CF
3
CO
2
-
159
F
3
C
O H
O
O
O
O
O
+H
3
N
CF3CO2
-
160
F
O H
O
O
O
O
O
+H
3
N
CF3CO2
-
161
NO2
O H
O
O
O
O
O
+
H3N
CF
3
CO
2
-
162
NO2
OH
O
O
O
O
O
+H
3
N
CF3CO2
-
163
CF3
CF
3
OH
O
O
O
O
O
+
H3N
CF
3
CO
2
-
164
N OH
O
O
O
O
O
+
H3N
CF
3
CO
2
-
165  
 xxix 
OH
O
O
O
O
O
OH
O
O
O
O
O
(R,R)-166 (R,S)-167
OO
OH
O
OH
H
N
S
H
N
N
H
HO
H
OH
O
H
HH
FITC-DOC (168)  
 
 
 
  1 
Introduction 
 
 
 The Favorskii1 reaction or rearrangement, though discovered over a century 
ago, continues to be widely exploited by synthetic chemists in the manipulation and 
assembly of organic molecules, such as Tricycloclavulone2 and Kelsoene.3 This 
assertion is buttressed by the manifestation of 832 references in a SciFinder Scholar® 
search.4 The “classical” Favorskii rearrangement involves base-mediated 
rearrangement of ketones bearing α-substituents with favorable nucleofuge attributes, 
to produce carboxylic acids, esters, or amides (Equation 1, with KOH as the base).  In 
equation 1, the rearrangement leads to a ring contraction and conversion of the ketone 
to a carboxylic acid. Further designations can be made depending on whether α-
hydrogens exist to the carbonyl moiety (these will be elaborated later). 
 
  
         Eq. 1 
 
I.  Early investigations into the mechanism of Favorskii rearrangement. 
  Efforts to generate a “working” mechanism to explain classical Favorskii 
rearrangement have been pervasive5 and continuous,6 and have centered on four 
discrete pathways:7 a) Aston’s proposition8 (Equation 2) related a nucleophilic 
  2 
approach by alkoxide (RO-) to the carbonyl moiety (2), followed by nucleofuge 
(bromide) disjunction to generate an epoxyether (3). Rearrangement through methyl 
migration proceeded to the Favorskii product (4). An independent study by Stevens 
and coworkers,9 however, using a related set of reaction conditions, failed to find the 
anticipated ester products. 
 
 
        Eq. 2 
 
From this and accompanying studies,10 the transposition of epoxyether 
intermediates to acids/esters (Aston’s postulate) has been judged as unsuitable for 
Favorskii-type rearrangements.  b) A second hypothesis11 (Scheme 1) accentuated the 
formation of a ketene (7), initiated by base induced α-proton abstraction, then abrupt 
halide departure to form carbene (6), with a supervening “Wolff” rearrangement to 
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the ketene. Once formed, the ketene was promptly attacked by the nucleophilic 
alkoxide to produce the Favorskii ester (8). Several related studies evinced the direct 
formation 
 
Scheme 1. Richard’s asserted mechanism of the Favorskii rearrangement. 
 
 
of trialkyl acids and esters from ketones,7 which would directly oppugn a ketene 
precursor.  c) A third proposal suggested an initial unimolecular disjunction of the 
 
Scheme 2. McPhee’s mechanism of the Favorskii reaction. 
 
 
nucleofuge to afford an α-ketocarbenium ion (10), followed by tautomerizations 11 
and 12, acylium formation from alkyl migration (13) and then rearrangement to the 
acid/ester12 (14) (Scheme 2).  In this mechanism, there appeared to be a marginal role 
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for the base, which, in subsequent studies, was shown to be indispensible for the 
generation of Favorskii products.  d) The most widely accepted mechanism was first 
proposed by Loftfield13 and advanced by several researchers.14,15,16,17 The reaction 
sequence has been suggested as stepwise,13,18,14 involving base induced 
deprotonation19,14 at the α position to the carbonyl to form an enolate (16) followed 
by intramolecular displacement and cyclization via halide disjunction to educe a 
cyclopropanone intermediate (17) then nucleophilic attack at the carbonyl to induce 
the signature 1,2-rearrangement product in the furnishing of Favorskii ester (18)  
 
Scheme 3. Loftfield’s mechanism of the Favorskii rearrangement. 
 
     
(Scheme 3).  Loftfield demonstrated that the preponderance of products derived only 
from epoxyether intermediates were generated from the α-Cl precursor and posited 
the rate determining step (RDS) for these analogs as the reversible, initial 
deprotonation.  Dewar,20 through computational efforts, averred that a disfavored 
overlap between the newly formed enolate 20 (Scheme 4) and chloro-bearing carbon 
would preclude cyclization by an SN2 process and proposed a dipolar, planar oxyallyl 
ion 21 formed by chloride departure, followed by rearrangement to the Favorskii ester 
  5 
22. This intermediate would be amenable to the formation of α-methoxyketone 
derivatives, which are common by-products in Favorskii rearrangements. 
  
Scheme 4. Dewar’s proposed mechanism of the Favorskii reaction. 
 
A dipolar ion (i.e., a zwitterion) was suggested as a prominent Favorskii 
intermediate in subsequent studies by Bordwell (vide infra).29At this time, both 
cyclopropanone and oxyallyl intermediates are considered to be practicable 
intermediates in the course to Favorskii products21 as neither has been precluded 
empirically. 
 
II. Bordwell’s contribution to evidence for the Favorskii rearrangement. 
 A luminary in the study of the Favorskii rearrangement was Bordwell22, who, 
in a series of 11 reports, communicated the results of his all-encompassing efforts 
towards an improved comprehension of the mechanism: (1) rate parameters (rate 
determining steps, accelerating/decelerating factors),14,23,24  (2) substituents 
(structure/reactivity correlations),25,26 (3) neighboring groups (anchimeric 
assistance),27 (4) nucleofuges,23 (5) temperature,23 (6) base concentration and ionic 
strength,23 (7) intermediates,28,29 (8) competing mechanisms (by-products),25,27 and 
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(9) stereochemistry,30 among several others.  A conspectus of some noteworthy 
findings from his research concerning the Favorskii rearrangement is presented.   
A.  Rate, Isotope and Nucleofuge studies.   His seminal publication14 scrutinized 
earlier findings by Loftfield13 concerning the disparate product distributions obtained 
with α-Br vs. α-Cl ketone precursors.   In his studies, Bordwell evaluated isotope and 
leaving group effects on rates of halogen ion release for protonated and deuterium 
labeled 2-chloro and 2-bromo-4,4-diphenylcyclohexanones (23-26) (Figure 1) in 
sodium methoxide/methanol at 00C, common conditions for the Favorskii 
rearrangement. 
 
Figure 1. Diphenylcyclohexanones examined in the Favorskii reaction. 
 
 
In choosing di-substitution at the 4 position, he reasoned that the axial 
orientation of the diphenyl groups would encumber the preferred axial position of the 
halogen that promotes the formation of epoxyether intermediates (precursors for side 
reactions) and thus optimize conditions for monitoring any of the aforementioned 
effects.  The series of steps involved in these reactions of interest for 25 are depicted 
in Scheme 5 with associated steady state expressions.  
  7 
Scheme 5. The reaction of 2-bromo-4,4’-diphenylcyclohexanone, 25, with CH3O- to 
corresponding intermediates.  The rates for each step are provided, along with an 
overall rate expression. 
 
 
 
Preliminary results from these studies are summarized in Table 1.  The lack of 
a 10 kinetic isotope effect (KIE) and a considerable rate enhancement with Br- over 
Cl- as the nucleofuge were evident and from these observations, it was asserted that 
the enolate formation for 25 was formed reversibly and chloride departure was rate 
determining.   
 
Table 1.  Summary of rates of halide release, k; isotope exchange ratios, kH/kD, and 
rate comparisons, kBr/kCl for reactions of 23-26 under Favorskii conditions.  Table 
adapted from ref. 14. 
 
Substrate 
k (104 M-1s-
1) kH/kD kBr/kCl 
        
α-chlorocyclohexanone 40     
        
23 0.61     
    
1.05 
(23/24)   
24 0.58    
        
25 71   
 116 
(25/23) 
    4.1   
26 17     
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The near unity (kH/kD = 1.05) for 23 suggested a rapid, possibly reversible 
deprotonation prior to the rate determining C-Cl ionization.  The relatively low KIE 
(kH/kD = 4.1) for 25, typically 13 for acetone in hydroxide at 0o C,31 indicated the high 
probability of partial deuterium exchange prior to Br- departure, but was insignificant 
when compared to the prodigious leaving group effect (kBr/kCl = 116) in contribution 
to the rate determining step, which, from this data, was posited to be proton 
abstraction for 25.  The rationalization for differences in the RDS of 23 and 25 reside 
in the relative barriers to the formation of the Favorskii intermediate, for each are 
expected to be similar, but that a “nucleofuge effect” preponderates; Br- is a much 
better nucleofuge than Cl-.    
To corroborate this proposal, assays to establish the extent of H-D exchange 
with 24 and 26 and the Favorskii rearrangement product (Table 2) were conducted by 
1H NMR and mass spectrometry (MS) prior to and at one half-life, t1/2 ~ 3h, of the 
disappearance of reactant.  It must be noted that the samples of 24 and 26 were not 
replete with deuterium (<3 D atoms/molecule on average); the rigors of synthesis and 
prolonged processing times, i.e., isolation and purifying stages, precluded the 
production of 100% d3 for either target.  The larger amount of deuterons for 26 vs. 24 
was attributed to truncated processing times; there appears to be a connection 
between the degree of deuterium insertion and processing time length.  In addition, 
some of the deuterium loss of 26 at t1/2 was ascribed to processing.  
Notably fast H-D exchange occurred during the reaction with 24, evidenced 
by complete loss of deuterium in MS analysis, which revealed that nearly 96% of 24  
  9 
Table 2.  Summary of hydrogen-deuterium exchange with 24, 26, and the rearranged 
Favorskii esters over one half life (~3 h) at 0oC with 0.05 M CH3O-.  Table adapted 
from ref. 14. 
 
Substrate Material Analyzed Deuterons
a
 NMRb  Mass Spec.c 
          
24 24 ~2 1.8 do  3.2 
    d1  24.7 
    d2  60.5 
    d3  11.6 
24 24 (recovered at t1/2c) 0 0.3 do  96.7 
    d1  3.3 
24 Rearranged Ester 0 0.05 do  94.6 
    d1  5.4 
26 26 ~2.8 2.28 do   0.7 
    d1  10.9 
    d2   47.6 
    d3   40.8 
26 26 (recovered at t1/2) 1.5 1.68 do   8.0 
    d1   33.1 
    d2   49.5 
    d3   9.4 
26 Rearranged Ester 0.7 0.78 do  22.2 
    d1  77.1 
    d2   0.7 
aDeuterium atoms per molecule.  bThe number of deuterium atoms determined by 1H 
NMR. cDetermined by mass spectrometry.  
 
and 95% of the rearranged ester contained no deuterons at t1/2.  These observations 
adduce a rapid pre-equilibrium with 24/23, where k-1>>>k2 (Scheme 5) and thus α-
proton abstraction as rate determining. This phenomenon is significantly reduced for 
26 based on considerable deuterium retention at t1/2 (1.5 deuterons from initial 2.8 
deuterons).  Bordwell asserted that some of this deuterium loss was not from the 
reaction but due to; a) processing and b) background H-D exchange that is known to 
occur with α-chloro and α-bromoketones in protic solvents.32 Parallel studies 
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involving the hydrolysis and reesterification of a partially deuterated, rearranged ester 
revealed virtually no H-D exchange. Thus, the presence of only 0.05 deuterons per 
molecule of the rearranged ester corroborates the notion of a swift pre-equilibrium for 
deprotonation and C-Cl ionization as the RDS. 
For 26, based on greater retention of deuterium and, above all, the prodigious 
kBr/kCl~116 (a typical kBr/kCl value for SN2 and SN1 reactions is 5033), it was 
postulated that k2>>k-1 and thus kobs approximated k1.  It should be noted that the 
substantial yield of epoxy ether byproducts from attack of CH3O- at the carbonyl of 
unsubstituted α-bromocyclohexanone, as demonstrated by Loftfield,19can be 
explained by competitive side reactions with large kBr/kCl.34 The results confirm the 
proposed α-deprotonation as the RDS in the Favorskii process for 26; this also 
denotes a change in RDS compared to 24.  The nature of the nucleofuge was 
emphasized as a pertinent factor in determining the outcomes of Favorskii 
rearrangement in these studies.    
Expeditive H-D exchange obviates a concerted process for the α-
chlorocyclohexanones 23 and 24.  Complementary studies involving 23 and 25, 
where a methyl or -C20H36 (cholestan-3-one) had been commuted with one of the 
phenyl moieties, demonstrated dissimilar kBr/kCl ratios (35 for -CH3, 52 for cholestan-
3-one).  If the mechanism was concerted, a relatively constant, sizeable nucleofuge 
influence would be anticipated.  This was inconsistent with the above observations 
and effectively precluded a concerted process for the Favorskii mechanism for 25 and 
26. 
  11 
As Bordwell anticipated, the 4-substituted-2-halocyclohexanones established 
the prevalent formation of rearranged, ring contracted esters.  For 2-
chlorocyclohexanone analogs, the route to these esters was favored whether or not 
there existed ring substituents.  In contrast to this, unsubstituted 2-
bromocyclohexanone exhibited an epoxyether as the primary product, resulting from 
a reaction course through an epoxide intermediate.  It is apparent that the 4,4’ 
moieties effectively prevented the epoxide intermediate from forming, as no 
epoxyethers were reported.  These studies divulged, in addition to the salient 
nucleofuge impact on the RDS, a structural influence that is pronounced for ring 
substitutions of α-bromocyclohexanones and that exert direct control over the 
outcomes of the Favorskii rearrangement. 
 
B.  Substituent Effects, Linear Free Energy Relationships (LFER’s), Salt and 
Media effects, and Further Evidence for a Nucleofuge Effect.   
In a supervening report,23 Bordwell conveyed results from a) temperature studies; b) 
studies involving adjusting base [CH3O-] and ancillary salts [LiClO4] (ionic strength) 
to discern these effects on overall yields and product distributions; c) structure-
reactivity linear free energy relationships, i.e., how meta and para arene substituents 
impact the rates (kobs) of nucleofuge release and Favorskii ester formation; d) an 
expansion on the nucleofuge character of the halogen, i.e., its influence on the 
mechanism and product outcomes. The model systems for these studies were a series 
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of 1-chloro-1-phenylpropan-2-ones (28) in CH3OH at 0oC (Scheme 6). The results 
from these experiments are listed in Table 3. 
  
Scheme 6. Disparate reaction pathways for α-chlorobenzyl methyl ketone derivatives 
in CH3O-/CH3OH. 
 
 
 
 
 
 
Table 3.  Results of the reactions of 28 at various [CH3O-] and [LiClO4] in CH3OH at 
various temperatures.  Table adapted from ref. 23.   
 
[MeO-], M T (o C) Yield of 29 (%) Yield of 32 (%) 
Inverse additiona 0 9 68 
0.05 0 13 81 
1.00 0 17 77 
2.00 0 21 70 
0.05 65 37 51 
2.00 65 61 35 
0.05 (1 M LiClO4) 65 57 17 
0.05 (2 M LiClO4) 65 63 19 
aSlow addition of 10% excess 0.05 M [CH3O-] to a solution of 28. 
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The enhanced yield of 29 at higher temperatures, 13% vs. 37% at 0.05 M, was 
attributed to the calculated 2-3 kcal/mol higher activation energy, ΔG‡, of 29 
compared with hydroxy ketal 32. This was derived from work done by Bordwell that 
found that ΔG‡ for 28, based on rates in 0.05 M NaOCH3/CH3OH between 0o and 
25oC, was 17.2 kcal/mol and manifested 29 as the major product.  ΔG‡ for the α-
methyl derivative of 28 (geminal with -Cl) was calculated to be 19.7 kcal/mol under 
the same conditions with the primary product being 32.  Complementary experiments 
with 29 and 32 in the presence of CH3O- at high temperatures evinced no reactivity.23 
Augmented yields of the Favorskii ester 29 as a function of base concentration were 
shown to be marginal at 0oC but improved at 65oC.  Accompanying these 
observations was an enhancement in the yield of 29, 37% vs. 57%, as a function of 
increased ionic strength from increasing the LiClO4 concentration, i.e., a salt effect.  It 
was theorized that the Favorskii reaction was impacted to a greater degree by ionic 
strength adjustments than the corresponding formation of 32 as evidenced by the 
higher yields of 29.   
A parallel study by Skrobek35 divulged improved yields of the Favorskii ester 
from 1-chlorocyclohexyl methyl ketone in the presence of higher  concentrations of 
CH3O- or LiClO4 and stereochemical differences of trans-1-chloro-2-
methylcyclohexyl methyl ketone arose from changes in [CH3O-] or [LiClO4].  No 
explanations, however, were proffered.  Later studies25 with 0.0075 M 
PhCH2COCH2Cl (40, pg 21, vide infra) in CH3O-/CH3OH and 0.1 M LiClO4 at 0oC 
revealed a 20-30% acceleration in reaction rate and furthermore, a 100% acceleration 
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in 1.0 M LiClO4.  It was hypothesized that LiClO4 imparted a stabilizing effect on the 
highly ionic transition state through salt-facilitated ionization of the halide. Bordwell 
theorized this from similar findings with t-butylbromide in 90% aqueous acetone and 
Ph2CHCl in 80% aqueous acetone,36 two SN1 model mechanisms.  No further studies, 
however, were conducted by Bordwell to supplement or to elaborate on the salt effect.  
Complementary to the salt effect was a boost in reaction rates for 40 (vide infra) in 
0.05 M CH3O-/CH3OH at 0oC as the water content was increased (Table 4).    
 
 
Table 4.  Effect of water composition on the reaction rate, k2, of PhCH2COCH2Cl in 
0.05 M CH3O-/CH3OH at 0oC.  Table adapted from ref. 25. 
 
 
Vol % H2O k2 (102, M-1s-1) 
0 2.63 
5 6.23 
10           13.1 
25           50.3 
50          289 
 
 
A 110-fold acceleration in the reaction rate for 40 occurred as the water 
concentration increased from 0 to 50% (2.63 to 289 x 102 M-1s-1).    A plot of the log 
k2 vs. the Grunwald-Winstein Y,37 which represents quantitative measures of the 
effect of the “ionizing power” of the solvent on the reaction, provided an excellent 
correlation (slope = 0.647; R2 = 0.995; standard deviation = 0.037).  For 28, a 197 
fold increase in reaction rate was distinguished by increasing content of water from 0 
to 50% (0.22 to 42 x 102 M-1s-1) and thus the slope would be expected to be even 
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greater. The considerable ionizing power of water (Y = 3.56 for ionization of 
(CH3)3C-Cl),37was apparent from data in Table 4.   These observations further support 
the prior contention that heterolysis of the C-Cl possesses a high degree of ionic 
character in the transition state and accordingly, Cl- departure represents the RDS. A 
media effect was clearly distinguished from these studies.  
Several aryl-substituted functionalities were examined for their impacts on 
observed rates of halide ion release from 28, i.e., to explore whether a linear free 
energy relationship existed. The data for substituents are revealed in Table 5. A 
modest surge in yields of 29 was observed for nearly every substituent as the base 
concentrations were increased from 0.05 to 1.0 M.  The influences of temperature and 
base concentration on product distribution denoted competing reaction pathways, 
each of which displayed a first order dependence on [CH3O-]. The impacts of 
substituents on yield and kobs were conspicuously related to their electron releasing 
and withdrawing capacities relative to -H; para-substituted, electron donating groups  
 
Table 5.  Summary of observed and Favorskii rate constants and product yields in 
CH3O-/CH3OH at 0o for substituted 28 as a function of substituent. Table adapted 
from ref. 23. 
 
   %Yield of 29 %Yield of 29 %Yield of 32 
Precursor 
kobs/ 103 
M-1s-1 
kFavorskii/103 
M-1s-1 [MeO-], 0.05 M [MeO-], 1.0 M [MeO-], 0.05 M 
H 3.09 0.4 13 17 81 
p-NO2 5.09  ND 0 - 62 
p-Cl 6.21 0.31 5 9 83 
p-OMe 39.4 26.8 68 65 - 
m-OMe 2.72 0.33 12 25 79 
p-Me 6 1.5 25 36 56 
m-Me 3.23 0.45 14 22 61 
p-F 7.5 0.83 11 16 65 
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(-OCH3, -CH3) manifested elevated rates for the production of 29 while para-
substituted electron withdrawing groups (-F, -Cl and NO2) evinced preferences for 
32. Initial attempts to rationalize these phenomena through linear free energy 
relationships (LFER) led to poor correlations using log kobs and Hammett 
σ substituent constants (ρ = -1.1; R2 = 0.875; standard deviation = 0.275); 
ameliorated correlations were found by employing σ+ constants (ρ = -2.37; R2 = 
0.992; standard deviation = 0.13 (5%)).  The negative ρ suggested an accumulation of 
positive charge (carbocation character) or a loss of electron density (decreased 
anionic character) in the transition state of the RDS.  From this, Bordwell postulated 
that two key steps in the mechanism leading to 31 were impacted the most by 
substituents.  First, the reversible addition of CH3O- to 28, the initial step in forming 
31, is estimated to have a ρ ~ 0.8 based on analogous studies.38  Electron withdrawing 
groups would be expected to accelerate this process; this prediction was confirmed by 
the present study. Secondly, halogen departure from 30 was calculated to have a ρ ~ -
0.9.  Electron donating groups were expected to accelerate the rate of this process; 
results from this study were also consistent with this prediction.  The electron 
donating or withdrawing natures of the arene-substituted functional groups were 
shown to exert a direct control over reaction pathways of 28 in forming 29 and 32. 
 
 
 
 
  17 
C. The Ramberg-Backland (R-B) analogy and role of orbital overlap.   
To obtain an improved perspective on the step entailing halide ionization, 
Bordwell examined the Ramberg-Backland (R-B) reaction39 of α-halosulfones as an 
alternative model (Scheme 7). The reaction is well understood and characterized by  
 
Scheme 7. A depiction of the Ramberg-Backland reaction. 
 
 
swift, reversible carbanion formation 34 which mediates the rate determining 
departure of the halide ion to produce an episulfone 35 that readily extrudes SO2 to 
form styrene 36.  A leaving group effect, kBr/kCl > 50, though smaller than in the 
Favorskii reaction, nevertheless, suggested considerable C-X cleavage in the 
transition state of the RDS.  A positive ρ value (+0.8) in 40% aqueous dioxane was 
determined from the rate dependence on substituents.  Despite significant C-X ionic 
character, a positive ρ indicated that electron withdrawing groups should accelerate 
C-X heterolysis and required the inchoate C-C bond to be nearly completed in the 
transition state. This finding diverged from the Favorskii reaction; a large negative 
ρ −1.1 predicted that electron withdrawing groups would decelerate the rate of C-X 
cleavage22and the C-C bond formation would be much less developed.  Here, 
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mechanistic disparities in the two reactions became obvious. The negative charge 
afforded from hydrogen atom abstraction was localized on the carbon of the sulfone 
due to poor p-d π orbital overlap, whereas the carbanion was primarily a delocalized 
entity in the Favorskii reaction (Scheme 8); the p-orbital is held preferentially parallel  
 
Scheme 8. Delocalized (sp2) vs. localized (sp3) electron models. 
 
 
 
to the contiguous carbonyl π system (I).  To educe the appropriate trajectory for a SN2 
cyclopropanation, the carbanion orbitals must contort out of plane (deconjugate) with 
the carbonyl (II), localizing electron density, i.e., inducing a hybridization change 
from sp2 to sp3 and thus diminishing the feasibility of this route, at least from an 
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energetics perspective.  Conversely, an arrangement where the C-Cl bond is held 
parallel to the enolate p orbital (Scheme 9) effectuates partial π overlap of the  
 
Scheme 9. Anchimeric π assistance in establishing a cyclopropanone intermediate. 
 
 
 
developing p-orbital of the C-Cl center in the transition state, a stabilizing interaction 
that would promote the formation of cyclopropanone through disrotatory rotation.  
Energetically, anchimeric π electron participation in halide discharge to effect 
Favorskii precursors was perceived to be the favored route.  To probe this hypothesis, 
Bordwell determined first order rate constants of bromide release from the base 
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promoted anions corresponding to three similar α-bromo substrates in 0.05 M CH3O-
/CH3OH at 0oC (Scheme 10).  A five order of magnitude rate enhancement was 
 
Scheme 10. Rates of bromide release from anionic α-bromo substrates.  
 
 
evinced by the enolate, 38, compared to the carboxylate, 37.  An obvious neighboring 
group effect, anchimeric π assistance, seemed reasonable to Bordwell, as the only 
other feature common to both 37 and 38 was resonance delocalization.  Bordwell 
reasoned that if resonance stabilization predominated, 37 would manifest a more 
rapid rate of bromide release.  For 39, as a sulfur enolate is a less important resonance 
contributor due to the poor p-d orbital overlap, the more localized carbanion 
displayed further a five order of magnitude increase for bromide release, imputing σ 
(electrons localized on a sp3 orbital) electron participation.  Bordwell inferred from 
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these studies that π  electron participation was a salient feature in the mechanism of 
Favorskii reaction. 
 
D. The influence of α-substituents.  Earlier, it was revealed by Bordwell that both 
the nature and locus of the substituent in cyclohexanones strongly influenced product 
distributions of the Favorskii reaction, i.e. a structure-reactivity relationship was 
established.  Analogous investigations were extended to linear α-haloketones, 
specifically the role of methyl27,28and phenyl26 substituents in altering parameters of 
the Favorskii reaction such as rates of halide departure and product yields.  Previous 
investigations of 1-chloro-3-phenylpropan-2-one 40 (Scheme 11) in 0.05 M  
 
Scheme 11. Reactions of α-chloro analogs in CH3O-/CH3OH. 
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CH3O-/CH3OH at 0oC exhibited rapid H-D exchange and a ρ of -5.0,23 denoting an 
initial, reversible deprotonation step and suggesting a high degree of C-Cl bond 
dissociation in the transition state.  From this, Bordwell rationalized that α-methyl or 
phenyl substituents (e- contributors) should stabilize this accumulation of positive 
charge and augment the rate of halide ionization, k2.  He studied the behaviors of 3-
chloro-1-phenylbutan-2-one (43) and 1-chloro-1,3-diphenylpropan-2-one (46) under 
an assortment of conditions and compared results to those obtained for 40.23 Results 
from these examinations are displayed in Table 6. As observed earlier, a direct 
 
Table 6.  Results from the reaction of 40, 43, and 46 in varying [CH3O-] in CH3OH at 
0oC.  Table adapted from ref. 27. 
 
  40 43 46 
Relative ratesa 1 >250 >330 
Deuterium exchange ~80% ~6% Nb 
kBr/kCl 63 0.9 1.0 
Hammett ρ -5.0 1.4 1.1 
Salt effectc 25-30% Nb ~7% 
Products with:    
2 M NaOCH3 100% 41 100% 44 39% 47, no 48d 
0.05 M NaOCH3 100% 41 61% 44, 39%45 15% 47, 85% 48 
10-5 M NaOCH3 100% 41 100% 45 100 % 48 
aChloride ionization. bN = negligible. c0.1 M LiClO4. dAn unidentified compound was 
formed. 
 
correlation was found between [OCH3-] and product composition for 43 and 46; 
larger quantities of OCH3- favored Favorskii product formation.  No changes in 
product distribution as a function of [OCH3-] for 40 were noticed; the Favorskii ester 
was the dominant product in all cases.  A mechanistic interpretation will be provided 
later.   
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Control experiments were performed for validation and found that: 1) No 
chloride was released from 43 or 46 in the absence of CH3O- in CH3OH over 24 h and 
2) neither 44 nor 47 reacted in 2 M [CH3O-] for 2 h; this ruled out degradation of 
these Favorskii esters to other products, which would result in false percent yields to 
be reported for their formation.  Furthermore, it was found that the product ratios for 
40, 43 and 46 remained steady at 0oC and 70oC in 0.05 M CH3O-/CH3OH, 61% and 
39% respectively, negating a temperature effect.  In the presence of 0.1 M LiClO4, a 
salt effect was minimal for 43 as there was essentially no change in yield and for 46 
only a 7% increase was reported; a significant salt effect for 40 amounted to a ~25-
30% increase in the production of Favorskii esters.  
When the Br- analogs were tested under the same conditions, the product 
ratios were nearly identical.  However, the reaction rates for halide detachment in 10 
molar excess CH3O- under the same conditions revealed no variation for 43 and 46 
(kBr/kCl ~ 0.9 and 1 respectively) but was pronounced for 40 (~63).  This 
phenomenon, in itself, intimates distinct mechanisms for 40 and 43/46 to rearranged 
products.  Corroborating these are the sizeable differences in ρ for 40 (-5.0) compared 
to 43 (1.4) and 46 (1.1).  A substantial buildup of positive charge in the transition 
state of the RDS for 40 is anticipated and thus C-Cl bond breakage should possess a 
large degree of ionic character at the transition state. Analogous to its structural 
isomer (28) the RDS for 40 is hypothesized as chloride ionization.  In contrast, 
positive ρ values for 43 and 46 indicate a buildup of negative charge in the transition 
state and adduce that the RDS is, in fact, proton abstraction.  As Bordwell anticipated, 
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the α-methyl 43 and phenyl 46 moieties, through stabilization of the positive charge 
on the chloride-bearing carbon, unambiguously transposed the RDS of the Favorskii 
reaction to proton abstraction, comparable. From these results and those obtained 
from related experiments, Bordwell formulated a mechanism to account for the 
formation of 44 and α-methoxy ketone (45) (Scheme 12). 
 
Scheme 12. Discrete mechanistic pathways for α-chlorobenzylpropiophenone 43 to 
the rearranged ester (44) and α-methoxyketone (45). 
 
 
 
 
The RDS, as previously derived, represents k1, or rate of enolate formation.  
The rearranged ester (44) was engendered from the enolate intermediate (51) through 
the Favorskii rearrangement. The β-hydroxy allyl chloride (enol) intermediate (52) 
was assumed to be in rapid equilibrium with 51 and thus permitted solvolysis to occur 
in forming 45.  The relative magnitudes of k2 and k3, along with direction of 
equilibrium, control the 44 to 45 ratios.  When methoxide concentrations are high, 
enolate [51] is high, k2 > k3, and the formation of 44 is promoted.  Conversely, when 
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CH3O- concentrations are reduced, enol [52] is high, k3 > k2, and 45 preponderates.  
Bordwell estimated that the enol to enolate ratio, [52]/[51] ~ 40 at 0.05 M [CH3O-].26 
The α-substituted methyl 43 and phenyl 46 groups were vital to this mechanistic 
change. Structure-reactivity relationships, once again, were indicated as important 
factors in the Favorskii reaction.  Recall that the Favorskii ester is produced solely 
from 40 irrespective of [CH3O-]. To recapitulate the importance of [CH3O-] in 
determining product outcomes of the Favorskii reaction, a side by side, detailed 
mechanistic depiction of the reaction pathways of 43 and its isomer 53 (R = H) is 
exhibited in Scheme 13.  The primary route to 44 for each precursor, after 
predominant enolate (51a and 51b) formation when concentrations of CH3O- were 
higher, was postulated to be through an oxyallyl zwitterion, 54, which was presumed 
to be in equilibrium with the reactive cyclopropanone. The competing route to 45 was 
thought to involve the protonated oxyallyl zwitterions (55) when enols (52a and 52b) 
preponderated at low [CH3O-].  Rearrangement to 44 was precluded from 55, where 
CH3O- addition was favored to furnish 45.  An additional consideration in 
determining the pathways to 44 and 45, though not explicitly mentioned, is the 
interconversion between oxyallyl intermediates 54 and 55, i.e., a Curtin-Hammett 
condition.  Small energy barriers for proton exchange would rapidly interconvert 54 
and 55.  High [CH3O-] would favor 54, while low concentrations would favor 55. 
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Scheme 13. Reaction pathways of isomers 53 and 43 to rearranged 44 and α-methoxy 
ketone (45). 
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An extension28 of investigations into structure-reactivity relationships of the 
Favorskii rearrangement was applied to tertiary α-haloketones 46, 49, and 53, each 
containing two substitutions on the α-position of the carbonyl (Scheme 14).  Control  
 
Scheme 14. Reactions of alkyl substituted α-chloro ketones with CH3O-. 
 
 
 
experiments demonstrated the isomerization of 53 to 43 at ~20% over 6 months at ~ 
0oC; this was accounted for in determining relevant factors pertaining to product 
formation.   Results from these experiments are displayed in Table 7. 
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Table 7.  Summary of product yields and rates of reaction for 46, 49 and 53 as a 
function of CH3O- in CH3OH. Table adapted from ref. 28. 
 
Substrate [CH3O-], M 
% Yield α-methoxyketone 
45/48 
% Yield of Favorskii 
ester 44/47 k (103 M-1 s-1) 
46 (Br) 0.05 97 3 - 
  1 60 35 - 
46 (Cl) 0.05 ~97 ~3 - 
49 (Cl) 0.05 - 10 0.016 
  1 - 45 - 
49 (Br) 1 - - 0.024 
 53a,b (Cl) 0.05 30 70  
aThe yield of Favorskii ester is 100% in 2 M NaOCH3. bAt 10-5 M, the α-
methoxyketone was the sole product. 
 
An improved yield of Favorskii ester as the [OCH3-] increased was 
manifested.  This observation seemed to bolster the plausibility of the previously 
posited enol/enolate mechanism in accounting for product distributions, i.e., a greater 
quantity of OCH3- (greater basicity) would shift the enol/enolate towards the enolate 
that promotes the rearrangement process. The lack of a halogen effect, kBr/kCl ~1, for 
49 was similar to previously encountered examples and signifies rate determining 
proton abstraction.  The rate for proton abstraction of PhCH(Cl)COCH3, 28 (vide 
supra), was accelerated 35 fold compared to 49; this phenomenon implies an 
encumbering (possibly steric), effect exerted by the methyl group in retarding the rate 
of proton abstraction.  The RDS changes from proton abstraction to halide departure.  
A steric component to the Favorskii mechanism is further advanced when one 
compares the deprotonation rates of 53 with 46; the former disclosed a 35 fold 
acceleration over the latter. The RDS for 46 was postulated as proton abstraction 
based on analogy with previous work.25 
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E.  Evidence for a dipolar (oxyallyl) intermediate in the Favorskii reaction.  
 Bordwell inadvertently provided evidence for the formation of Dewar’s20 
proposed dipolar ion in studies29 involving 1-chloro-1,1-diphenylpropanone (56) and 
3-chloro-1,1-diphenylpropanone (60) in CH3O-/CH3OH at 0oC; his specific aims were 
to probe the effects phenyl substituents on the Favorskii reaction. 
 
Scheme 15. Product distributions from the reaction of α-chloro ketones with low 
concentrations of CH3O-. 
 
 
 
At 0.05 M CH3O-, both precursors gave the Favorskii ester (57) in 
approximately 97% yield.   At lower concentrations of base, however, an array of 
products was obtained (Scheme 15), along with, perhaps most interestingly, 59.  
Noteworthy, were the identical constituents that materialized from each precursor 
under Favorskii conditions, although the compositions of each product set were 
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discrete. It was reasoned that the emergence of 59 stemmed from low [CH3O-], 
permitting the intramolecular cyclization of the enolate to engender an indanone, 61, 
that thenceforth, would react with O2 in the presence of CH3O- (Scheme 16). This 
 
Scheme 16. Proposed mechanism for the reaction of α-chloroketone, 56, with low 
[CH3O-] to form the methyl ester, 59. 
 
 
 
 
proposed sequence was supported by an independent study from Smith40 that 
demonstrated an “unknown acid, melting point 131oC ” from reaction of 61 with cold 
sodium hydroxide.  In a supplementary study, a pure sample of 61 promptly 
transformed to 59 upon oxidation (O2) in a methanolic solution of methoxide.  The 
rate of halide ionization for 56 was estimated to be enhanced 625 fold compared to its 
mono-phenyl analog; this unequivocally demonstrated a stabilizing effect by the 
phenyl moiety.  In addition, only about 11% deuterium exchange occurred with 56.  
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The RDS for 56, therefore, was posited to be deprotonation.  A “dipolar-like” 
transition state was advanced, resulting from halide ion departure from the enolate 
intermediate.  It was reasoned that the second phenyl group would effectively 
disperse the positive charge accumulation at the C-Cl center through resonance.  A 
parallel phenomenon, though not as marked, was observed for 60, where the rate of 
halide ionization was augmented 25 fold vs. its unsubstituted analog 40.  
Additionally, kBr/kCl was found to be ~4, supporting enolate formation as being rate 
determining.  After extensive, congruent investigations using analogs of 56 and 60, 
Bordwell maintained that an oxyallyl intermediate (62) was formed (Scheme 17).   
 
Scheme 17. Suggested dipolar (oxyallyl) mechanism to indanone (61). 
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Hoffmann41 independently determined energetic preferences (22 kcal/mol) for dipolar 
ions at equilibrium relative to cyclopropanone.  However, Dewar42 and Liberles43 
asserted cyclopropanones to be more stable by 78 and 83 kcal/mol, respectively. 
 
F.  Studies in Stereochemistry.  Stereochemical investigations of the classical 
Favorskii reaction have been carried out by several groups,6 most notably Stork and 
Borowitz,18 who discerned the stereospecific formation of esters from non-
epimerizable ketones (Scheme 18).   They suggested an operating, inversion or SN2 
 
Scheme 18. Stork-Borowitz proposal for stereochemical inversion of precursors to 
Favorskii products. 
 
 
 
           
process.  Solvent polarity, however, was determined to direct the stereochemical 
outcome; this theory was advanced by House44 et. al., who’s studies divulged the 
formation of inversion products only in non-polar media.  
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Bordwell30 also explored Favorskii reactions involving stereochemical 
conversions, specifically 2-bromo-4-methyl-4-phenylcyclohexanone (63) and the 
cis/trans isomers of 2-bromo-5-methyl-5-phenylcyclohexanones (66) under Favorskii 
conditions.  The reactions of 63 and 66 to generate corresponding products are 
outlined in Scheme 19 and results presented in Table 8. 
 
Scheme 19. Reactions of α-bromo ketones 63 and cis/trans diastereomers 66 with 
CH3O- in CH3OH. 
 
 
Table 8.  Results of reactions of 63 and 66 with various [CH3O-] in CH3OH at 00C.  
Table adapted from ref. 30. 
 
Substituent [NaOCH3], Ma % ester % hydroxyketal 
      
63 ~ 10-5 40 (1:3, 64:65)  36 
  2 55a 37 
66 0.05 
9 (57:6:14:23, 
64:65:67:68)  NDb 
  1 22a  ND 
  2 
69 (45:7:9:39, 
64:65:67:68)  ND 
aProduct ratio not provided. bPercentage not given.  
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For both precursors, a pronounced increase in Favorskii ester yield was seen to 
accompany concentrated base solutions, a common occurrence for several α-
haloketones previously encountered.  The relatively enhanced ester yields for 63 vs. 
66 was evidence for a 1,3-diaxial effect, specifically in impeding the halide from 
adopting the axial position, a favored orientation for epoxyether (α-methoxyketone 
precursor) formation. This effect was not revealed for 66. When the reaction of 63 
was conducted at low [CH3O-], a 40% ester yield was obtained with relative inverse 
ratios of 1:3 for 64 and 65.  Reactions of 66 (either isomers) afforded 64, 65, and two 
other esters 67 and 68 with relative ratios of 57:6:14:23, respectively, in 0.05 M 
CH3O- in methanol, that changed to 45:7:9:39 for 64, 65, 67, and 68, respectively, in 
2 M [CH3O-] in methanol, and 26:24:28:22, respectively, when equilibrated (>150 h 
reflux).  It appeared that greater base concentrations fostered the formation of 68 over 
64.  It was postulated that for 63, an internal SN2 reaction (Loftfield’s mechanism13) 
would educe an inverted product if the halide was equatorial and retention if axial.  
The principal ester for 63 was found to be 64, advancing the notion that retention had 
occurred (presumed disjunction of an axial halide).  This is not manifested with 66 
(cis), where 65 would have been anticipated to be major product according to 
Loftfield’s mechanism, but, in fact, demonstrated a preponderance of 64.  The 
uniform product distribution for cis/trans 66 denoted that an epimerization at the 
halide locus may have been operative.  To furnish an SN2 reaction, cis/trans 66 would 
have to first equilibrate and then generate the ester via the equatorial halide; an 
inversion step required an equatorial halide orientation for 66.  Consequently, 
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Bordwell proposed that the dipolar ion intermediate was a feasible precursor to the 
Favorskii ester (Scheme 20).  Upon the formation of the dipolar ion, 69, a disrotatory 
ring closure was effected, producing cyclopropanones 70 and 71. The stereochemistry 
 
Scheme 20. Bordwell’s suggested reaction pathways of 63 to diastereomers 64 and 
65 in CH3O-, directed by the oxyallyl intermediate (69). 
 
 
 
 
of the products was decided following halide detachment, which adequately justified 
the product distributions above.  Low [CH3O-] advanced the formation of 65 over 64 
but the converse at 2 M concentration.  Bordwell speculated that this phenomenon 
was due to the more rapid formation of 71 over 70; low concentrations of CH3O- 
permitted equilibrium to be achieved between the two cyclopropanone intermediates. 
The product ratios were, thus, controlled by the equilibrium position and rate 
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constants of reactions of cyclopropanone or corresponding hemi methylketal with 
CH3O-.  The product distributions were directed by the rates in which 70 and 71 were 
produced.  The formation of 4 esters from cis/trans 66 was reasoned to occur from 
two cyclopropanone intermediates, 66a and 66b (Equation 3), each of which reacted  
 
 
         Eq. 3 
 
with CH3O- in CH3OH to bear two products; a) 66a, which manifested the phenyl and 
carbonyl groups trans to each other, reacted with CH3O- to produce 64 and 67 and b)   
66b, which engendered 65 and 68 under the same conditions.  Increasing the [CH3O-] 
from 0.05 M to 2.0 M seemingly improved the yields of 66b over 66a, since the ratios 
of 65 and 68 to 64 and 67 increased. A similar explication as for the product ratios 
from 63 was advanced, i.e., a zwitterion intermediate first formed that underwent 
disrotatory ring closure in two modes to make the two cyclopropanones.  In the end, 
however, Bordwell conceded that further studies were required to better comprehend 
the stereochemical inversions and retentions that were exhibited by the product 
distributions. 
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III. Computational Investigations.  Andres45 and coworkers recently communicated 
results from extensive computational investigations using ab initio calculations at the 
Hartree-Fock level of theory with 6-31G* and 6+31G* basis sets and electron 
correlations at the MP2/6-31G* level based DFT, BLYP/6-31G* of the Favorskii 
reaction mechanism.  Hydroxide ion (HO-) mediated rearrangement of α-
chlorocyclobutane to cyclopropanecarboxylic acid was utilized as a model system.  
Two mechanisms were accentuated in the investigations; 1) the signature Favorskii 
route with cyclopropanone intermediate and 2) semibenzilic path, which has been 
coined the “quasi”-Favorskii reaction and will be elaborated on later, in the gas and 
aqueous phase.  For each mechanism, a series of reactant complexes (RC), transition 
states (TS), intermediates (I), and corresponding precursor (R) and product (P) 
entities were determined along with relative energies.  These were termed stationary 
points.  The semibenzilic acid route showed 6 stationary points (Scheme 21).  
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Scheme 21. The proposed semibenzilic mechanism of conversion of α-
chlorocyclobutanone to cyclopropane carboxylic acid through calculated stationary 
points.  Reproduced with permission from the ACS, ref. 45. 
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The relative energies for stationary points corresponding to the semibenzilic acid 
rearrangement are tabulated for gas and aqueous phases in Table 9. 
 
Table 9. Relative energies (kcal/mol) of stationary points associated with the 
semibenzilic rearrangement mechanism, in the gas and aqueous phases, as determined 
by various computational methods. ND, not determined.  Table adapted from ref. 45. 
 
  HF/6-31G* HF/6+31G* MP2/6-31G* BLYP/6-31G* 
    Gas Phase     
R 0.00 0.00 0.00 0.00 
RC ND -19.07 -36.57 -54.21 
TS1A ND -17.58 -33.90 -45.56 
I1A -63.97 -44.86 -73.70 -75.22 
TS2A -48.55 -27.21 -62.56 -73.21 
P -115.46 -94.03 -107.07 -109.58 
    Aqueous Phase     
R 0.00 ND ND ND 
RC -20.74 ND ND ND 
TS1A -15.59 ND ND ND 
I1A -29.60 ND ND ND 
TS2A -26.56 ND ND ND 
P -100.55 ND ND ND 
 
 
In the gas phase, nucleophilic approach by HO- was calculated to be, for the most 
part, barrierless; the initial interaction was manifest by strong hydrogen bonding 
between the anionic HO- and α-hydrogen atoms to the carbonyl, leading to a 
stabilized RC complex.  The RC complex was thought to ready HO- for nucleophilic 
attack on the carbonyl, in assembling the intermediate IA, through a transition state, 
TS1A; the energy barrier to IA ranged from 1.5 (HF/6-31G*) to 8.6 (BLYP/6-31G*) 
kcal/mol; this approach was calculated to occur on the very flat region of a potential 
energy surface, PES, exhibited in Figure 2.  
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Figure 2.  A potential energy illustration of the semibenzilic rearrangement process, 
revealing relative energies (in kcal/mol) of stationary points on the reactive surface 
that were calculated at the HF/6-31G* level.  The broken line indicates the aqueous 
phase; the bold line, gas phase. Reproduced by permission of the ACS, ref. 45. 
 
 
 
 
The rearrangement step (TS2A) displayed a diverse range of activation energies, 17.6 
kcal/mol (HF/6+31G*) to 2.0 kcal/mol (BLYP/6-31G*); this was the obvious rate 
determining step for the reaction, as collectively, these energies were higher than 
those calculated for TS1A.. 
 In an aqueous environment, the PES was quite disparate from the gas phase 
for the semibenzilic acid rearrangement.  Reliable relative energies originated only 
from HF/6-31G* level computations.   The rate determining step changes to TS1A 
(recall that it was TS2A in the gas phase from HF/6+31G* and MP2/6-31G* 
calculations) by nucleophilic attack by HO- at the carbonyl; the activation barrier for 
this was 5.1 kcal/mol.  An extensive solvation of HO- by water was designated as the 
primary source of this observation and further impacted the relative energies of I1A 
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Scheme 22. The Favorskii rearrangement mechanism of α-chlorocyclobutanone to 
cyclopropane carboxylic acid through calculated stationary points.  Reproduced with 
permission from the ACS, ref. 45. 
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and TS2A that were destabilized 34.4 and 22.0 kcal/mol, respectively.  An additional 
solvation effect was manifest on the energy barrier for the rearrangement (TS2A) 
step, which dropped from 15.4 kcal/mol in the gas phase to 3.0 kcal/mol in solution.   
 A total of 8 stationary points were determined for the Favorskii rearrangement 
mechanism (Scheme 22). The relative energies for associated stationary points in the 
gas and aqueous phases are presented in Table 10. 
 
Table 10. Relative energies (kcal/mol) of stationary points associated with the 
cyclopropanone rearrangement mechanism in the gas and aqueous phases, as 
determined by the connoted computational methods. ND, not determined.  Table 
adapted from ref. 45. 
 
  HF/6-31G* HF/6+31G* MP2/6-31G* BLYP/6-31G* 
    Gas Phase     
R 0.00 0.00 0.00 0.00 
RC ND -19.07 -36.57 -54.21 
TS1B ND -15.46 -32.83 -45.66 
I1B -49.50 -31.28 -56.14 -64.35 
TS2B -42.17 -22.83 -50.05 -60.79 
I2B -47.68 -29.79 -45.49 -49.89 
TS3B -6.91 12.80 -9.18 -24.14 
P -115.15 -94.03 -107.07 -109.58 
    Aqueous Phase     
R 0.00 ND ND ND 
RC -20.74 ND ND ND 
TS1B -19.36 ND ND ND 
I1B -23.14 ND ND ND 
TS2B -20.04 ND ND ND 
I2B -41.79 ND ND ND 
TS3B -11.63 ND ND ND 
P -100.55 ND ND ND 
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Akin to the semibenzilic mechanism, the RC was determined as the initial point of 
contact for HO- and α-chlorobutanone in the gas phase. The activation barrier for 
proton abstraction (TS1B) ranged from 3.61 (HF/6+31G*) to 8.55 kcal/mol 
(BLYP/6-31G*), while that for the formation of cyclopropanone (TS2B) spanned 
from 3.56 (BLYP/6-31G*) to 8.45 (HF/6+31G*) kcal/mol.  The rearrangement step 
through TS3B was established as the rate determining step in all methods of 
calculation; the energy barriers ranged from 42.59 (HF/6+31G*) to 25.77 (BLYP/6-
31G*) kcal/mol. The cyclopropanation pathway for rearrangement in water 
manifested stationary point energies that were appreciably higher than in the gas 
phase, matching earlier observations for semibenzilic acid in water.  A potential 
energy surface diagram denoting the cyclopropanone rearrangement route is provided 
in Figure 3. 
Figure 3.  A potential energy surface diagram of the cyclopropanone rearrangement 
mechanism, revealing relative energies (in kcal/mol) of stationary points on the 
reactive surface that were calculated at the HF/6-31G* level.  The broken line 
indicates the aqueous phase; the bold line, gas phase.  Reproduced with permission by 
the ACS, ref. 45. 
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Similar to the semibenzilic mechanism above, a change in curvature of the incipient 
reaction steps inferred pronounced, solvation-incited encumbering effects on the 
reactivity of HO-. A very low energy barrier (TS1B, 1.4 kcal/mol) to forming the 
enolate intermediate I1B was manifested.  The ensuing conversion to cyclopropanone 
through TS2B disclosed an energy barrier of 3.1 kcal/mol, a decline from the gas 
phase that was 7.2 kcal/mol.  Lastly, the rearranging, rate determining step through 
TS3B, showed an energy barrier of 30.2 kcal/mol (I2B); this represented a steep drop 
compared to 40.8 kcal/mol in the gas phase.  The exothermicity of the reaction was 
reduced by 15 kcal/mol compared to the gas phase.  Akin to results for the 
semibenzilic mechanism, a general solvent influence on the cyclopropanone 
mechanism was to lower the activation barriers to intermediates and the 
corresponding product; this phenomenon was particularly noticeable on the PES 
(Figure 3).  The semibenzilic mechanism appeared to be the most favored pathway to 
the Favorskii acid in either phase, by virtue of the drastically reduced energy barriers 
of rate determining steps to rearranged product.  However, the inherently large ring 
strain of cyclobutanones, though not considered in the report, would be anticipated to 
play a substantial role in directing the preferred reactivity through the semibenzilic 
mechanism which requires fewer steps to the rearranged product.  
 
IV. Variations to the classical Favorskii Reaction. 
As alluded to earlier, several variations of the Favorskii reaction have been 
recognized and implemented in the realm of synthesis:  1) Non-enolizable ketones 
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can undergo rearrangements to acids/esters in what is termed the “quasi-Favorskii” 
reaction46(Equation 4), this likened to a semibenzilic acid type of rearrangement.  The 
primary distinction from the classical Favorskii is that no enolate or cyclopropanone 
intermediates are formed in the reaction course. 2) Ketones with γ-nucleofuges 
 
         Eq. 4   
can undergo base-moderated rearrangements, the “homo-Favorskii”reaction47 
(Scheme 23), to produce cyclobutanones, which, being more robust than 
cyclopropanone homologs, are isolable.3  
 
Scheme 23. Proposed mechanism of the homo-Favorskii reaction. 
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In general, reactions involving the formation of acids/esters from base 
facilitated rearrangements of α-nucleofuge substituted ketones can be considered the 
“Favorskii” sort. Up to this point, the focus has been on the ground state Favorskii 
reaction.  The excited state complement is now presented.   
 
V.  The Photochemical Version of the Favorskii Rearrangement. 
A more obscure, lesser known reaction involving rearrangements of α-
substituted ketones to effect acids/esters in the excited state, the “Photo-Favorskii”, 
has, comparatively, received little attention.10 The earliest report of photolyses 
involving α-haloketones, practical antecedents for these types of rearrangements, was 
by Strachan et. al.,48 where chloroacetone was irradiated either neat or in non-
hydroxylic solvents at 313 nm.  Although a curious array of photoproducts was 
conveyed, including acetone, no rearrangements were demonstrated. However, the 
formation of acetone as a principal photoproduct intimated homolytic C-Cl bond 
scission and thus radical transients, which have been posited as viable precursors to 
Favorskii products. Though not broached in this report, it can be surmised that the 
excited state pathway for chloroacetone photolysis to photoproducts was through the 
triplet, as acetone is known to intersystem cross with an efficiency of near unity.49 
Multiplicities will become a prominent interest later in this thesis. The seminal 
publication for the photo-Favorskii reaction was by Anderson and Reese50 almost 50 
years ago and involved UV irradiation of 1% α-chloroacetophenone derivatives in 
ethanol over a 1-2 hour time span.  With certain substituents (R = p-OH, p-OCH3, and 
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o-OMe) two major products, acetophenone (72) and ethyl 2-phenylacetate (73) were 
obtained, the latter in abundance (Equation 5). 
 
   
        Eq. 5 
 
The pathway to 72, as depicted in Equation 5, was hypothesized to occur by 
the homolytic cleavage of the C-Cl bond, yielding an α-ketoradical (74) which would 
then abstract a hydrogen atom from ethanol, effecting 72.  The provenience of this 
stemmed from the aforementioned Strachan48 studies and is presented in Equation 6 
with the p-OCH3 derivative. To obtain 73, the authors rationalized the intermediacy 
 
 
         Eq. 6 
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of a spiro-cyclopropanone (75), with subsequent attack by EtOH at the carbonyl and, 
lastly, a ring-opening, 1,2-aryl shift, affording 73 that effectively amounted to a 
Favorskii rearrangement (Equation 7).  Other intermediates were proposed, but no 
mechanistic explorations were related nor appeared subsequently in the literature.  A 
 
 
         Eq. 7 
 
potential ethyl ether substituent product, envisaged by the attack of EtOH at the 
methylene locus with concomitant chloride disjunction, was not reported, though 
precursor decay, presumably through ketene extrusion to chlorobenzene was formed 
as a minor product (Scheme 24).   
 
 
 
 
 
 
 
 
 
 
 
 
  49 
Scheme 24. Posited mechanism to account for the formation of chlorobenzene from 
α-chloroacetophenone derivatives. 
 
 
 
The electronic and positional influences of several substituents were discerned and 
are disclosed in Table 11.  Strong electron donors, i.e., p-OH, o-OMe, p-OMe  
evinced the highest yields of Favorskii rearrangement product (73) while moderate 
donating (-Cl, -Me), generated none, except for, curiously o-Me (4%). In addition, 
electron withdrawing moieties (-CO2Me) failed to reveal 73.   
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Table 11.  Substituent effects on the photoproduct distributions from photolysis of 
substituted α-chloroacetophenones in ethanol, irradiated at 300 nm for 1-2 h.  Table 
adapted from ref. 50. 
 
Substituent (X) %Yield, acetophenone,  72 %Yield, ethyl phenylacetate, 73 
p-OH 26 32 
p-OMe 30 32 
o-OH 3 0 
o-OMe 16 32 
o-Me 58 4 
H 53 0 
p-CO2Me 48 0 
p-Cl 55 0 
o-Cl 45 0 
m-OMe 15 0 
 
 
Since this seminal report, a paucity of research has been reported regarding 
the photo-Favorskii reaction.  Sheehan51 investigated the use of the p-
methoxyphenacyl chromophore as a phototrigger for carboxylic acids. This entity had 
previously been shown by Anderson and Reese to be a precursor for rearranged 
products and substrate release after irradiation (Equation 8). However, after 
irradiation at 254 nm in 1,4-dioxane or ethanol for 5-17 h, they reported that 76 was 
converted to free acid (77) and p-methoxyacetophenone (78).   
 
         Eq. 8 
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The theorized mechanism to explain the formation of photoproducts (Scheme 25) is 
in accord with those previously addressed,48,50 where upon irradiation, C-O bond 
 
Scheme 25. Posited mechanism of benzoic acid release from the p-
methoxyacetophenone chromophore. 
 
 
 
homolysis occurs producing geminate radicals 79 that are posited to readily abstract 
H atoms from the solvent, yielding primary photoproducts 80 and 81 and products 
from solvent oxidation (e.g. acetaldehyde).  Unlike Anderson and Reese’s earler 
results, no Favorskii rearrangement esters were reported.  The disparate results 
suggested a nucleofuge effect, but this premise was not further substantiated.  
Sonawane52 et. al., recognized the versatility of this method in the practical synthesis 
of useful phenylacetic acids.  An early report concentrated on the nature and position 
of the substituent on the chromophore in determining photolysis products of α-
chloropropiophenone derivatives (Equation 9).53 
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         Eq. 9  
        
The principal photoproducts generated from 300 nm irradiation of a 3% solution of 
82 in degassed methanol for 6 h were propiophenone (83) the o-chloropropiophenone, 
(84) the Favorskii ester (85) and the methylether (86)  It was revealed that the 
substituent locus and electronic characteristics profoundly affected the product ratios 
(Table 12).  Notably, both p and m-methyl derivatives of 82c (methyl as a mild 
electron donor) produced 85 as the primary product while the p-OCH3 (stronger 
electron donor) 82a and m-OCH3 (electron withdrawing) each afforded an exiguous 
amount of 85, the latter consistent with the previous findings of Anderson and Reese. 
 
Table 12.  Photoproduct % compositions from photolysis of 3% solutions of 82a-d in 
degassed CH3OH.  Table adapted from ref. 53. 
 
Compound R   Product Compositions, % 
    83 84 85 86 
82a  (m-OCH3) 13 68 0 19 
  (p-OCH3) 12 0 8 70 
82b  (m-OPh) 70 21 8 0 
82c  (m-CH3) 33 0 66 0 
  (p-CH3) 8 0 76 0 
82d  (m-NO2) 100 0 0 0 
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Since the late 1960’s, Givens and coworkers54 have gained considerable 
insight by studying photo-induced extrusion and rearrangement reactions, though 
those amenable to the photo-Favorskii rearrangement are the most recent among their 
studies.  Early studies55 were aimed at comprehending stereoelectronic effects, i.e., 
the role of the nucleofuge (e.g., halogen, carboxylate, phosphate, and others) in 
determining the outcomes of photolyses of α-substituted chromophores, such as 
isomers of 2-chloro bicyclo[2.2.2.]octanone (Scheme 26).  These were not tailored 
 
Scheme 26. Product compositions from photolysis of corresponding α-chloroketones. 
 
 
 
specifically to investigate the photo-Favorskii rearrangement, that is, products derived 
from 1,2 migrations or cyclopropanone/oxyallyl intermediates. Nevertheless, a 
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detailed understanding of the rearrangement process that afforded esters, acids, or 
amides provided a stimulus for future endeavors with the ‘less-than-familiar’ 
Favorskii rearrangement.  Photolysis of syn and anti 2-chloro- 
benzobicyclo[2.2.2]octadien-3-one isomers of 87 in methanol was shown to generate 
esters 89 and 90, though in dissimilar ratios.  The compound syn-2-Chloro-
bicyclo[2.2.2]octenone, 91, produced the ester 92 as the major photoproduct, while 
from corresponding anti-91 isomer emerged a complex assortment of products.  
Rearrangements had occurred to produce esters, though a Favorskii-like, 1,2-aryl 
migration was not discerned in these systems. Additionally, a salient impact of the 
chloride orientation was demonstrably a determinant in the product compositions.  It 
was assumed that the initial step in these reactions involved carbon-chloride bond 
scission,48 though whether through homolysis56 that would engender a geminate 
radical pair, or heterolysis50 to form chloride ion and an α-carbenium ion was 
speculative.  A number of plausible radical and ionic intermediates were surmised 
and, ultimately, through sets of supplementary experiments, a conflation of 
radical/ion attributes for the intermediates was proposed to account for product 
distributions.57 The singlet was determined to be the reactive excited state in these 
reactions.  Experiments involving triplet quenching with piperylene failed to divulge 
any vicissitudes in product yields and those involving triplet sensitization with 
acetophenone manifested marked declines in quantum yields, 0.03 for 87 (anti Cl) 
and 0.09 87 (syn Cl), than those from direct irradiation, 0.35 and 0.32, respectively.   
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 The use of benzoin (desyl) as an α-keto phototrigger, originally established by 
Sheehan and Wilson58 for caging phosphates,59,60 was explored principally for its 
longer wavelength absorption (λmax >350 nm), efficacious quantum yields (Φ > 0.28) 
for substrate release or “decaging”, and trenchant photochemistry; the primary 
photoproducts were the released substrate and benzofuran, derived from an internal 
benzoin photocyclization.   
Despite its obvious utility as a phototrigger, the mechanism for substrate 
release and cyclization doesn’t abide by a “Favorskii-like” process, i.e., no 
cyclopropane intermediates nor 1,2-migrations were borne and would not warrant 
further discussion except for one salient feature.  The triplet state preponderated and 
as such a plausible α-keto carbocation intermediate61 appeared to be viable to 
product formation; a similar α-keto carbocation intermediate is thought to be a 
possible precursor to the cyclopropanone intermediate in the Favorskii rearrangement.  
Independent studies55,62 reported a Hammett correlation of ρ = -0.9 vs. σ, imputing 
positive charge buildup (carbocation character) in the transition state.  Indirect 
evidence for an α-aryl carbocation intermediate was obtained by Givens and 
Matuszewski59 through 18O labeling experiments with corresponding arylmethyl 
phosphate esters. These studies disclosed that expeditive oxygen exchange between 
benzylic and phosphoryl units had occurred by, presumably, an ion-pair species.  The 
same report59 revealed an observed photostereoisomerization of (S)-(-)-93 in n-
butanol, shown in Equation 10, that competed with the substitution reaction to 
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produce (S)-(-)-94, which itself was formed with a slight, net retention; the 
phenomenon strongly suggested the intermediacy of ion-pairs. 
 
 
        Eq. 10 
 
Givens’ seminal photo-Favorskii report63 concerned the p-hydroxyphenyacyl  
chromophore as a cage for ATP (pHP ATP, 95) and for inorganic phosphate (pHP 
phosphate, 97) (Scheme 27).  Photolysis of 95 and 97 at 300 nm in Tris buffer 
efficiently produced ATP and inorganic phosphate, Φapp1 = 0.37 and Φapp3 = 0.12, 
respectively, as well as the rearranged (Favorskii) p-hydroxyphenylacetic acid (97, 
Φapp2 = 0.31). The process was shown to originate from the triplet surface by studies 
on the Stern-Volmer (S-V) quenching using 2-naphthalenesulfonate by the decline in 
Φdis as the concentration of 2-naphthalenesulfonate was increased.  The slope of the 
resulting linear dependence (KSV) provided an indirect measure of the triplet lifetime 
and a rate constant for fragmentation, kobs = 6.0 x 108s-1. 
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Scheme 27. Results from photolysis of pHP ATP and pHP diethyl phosphate in 
aqueous media.  The quantum yields for these processes are included. 
 
 
  
 Unlike unsubstituted or m-substituted phenacyl esters studied by Anderson 
and Reese50 and Givens64 which primarily generated reduced acetophenones or 
radical-based products upon photolysis in aqueous media, p-hydroxyphenylacetate 
esters and acids (96) were the predominant products of photolysis of p-
hydroxyphenacyl cages.  The putative mechanism (Scheme 28) was derived from 
several consonant studies65,66 involving photo-induced solvolyses of benzhydryl 
chlorides, and involved a sequence beginning with prompt intersystem crossing to the 
triplet (98) followed by homolytic or heterolytic bond scission to generate geminate 
radical (99a) or ion pairs (99b). For the reduced pair, a neighboring group assisted, 
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electron transfer was a possible supervening step before or after the Favorskii 
dienedione (100) and release of inorganic phosphate.  These discrepancies were the 
subject of extensive investigations by Givens, Wirz, Wan and Corrie, Phillips and 
others and will be a major theme of the study reported here. 
 
Scheme 28. Proposed mechanism for phosphate release from the pHP chromophore. 
 
 
Lastly, solvent mediated cyclopropanone ring opening was proposed to occur 
to generate the Favorskii rearrangement product, p-hydroxyphenylacetic acid (96). 
The relatively high efficacy for photo-stimulated substrate release from the pHP 
chromophore with accompanying Favorskii rearrangement provided the thrust for 
Givens, et. al.,67,68,78 not only to investigate the utility of the reaction as an effective 
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phototrigger for biologically relevant substrates, but also to experiment with the 
design of better analogs and ultimately, to understand the mechanistic features of this 
reaction.  A follow up report67 concerned the photochemistry of pHP-caged 
neurotransmitters, γ-aminobutyric acid (GABA) and l-glutamate (Glu), as depicted in 
Equation 11.  Photolysis of pHP GABA (101, Φ = 0.35) or pHP Glu (102, Φ = 0.12) 
in aqueous buffer at λ = 300 nm cleanly educed the release of GABA and Glu with 
the rearranged 96. Stability studies revealed that 101 and 102 resisted hydrolysis for 
 
 
         Eq. 11 
 
more than 24 h when placed in aqueous media, an important feature for application as 
a phototrigger.  The mechanism was posited to resemble that delineated in Scheme 
27.   
These findings served to expand the utility of pHP as a phototrigger for 
carboxylates as well as phosphates and unequivocally demonstrated an operative 
photo-Favorskii process, i.e., the discrete nucleofuge characteristics did not alter the 
photorelease pathway.  This phenomenon, as will be demonstrated later, is 
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inconsistent for nucleofuges whose conjugate acids are weaker than phenols. Other 
biologically significant carboxylic acids such as the oligopeptide bradykinin68 and  
the dipeptide (Al-Al)68 were caged by pHP and demonstrated consistent release 
efficiencies through the photo-Favorskii route.  In addition, pHP was shown to be an 
effective and precise delivery agent for Glu67 and bradykinin68 in biochemical 
neuronal function assays. These excitatory neurotransmitters evoke [Ca2+] increases 
in sensory neurons.  This effect was probed by Ca2+ sensitive dyes, FURA-267 and 
indo-1,68 that are loaded into the neurons prior to the assay.  An enhancement in the 
fluorescence intensity of these dyes as a function of [Ca2+] indicates neurotransmitter 
action at the sensory neuron.  Caged pHP bradykinin and Glu are silent in this 
regards, i.e., they effectuate no significant changes in [Ca2+] as demonstrated by no 
significant variations in the fluorescence intensity of the dye.  However, upon 
irradiation, abrupt fluorescence from the dyes was observed, indicating the neuronal 
release of augmented [Ca2+] in response to the newly liberated bradykinin or l-
glutamate. 
 Falvey69 was among the first to introduce an alternative photo-Favorskii 
mechanism to account for photosolvolysis products he observed when conducting 
LFP studies with phenacyl phenylacetate 103 in CH3CN (Equation 12).   
 
         Eq. 12 
  61 
It was anticipated that if the presumed mechanism initiated with bond homolysis 
(Scheme 29) the phenylacetoxy radical (105) would rapidly decarboxylate to form the 
benzyl radical (106),70 then dimerize to 1,2-diphenylethane (107).  However, 107 was 
detected only in minute amounts (<0.5%) by HPLC analysis after photolysis. 
 
Scheme 29. Radical pair mechanism for the formation of dibenzyl (107) from 
phenacyl caged phenylacetic acid. 
 
 
 
 
Photolysis conditions for 103 were modulated with isopropanol, a H atom donor, or 
the H atom donor tributyltin hydride, each of which divulged markedly improved 
quantum yields for disappearance.  A complex, hydrogen atom transfer 2-
hydroxypropyl (or stannyl) radical addition mechanism was posited (Scheme 30).  
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Scheme 30. Hydrogen atom transfer mechanism for substrate release. 
 
 
A transient absorption spectrum was obtained that indicated the presence of a triplet 
species (3103), which was further characterized by O2 quenching and the likeness of 
the LFP absorption spectrum (λmax = 340 nm with a lifetime τ = 5.5 ns) to 
acetophenone’s known triplet (λ = 330-350 nm, depending on solvent composition).71  
It was hypothesized that the triplet state would abstract a hydrogen atom from 
isopropanol or tributyltin hydride to generate a ketyl radical transient (108).  
Evidence for this came again from a transient absorption spectrum that exhibited a 
longer lived species with a λmax = 310 nm, corresponding nicely to known ketyl 
radicals obtained from other acetophenone derivatives.71 The triplet 108 was then 
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observed to decay to a transient with a lifetime, τ, of > 1 ms and a λmax ~330 nm; this 
entity was tentatively assigned 109a or 109b, dependent on the H-atom source and 
termed a metastable, “light absorbing transient” (LAT).72 LAT promptly disintegrated 
to 104 and 105.  Favley’s experiments explicitly demonstrated the importance of 
hydrogen atom abstraction to initiate events leading to the formation of fragmentation 
products from α−substituted acetophenone derivatives.   
 Wan and Corrie73 conducted a series of photolyses with the analogous p-
methoxyphenylacyl chromophore, specifically gauging the photorelease of a series 
carboxylic acids.  A noteworthy discovery, however, was made in that no photolysis 
was seen to occur with p-methoxyphenacyl acetate in 1:1 D2O/CD3CN after 
protracted irradiation times.  Earlier studies carried out by Givens62 had shown that 
photosolvolysis of p-methoxyphenyacyl phosphate esters readily occurred after short 
irradiation times in mixed organic media.  The nucleofuges (acetate and phosphate) 
were the only significant differences in these studies.  It follows that the nucleofuge 
character seemed to have a significant impact on the photochemistry of p-
methoxyphenacyl derivatives, akin to Bordwell’s earlier findings with ground state 
reactions. Dissimilar to “photo-inertness” of the p-methoxyphenacyl acetate, the p-
hydroxy analog revealed a photosolvolysis and rearrangement to the p-
hydroxyphenylacetic acid with a high efficiency in 1:1 H2O/CH3CN, Φ = 0.41.  The 
discrepancy in photolysis behavior asserts the pertinence of the phenolic O-H in 
photosolvolysis of these precursors.  It was reasoned, then, that initial homolytic 
scission was obviated by the assumption that the excited state electronic differences 
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between the -OH and -OCH3 moieties were negligible and hence would not be 
expected to evoke such drastic changes in the product distribution.   
 Wan and Corrie went on to suggest a singlet excited-state proton transfer 
(ESPT) mechanism to describe the photo-Favorskii rearrangement of pHP acetate 
(Scheme 31).   
 
Scheme 31. Singlet excited state proton transfer mechanism for acetate release. 
 
 
 
Cogent evidence for this mechanism was empirically derived and included: (1) 
Insignificant declines in the quantum yields for decay of 110 in 1:1 H2O/CH3CN in 
the presence of known triplet quenchers piperylene and sodium sorbate, signaling the 
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singlet state as the reactive excited state.  These findings were in direct contradiction 
to the previously mentioned report by Givens,63 where pHP ATP (95) imparted, 
unequivocally, a significant decline in Φdis in the presence of the triplet quencher, 2-
napthylsulfonate.  (2) A singlet excited state correlation with solution pH (pK(S1) ~ 1) 
and quantum yield for acetate formation, Φp, in 1:1 H2O/CH3CN was observed for 
pHP acetate.  This phenomenon was ascribed to ESPT based on consistencies with 
other pK(S1) studies.74 (3) From laser flash photolysis studies, a strong absorption 
band appeared at λmax = 330 nm that was not quenched by O2.  Absorption decay 
profiles indicated two transients, one shorter lived (112, kd = 6.3 x 106 s-1)75 and one 
longer (111, kd = 1.8 x 105 s-1)76,77 with similar λmax values (~ 330 nm). When excited, 
110 underwent rapid, adiabatic ESPT to generate 111*.  This then abided two decay 
routes; one through solvent mediated deprotonation, restoring 110, while the other 
decayed by intramolecular proton transfer and acetate dissociation to generate 100, 
and subsequent solvolysis to 96.  One additional, concerted mechanism was proposed, 
which entailed phenol deprotonation coupled with acetate departure through 
transition state 113 directly to 96 (Scheme 32). 
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Scheme 32. Concerted mechanism for acetate release from pHP. 
 
 
 Results from a comprehensive study into the identification of triplet excited 
state transients of pHP diethylphosphate were communicated by Givens and Wirz,78 
employing both direct laser flash photolysis and indirect S-V quenching methods of 
analysis.  Photolysis of pHP diethyl phosphate (114) in wet CH3CN (> 5% water) 
disclosed only the production of 96, contrasting the product mixture reported in dry 
CH3CN.  The photoreaction was accelerated 5-fold in the presence of H2O, while air 
saturation or 0.5 mM piperylene, a triplet quencher, educed a 4-fold deceleration.  
The quantum yield of diethyl phosphate release from 114, Φdis, in wet CH3CN, was 
conveyed as 0.94 from laser flash photolysis studies, which dwindled to 0.37 with 10 
mM piperylene.  To understand and interpret the laser flash photolysis results from 
114, p-hydroxyacetophenone (115) was employed as a model system, lacking a 
leaving group.  Triplet p-hydroxyacetophenone (3115) underwent singlet-triplet 
crossing with a rate constant, kISC ~ 2.7 x 1011s-1, identified by signature λmax = 370 
nm triplet-triplet absorption band in dry CH3CN that was red-shifted to λmax = 395 nm 
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in wet CH3CN. The acidity of the triplet excited p-hydroxyacetophenone was 
registered by rapid protonation of bromophenol blue, suggesting a pKa ~ -1.0 for the 
phenolic OH.  The triplet energy of 3115 as determined to be 70.5 kcal/mol79 by 
phosphorescence and accordingly was observed to transfer energy to added 
naphthalene, which has a triplet energy ET = 62 kcal/mol.78  The equilibrium constant 
for enolization of 115 with the hydroxyquinomethylene (115'), pKE, was calculated to 
be 16.4 by DFT, and subsequent dissociation constant for 115', Ka = -8.5, forming 
115-.  Ionization of 3115'  was shown to be suppressed in dry CH3CN, but occurred 
adiabatically in 50% aq. CH3CN to generate 3115-, with kion = 9.6 x 106 s-1 (pKa 4.6); 
3115- showed absorption bands similar to 3115,  λmax = 405 nm and a weaker band at 
λ = 500 nm.   
Excitation of ground state 115- at λ = 308 nm in 0.1 M NaOH manifested 
bands at λ = 405 nm and λ = 500 nm, signifying that these were due to 3115-. 
Corresponding studies in acidic solutions demonstrated that 3115- underwent rapid 
protonation with a kH+ ~  4 x 1010 M-1s-1 from the decay of the band at λmax = 350 nm.  
The enol protonated form was denoted as 3115' based on the lack of naphthalene 
quenching and supporting DFT calculations that suggested a triplet energy of 
approximately 38.4 kcal/mol.  These aforementioned results were assimilated into a 
thermodynamic cycle for the triplet manifold that parallels the ground state (Scheme 
33).   
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Scheme 33. Proposed thermodynamic cycle of p-hydroxyacetophenone (115).  
Adapted from ref. 78. 
 
 
 
The thermodynamic cycle of the triplet state proton tautomerization, 
determined from the laser flash photolysis studies of 115 and DFT modeling, was 
subsequently applied to pHP diethyl phosphate 114.  An intense absorption band at λ 
= 395 nm appeared in dry CH3CN, which was ascribed to its corresponding triplet 
3114 based on observed energy transfer to added naphthalene with a rate kET ~ 7.8 x 
109 M-1s-1 and phosphorescence spectra at 77 K in a solid matrix of ethyl ether, 
isopropanol, and isopentane (5:2:2).  The self-quenching of 3114 accelerated with 
increasing concentrations of 114, by a second order decay, ksq = 8.5 x 108 M-1s-1.  The 
decay rate of 3114 was accelerated by the addition of air or oxygen; kq = 3.0 x 109 M-
1s-1, a 2.8 fold increase in oxygen or 0-1.25 x 10-2 M piperylene that revealed kq ~ 4.5 
x 109 M-1s-1, a 1.9 fold increase.  The rate constant for phosphate release from 114 
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increased exponentially with water through 5% H2O, kdis ~ 2.8 x 107 s-1.  Above 5%, 
the rate was too fast to be measured by the LFP system utilized.  A good correlation 
between the influence of piperylene on the steady state lifetime and the time resolved 
laser flash photolysis parameters adduced a reactive triplet state for release of diethyl 
phosphate from 114.  The ratio of lifetimes of 3114 in 10 mM piperylene quencher 
(Q) in 5% aq. CH3CN were τq/τo =  kobs(kobs + kq[Q]) = 0.38.  The quinomethylene 
(3114') was monitored by acid titration with HClO4 (0.1 - 10 mM) at half-protonation, 
4.0 mM HClO4.  In accord with Wan’s findings73, Φdis of 3114 declined with 
increasing [H+], due to protonation of 3114- to form 3114'. Collectively, these findings 
adduced the triplet as the reactive state of p-hydroxyacetophenone (3115) for the 
photo-Favorskii rearrangement.   
The lack of detail in the mechanistic interpretations, the easily synthesized 
pHP ester and the available TR3 spectrometer for detailed vibration spectra of triplet 
and other sufficiently long-lived intermediates, attracted Phillips and coworkers to 
enter the research arena of the pHP photoremovable protecting group. A series of 
empirical and theoretical investigations further probed the decay mechanism of pHP. 
Their first report80 examined the excited state structures of pHP diethyl phosphate 
(114) and p-hydroxyacetophenone (115) in N2 purged CH3CN, employing picosecond 
(ps) and nanosecond (ns) Time Resolved Resonance Raman spectroscopy (TR3).  No 
bands were observed in the 0-2 ps vibrational spectrum of 115 and 114.  After 10 ps, 
however, a band at 1600 cm-1 was discerned for each, and its decay monitored on the 
nanosecond timescale.  The inception of this band was established as 5.3 and 6.7 ps, 
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respectively, with a growth rate of 86 and 150 x 109 s-1, respectively, and completely 
disappeared after ~ 200 ns (Figure 4).  The decay rates for transients of 114 and 115 
were hastened in air, implying excited triplets (3114, 3115).  This supposition was 
corroborated by Kerr-gated, time-resolved fluorescence (KGTRF) measurements of 
pHP-diethylphosphate (114) and p-hydroxyacetophenone (115) which decayed with 
rate constants kISC ~ 5 x 1011 s-1 that correlated with ~3.8 x 1011 s-1 for Givens.78 
Perhaps more importantly, however, was that this value was congruent with the ps 
growth of the 1600 cm-1 band seen by TR3 above and attributed to the triplet state of 
114 and 115.  The pump λ = 267 nm was consistent with the high energy absorption 
band of 114 and 115, stemming from a S0-S3, ππ* transition.  Excitation wavelengths 
near 300 nm were characterized by S0-S1, ππ* transitions. KGTRF data suggested 
 
Figure 4.  Left:  Time dependent decay profile of 3114 band ~1600 cm-1 with ns 3TR.  
Right: Time dependent decay profile of 3114 band ~1600 cm-1 with ns 3TR. 
Reproduced with permission from ACS, ref. 80. 
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that intersystem crossing for both 114 and 115 adhered to the nπ* S1 to ππ* T1 
pathway in both 1:1 CH3CN:H2O and neat CH3CN.   The similar decay attributes of 
triplet pHP diethyl phosphate (3114) and triplet p-hydroxyacetophenone (3115) 
gleaned from ns-TR3 and KGTRF analyses, and pHP acetate (3110)81 in neat CH3CN, 
inferred that photophysical processes of 115 were thus independent of the nucleofuge.  
This disposition, however, was reversed in a later TR3 study82 with 114 and 115 in 
aqueous CH3CN that disclosed a strong correlation between the triplet lifetime and 
nature of the nucleofuge. Energies of 3115 were computed by DFT to be 69 kcal/mol 
(cp. experimental ~70.5 and Wirz78 ~69.6) and for 3114, 67 kcal/mol (cp. 
experimental ~ 70.674).  TR3 spectra provided conformational analyses of 3115 and 
3114; DFT applications were consistent with the TR3 results.  TR3 spectra suggested 
that the carbonyl of 3115 was distorted ~160 out of plane (OOP) of the ring, in 
contrast to ground state, where the chromophore is planar.  Similarly, a ~210 OOP 
orientation of the carbonyl relative to the aryl ring was found for 3114, compared to 
~20 OOP for the ground state.  From the planarity of the carbonyl and attached 
groups, the sp2 nature of the carbonyl for the triplet species was thought to be 
preserved.   
 A second report that year81 detailed a similar set of TR3, KGTRF, and DFT 
studies for pHP acetate (110), akin to Corrie and Wan’s model.73 Coincident ps and ns 
TR3 spectra were obtained to those of 114 and 115 (Figure 5).  No activity was 
observed after initial excitation (0-2 ps), after which a time-dependent band at 1601 
cm-1 emerged at ~50 ps.  The decay of this, analogous to 114 and 115, revealed a 
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good fit to a single exponential growth and a decay function by least squares analysis; 
time constant for growth was 12 ps and 137 ns for decay in N2 purged CH3CN, 
(Figure 5).  
 
Figure 5.  Time dependent decay profile of 3110 at ~1600 cm-1 in ns-3TR spectra.  
Circles indicate degassed, triangles open air, and squares oxygen. Reproduced with 
permission from the ACS, ref. 81. 
 
 
 
In the presence of air, the decay constant decreased to 50 ns, and in oxygen to 16 ns, 
consistent with a likely triplet excited state.  Once again, the decay summary of 3110 
was consonant with triplet diethyl phosphate (3114) and triplet p-
hydroxyacetophenone (3115) and was consistent with previous work with 3110. 
Additionally, the nanosecond rate of deactivation, as indicated by the disappearance 
of bands associated with 3110, was seen to accelerate as a function of pHP 
concentration. This observation was consistent with earlier studies78 and was ascribed 
to self-quenching from head-tail hydrogen abstraction by the carbonyl from a 
neighboring phenolic OH.  To support the assignment of triplet state reactivity, KTRF 
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studies on 110 gave kISC ~ 5.0 x 1011 s-1 that were congruous with the rapid growth of 
the ~1600 cm-1 band seen in 3TR spectra and assigned to the carbonyl triplet as well 
as the results of previous studies.74,75 This result was divergent from the 1.1 µs triplet 
lifetime of 110 that Corrie and Wan73 reported.  It was believed that Corrie and Wan’s 
value was obtained in thoroughly O2 purged conditions and that residual O2 was 
believed to be the cause of a shortened, 137 ns lifetime of 3110 in Phillips’ study.   
 A fluorescence decay of 2 ps was detected that conflicted with the 12 ps 
growth of the 3110 described earlier.  Phillips, therefore, concluded that some other 
process early in the ps time regime must be active in developing the triplet TR3 
spectrum.  This was designated as triplet relaxation of surplus energy brought forth by 
efficient intersystem crossing to an unrelaxed, upper triplet.  Evidence for this 
assertion originated from frequency changes in the band centered at 1600 cm-1 up to 
200 ps; a band shift from 1570 cm-1 at 4 ps to 1601 cm-1 at 50 ps was observed.  In 
addition, band widths were reported to narrow during this time, an indication of 
excess energy relaxation. The implications for this were as follows:  The lowest 
triplet of 110 was considered to be much lower in energy than the corresponding 
singlet.  The energy gap between 1nπ* and 3nπ* had been determined to be ~1800 cm-
1 for acetophenone;83 this corresponds to 3nπ* and 3ππ* energy gap of analogous p-
hydroxyacetophenone,79 ~2500 cm-1.  Phillips reasoned that these values and the 
similarity of energies of 1ππ* and 1nπ* for 110, as determined by ground state UV 
absorption, would provide some insights into the ππ* triplet energy.  Several 
empirical studies reported a near degeneracy in lowest nπ* and ππ* triplet states of 
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acetophenone.84,79,83 Hence, the triplet state is thought to be easily perturbed by 
environmental changes, such as substituents, phase (gas, liquid, solid), solvent 
polarity, H-bonding, etc.  For example, the lowest triplet energy of acetophenone is 
considered to be nπ* in the gas phase85 and in non-polar solvents,79 and ππ* in polar 
solvents and in the solid phase.79 Most p-substituted acetophenones including pHP 
diethyl phosphate (114), are believed to have a lowest ππ* triplet both in polar and 
non-polar media.79 TR3 measurements for 110 revealed close similarities to 114, as 
did the corresponding phosphorescence profiles.  These attributes, as well as the 
likeness of their triplet lifetimes, led Phillips to conclude that 3110 is ππ* in character.  
A triplet energy of 67 kcal/mol was calculated for pHP acetate (110) by DFT that was 
in agreement with previous studies.78 Conformational analysis imparted by DFT 
revealed a ~200 OOP contortion of the carbonyl relative to the aromatic ring for 3110 
compared to a planar ground state, also consistent with other pHP analogs.    
 To discern the initial steps of substrate photorelease from pHP and 
concomitantly reconcile two disparate assertions regarding reactive state 
multiplicities, Phillips86 employed his psTR3 and nsTR3 methods for the analysis of p-
hydroxyacetophenone (115) in aqueous media.  The focus of this study was on the 
solvent-assisted deprotonation of 115, believed to be crucial in the rearrangement 
process.  This investigation derived from results of an analogous study87 of the p-
methoxy derivative of 115 in water, which substantiated a water-stimulated 
modification in properties of the triplet state vs. dry CH3CN.  Dynamics of 115 from 
ps-TR3 analysis in water are depicted in Figure 6.  Contrary to earlier results in dry  
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Figure 6.  Left:  1) Bottom - psTR3 spectrum of 115 in water.  2) Top - psTR3 
spectrum of 115 in water.  Right:  1) Bottom - psTR3 spectrum of 115 in buffer, pH = 
9.00.  2) Top - psTR3 spectrum of 115 in buffer, pH = 9.00.  Reproduced with 
permission from the ACS, ref. 86. 
 
 
 
CH3CN80 that evinced one transient species, two short-lived transients were 
conspicuous in the spectra: (1) one conveyed a band at 1600 cm-1 that correlated with 
previous studies80 in dry CH3CN, emerging at 2 ps and decaying within ~10 ns, (2) 
another showed bands at 1599, 1481, 1357, and 1167 cm-1 that decayed within 95 ns. 
When measured in N2 purged water, the decay of bands associated with the second 
transient lengthened to 140 ns, a clear indication of O2 quenching and evidence for a 
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triplet reactive state.  The new transient was ascribed to H-bonding between the 
solvent and 3115, not evidenced in aprotic CH3CN, and now distinguished as 3115'.  
Results of ps-TR3 analysis of 115 in buffer, pH = 9.00 (Figure 6) revealed that the 
formation of the new entity was faster than in neutral water, and was the sole entity 
that emerged in the ns spectrum.  It was deduced that this species was the triplet p-
hydroxyacetophenone anion (3115-).  The direct excitation of a ground state anion of 
115 under these conditions was precluded on the basis of its very low ε at the pump λ 
= 267 nm, and probe wavelengths of 400 and 415 nm.  Control experiments in basic 
solutions with 115- as the conjugate base tautomer and using a pump wavelength of λ 
= 341 nm, produced parallel spectra that had similar triplet decay dynamics, thus 
supporting the likelihood of 3115- as the intermediate.  Full Raman spectral 
assignments of bands associated with 3115- and the corresponding protonated 
tautomer (3115) manifested salient differences that were reproduced by DFT model 
calculations.   
 The kinetic profile of 3115 was shown to be a good fit for a two-exponential 
function comprised of a growth, 90 ns, and decay constant, 200 ns. Control TR3 
experiments with 115 in acidic media (pH = 1) demonstrated the presence of only this 
entity.  A similar transient was observed from Wirz and Givens78 at low pH, and was 
tentatively designated as a quinoid enol triplet (115') (Scheme 32).   From this 
comprehensive study, it was inferred that an excited state deprotonation step was 
plausible for pHP, and 3115- a likely precursor to nucleofuge release.  An optimized 
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conformation from DFT fit of TR3 spectra for triplet p-hydroxyacetophenone 3115 in 
water is depicted in Figure 7.   
 
Figure 7.  DFT determined, optimized geometry and bond distances (Ǻ) of 3115 in 
water.  Reproduced with permission by the ACS, ref 86. 
 
 
 
 
 The results depicted extensive hydrogen bonding between water and 3115. 
Two water molecules associated with the phenolic O-H, affording 14.8 kcal/mol of 
stabilization energy; one water molecule interacted with the carbonyl moiety, 
affording 6.8 kcal/mol of stabilization energy. H-bonding with the phenolic O-H was 
thought to preface water-mediated deprotonation of triplet p-hydroxyacetophenone 
(3115) to the corresponding the triplet anion, 3115-.  This event seemed plausible by 
the increased acidity of the phenolic proton of 115 in the triplet state, pKa = 3.6, 
compared to the ground state, pKa = 7.6.78 TR3 analysis disclosed an unspecified 
transient (termed X) that emerged contemporaneously with 3115-; this entity exhibited 
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a decay constant of 88 ns, similar to 95 ns for 3115-.  UV measurements of the 115 
after TR3 analysis manifested no significant degradation, leading Phillips to conclude 
that X rapidly deactivates back to ground state 115.  No further efforts were 
conducted to identify X.  TR3 and DFT results were assimilated to propose a decay 
and deprotonation mechanism for 115 (Scheme 34). This mechanism deviated from 
 
Scheme 34. Phillips proposed mechanism for excited state processes of p-
hydroxyacetophenone (115).  
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Wirz and Givens’ (Scheme 32), chiefly in regards to the identification of X. Givens 
and Wirz assigned this to the triplet enol (3115') formed from a step involving 
solvent-induced protonation of 3115-.  The aforementioned TR3 measurements of 115 
in water manifested concomitant formation of 3115- and X that represented the decay 
of 3115.  Experiments conducted in acidic media, where a reprotonation step is 
obviated, indicated a direct decay route of 3115 through X.  Having elucidated the 
sequence of photophysical and reaction events leading up to substrate release from 
pHP, Phillips turned to mechanism of substrate release, the heart of the photo-
Favorskii reaction.88  
As before, ps and ns-TR3 spectroscopy were employed along with 
femtosecond transient absorption (fsTA) spectroscopy, for the investigations of pHP 
diethyl phosphate (114) and pHP diphenyl phosphate (116) in dry and 1:1 
CH3CN:H2O (aq. CH3CN) solutions.  Results from fsTA analysis of 114 in both 
solvents revealed the formation of a strong absorption band at ~400 nm while one at 
~320 nm decayed rapidly; one exponential function fit the simultaneous growth and 
decay components, with a time constant of 2.5 ps.  This value matched the ISC 
constant derived previously80 and implied a rapid ISC to the triplet state.  Pronounced 
changes in shape of the 400 nm band from 4 to 35 ps were observed in aq. CH3CN 
but not in neat CH3CN; the band was wide and structureless earlier than 4 ps, but 
better defined later.  Phillips ascribed this occurrence to specific solvent-solute 
interactions, such as H-bonding.  Investigations with fsTA of p-hydroxyacetophenone 
(115) in aq. CH3CN exhibited no such shifts in the band shape at 400 nm. Concerning 
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116, fsTA measurements were congruent with 114, imputing structurally similar 
triplet reactive states.  The triplet lifetimes of these, however, proved to be different, 
as determined by TR3 analysis; 3114 exhibited ~ 150 ns lifetime in CH3CN and ~350 
ps in aq. CH3CN.  Those for 3116 were ~27 ns in CH3CN, ~150 ps in aq. CH3CN.  A 
synopsis for decay profiles of pHP diethyl phosphate (3114) and pHP 
diphenylphosphate (3116) as a function of water concentration are presented in Table 
13, with pHP acetate (3110) for comparison.82 Hydrogen ion dissociation constants, 
pKa, for the nucleofuges were included; these directly correlate with the respective 
anion stabilities in aqueous media as well as relative leaving group ability in the 
context of heterolysis in aqueous media.  A higher pKa indicates a more stabilized, 
anionic leaving group. A noticeable trend was observed between the pKa and triplet 
lifetime; 3116, with the lowest nucleofuge pKa of 0.4, manifested the shortest triplet 
lifetime, 150 ps in aq. CH3CN, while for 3110 with a pKa of 4.76, one order of 
magnitude longer at 2.130 ns.  
 
Table 13.  Time constants for triplet decays of 116, 114, and 110 in mixed 
CH3CN/H2O solvents and corresponding pKa’s of the nucleofuge.  Table adapted 
from ref. 88. 
 
   triplet decay (τ1, ps)   
H2O % (vol)         
 75% 50% 40% 30% 25% 15% 10% pKa 
         
pHP diphenyl phosphate, 3116  150     830 0.4 
pHP diethyl phosphate, 3114 290 350 530 800 1280 2400 9000 1.39 
pHP acetate, 3110  2130      4.76 
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A correlation between water concentration and triplet lifetime was also 
apparent; the lifetime of 3114 progressively shortened as the water content increased, 
with initial pronounced changes (10%-30% 11.2-fold, 30-50%, 2.2-fold, and 50-75%, 
1.2-fold) and later leveling off as water was added. The same was observed for 3116, 
though not to the same caliber.  Stern-Volmer analysis of 114 and 116 evinced a 
curved, near quadratic dependence on water concentration (Figure 8).  Presupposing 
that water addition influences heterolysis in a non-linear fashion,88 the S-V results 
indicated a likely, triplet heterolytic dissociation route for phosphates from excited 
state 114 and 116.  The salient influence of water concentration asserts that water is 
not only involved in early pHP deprotonation but also in the rearrangement 
(solvolysis) step.  These studies adduce a 2nd order dependence of the triplet lifetime 
on water. 
 
Figure 8.  Stern Volmer  analysis of  3114 lifetimes as a function of water 
concentration, in percentage.  Reproduced with permission by the ACS, ref. 88. 
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Solvation of the nucleofuge, as well as the pHP chromophore, was considered 
to be an important constituent in the correlation between triplet decay dynamics and 
leaving group ability, demonstrated in Table 9.  The double bonded oxygen of 
phosphate, like the carbonyl, has strong basic character and hence would be expected 
to interact strongly with water as an H-bond acceptor.  The effect of this interaction is 
an electrophilic pull towards ionization. Acidic and basic sites of the pHP 
chromophore and nucleofuge are anticipated to be strongly solvated by water.  To 
corroborate this “concerted” solvation premise, fsTA studies were performed with 
114 in DMSO, a H-bond acceptor but poor donor, and trifluoroethanol (TFE), an H-
bond donor but poor acceptor. In DMSO, the fsTA spectrum, denoting the triplet 
decay profile, was akin to that obtained in dry CH3CN and demonstrated a triplet 
lifetime > 200 ns with an accompanying low quantum yield (<0.01).  In TFE, a 
slightly shorter triplet lifetime was reported, as well as a low quantum yield (no data 
was provided for this).  However, a 1:1 combination of DMSO/TFE revealed a 
significantly shortened lifetime for triplet pHP diethyl phosphate (3114) and a 
quantum yield of 0.17 for phosphate release.  These findings seem to support a 
general requirement for “concerted” solvation of the pHP chromophore and 
nucleofuge for efficient nucleofuge release from the excited state pHP chromophore.  
A comparison of spectra obtained from psTR3 analysis of 114 and an authentic 
sample of rearranged p-hydroxyphenylacetic acid photoproduct (95) (pump λ = 267 
nm, probe λ = 200 nm) in 1:1 CH3CN:H2O was carried out to inspect the formation 
dynamics of 95.  The formation and growth of bands following excitation of 114 were 
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undeniably associated with the formation of 95.  A first order exponential curve fit 
resulted in a time constant of ~1100 ps.  When comparing this to the triplet delay for 
114 (~350 ps), a discrepancy was ostensible between the rearrangement reaction and 
triplet decay.  The triplet decay was associated with nucleofuge (phosphate) 
disjunction; hence, to account for the delay time (~750 ps) between the triplet decay 
and formation of p-hydroxyphenylacetic acid (95), an intermediate (M) was proposed 
in Scheme 35 and thought to be produced immediately after nucleofuge disjunction 
but before the appearance of 95.  An evasive, but accepted intermediate in the 
Favorskii reaction is cyclopropanone (100) which, as of yet, has not been detected. 
Thus, M, was perceived as a likely fit for 100, but necessitated corroborating data. 
 
Scheme 35. Proposed intermediate precursor to rearranged product. 
 
 
A formula was proposed to describe the formation of 95 from 3114 (Equation 13).   
 
 [95] = {[3121]/(k2-k1)} * [k2(1-e-k1t) - (k1(1-e-k2t)]   
         Eq. 13 
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The rate for phosphate detachment and decay of 3114 to M, k1, was deemed to be 
much faster than k2.  Efforts were concentrated on determining the rate of 
rearrangement, k2, through psTR3 measurements in CH3CN with various water at 
pump λ = 267 nm, probe λ = 200 nm.  From exponential fits of the spectra, k2 was 
determined to be 1.69 x 10-9 s-1 (k2 = 1/τ2, t2 ~ 470 ps) and was found to be insensitive 
to the water concentration.  To quantify the formation of M, as a model system, 
equation 14, derived directly from equation 13, was applied. Though not empirically 
 
   [X] = [3114]*[(k1/(k2-k1))*(e-k1t-e-k2t)] 
      Eq. 14 
 
confirmed, a solvent assisted, “push-pull” neighboring group89 stimulus from the H-
bonded solvent was postulated to afford M as a solvated complex containing features  
 
Figure 9.  Phillips’ proposed structure of unknown, M, as a solvation/contact ion pair 
complex. 
 
 
  85 
of a contact ion pair of α-protonated cyclopropanone (100) and liberated phosphate 
anion (Figure 9, with 114).  Calculations with DFT at the random phase 
approximations (RPA) of 100 indicated an electronic transition with a large oscillator 
strength at λ ~ 274 nm, which was consistent with a spectral band at λ = 274 nm 
associated with M.  Further empirical attempts to bolster this structural hypothesis, 
such as Kerr gated ps-TR3 were ineffectual, probably due to the relatively low 
concentration of M expected when k2 >>>k1 (steady state condition) as well as the 
lack of a strong absorption band between 300 to 700 nm when probed by fsTA.  
Incorporation of the mechanistic features acquired from these studies compelled 
Phillips88 to propose a new, detailed photo-Favorskii rearrangement to account for the 
formation of 95 (Scheme 36). The salient attributes of this mechanism are: (1) The 
rate of (a) is largely dependent on the water content and nature of the nucleofuge; (2) 
The rate of (b) is dependent on the nature of the nucleofuge but mainly independent 
of water concentration.  Phillips conveyed two more comprehensive, though 
theoretical, investigations concerning the excited state photochemistry of pHP acetate 
(110)90 and the role of water in assisting the nucleofuge disjunction/solvolytic 
rearrangement steps of the photo-Favorskii rearrangement for 3114 and 3116.91  
Information gleaned from these studies served to corroborate hypotheses derived 
from earlier, empirical data,80 and are beyond the scope of this introduction. 
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Scheme 36. Posited mechanism for phosphate release from the pHP chromophore. 
 
 
 
 In the latest installment of the ongoing exploration of the photo-Favorskii 
rearrangement, Givens and Wirz,92 reported the detection of an anionic pHP triplet 
biradical (117) in the reaction course of excited pHP diethyl phosphate (114), pHP 
tosylate (118) and pHP mesylate (119) from time resolved IR and UV studies.  An 
amended, generalized mechanism was proposed and represented in Scheme 37.   
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Scheme 37. Proposed mechanism for diethyl phosphate release from pHP. 
 
 
 
 
 It was revealed that the lifetime of 3114 reduced from ~0.4 ns in 50% aq. 
CH3CN88 to ~100 ps in 87% aq. CH3CN and ~63 ps in 100% H2O.  Transient 
absorption spectra for 118 and 119 were consistent with 114. Decay kinetics of 3114 
accorded with those reported by Phillips.80 However, new transient absorption bands 
were detected at 445 and 420 nm, and were assigned to triplet biradical (117) based 
on the likeness of shape, location, and weak intensity of analogous phenoxy 
radicals.93 MP2 calculations predicted the carbonyl of 117 to be contorted 27o out of 
plane from the aromatic ring.  TDFT and open shell PPP SCF CI94 calculations failed 
to detect the singlet analog of 117, implying an expeditive cyclization to 100 after 
ISC.  Efforts to detect 100 by step scan FTIR, anticipated to be found at ~1880 cm-1 92 
were ineffectual (Figure 10).   
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Figure 10.  Step-scan FTIR of 114 in CD3CN (2% D2O) at 50 ns (red) and 1µs (blue) 
delay.  Reproduced with permission from the ACS. 
 
 
 
 
However, bands at 1450 and 1300 cm-1 were immediately discerned after excitation 
and promptly decayed (first order) with a coincident emergence of another band at 
1647 cm-1, k ~ 8.5 x 106 s-1 (2% D2O in CD3CN).  This rate of appearance was 
accelerated with additional water at the expense of band amplitude.  This was 
tentatively designated as the p-quinone methide (120) and was congruent with results 
from recent work by Kresge95 et. al., in the photolysis of p-hydroxybenzyl acetate.  
Nanosecond LFP evaluation of pHP diethyl phosphate (114) in wet CH3CN supported 
the configuration of this transient; excitation of 3114, λ = 395 nm, produced an 
absorbing species, λ = 276 nm, which was relatively long-lived (k ~ 0.01 s-1 in 5% 
H2O, 0.05 s-1 in 10% H2O) and waned with increasing water content.  Kresge95 
reported a rate constant of 3.3 s-1 in 100% water. These observations provided strong 
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support for the triplet biradical (117).  Low temperature 1H NMR, (-25oC, 2.5% D2O 
in CD3CN) of 114 conveyed the abrupt emergence of peaks associated with 120 upon 
irradiation.  The likely route to the formation of 120 is through CO extrusion of 
spirodiendione (100).  To further elucidate the role of water in the photoreaction, 
SKIE were probed with pHP acetate (114) using ns-LFP (degassed, 10% aq. CH3CN, 
25oC), with a particular focus on the decay kinetics of 3114.  In addition, a secondary 
photoproduct, p-hydroxybenzyl alcohol (121), was asserted from the putative p-
quinone methide (120), derived from solvent kinetic isotope studies (SKIE) using 
laser flash photolysis (ns-LFP) in 87% aq. CH3CN (Table 14). 
 
Table 14.  Rate constants, kobs, for decay of 3114 as a function of the D/H mole 
fraction, n, using ns-LFP in 10% aq. CH3CN at 25oC. Table adapted from ref. 92. 
 
na average kobs (106 s-1) kH/kn 
0.00 11.4 ± 0.14 1.00 
0.20 9.53 ± 0.07 1.20 
0.40 8.36 ± 0.04 1.36 
0.60 7.24 ± 0.03 1.57 
0.80 6.29 ± 0.03 1.81 
1.00 5.25 ± 0.06 2.17 
an = mole fraction = nD/(nd + nH). 
 
 
By employing the proton inventory method96 of analysis the total SKIE was 
determined to be 2.17.  Decay constants for 3114, kobs, were then plotted against 
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Figure 11.  Plot of kobs of 3114 vs. mole fraction of deuterium in degassed, 10% aq. 
CH3CN at 25oC.  The black line signifies the expected correlation for a single site 
isotope effect (v = 1), see equation 4. The lower line indicates a multisite, general 
solvation (v = ).  The central two lines represent a two site effect (red, v = 2), and a 
three site effect (blue, v = 3).  Reprinted with permission from the ACS. 
 
 
 
 
deuterium mole fractions, nD, depicted in Figure 11. An appropriate comparison 
(Equation 15) was exploited to model the solvent kinetic isotope results where n is the 
mole fraction and v represents the number of isotope effect sites on 3114. 
    
    kn/kH = (1 - n + n[kH/kD]-1)v 
   Eq. 15 
 
When v = 1, the entire isotope effect (kH/kD = 2.17, Table 10) is realized at one site.  
When v = 2, two sites are equally affected, as in conterminous, two-proton transfer 
(kH/kD = 2.171/2 = 1.47).  When v = 3, three sites are uniformly impacted, (kH/kD = 
  91 
2.171/3 = 1.30), and when v = ∞ a general solvation condition at multiple sites by 
water is effected.96  The plot clearly exhibited a curved line, precluding a one site 
effect, while advancing a minimum of two site H-bonding between triplet pHP 
acetate 3114 and the solvent.  The phenolic proton of 3114 was calculated to be more 
than 4 orders of magnitude more acidic that 114, whereas, the carbonyl moiety is 
more basic.78 Two site SKIE results were in good agreement with these properties; a) 
one site, a robust H-bond donation of the phenolic proton to the enveloping water 
molecules and b) the other site, H-bond accepting of the carbonyl with the 
surrounding water molecules with concomitant phosphate departure.  These results 
confirm that hydration is a sine qua non for the photo-Favorskii reaction, as 
previously asserted by Wan,73 Givens,78 and Phillips.80,81,82, 86,87,88,89 
 A prodigious quantity of information has been gleaned over the past decade 
with respect to the photo-Favorskii rearrangement.  This has advanced a number of 
appropriate mechanisms to account for the steps leading to formation of the signature, 
rearranged phenylacetic acid (ester) photoproduct.  Further studies are warranted, 
however, to further improve the overall comprehension of the photo-Favorskii 
rearrangement, much the same as Bordwell’s pervasive studies on the ground state 
Favorskii rearrangement, such as the impacts of substituents, added salt (ionic 
strength), and media among others, which have received little or no attention. 
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Statement of Problem 
 
 
The p-hydroxyphenacyl (pHP) chromophore has received a considerable amount of 
attention over the past decade as a versatile photoremovable protecting group for a 
wide variety of substrates.  The intriguing rearrangement of pHP that accompanies 
photoinduced substrate release has been equated with the well known, ground state 
Favorskii rearrangement.  This excited state process, therefore, has been termed the 
“photo-Favorskii” rearrangement.  Several working mechanisms for this process have 
been posited, primarily from theoretical and spectroscopic studies.   
 These mechanistic studies, though useful in bringing together preliminary 
details on the rearrangement of the pHP chromophore, are narrowly restricted in 
scope, which emphasize only a small pool of pHP derivatives and photolysis 
conditions.  A number of programmed modifications of the photo-Favorskii 
substrates and conditions would add immeasurably to our understanding and would 
further elucidate the mechanistic picture of this rearrangement:  1) Would electron 
donating or withdrawing substituents on pHP impact the photorelease of substrates?  
2) Is there a positional effect expressed by the substituents?  If so, what are its 
origins?  Fluorine, from its inherently high electronegativity and lipophilicity, is an 
attractive substituent for pHP for the investigation of electronic effects on the 
photochemistry, solvent and solubility property effects, and spectroscopic 
characteristics.  3) The λmax of pHP at 280 nm extends slightly past 300 nm at 1 mM, 
a concentration that is typical for photolysis reactions.  One goal of this research has 
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been to extend the absorption profile of pHP beyond 350 nm, making it more 
amenable for biological studies.  The m-methoxy moiety has been the sole 
auxochrome investigated at this time; other groups and additional approaches 
addressing this goal could provide favorable efficiencies and extended λmax.  4) The 
range of leaving groups or nucleofuges examined in mechanistic studies of the photo-
Favorskii reaction has also been confined.  An expansion of substrates, especially to 
establish the limiting parameters of the nucleofuge and the determination of 
correlations between the nature of the nucleofuge and photorelease parameters, would 
be useful.  5) Lastly, the majority of studies tailored for the investigation of the 
mechanism of the photo-Favorskii rearrangement have employed water and/or 
aqueous acetonitrile as the media.  The variations of standard physical organic 
parameters related to the media, such as ionic strength, pH, water content, and 
lipophilicity, that influence the photoreactivity and product outcomes of pHP caged 
compounds have not been established and would certainly improve our mechanistic 
understanding of the photo-Favorskii rearrangement.       
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Results 
 
 
 
I. Synthetic Methodologies  
 
A.   pHP GABA series (122-141) and 4-fluorophenacyl GABA (142).  The novel 
pHP GABA esters that were synthesized along with 4-fluorophenacyl GABA are 
depicted in Figure 12. 
 
Figure 12.  Novel pHP GABA esters. 
 
 
 
 
 
1) Synthesis of 4-(2-(3-fluoro-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-
aminium 2,2,2-trifluoroacetate, (m-F-pHP GABA, 122).  The synthesis of 122 
(Scheme 38) was initiated with commercially available 4-bromo-2-fluorophenol, 
(122a), which was reacted with benzyl bromide to produce the benzyl protected 122b 
in high yield.  Protection of the phenol was required prior to the supervening, 
acetylation step.  The benzyl moiety is robust to severe conditions and easily removed 
  95 
when appropriate; thus it was a logical choice as a protecting group.  Stille conditions, 
entailing the use of tributyl-1-ethoxy(vinyl)stannane and Pd(0) in an inert atmosphere 
were then applied to 122b, effectuating 122c in 89% yield.  This approach to 
acetylation has received very little attention, in fact none for preparing p-
hydroxyacetophenones from phenol precursors.  We have refined this methodology to 
the point where we routinely obtain >80% yields of targeted compounds.  The 
supervening step entailed α-bromination of 122c through reaction with dioxane-
dibromide at 0oC, furnishing 122d in ~95% yield as estimated by 1H NMR.  Prudence 
was required to prevent α,α’-dibromination from occurring; the reaction was 
generally halted before complete conversion and the yield was estimated by GC/MS 
or 1H NMR.  Separation of 122d from 122c was cumbersome and not essential to the 
subsequent, caging step; thus, in subsequent studies, no purification was attempted. 
The procedures through the α-bromination step were routinely used for all pHP and 
5-acetylsalicylic acid derivatives.  The penultimate step, arguably the most critical, 
encompassed the “caging” or coupling of GABA with the pHP chromophore.  
Specifically, 122d underwent a facile SN2 reaction with the carboxylic acid terminus 
of N-Boc protected GABA (Boc, tert-butoxycarbonyl) at room temperature in the 
presence of potassium carbonate, to afford the fully carbamate protected pHP-ester, 
122e in 89% yield.  This substrate coupling procedure was commonly used for all 
carboxylic acid containing substrates, such as GABA, Glu, and long chain alkanes. 
Complete deprotection, i.e., the removal of the Boc and benzyl moieties of 122e was 
effected with distilled trifluoroacetic acid (TFA), 0oC to room temperature, over a 24    
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Scheme 38. The synthesis of m-F-pHP GABA (122). 
 
 
 
h period.  After lyophilization, 122 was produced in 78% yield.  The fabrication of 
123-132 followed a congruent set of steps as 122.     
 The synthetic sequence for 133-139 was initiated with commercially available 
p-hydroxyacetophenones. The m,m’-OCH3-pHP GABA (133) and m-OCH3-pHP 
GABA (134) were assembled following the procedure in a prior report.97 A modified 
synthetic procedure for 135-139 was utilized compared to 133 in efforts to achieve a 
better overall yield. 
2) Synthesis of 4-(2-(2,4-dihydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-
2,2,2-trifluoroacetate, (o-OH-pHP GABA, 135).  The synthetic strategy for 135 is 
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depicted in Scheme 39.  To ensure that complete benzylation of commercially 
available 1-(2,4-dihydroxyphenyl)ethanone (135b) was achieved, 3 equivalents of 
benzyl bromide and 4 equivalents of potassium carbonate were used and reacted for 
36 h under mild conditions.  After purification, 135b was furnished in 97% yield.  
Bromination to 135c was accomplished under standard conditions in ~94% yield by 
1H NMR.  The coupling of N-Boc GABA with 135c was achieved under standard 
conditions, though exhibited lower yields than other pHP’s giving, 135d in 48% 
yield.  The diminished yield for this step may originate from a steric effect of the o-
benzyl group. One additional step involving the facile removal of the benzyl 
constituent of 135d was used.   The method entailed dissolving 135d in ethyl acetate, 
adding activated Pd/C (30% w/w), and then plugging the reaction vessel with a 
septum.  While lightly stirring, hydrogen gas (H2) was suffused into the reaction 
vessel by balloon through a long needle positioned near the surface of the solution. A 
short needle was added as an outlet to permit gas to escape; thus the atmosphere 
becomes saturated with H2 generally after one full balloon, at which time the short 
needle is removed to prevent air from entering the vessel.  Prudence was required in 
the handling of the reaction not only due to the heightened flammability imparted by 
H2 but also Pd/C, which itself is extremely flammable.  After H2 addition, the reaction 
was monitored closely by TLC to prevent undesired reduction of the carbonyl moiety.  
Complete conversion was achieved after 4 h.  Following workup and drying, 135e 
was afforded in 97% yield.  The last step differed slightly from that used for 122-131.  
135e was immersed in 1:1 mixture of a TFA:CH2Cl2 solution at room temperature. 
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Scheme 39. Synthesis of the o-OH derivative of pHP GABA (135). 
 
 
  
Significant effervescence was observed from the degradation of the Boc group to CO2 
and isobutylene; the reaction proceeded for ~15 min, and following lyophilization, 
effected 135 in 85% yield. 
 Compounds 136-139 were generated in a manner analogous to 135.  When 
necessary, very slight variations and concentrations in the methodology were used. 
The yields in each step did not diverge significantly excepting the N-Boc coupling 
step.  Here, yields of 136d-139d were much improved (>80%); presumably, no o-
substituent of the magnitude of benzyl ether (135d) encumbered the substitution 
process.  
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 Compounds 140 and 141 represented enantiomeric mixtures of α-methyl and 
ethyl-pHP GABA analogs (α-methyl and ethyl-pHP GABA, Figure 13).   
 
Figure 13. α-methyl and ethyl-pHP GABA enantiomers, (R,S)-140 and (R,S)-141 
respectively. 
 
 
 
 
The synthetic procedure to (R,S)-140 is outlined in Scheme 40.  The reaction series 
commenced with commercially available p-hydroxypropiophenone (140a) which was 
then benzylated to 140b, α-brominated to racemic 140c and coupled with N-Boc 
GABA to furnish (R,S)-140d as a racemate.  Resolution of these using normal phase 
flash chromatography with various eluents and HPLC was unsuccessful.  Subsequent 
benzyl deprotection to (R,S)-140e also defied resolution as did the products after Boc 
deprotection to generate (R,S)-140.  Further efforts to isolate these enantiomers from 
one another were unsuccessful. The α-ethyl analogs, (R,S)-141, were synthesized by 
the same procedure as above and were not successfully resolved either. 
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Scheme 40. Synthesis of α-methyl-pHP GABA enantiomers, (R,S)-140. 
 
 
3) Synthesis of 4-(2-(4-fluorophenyl)-2-oxoethoxy)-4-oxobutan-1-aminium 2,2,2-
trifluoroacetate, (4-fluorophenacyl GABA, 142).  The preparation of 4-(2-(4-
fluoro-phenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-trifluoroacetate (142) 
patterned closely after the sequence to generate 135 (Scheme 41); the starting 
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material consisted of 4-fluoroacetophenone (142a).  The objective in preparing 142 
was to examine the π electron donating ability of fluorine, a mimic of hydroxyl, in 
assisting the photorelease of GABA. 
 
Scheme 41. Synthesis of 4-fluorophenacyl GABA (142). 
 
 
B.  pHP-caged l-Glu series. A small suite of pHP l-glutamate (Glu) compounds were 
synthesized; these are listed in Figure 14. 
 
Figure 14. pHP Glu derivatives, 143-145. 
 
 
 
The synthesis of pHP l-glutamate derivatives (pHP Glu, 143-145) involved a 
congruent set of steps with that of 122; the yields for corresponding intermediates 
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were equable with those for 122 as well.  A minor alteration for Glu, however, was an 
additional tert-butyl moiety that served to protect the ancillary carboxylic acid 
(Scheme 42). The effective removal of both the N-Boc and tert-butyl ester from Glu 
required extra reaction time in TFA:CH2Cl2 (1:1), approximately 2 h at room 
temperature.  
 
Scheme 42. Synthesis of m-F-pHP Glu (144). 
 
 
 
  C. Other pHP caged amino-acids. Four additional amino acids were caged to the 
pHP chromophore (146-149).  These compounds are listed in Figure 15. 
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Figure 15. Other pHP caged amino acids, 146-149. 
 
  
1) Synthesis of 2-(2-(4-hydroxyphenyl)-2-oxoethoxy)-2-oxoethanaminium 2,2,2-
trifluoroacetate, (pHP Gly, 146).  The synthetic progression of steps towards pHP 
Gly (146), are depicted in Scheme 43 and are similar to the sequence for pHP GABA. 
The sequence commenced with the benzylation of p-hydroxyacetophenone using 
standard conditions, affording 146b in 98%.  Bromination with DDB efficaciously 
generated 146c in ~95% yield as indicated by 1H NMR. The supervening coupling of 
146c with a slight excess of N-Boc Gly in the presence of potassium carbonate, 
afforded 146d in 95% yield, which, subsequently underwent Pd catalyzed 
debenzylation to form pHP N-Boc Gly (146e) in 94%. The last short step was routine 
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Scheme 43. Synthesis of pHP Gly (146). 
 
 
Boc removal to furnish 146 in 79% yield.   The assembly of 147-149 paralleled that 
for 146.  The other amino acids all possessed Boc-protected amine functionalities, 
akin to Gly; accordingly they were caged to pHP through their carboxylate termini. 
 
D.  pHP Deoxycholic acid.  The bile acid, deoxcholic acid (DOC), was caged to the 
pHP chromophore.   
1) The synthesis of (4R)-2-(4-hydroxyphenyl)-2-oxo-ethyl-4-((3R,5R,8R 
10S,12S,13R,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclo-penta 
[a]phenanthren-17-yl)pentanoate, (pHP DOC, 150).  The construction of (4R)-2-
(4-hydroxyphenyl)-2-oxoethyl-4-((3R,5R,8R,10S,12S,13R,17R)-3,12-dihydroxy-
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10,13-dimethyl-hexadeca-hydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate 
(150) is illustrated in Scheme 44.  The caging step of DOC was similar to 122e. 
 
Scheme 44. Synthesis of pHP DOC (150). 
 
 
but DMF was employed instead of CH3CN for solubility reasons, producing 146d in 
84% yield.  Reductive hydrogenation of 146d followed under standard conditions and 
afforded 150 in 93% yield. 
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E.  pHP Diethyl phosphonate.  A diethyl phosphonate moiety was tethered to the 
pHP chromophore. 
1) Synthesis of diethyl 2-(4-hydroxyphenyl)-2-oxoethylphosphonate, (pHP 
diethyl phosphonate, 151).  The preparation of 2-(4-(hydroxyphenyl)-2-oxoethyl-
phosphonate (151) to explore the nucleofuge ability of the phosphonate moiety, is 
displayed in Scheme 45.  The initial reaction involved the Michaelis-Arbuzov 
protocol;98 146c was heated to 100oC in dry triethylphosphite for 17 h, effectuating 
151d in 86% yield.  Catalytic debenzylation of 151d then afforded 151 in 96% yield. 
 
 Scheme 45. Synthesis of pHP diethyl phosphonate (151). 
 
 
F.  pHP F.  Fluoride was caged by the pHP chromophore.  
1) Synthesis of 2-fluoro-1-(4-hydroxyphenyl)ethanone, pHP F 152. 
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The short series of chemical transformations to make 2-fluoro-1-(4-hydroxy-phenyl)-
ethanone (152) was a study on the efficacy of fluoride release and is represented in 
Scheme 46.  A facile SN2 reaction between cesium fluoride and 146c in refluxing 
CH3CN for 3 h quantitatively produced 152d by GC/MS analysis, 90% isolated yield.  
This was followed by a standard Pd/C reduction protocol to debenzylation of 152d, 
engendering 152 in 92% isolated yield. 
 
Scheme 46. Synthesis of pHP F (152). 
 
 
G.  5-acetylsalicylate and salicylamide GABA’s.  An array of novel 5-
acetylsalicylate GABA and alkyl esters and one 5-acetylsalicylamide were assembled 
to distinguish possible antennae effects on GABA release.  These, 153, 154, and 157-
165 are represented in Figure 16.  Compounds 155 and 156, which possess alkanoyl 
substrates in place of GABA, will be introduced later. 
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Figure 16. 5-acetylsalicylic acid and salicylate GABA derivatives, 153, 154, 157-
165. 
 
 
1) Synthesis of 4-(2-(3-carboxy-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-
aminium-2,2,2-trifluoroacetate, (5-acetylsalicylic acid GABA, 153).  The synthetic 
approach to 4-(2-(3-carboxy-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-
aminium-2,2,2-trifluoroacetate (153), for a substituent effect study on GABA release, 
is manifest in Scheme 47.  The precursor, 5-acetylsalicylic acid (153a) was reacted 
with a surfeit of benzyl bromide and potassium carbonate, the same approach to 
generate 135b,  to provide the dibenzylated analog; the ensuing string of steps to 
produce 153 were analogous to those previously described for GABA coupling and 
complete deprotection.  The starting material utilized in the preparation of 154 was 
the methyl ester of 153a; an ordinary sequence of steps was followed for the coupling 
of GABA and subsequent deprotection.   
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Scheme 47. Synthesis of 5-acetylsalicylic acid GABA (153). 
 
 
2) Synthesis of 4-(2-(3-(4-benzoylphenylcarbamoyl)-4-hydroxyphenyl)-2-
oxoethoxy)-4-oxobutan-1-aminium 2,2,2-trifluoroacetate, (5-acetyl salicylamide 
benzophenone GABA, 157).  The procedure to compose 157 is divulged in Scheme 
48.  The initial step involved the benzyl protection of commercially available 157a 
under standard conditions that was then hydrolyzed in 6 M KOH for 2 h at room 
temperature generating benzyl protected 5-acetylsalicylic acid (157b) in 98% yield 
after workup with conc. HCl.  The second step involved concerned a Steglich 
esterification,99 whereby 157b was reacted with DCC and 4-aminobenzophenone in 
  110 
Scheme 48. 5-acetyl salicylamide benzophenone GABA (157). 
 
 
 
the presence of DMAP at 0oC for 12 h.  After filtration to remove dicyclohexylurea 
(DCU), a byproduct of the reaction, and purification, 157c was generated in 74% 
yield.  Subsequent conversion to the α-bromo analog (157d) was facile by standard 
procedure.  N-Boc GABA coupling to 157d proved to be challenging.  The reaction 
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was attempted several times; the number of equivalents of N-Boc GABA was altered 
from 1.3 to 2.5 and reaction times from 24 to 48 h.  TLC did not provide sufficient 
evidence to determine the extent of conversion and hence was abandoned.  The 
reaction yields hovered around 46% irrespective of changes in conditions.  At this 
time no explanation can be provided to account for the relatively low yields.  
Standard deprotection procedures converted 157d to 157 in relatively high yield. The 
same protocol was utilized to assemble 158-165.   
 The limiting step in the succession proved to be Pd-mediated hydrogenation to 
restore the phenol functionality, i.e., step c.  Due to the reduction prospect of the 
carbonyl moiety, the reaction was assiduously monitored by thin layer 
chromatography.  Compounds 153-165 exhibited discrete retentions in a variety of 
eluent mixtures and hence permitted the reaction to be followed until completion.  
However, at least a half dozen other analogs were synthesized that contained a Boc-
GABA tethered constituent but evinced unchanged retentions between the benzylated 
and free phenol forms in all eluent mixtures.  These compounds are listed in Figure 
17.    In these instances, the reaction progress could not be followed; highly variable 
product mixtures resulted from “guesses” of reaction times.  The segregation of these 
products was cumbersome as these reactions were conducted on very small scales.  
The relatively labile carbamate and ester linkages possessed by the precursors 
precluded other common approaches to debenzylation, such as TFA, TMSI, or AlCl3. 
Several iterations with minor changes in conditions, such as solvent, Pd/C content,    
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Figure 17. 5-acetylsalicylate GABA compounds where the standard Pd/C protocol 
for debenzylation wasn’t effective. 
 
 
 
 
etc. were ineffectual.  Hence, a new strategy is required to educe improved 
conversions for this step or simply the use of a different protecting group.  These 
derivatives were not studied further. 
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H.  5-acetylsalicylic acid alkanoyl compounds.  Two 5-acetylsalicylic acid alkanoyl 
compounds were synthesized, 155 and 156 (Figure 18). 
 
Figure 18. Two 5-acetylsalicylic acid alkanoyl derivatives, 155 and 156. 
 
 
 
1) Synthesis of 5-(2-(dodecanoyloxy)acetyl)-2-hydroxybenzoic acid, (5-
acetylsalicyic acid dodecanoate, 155).  The synthesis of 5-(2-
(dodecanoyloxy)acetyl)-2-hydroxybenzoic acid (155) was completed to study its 
utility as a photocleavable surfactant100 (Scheme 49).  The short series of steps 
commenced with 5-acetylsalicylic acid (153a).  The same benzylation protocol was 
utilized as for the assembly of 153b but without the hydrolysis phase, to afford 155b 
in high yield.  Standard bromination conditions were used to furnish 155c in high 
yield.  The subsequent reaction of 155c with a 2 molar excess of dodecanoic acid in a 
standard coupling method generated 155d in 71% yield.  Lastly, 155 was produced 
under common debenzylation conditions in high yield. The same procedure was 
adhered to in generating 2-hydroxy-5-(2-(tetradecanoyloxy)acetyl)benzoic acid (156). 
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Scheme 49. Synthesis of 5-acetylsalicylic acid dodecanoate (155). 
 
 
I.  α-alkyl-pHP diaseteromers.  Two α-alkyl-pHP diaseteromers were synthesized.   
1) Synthesis of ((R)-((R)-1-(4-hydroxyphenyl)-1-oxopropan-2-yl) 2-acetoxy-2-
phenylacetate, 166) and ((R)-((S)-1-(4-hydroxyphenyl)-1-oxopropan-2-yl) 2-
acetoxy-2-phenylacetate, 167).  The synthetic strategy for the construction of 
diastereomers (R)-((R)-1-(4-hydroxyphenyl)-1-oxopropan-2-yl) 2-acetoxy-2-
phenylacetate (166) and (R)-((S)-1-(4-hydroxyphenyl)-1-oxopropan-2-yl) 2-acetoxy-
2-phenylacetate (167(, is outlined in Scheme 50.  The starting material for the 
sequence consisted of racemic 1-(4-(benzyloxy)phenyl)-2-bromopropan-1-one (140c) 
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which underwent a SN2 reaction with (R)-2-acetoxy-2-phenylacetic acid in the 
presence of potassium carbonate to afford a mixture of 166a and 167a in 94% overall 
yield.  Efforts to segregate these diastereomers were ineffectual.  Standard 
debenzylation  
 
Scheme 50. Synthesis of α-methyl-pHP diaseteromers (166 and 167). 
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conditions permitted 166a and 167a to be converted to 166 and 167, respectively, in 
99% yield. Attempts to separate these diastereomers by normal phase silica 
chromatography and reverse phase HPLC were unsuccessful.  Further work on this 
series is expected upon completion of the thesis. 
 
J.  FITC-DOC.  A molecule derived from fluorescein isothiocyanate and 
deoxycholic acid was constructed and given to collaborators for use in biological 
assays.  Details from these assays will be provided in the Discussion section. 
1) Synthesis of (R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-
10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-N-(6-(3-
(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-yl)-thioureido)-
hexyl)-pentanamide, (FITC-DOC, 168).  The process for the fabrication of 168 is 
exhibited in Scheme 51. The series commenced with a modified Steglich 
esterification,101 where deoxycholic acid, 168a, was reacted with 1-ethyl-3-(3-
dimethyl aminopropyl) carbodiimide hydrochloride (EDCI) modified N-Boc-1,6-
hexaneamine with N-hydroxybenzotriazole as an initiator to furnish 168b.  This 
compound was not isolated but further reacted with 4 M HCl in 1,4-dioxane for a 
short time to induce N-Boc degradation and form the ammonium trifluoroacetate 
species (168c) in good yield.  The last step involved base (triethylamine) assisted, 
nucleophilic addition of 168c to fluorescein isothiocyanate (FITC) to afford 168 in 
moderate yield. 
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Scheme 51. Synthesis of FITC-DOC (168). 
 
 
 
II.  Exploratory Photochemistry 
As discussed in the Introduction, photolysis of the pHP caged complexes in aqueous 
media generally results in facile substrate release and concurrent precursor 
  118 
rearrangement to the major p-hydroxyphenylacetic acid chromophore and minor p-
hydroxybenzyl alcohol (abbreviated Scheme 37, Introduction).   
 
Scheme 37. (from the Introduction) Photolysis of p-hydroxyphenacyl diethyl 
phosphate (114) in water. 
 
 
 
 
The formation of p-hydroxyphenylacetic acid (95) and p-hydroxybenzyl alcohol 
(121), a newly discovered minor product, are easily discerned by 1H NMR analysis 
when pHP caged compounds are dissolved in deuterium labeled hydroxylic solvents, 
as D2O, then irradiated.  The methylene unit of 95 has a characteristic chemical shift, 
δ  = 3.6 ppm and that corresponding to 121, δ = 4.5 ppm.  The peaks corresponding to 
the methylene constituents of pHP GABA precursors, 95 and 121, being conspicuous 
indicators of a photochemical reaction, are denoted as signature peaks.  To 
investigate whether this phenomenon is consistent with caged pHP derivatives 122-
167, preliminary photolyses monitored by 1H NMR were conducted in aqueous media 
under standard (non degassed, room temperature) conditions in NMR tubes. 
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A.  pHP GABA and 4-fluorophenacyl GABA ester investigations employing 1H 
NMR spectroscopy. Irradiation at 300 nm of 1-10 mM concentrations of pHP GABA 
esters (122-142) in D2O were followed up to 2 h.  1H NMR analysis was implemented 
to identify the constituents of the mixture.  A number of pHP GABA derivatives 
manifested an inertness to photolysis; these included, m-NO2-pHP GABA (132), o-
OH-pHP GABA (135), m-OH-pHP GABA (136) and 4-fluorophenacyl GABA (142).  
Protracted irradiation times up to 24 h at 254, 300, and 350 nm produced no 
detectible p-hydroxyphenylacetic acids, as determined from the lack of characteristic 
chemical shifts, and only small amounts of hydrolysis products, i.e., α-hydroxyl 
(acyloin) acetophenones, presumably resulting from the thermal, ground state 
reaction.  Compounds 122-131 and 137-141 evinced clean photorelease of GABA, 
with p-hydroxyphenylacetic acids as the major products estimated to be >95% and p-
hydroxybenzyl alcohol as the minor product estimated to be <5%.  No other 
photoproducts from these precursors were observed by 1H NMR. An example of this 
is illustrated with 1H NMR spectra associated with photolysis of 0.02 M m-OCF3-
pHP GABA (131) in D2O (Figures 19-23).  Prior to photolysis, 131 manifested two 
signature sets of signals; the methylene component, labeled a at δ = 5.47 ppm, and the 
tethered GABA region in the aliphatic region, assigned b. The large signal at δ ~ 4.80 
ppm represents HOD, which will be commonly seen in all spectra where D2O was 
utilized as the primary solvent.  After 2 h of irradiation, pronounced vicissitudes in  
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Figure 19. 1H NMR spectrum of m-OCF3-pHP GABA (131) in D2O. 
 
 
the 1H NMR spectrum was evident (Figure 20).  The signal associated with a is 
absent and two new peaks have materialized; the signal labeled c at δ = 3.66 ppm 
represents the methylene unit of p-hydroxyphenylacetic acid (1311) and the small 
peak labeled d at δ = 4.56 ppm that corresponds to the methylene group of p-
hydroxybenzyl alcohol (1312). The bands that are assigned e correlate with free 
GABA, which divulge subtle differences in chemical shifts compared to caged 
GABA. The peak at c is incontrovertibly linked to the methylene of 1311 based on  
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Figure 20. 1H NMR spectrum after 2 h photolysis of 131 in D2O. 
 
 
 
spiking experiments with an authentic sample; this entailed adding a pure sample of 
p-hydroxyphenylacetic acid to the photolysis mixture. Supervening 1H NMR analysis 
manifested increases in intensities of peaks linked to this entity.  In addition, to 
corroborate the assignment of d to 1312, p-hydroxy-m-trifluoromethoxybenzyl 
alcohol was independently synthesized and the authentic sample was then added into 
the photolysis mixture for 1H NMR analysis, shown in Figure 21. The 1H NMR band 
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Figure 21. Spiking experiment with p-hydroxy-m-trifluoromethoxybenzyl alcohol 
(1312). 
 
 
 
intensity of d at δ = 4.55 ppm is pronounced and is associated with the increase in the 
concentration of 1312, unequivocally confirming the presence of the benzyl alcohol.  
It should be noted that the peak near δ = 4.90 ppm could constitute another variant, 
the acyloin 1313.  Another, authentically synthesized sample of the m-OCF3-acyloin 
was prepared and added to the sample to discern whether it was a photoproduct; the 
appearance of a new signal at e with δ = 4.95 ppm next to the 4.90 ppm signal clearly 
demonstrated the absence of 1313, precluding the acyloin as a photoproduct. 
Likewise, 19F NMR’s were examined where spiking experiments bolstered the 1H 
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NMR results. The results of photolyses of m-OCH3-pHP GABA (134) and m,m’-
diOCH3-pHP GABA (133) were also investigated by 1H NMR analysis.  These had 
been reported to exhibit preponderant GABA release pathways that were not related 
to pHP rearrangement at 300 nm.97 A 0.03 M solution of 134 in D2O was prepared 
(Figure 22 the signature band is designated a, the methylene protons at δ = 5.53 ppm) 
 
Figure 22. Pre-photolysis 1H NMR spectrum of m-OCH3-pHP GABA (134) in D2O. 
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and then irradiated for 90 min at 300 nm (Figure 23). The salient chemical entity in 
the photolysis mixture was unmistakably unreacted starting material; it held true to 
the reported very low quantum efficiency for conversion.  The major photoproduct, 
however, was the rearranged p-hydroxy-m-methoxyphenylacetic acid, its signature 
resonance band for methylene protons labeled b δ = 3.69 ppm.  In addition, a band 
labeled c at δ = 4.5 ppm, likely to be associated with the methylene protons of p-
hydroxy-m-methoxybenzyl alcohol, was apparent.  There were a few minor signals 
due to the presence of other photoproducts which were not identified. The photolysis 
of nearly the same concentration of m,m’-diOCH3-pHP GABA (133) in D2O with 300 
nm lamps for 90 minutes produced new bands at δ = 3.67 and δ = 4.56 ppm; the 
former probably indicated the p-hydroxyphenylacetic acid analog of 133 and the 
latter the p-hydroxybenzyl alcohol.  The primary chemical species in the mixture was 
unreacted 133.  It is noteworthy to point out the significant disparities in 
photochemical behavior of m-OCF3-pHP GABA (131) and m-OCH3-pHP GABA 
(133); the former manifests a much higher efficacy for chromophore rearrangement 
and GABA release.  The primary structural deviations are fluorine moieties in 131 
that commute with hydrogens in 133; the provenience will be discussed later in the 
Discussion section. 
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Figure 23. 1H NMR spectrum of the photolysis mixture of 134 at 300 nm in D2O. 
 
 
 
 
B.  1H NMR examination of α-alkyl-pHP GABA esters.  Compounds (R,S)-140, 
α-methyl-pHP GABA enantiomers, and (R,S)-141, α-ethyl-pHP GABA enantiomers, 
exhibited uncomplicated and complete photoconversions under similar conditions as 
described above.  For example, a 0.05 M solution of a racemic mixture of (R,S)-140 
in D2O (Figure 24) was irradiated for 1 h with two 300 nm lamps (Figure 25) and 
showed nearly complete conversion to photoproducts by diminutive a with δ = 6.08     
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Figure 24. 1H NMR spectrum of α-methyl-pHP GABA enantiomers (R,S)-140 in 
D2O prior to irradiation. 
 
 
 
ppm and new bands for free GABA and photoproducts with resonance bands at b δ = 
5.22 ppm, c δ = 3.63 ppm and d δ = 3.23 ppm. A spiking experiment with 2-(4-
hydroxyphenyl)propanoic acid (Figure 26) revealed an enhanced band intensity at d 
with δ = 3.63, the identity of the p-hydroxyphenylpropionic acid photoproduct.  The 
signals at b are tentatively assigned to the methine protons of α-hydroxy (acyloin) 
ketone of pHP based on the downfield chemical shift of aromatic hydrogen atoms 
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Figure 25. 1H NMR spectrum of the product mixture after 1 h irradiation of (R,S-
140) at 300 nm, in D2O. 
 
 
 
 
 
i.e., δ = 7.89 ppm, that are similar to 140 and impute a ketone moiety. The resonance 
band at d could not be identified.    
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Figure 26. 1H NMR spectrum of photolysis mixture with added 2-(4-
hydroxyphenyl)propanoic acid.  The enhanced peak intensity of c confirms the 
structure of the photoproduct. 
 
 
 
 
C.  Examinations of pHP-l-glutamate derivatives (143-145) by 1H NMR analysis.  
The photochemistry of pHP Glu derivatives, o-F-pHP Glu (143), m-F-pHP Glu (144), 
and m-CF3-pHP Glu (145) was congruent with the corresponding GABA analogs 122, 
123 and 130, respectively, employing identical photolysis conditions.  Free l-
glutamate along with rearranged p-hydroxyphenylacetic acids were released as major 
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Figure 27. Pre photolysis 1H NMR spectrum of m-CF3-pHP Glu (145) in 1:1 D2O: 
CD3OD.   
 
 
  
products; the sole minor products were p-hydroxybenzyl  alcohols.  For example, 1H 
NMR analysis of 0.01 mM of 145 in 50% aq. CD3OD (Figure 27) that was 
photolyzed for 1 h at 300 nm (Figure 28) revealed the complete disappearance of the 
signature methylene bands labeled a at δ = 5.45 ppm and Glu labeled b, with 
appearance of bands that correspond to methylene protons of p-hydroxy-m- 
trifluoromethylphenylacetic acid, labeled c at δ = 3.66 ppm and p-hydroxy-m-
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trifluoromethylbenzyl alcohol, labeled d at δ = 4.55 ppm, as well as free Glu (bands 
labeled e).   
 
Figure 28. 1H NMR analysis of products from photolysis of m-CF3-pHP Glu (145) at 
300 nm in 1:1 CD3OD:D2O. 
 
 
 
 
 
D.  Investigations of pHP-caged amino acids (146-148) by 1H NMR analysis.  The 
photochemistry of pHP caged glycine (146), valine (147), tryptophan (148) and 
phenylalanine (149) paralleled that of GABA under the same photolysis conditions.  
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Clean transformations to p-hydroxyphenylacetic acid and p-hydroxybenzyl alcohol, 
along with substrate release, were observed.   
  
E.  1H NMR analysis for the photolysis of pHP deoxycholic acid, (pHP DOC, 
150).  A sample of 0.009 M pHP DOC (150) in 1:9 D2O:CD3OD was prepared 
(Figure 29, the signature band is denoted a for methylene protons at δ = 5.37 ppm and  
 
Figure 29. 1H NMR spectrum of 150 in 1:9 D2O:CD3OD prior to photolysis. 
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b for methylene protons at δ = 2.49 ppm) and was irradiated at 300 nm over 4 h 
(Figure 30); complete disappearance of precursor was divulged by the absence of a.  
New bands appeared at b with δ =  4.37 ppm and c at δ = 3.57 ppm which are posited 
to represent the methylene protons of rearranged p-hydroxyphenylacetic acid and p-
hydroxybenzyl alcohol entities respectively.  Additionally, free DOC was observed 
from signature resonance bands b at δ = 2.38 ppm.   
 
Figure 30. 1H NMR spectrum of the product mixture after irradiation of 150 for 4 h 
at 300 nm in 1:9 D2O:CD3OD. 
 
 
 
 
  133 
F.  1H NMR exploration of pHP diethyl phosphonate (151).  Irradiation of 0.02 M 
of 151 in D2O for 2, 4, 16, and 36 h at 300 nm lamps failed to disclose any photolysis 
products.  Additional photolysis studies with 0.015 M 151 in D2O at 254 nm over 12 
h evinced no photoproducts.   
 
G.  1H NMR analysis of pHP F (152).  A 0.01 M sample of 152 in 1:3 D2O:CD3OD 
 
Figure 31. 1H NMR analysis of 152 in 1:3 D2O:CD3OD prior to irradiation. 
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(Figure 31, with signature, discrete signals for each the methylene group alpha to the 
ketone a at δ = 5.72 and 5.61 ppm respectively) was irradiated at 300 nm for 1 h 
(Figure 32). Noticeably, the bands at a were significantly diminished in intensity. 
Prominent new signals were also observed at δ = 3.56 and 3.52 ppm. These are 
located at a similar position in the spectrum as the methylene protons of p- 
hydroxyphenylacetic acid; the exhibition of two signals in this spectrum, however, 
differs with the acid, which typically reveals only one resonance band.  A second 
 
Figure 32. 1H NMR assessment of the product mixture after 1 h photolysis of 152 at 
300 nm in 1:3 D2O:CD3OD. 
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prominent signal is conveyed at δ = 4.36 ppm and could not be identified.  Further 
studies are required to better understand the photochemistry of pHP F (152.   
 
H.  1H NMR evaluation of 5-acetylsalicylic acid (153) and salicylate GABA 
derivatives (154, 157-165).  A 0.18 M solution of 5-acetylsalicylic acid GABA (153) 
in D2O (Figure 33, with signature methylene bands a at δ = 5.46 ppm and GABA  
 
Figure 33. 1H NMR spectrum of 153 in D2O prior to photolysis. 
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alkyl bands b at δ = 3.10, 2.69 and 2.04 ppm) was irradiated for 1 h at 300 nm (Figure 
34) manifesting the clean photorelease of GABA, d. This was evidenced by the  
 
Figure 34. 1H NMR analysis of the product mixture from 1 h photolysis of 153 at 300 
nm in D2O. 
 
 
 
 
appearance of resonance bands associated with free GABA at δ = 3.03, 2.54, and 1.96 
ppm, which are slightly offset in the spectrum from caged GABA.  A considerable 
amount of starting material, 153, remained due to the relatively short irradiation time. 
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A new, prominent signal at δ = 3.66 ppm suggests the presence of rearranged 
phenylacetic acid analog labeled c, analogous to the previously assigned derivatives. 
Salicylic esters and amide derivatives of 153, compounds 154 and 157-165, exhibited 
congruent photochemical behaviors with 153.  Several of these exhibited limited 
water solubilities and required, first, dissolution in a CD3OD or CD3CN, followed by 
dilution with D2O.  
  
I.  1H NMR studies of (5-(2-(dodecanoyloxy)acetyl)-2-hydroxybenzoic acid, 155) 
and (2-hydroxy-5-(2-(tetradecanoyloxy)acetyl)benzoic acid, 156).  The 
photochemical behavior of model photocleavable surfactants 155 and 156 were 
investigated in 1:9 D2O:CD3OD.  Similar to antennae compounds 157-165, water 
solubility was a restriction. However, it was found that this was obviated by 
dissolution in basic buffer, which will be elaborated on later.  An 1H NMR study of   
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Figure 35. 1H NMR analysis of 155 in d6-DMSO prior to irradiation. 
 
 
 
155 consisted a 0.03 M solution in 1:9 D2O:CD3OD (Figure 35), with methylene 
protons labeled a at δ = 5.40 ppm and b at δ = 2.40 ppm, was irradiated for 1 h at 300 
nm (Figure 36) to give three new resonance signals centered at δ = 4.42 (d), 3.64 (c), 
and 3.59 ppm (c).  A significant amount of 155 was retained, evidenced by the band 
at a.   It was deduced that dodecanoic acid was released from the 5-acetylsalicylic 
acid chromophore from the appearance of new bands at e at δ = 2.31 ppm, 
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Figure 36. 1H NMR spectrum of the product mixture after irradiation of 155 in 1:9 
D2O:CD3OD. 
 
 
 
 
 
corresponding to free dodecanoic acid, which were slightly offset from the caged 
analog.  The chemical shifts of other products indicate that b might represent the 
methylene protons of the p-hydroxyphenylacetic acid derivative, and c or d 
correspond to methylene protons of p-hydroxybenzyl alcohol derivative. 
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J.  1H NMR investigations of ((R)-((R)-1-(4-hydroxyphenyl)-1-oxopropan-2-yl) 2-
acetoxy-2-phenylacetate, 166) and ((R)-((S)-1-(4-hydroxyphenyl)-1-oxopropan-2-
yl) 2-acetoxy-2-phenylacetate, 167).  A 0.05 M solution of a mixture of pHP  
 
Figure 37. 1H NMR spectrum of a mixture of 166 and 167 in 1:1 D2O:CD3OD. 
 
 
phenylacetate diasteromers (166 and 167) in 1:1 D2O:CD3OD (Figure 37) with 
signature methine protons for each at a and b that overlap at δ = 6.08 and 6.04 ppm 
was irradiated with at 300 nm lamps for 2 h.  Complete conversion of precursors 
(Figure 38) were apparent from the absence of signals corresponding to a and b. New 
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resonance signals were manifested at c with δ = 5.92 ppm that corresponded to the 
released (R)-2-acetoxy-2-phenylacetic acid with resonance signals at 5.27, 4.34, 3.71 
and 3.67 ppm.  Comparing these to those obtained from the product mixture of  (R-S) 
140 above, the bands at δ = 5.27 ppm are posited as the methine protons of the α-
hydroxy (acyloin) derivative d; those at δ = 3.71 and 3.67 ppm likely represent the 
methylene protons of rearranged p-hydroxyphenylacetic acid derivative e, which had 
been confirmed previously from spiking experiments.  In addition, the small 
resonance bands labeled f at 4.34 ppm could represent the methylene protons of p-
hydroxybenzyl alcohol analogs. 
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Figure 38. 1H NMR spectrum of the product mixture from irradiation of 166 and 167 
at 300 nm in 1:1 CD3OD:D2O. 
 
 
 
 
 
K.  19F NMR analysis of fluoro pHP and 5-acetylsalicylic derivatives.  19F NMR 
spectroscopy provided a useful technique to assess the progress of photoreactions of 
certain pHP derivatives.  The compounds that were anticipated to manifest the most 
conspicuous changes in 19F resonance band positions  
 
 
 
  143 
Figure 39. 19F NMR spectrum of 2,3,5,6-tetraF-pHP GABA (129) in D2O prior to 
photolysis. 
 
 
 
were those that possessed an o-fluoro moiety; the powerful inductive effect imparted 
by the carbonyl of pHP ketone on the o-fluoro atom is quite disparate from the 
corresponding p-hydroxyphenylacetic acid, where this effect is obtunded by a more 
remote and modified carboxylate functionality.  For example, a 0.03 M D2O solution 
of 2,3,5,6-tetrafluoro-pHP GABA (129) (Figure 39) with signature 19F NMR bands 
for the m-fluoro moieties labeled a ( δ = -162 ppm), the o-fluoro moieties labeled b (δ 
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-142 ppm), and the trifluoro constituent of the trifluoroacetate anion labeled c (δ = -
76) ppm) was photolyzed for 15 min with at 300 nm (Figure 40). Incomplete 
  
Figure 40. 19F NMR spectrum of the product mixture from photolysis of 129 at 300 
nm in D2O. 
 
 
 
  
conversion to the rearranged p-hydroxy-2,3,5,6-tetrafluorophenylacetic acid, with 
resonance signals assigned d for o-fluorines (δ = -147 ppm) and e for m-fluorines (δ = 
-164 ppm), and p-hydroxy-2,3,5,6-tetrafluorobenzyl alcohol, with resonance signals 
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assigned f for o-fluorines (δ = -147 ppm) and g for m-fluorines ( δ = -164 ppm) are 
clearly discernible with respect to those from 129.  The intensity of the band e is 
greater than f, which is expected, as the former is the major product.  The 
corresponding 1H NMR studies divulged that the major photoproduct of 129 was 
rearranged p-hydroxy-2,3,5,6-tetrafluorophenylacetic acid and thus the 19F intensities 
would be major at δ = -147 (d) and at δ = -164 ppm (e).  The p-hydroxy-2,3,5,6-
tetrafluorobenzyl alcohol product, exiguously formed, would be identified with 
signals at lower intensities, i.e., f and g.  A sizeable upfield shift in the o-fluoro 
resonance band, a to d of -5 ppm for the phenylacetic acid and a to g -6 ppm for the 
benzyl alcohol, is due to the loss of deshielding from the carbonyl.  Additionally, 
minor vicissitudes in chemical shifts of m-fluoro moieties were perceived; 1 ppm for 
b to e and f, respectively, were due to the loss of the resonance and inductive 
withdrawing contribution of the carbonyl.  The resonance and inductive bearing of 
the carbonyl ketone is underscored by these chemical shift changes.   
  
III.  UV-Vis Spectroscopic Studies. 
A.  pHP and p-fluorophenacyl GABA esters 122-142 in water and buffers, pH = 
7.3 and 8.2. UV-Vis spectroscopic analysis of compounds 122-142 in water and pH = 
8.2 buffer were completed and results presented in Table 15.   
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Table 15.  UV-Vis properties of 122-142 with corresponding pKa values. 
 
 
 
The impetus for spectral investigations in buffers relates to the protonated versus 
conjugate base forms of the pHP chromophore, i.e., to discern whether the conjugate 
bases manifest disparate photophysical properties to their protonated counterparts. 
 Several other buffers of identical concentration and adjusted ionic strengths 
were utilized; these included TRIS pH 7.5, tetrasodium pyrophosphate pH 7.4, 
sodium phosphate pH 7.0, ammonium acetate, pH = 7.0 and HEPES pH = 7.2 with 
0.1 M LiCl.  The UV-Vis parameters for these were consistent with those obtained 
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with HEPES, pH = 7.3, shown in Table 15. The pKa of the phenol influenced the 
UV-Vis spectra for all pHP esters; many derivatives manifested two or more 
absorption bands in unbuffered, aqueous media, resulting from the equilibrium 
between the protonated and conjugate base concentrations of the phenol.  In HEPES 
buffered solution at pH = 8.2 the conjugate bases of all pHP esters dominated.  The 
long wavelength maxima were bathochromically shifted by ~50 nm compared with 
the protonated form.  For example, o-F-pHP GABA (123) revealed a λmax = 271 nm 
in water, signifying the protonated form; in HEPES buffer, pH = 8.2, the λmax shifts to 
328 and 319 nm (Figure 41), respectively, a clear indication of the conjugate base.  
The photophysical parameters that influence substrate release depend on the nature of 
the protonated and conjugate base of the pHP chromophore and will be discussed 
later.  
By manipulating the pH of the photoreaction media and the lamps for the 
Rayonet reactors (300 and 350 nm), the photoreactivity of the two forms of 122-141 
allow the accurate quantization of quantum yields and rate constants for each form 
individually.  In water, 122-141 exist dually as a mixture which makes the analysis 
complex (two competing photoreactions).  Furthermore, as the reaction progresses, 
two additional changes are occurring.  The pH of the aqueous solution will change, 
since the Favorskii rearrangement both releases an acid as the leaving group and 
generates a phenylacetic acid, each have different pKa’s than the phenol.  The second 
factor is a consequence of this change in that the absorption spectrum will shift to 
represent a higher proportion of the original protonated form of the caging 
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Figure 41. Comparison of UV-Vis spectra of 123 in water (red) and pH = 8.2 buffer 
(pink).  
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chromophore.  For example, o-F-pHP GABA (123) revealed a λmax of 271 nm (Figure 
41) at low concentrations (10-5 M) in water, with a tapering off at 320 nm. At 1 mM 
concentrations, an extended absorbance profile used for photolysis was manifested 
(Figure 42) and reached the baseline at 350 nm. The cutoff was at 350 nm for 
excitation of the protonated forms of 122-132 and 135-141 in water (the m-methoxy 
compounds 133 and 134 extended past 370 nm at 5 mM concentrations).  Such was 
not the case for the corresponding conjugate bases of pHP chromophores 122-141 
(Table 15).  Congruent with their protonated counterparts, saturation UV-Vis profiles 
of 5 mM concentrations of 122-141 conjugate bases, all or nearly all of the light was 
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being absorbed at wavelengths up to 400 nm and therefore the 350 nm lamps would 
seem to be amenable for photorelease.  For example, when probed at 5 mM in 0.01 M 
 
Figure 42. UV-Vis spectroscopic analysis of 1 mM solution of 123 in unbuffered 
aqueous solution.  The spectrum indicates a saturation condition. 
 
 
 
HEPES, 0.1 M LiClO4, pH = 8.2, 123 showed absorbances that extended past 350 nm 
(Figure 43), with a cut off nearer to 370 nm.   
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Figure 43.  UV-Vis spectroscopic analysis of 5 mM 123 in 0.01 M HEPES, 0.1 M 
LiClO4, pH = 8.2.  The conjugate base predominates.  The spectrum signifies a 
saturation condition. 
 
 
 
 
 The photo-conversion process of pHP GABA esters 122-141 was probed by 
UV-Vis spectroscopy. Recall the p-fluorophenacyl GABA 142 demonstrated photo-
inertness at λ = 254 and 300 nm as determined by 1H NMR and thus was not 
examined.  All of the caged GABA derivatives were converted to products with a 
high efficiency when irradiated as 2 mM aqueous solutions at 300 nm (light output, 
0.01 mE/mol) where complete transformation to photoproducts occurred within 20 
min (Table 16).  This was verified by HPLC (UV-detection) through analysis of  
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Table 16. Times for 100% conversion to photoproducts of 1 mM concentrations of 
122-141 in water. 
 
 
Compound 
Timea 
(min) 
Timeb 
(min) 
Timec 
(min) 
Timed 
(min) 
122 7 9 70 >8h 
123 5 6 45 >8h 
124 6 12 40 >8h 
125 6 12 60 >8h 
126 10 10 80 >8h 
127 8 9 40 >8h 
128 13 15 70 >8h 
129 9 9 20 >8h 
130 6 9 40 >8h 
131 12 13 60 >8h 
132e  -  - -   - 
133f ND ND ND ND 
134f ND ND ND ND 
135g -  -  -   - 
136g -  - -   - 
137 8 7 50 >8h 
138 9 7 50 >8h 
139 12 10 70 >8h 
140 20 24 90 >8h 
141 20 24 90 >8h 
142g -   -  -  - 
 aTwo 300 nm lamps, in water, estimated by HPLC/UV analysis in water. bTwo 300 
nm lamps, in 0.01 M HEPES, 0.1 M LiClO4, pH = 7.3, estimated by HPLC/UV 
analysis. cTwo 300 nm lamps, in 0.01 M HEPES, 0.1 M LiClO4, pH = 8.2, estimated 
by HPLC/UV analysis. d16 350 nm lamps, in 0.01 M HEPES, 0.1 M LiClO4, pH = 
8.2, estimated by HPLC/UV analysis, overnight irradiation. eNo photolysis was 
observed. fNot determined. 
 
aliquots every 30 seconds. For 122-141 in 0.01 M HEPES buffer with 0.1 M LiClO4 
at  pH = 8.2 (Table 15), the conjugate bases were irradiated with two 300 nm lamps 
over longer time periods also achieved complete conversion to photoproducts.  
Exposure of the conjugate bases to sixteen 350 nm lamps (0.09 mE/min) led to 
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complete conversion to photoproducts but at much longer times, i.e., >8 hours.  An 
illustration of a typical photolysis, as probed by UV-Vis spectroscopy, is shown in 
Figure 44.  Here, a 10-4 M sample of 2,3,5,6-tetrafluoro-pHP GABA (129) in water 
was irradiated with at 300 nm and analyzed at 3 minute intervals to complete 
conversion at 9 min.  For 129, the absorption decrease at λ ~ 316 nm was  
 
Figure 44. UV-Vis probe of the photolysis of 129, predominantly the conjugate base 
in water, monitored at 3 minute intervals.  
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accompanied by an increase at λ~220 nm due to the principal photoproduct, p-
hydroxy-2,3,5,6-tetrafluorophenylacetic acid (pHP Acid).  An isosbestic point at 225 
nm further validates that p-hydroxy-2,3,5,6-tetrafluorophenylacetic acid is the 
primary photoproduct of 129. 
 
B. pHP l-glutamate derivatives (143-145) in water and buffer pH = 8.20.  As 
anticipated, the UV-Vis analysis of pHP Glu derivatives (143-145) paralleled the UV-
Vis profiles in water and buffer of their GABA counterparts 123, 122, 130 
respectively.  Corresponding λmax values, times for complete conversions (at 300 nm) 
in water, and pKa’s of 143-145 are shown in Table 17.   
 
Table 17. UV-Vis parameters and estimated times for 100% conversion to 
photoproducts from irradiation at 300 nm and associated pKa’s for 143-145.  
 
Cmpd λmax/nm (log ε[M-1cm-1])a λmax/nm (log ε[M-1cm-1])b 
time 
(min)c 
time 
(min)d pKa 
143 272 (4.01) 323 (4.02) 7 60 7.2 
144 274 (4.02), 302 (3.46) 348 (3.66), 330 (3.99) 7 70 6.5 
145 328 (4.09) 326 (4.05) 6 30 5.5 
aMeasured in water. bMeasured in 0.01 M HEPES, 0.1 M LiClO4, pH = 8.20. cIn 
water, estimated by HPLC/UV-Vis analysis. dIn 0.01 M HEPES, 0.1 M LiClO4, pH = 
8.20, estimated by HPLC/UV-Vis analysis. 
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C.  Other pHP amino acids (glycine (146), valine (147), tryptophan (148), 
phenylalanine (149)), deoxycholic acid (150), diethyl phosphonate (151) and 
fluoride (152).  The UV-Vis profiles for 146-152 in water and buffered media 
paralleled those  
 
Table 18.  UV-Vis parameters and 100% conversion times for 146-152 from 
irradiation at 300 nm.  
 
Cmpd λmax/nm (log ε[M-1cm-1])a 
λmax/nm (log ε[M-1cm-
1])b 
time 
(min)c 
time 
(min)d pKa 
146 280 (4.09) 330 (3.94), 282 (3.89) 7 5 7.9 
147 279 (4.07) 327 (3.89), 281 (3.76) 7 6 7.9 
148 
272 (4.12), 300 (3.89), 310 
(3.67) ND 15 13 7.9 
149 282 (4.09) 328 (3.98), 282 (3.91) 7 6 7.9 
150 279 (4.00) e ND 20e ND 7.9 
151f 280 (4.03) ND - - 7.9 
152 282 (4.12) g 331 (3.65), 282 (4.05)h 12 10 7.9 
aMeasured in water. bMeasured in 0.01 M HEPES, 0.1 M LiClO4, pH = 7.3. cIn water, 
estimated by HPLC/UV-Vis analysis. dIn 0.01 M HEPES, 0.1 M LiClO4 pH = 7.3, 
estimated by HPLC/UV-Vis analysis. eMeasured in 5% aq. CH3OH. fNo 
photoreaction occurred. g50% aq. CH3OH. h20% aq. CH3OH. 
 
 
for GABA analogs 140 and 141 above except for pHP Trp (148). The tryptophan 
moiety contributes to the absorptivity of the caged derivative.  The nucleofuges for 
each, however, were quite distinct, resulting in variable conversion times. UV-Vis 
parameters and times for complete conversion are depicted in Table 18.   
 
D.  5-acetylsalicylic acid and salicylate GABA and alkanoyl derivatives, 153-165. 
UV-Vis spectra were obtained for compounds 5-acetylsalicylic acid GABA and 
alkanoyl analogs 153, 155-156, and 5-acetylsalicylate/amide GABA derivatives 154, 
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157-165.  The parameters associated with these, along with times for complete 
conversion of 2 mM concentrations of precursor in water to photoproducts at 300 and  
 
Table 19. UV-Vis parameters, 100% conversion times from irradiation at 300 nm, 
and % conversion after 24 h from irradiation at 350 nm for 153-165.  
 
Compound λmax/nm (log ε[M-1cm-1])a 
time 
(min)b 
% 
conversionc 
153 280 (3.90), 310 (3.58) 12 25 
154d 272 (4.09), 310 (3.22), 330 (3.94) 12 ND 
155e 282 (3.96) 20 20 
156e 281 (4.00) 20 20 
157f 340 (3.76), 310 (3.92), 274 (4.15) 25 50 
158g 343 (2.61), 320 (3.16), 300 (3.36), 271 (3.80) 13 50 
159 305 (3.52), 269 (3.92) 22 33 
160 306 (3.46), 269 (3.96), 229 (4.17) 21 33 
161 308 (3.36), 271 (3.88), 233 (4.16) 16 33 
162 310 (3.70), 272 (4.08) 21 25 
163 307 (3.38), 271 (3.82), 234 (4.11) 13 25 
164g 312 (3.52), 273 (3.89) 17 25 
165f 313 (3.64), 273 (3.95), 227 (4.20) 11 50 
aMeasured in water. bTwo300 nm lamps, estimated by HPLC with UV-Vis detection 
in a gradient of methanol/water. cSixteen 350 nm lamps, estimated by 1H NMR 
analysis after 24 h, in 1:1 CD3OD:D2O. dPreviously determined. e90% aq. CH3OH. 
f75% aq. CH3OH. g95% aq. CH3OH. 
 
350 nm are illustrated in Table 19.  The pKa’s for these were not determined.  The 
principal intentions for synthesizing 157-165 were: a) To lengthen the λmax of the 
chromophore towards 350 nm and b) to construct and evaluate a potential for an 
energy relay (antennae) system from the added auxochrome to enhance the 
photochemical efficiency.  Most of the entities manifested higher molar absorptivities 
at 300 nm rather than at 350 nm.  The full transformations to photoproducts at 300 
nm, however, were markedly longer than the pHP analogs lacking the auxochrome.  
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Excitation at 350 nm effectuated only marginal substrate release and necessitated 
more than 24 h for sufficient substrate release.  
 
E.   α-Alkyl pHP diastereomers (R,R)-166, and (R,S)-167.  UV-Vis assessment of 
(R,R) 166 and (R,S) 167 produced an absorbance summary akin to 101 above.  
Exposure to two 300 nm lamps in 50% aq. CH3OH conveyed complete conversion to 
photoproducts at 10 minutes for (R,R)-166  and 11 minutes (R,S)-167,  as determined 
by HPLC/UV-Vis analysis.  
 
IV. Fluorescence Spectroscopic Studies 
 The pHP chromophore does not fluoresce sufficiently for detection on a 
conventional, benchtop Varian Eclipse® spectrofluorimeter. The corresponding 
conjugate bases were weakly fluorescent.  An example of fluorescence from m-CF3-
pHP GABA (130) in 0.01 M HEPES, 0.1 M LiClO4 at pH = 8.2 is shown in Figure 
45. The excitation wavelength was 325 nm, which produced a single, broad emission 
signal λem at 380 nm that tailed out past 500 nm.   Examinations of the fluorescence 
properties of pHP GABA derivatives, 122-131 and the unsubstituted parent in the 
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Figure 45. Fluorescence spectrum of 130 in 0.01 M HEPES, 0.1 M LiClO4 pH = 8.2, 
λex = 325 nm. 
 
 
 
same media as 130 gave the same results as 130 and are reported in Table 20.   
 
Table 20.  Fluorescence of 122-131 in 0.01 M HEPES, 0.1 M LiClO4 at pH  8.2. 
 
Compound λem (nm) 
122 395 
123 382 
124 390 
125 385 
126 399 
127 374 
128 392 
129 384 
130 380 
131 395 
Parent 
(101) 382 
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V.  Time correlated single photon counting, TCSPC. TCSPC (see experimental), 
studies were carried out to obtain the fluorescence lifetimes for conjugate bases of 
122-131. Exponential decay profiles and the fluorescence lifetimes were obtained 
(Table 21).  The transients were determined by the Maximum Entropy Method. 
 
Table 21. TCSPC derived fluorescence decay profiles of 101, 122-131 in aq. 0.1 M 
LiOH. 
 
Compound # transients t1 (ns) t2 (ns) 
101 
(parent) 2 0.106  
122 2 0.129  
123 2 0.115  
124 2 0.156  
125 1 0.197   
126 2 0.099  
127 3 0.145 0.492 
128 3 0.189 0.422 
129 2 0.257   
130 3 0.039 1.803 
131 2 0.013  
 
 
An illustration of a TCSPC decay profile is provided in Figure 46 for a 0.1 mM 
solution of 130 in 0.1 M LiOH. In this example, a curve fitting application (red) 
correlated the fluorescence decay (black) to a single exponential best fit with a 
lifetime of 1.80 ns respectively.   
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Figure 46.  TCSPC decay profile for m-CF3-pHP GABA (130) in 0.1 M LiOH. 
 
 
VI.  Quantitative Photochemical Analysis 
 The quantum yields, Φ, equal the ratio nx/np, where nx depicts the number of 
photochemical or photophysical occurrences x, effectuated by light absorbed, p, by 
the precursor at a particular wavelength λ.102  The value can be considered as a 
percentage; for example, a Φ of 0.20 for pHP GABA disappearance signifies that 
20% of the excited state pHP GABA molecules decayed by substrate release.  It 
follows that the higher the quantum yield, the greater efficacy for the overall 
photochemical process. Quantum yields were determined for those compounds 122-
167 that conveyed substrate photorelease from preliminary 1H NMR studies; these 
included reactant disappearance (Φdis), substrate appearance (Φapp), and appearance of 
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p-hydroxyphenylacetic acids (Φacid). The quantum yields of the minor p-
hydroxybenzyl alcohols were not quantified.  Analyses were accomplished by 
HPLC/UV and LC/MS/MS techniques and were done in triplicate.  
  
A. Quantum yields of pHP GABA derivatives 122-141 from photolysis at 300 
nm.  The determination of quantum yields, Φdis, Φapp, Φacid for 1-10 mM of 122-141 
and the unsubstituted parent (101) at 300 nm were determined in an assortment of 
media. The principal objectives for these studies were to distinguish any pronounced 
variations in the quantum yields as a function of the media, i.e., effects due to buffer, 
pH, added salts, and changes from organic to aqueous solvent ratios.  Initial 
photolysis studies involved the use of water buffered by 0.01 M ammonium acetate 
that spanned from pH 5.0 to pH 9.0.  Not all precursors were probed in these media. 
The results are presented in Table 22.  Blank spaces indicate “not determined”. In all 
cases, the quantum yields for precursor disappearance, Φdis, were commensurate with 
those for the emergence of GABA, Φapp. The quantum yields for appearance of p-
hydroxyphenylacetic acids, Φacid, were always slightly reduced; this phenomenon was 
expected from a competing pathway to the minor product, p-hydroxybenzyl alcohol.  
As such, Φdis will be emphasized from this point on with the assumption that Φapp and 
Φacid do not diverge significantly from Φdis.   
 In general, values for Φdis were optimum in water or 0.01 M ammonium 
acetate solutions at pH 5.0.  At pH 6.0, the values for some are lower; for example, m- 
F-pHP GABA (123) exhibited a Φdis = 0.28 (±0.02) at pH 5.0 and 0.22 (±0.01). 
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This downward trend continued at pH 7.0; only the unsubstituted parent displayed 
unchanged yields from pH 5.0 to pH 7.0 (Φdis = 0.20 (±0.01)) to 7.0 (Φdis = 0.20 
(±0.01)).  At pH 9.0, Φdis for 122-141 were minimal; the conjugate base forms of 
122-141 prevail in this medium. This important trend correlating the pKa’s of 122-
141 with solution pH will be analyzed further in the Discussion section.   
 A series of studies with 122-141 were performed in several other, commonly 
used buffers including TRIS, HEPES, and sodium phosphate, ranging in pH from 7.0 
to 9.0.  In some cases, salts were added to control the ionic strength.  The findings 
from these are depicted in Table 23.  Blank spaces indicate “not determined”.  
Collectively, Φdis were relatively uniform in neutral pH ~ 7 media, regardless of the 
buffer type or modified ionic strength.  A slightly enhanced Φdis was observed when 
added LiClO4 was used instead of LiCl in HEPES buffer.  When photolyses were 
conducted in HEPES buffer pH = 8.2, the efficiencies universally declined; for 
example, the unsubstituted parent (101) manifested a Φdis of 0.21 (±0.01) in 0.01 M 
HEPES and 0.1 M LiClO4 at pH 7.3, which plummeted to 0.09 (±0.01) under 
identical conditions at pH 8.2.  Additionally, when photolyses were executed in 0.01 
M TRIS buffer with 0.1 M LiClO4 at pH 9.0, where the conjugate bases are the sole 
species, most precursors evinced low quantum yields (>0.05).  The declines in Φdis of 
the conjugate bases were congruent with the results of the ammonium acetate buffers. 
 Another assemblage of photolysis experiments involved the use of organic 
media and mixed aqueous organic solvents. Degassing before photolysis with argon 
was also examined for O2 effects on the quantum yields.  The former studies 
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were performed to determine whether hydroxylic solvents, excepting water, were 
sufficient to induce substrate photorelease from pHP caged compounds.  Of particular 
note, all pHP GABA esters displayed full solubility in 1-pentanol and perhaps more 
remarkably, in 1-octanol. The results are provided in Table 24.  Blank spaces indicate 
“not determined”. 
Reasonable Φdis values were observed for nearly all precursors in 1-pentanol 
and 1-octanol, though in general these were lower than in water.  Exceptions to this 
were 2,3,6-triF-pHP GABA (128) where Φdis were essentially the same as in water 
(0.09 (±0.01) and 0.08 (±0.008)  respectively) and m,m’-diOCH3-pHP GABA (133) 
which displayed a pronounced improvement compared to water from (Φdis = 0.07 
(±0.003) to 0.03 (±0.005)  respectively).  In 25% aq. CH3CN, marginal differences 
were observed for Φdis compared to water.  However, 3,5-diF-pHP GABA (126) and 
2,3,5,6-tetraF-pHP GABA (129) conveyed marked improvements (0.16 (±0.01) vs. 
0.11 (±0.01)  for the former, 0.14 (±0.01)  vs. 0.10 (±0.01)  for the latter).   
 Nearly all precursors manifested low quantum yields in DMSO; the fact that 
substrate photorelease occurred at all in this aprotic media is noteworthy.  
Interestingly, 128 exhibited an enhanced quantum yield in DMSO compared to water 
(0.12 (±0.01) and 0.08 (±0.008), respectively); this was further ameliorated in 10% 
aq. DMSO to Φdis = 0.15 (±0.02).  Several other pHP GABA derivatives manifested 
slightly augmented yields in 10% aq. DMSO compared to water, including 2,5-diF-
pHP GABA (125, 0.27 (±0.01) and 0.24 (±0.01), respectively), 126 (0.14 (±0.01) and 
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0.11 (±0.01), respectively), 129 (0.18 (±0.01) and 0.11 (±0.01) respectively), and m-
OCH3-pHP GABA (131 (0.12 (±0.01) and 0.09 (±0.01) respectively)).   
Degassing, that entailed purging the aqueous solution of the pHP GABA 
derivative for 45 minutes with argon, failed to change the quantum yields. 
 Photolyses of 122-141 were conducted in water with modified ionic strengths 
to distinguish whether a salt effect would be reflected in Φdis.  The first set of 
experiments focused on LiClO4 as the ancillary salt, ranging from 0.008 to 1.0 M 
(Table 25).  Remarkably, nearly all pHP derivatives manifested enhancements in 
quantum yield at 1.0 M LiClO4 in water.  For example, a ΔΦdis of 0.14, from 0.16 
(±0.01) to 0.30 (±0.02) or a 94% increase for 122 was observed.  Several pHP 
derivatives evinced improved quantum yields in 0.01 M LiClO4 relative to water as 
well, such as 126 with a ΔΦdis = 0.07, from 0.11 (±0.008) in water to 0.18 (±0.01) in 
0.01 M LiClO4.   
Other ancillary salts (NaClO4 and Mg(ClO4)2) were explored for similar 
influences on a few pHP GABA derivatives, including the parent, 122, 123, and 124.   
In addition, experiments involving the addition of free GABA (1 and 10 equivalents) 
to aqueous solutions of these four pHP-GABA precursors were performed to discern 
any changes in Φdis due to a common ion effect.103  The findings from these studies 
are depicted in Table 26.  Each of the precursors gave increased quantum yields in 1.0 
M NaClO4 and Mg(ClO4)2 relative to water, consistent with the results in LiClO4.  A 
curious observation, however, was the marked decline in Φdis at low concentrations of 
Mg(ClO4)2. For example, a decline in Φdis was observed for the 2,3-diF-pHP GABA 
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Table 26. Quantum yields for 122-124 and the unsubstituted parent (101) from 
photolysis in water with adjusted ionic strengths and added GABA at 300 nm. 
 
 
 
 
 
(124), from 0.24 (±0.02) in water to 0.12 (±0.01) in 0.01 M Mg(ClO4)2.  At 1.0 M 
Mg(ClO4)2, however, Φdis increased to 0.31 (±0.02).   Added GABA imparted no 
change in Φdis relative to solutions without added GABA. 
 
B. Quantum yields of pHP-GABA derivatives, 122-131, from photolysis at 350 
nm.  The quantum yields for 1-10 mM concentrations of 122-131 in 0.01 M TRIS, 
0.1 M LiClO4 at pH 9.0 were determined by photolyses at 350 nm (Table 27), where 
the conjugate bases preponderate.  
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Table 27.  Quantum yields for 122-131 in 0.01 M TRIS, 0.1 M LiClO4 at pH 9.0 at 
350 nm.  
 
Cmpd Φdis Φapp 
   
Parent (101) 0.0041 0.0038 
122  0.0086 0.0083 
123 0.0046 0.0045 
124 0.0017 0.0013 
125 0.0029 0.0024 
126 0.0019 0.0018 
127 0.0037 0.0035 
128 0.0042 0.0035 
129 0.0069 0.0067 
130 0.0081 0.0074 
131 0.0058 0.0054 
 
Conspicuously, the quantum yields were substantially diminished in contrast to those 
obtained with 300 nm lamps.  
 
C.  Quantum yields for pHP-l-glutamate derivatives, 143-145, determined by 
photolysis at 300 nm.  The quantum yields of 143-145 and unsubstituted parent 
(102) were ascertained from photolysis of 1-10 mM in water, 0.01 M ammonium 
acetate, 0.01 M HEPES buffers with 0.1 M LiClO4 at pH 7.3 and pH 8.2 (Table 28) at 
300 nm.  The determination of Φdis, Φapp (Glu) and Φacid were consistent with those 
from pHP GABA’s. Only Φdis will be discussed. No significant variations were 
observed in Φdis in water and with neutral pH ~ 7 buffers, apart from 145, which gave 
lower Φdis in pH 7.3 buffer (0.11 (±0.01) versus 0.18 (±0.01) in water).  All showed 
declined Φdis in pH 8.2 buffer, associated with conjugate bases, and coherent to 
findings from those pHP GABA derivatives. 
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Table 28. Quantum yields of 143-145 and unsubstituted parent (102) from photolysis 
in water, pH 7.0, pH 7.3 and pH 8.2 buffers at 300 nm. 
 
 
 
 
D.  Quantum yields of pHP caged amino acids glycine, valine, phenylalanine, 
and tryptophan, 146-149, at 300 nm.  The quantum yields (Φdis and Φacid) 
associated with 146-149 at 300 nm at 1-10 mM concentrations in water and 0.01 M 
HEPES with 0.1 M LiClO4 at pH 7.3 were determined.  In addition, salt effects were 
explored for 149 (0.1 and 1.0 M LiClO4 aqueous solutions).  The findings from these 
studies are summarized in Table 29. No noteworthy variations were discerned for 
Φacid and Φdis under any conditions.  In HEPES buffer pH 7.3, an enhancement in the 
quantum yields was observed for 146-148.  Added salts did not significantly improve 
Φdis. 
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Table 29. Quantum yields of 146-149 in water, pH 7.3 buffer, and water with 
adjusted ionic strengths. 
 
 
 
E.  Quantum yields of pHP DOC (150) and pHP F (152) at 300 nm.  Photolysis of 
1-5 mM of 150 in 5% aq. CH3OH produced Φdis of 0.06 (±0.007) and Φacid of 0.04 
(±0.006) at 300 nm.  For 152, Φdis was determined to be 0.10 (±0.01) at 1 mM in 50% 
aq. CH3OH at 300 nm.    
 
F.  Quantum yields of 5-acetylsalicylic acid derivatives 153-165 at 300 nm.  The 
quantum yields for disappearance, Φdis, of 1-10 mM of 5-acetylsalicylic acid GABA 
(153) in an assortment of media at 300 nm are listed in Table 30.  The quantum yields 
for appearance of GABA were found as the same Φdis. The quantum yields were 
relatively uniform, regardless of the nature photolysis medium, though slightly 
enhanced in aqueous 1.0 M LiClO4 and 1.0 NaClO4 solutions.  In a previous report,104 
the Φdis of the m-carbomethoxy derivative of 5-acetylsalicylic acid GABA (154) was 
given as 0.31 from photolysis in water at 300 nm; this diverges significantly from Φdis 
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Table 30. Φdis of 153 in various media from photolysis at 300 nm.  
 
 
= 0.09 (±0.01) for 153.  The quantum yields for 154 were re-evaluated at 300 nm in 
an assortment of media.  The results are depicted in Table 31. Evidently, the quantum 
 
Table 31. The values for Φdis and Φapp of 154 from photolyses at 300 nm in a variety 
of media.  
 
 
 
yields for 154 are consistent with those determined for the parent and substantially 
lower than the Φdis = 0.31 previously reported. Additionally, insignificant variations 
in these values were observed in all solvents tested. 
 The quantum yields for the disappearance (Φdis) of 5-acetylsalicylic acid 
dodecanoyl (155) and tetradecanoyl (156) esters were determined to be 0.04 (±0.005) 
and 0.06 (±0.006) respectively, from photolyses at 300 nm in 5% aqueous CH3OH.  
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Additionally, Φdis in 0.01 M HEPES, 0.1 M LiClO4, at pH 8.2 were 0.10 (±0.01) and 
0.09 (±0.01) respectively, consistent with the GABA caged 153. 
 The quantum yields for the disappearance (Φdis) of 157-165 “antennae” 
derivatives of 5-acetylsalicylic acid GABA, and appearance (Φapp) of GABA were 
determined in 3:1 H2O:CH3OH at 300 nm (Table 32). The values were slightly 
irregular and except for 157 (Φdis = 0.01 (±0.002)), 159 (Φdis = 0.02 (±0.002)), and 
162 (Φdis = 0.04 (±0.006)), did not vary appreciably from the parent 153 ((Φdis = 0.09 
(±0.01)).  When irradiated at 350 nm in water and 0.01 M HEPES, 0.1 M LiClO4 at 
pH 8.2, 157-165 gave very low Φdis and Φapp values (<0.01). 
 
Table 32. Φdis and Φapp for 157-165 in 3:1 H2O:CH3OH at 300 nm. 
 
Cmpd Φdis Φapp 
      
157 0.01 < 0.01 
158 0.08 0.07 
159 0.02 < 0.01 
160 0.06 0.05 
161 0.08 0.07 
162 0.04 0.04 
163 0.11 0.11 
164 0.07 0.06 
165 0.12 0.11 
  
 
G.  Quantum yields of α-alkyl-pHP caged diastereomers (R,R) 166 and (R,S) 167 
at 300 nm.  The quantum yields for a mixture of (R,R) 166 and (R,S) 167 
diastereomers was determined from photolysis at 300 nm of 5 mM concentrations of 
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precursor in 50% aq. CH3OH; these were found to be Φdis = 0.18 (±0.01) and Φacid = 
0.16 (±0.01), consistent with unsubstituted pHP-GABA, 0.20 (±0.01) and 0.16 
(±0.01)  respectively. 
 
VII. Determination of Rate Constants for Substrate Release by Stern-Volmer 
Quenching   
 The Stern-Volmer (S-V)78 quenching method to indirectly determine the rate 
constants for substrate release was employed for GABA esters of 122-131, 137-139, 
and 153.  One to five mM of each was prepared in water or buffer, photolyzed at 300 
nm and Φdis determined. Potassium sorbate, a triplet quencher Q, was added in 
increments and Φdis determined.  Using linear regression analysis, plots of the ratios 
Φo (quantum yield without Q)/Φ (quantum yield with Q) vs. [Q] gave linear S-V 
plots with KSV as the slope.  For example, a 5 mM aqueous solution of 2,3-diF-pHP 
GABA (124) was photolyzed at 300 nm lamps along with three other solutions 
containing 20 mM, 40 mM, and 60 mM of potassium sorbate.  A plot of 
corresponding Φo/Φ vs. [Q] values is illustrated in Figure 47.  The slope, KSV, is 
shown as the product of the diffusion rate, kq, of the quencher in water (estimated to 
be 7.4 x 109 M-1s-1)1 and the triplet lifetime of chromophore, τ3.  The rate of sorbate 
quenching is assumed to be diffusion controlled, i.e., kdiff = kq.  From the plot, τ3 was 
calculated to be 4.14 x 10-9 s or 4.14 ns, and the rate of GABA release, kr, = 5.75 x 
107 s-1.  Congruent analyses were completed for the other pHP GABA derivatives and 
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153 in water and 0.01 M HEPES, 0.1 M LiClO4 at pH = 7.3.  The results are listed in 
Table 33. 
 
Figure 47. Stern-Volmer relationship from the photolysis of 2,3-diF-pHP GABA 
(124) in water with potassium sorbate as the quencher, Q. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The rate constants for GABA release spanned about 1 order of magnitude, from kr = 2 
x 107 s-1 for m-OCF3-pHP GABA (131), to kr =1.58 x 108 s-1 for o-F-pHP GABA 
(123), in water.  An overall decline in the rate constants was observed when the 
!
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kdiff = kq = 7.4 x 109 s-1 
 
KSV = kq x τ3 
 
τ3 = 4.14 x 10-9 s 
 
kr = Φo/ τ3 = 5.75 x 107 s-1 
Φo/Φ = 1 + KSV[Q] 
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solvent was changed to 0.01 M HEPES pH 7.3, except for 2,6-diF-pHP GABA (126) 
and 2,3,5,6-tetraF-pHP GABA (129), which evinced a near doubling of rate constants 
(4.7 to 8.9 and 2.7 to 5.5 x 107 s-1, respectively). 
 
Table 33. Parameters derived from Stern-Volmer quenching analysis for 122-131, 
137-139, and 153 in water and 0.01 M HEPES, 0.1 M LiClO4 at pH = 7.3. 
 
 
 
VIII. Computational Studies with analogs of pHP GABA (122-131) and pHP Glu 
(143-145). 
 Several computational studies were conducted with derivatives of pHP GABA 
(122-131, 133-134) and pHP Glu (143-145) in order to provide insights into relevant 
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parameters of solubility (ClogP), correlations between structure and relative energies, 
and electronic parameters such as spin densities and charge densities. 
 
A.  Determination of calculated logP (ClogP)108 values for 122-131, 133-134 and 
143-145.  The log of the partition coefficient for 1-octanol versus water, P, which 
represents the ratio of the concentration of a particular substance S in 1-octanol (o) 
and water (w) (P = [S]o/[S]w) is a commonly employed indicator of compound 
hydrophobicity.105 This criterion is particularly important in predicting the biological 
compatibility of the compound, e.g., solubility in lipids, metabolism, receptor 
interaction, and bioavailability, among others.105 1-Octanol has been traditionally the 
preferred organic constituent because of its likeness to lipids and its easy access.  A 
positive ClogP value indicates a greater lipophilic bearing, i.e., a higher concentration 
of the substance in the 1-octanol layer versus the water layer.  Using the CLogP® 
software package, version 3.4106 implemented in SYBYL 7.3,107 which models these 
values for ClogP, were calculated for 122-131, 133-134 and 143-145.  In addition, 
ClogP values were determined for the conjugate bases of 122-131, since these play a 
prominent role in many of the substituted pHP derivatives.  These are displayed in 
Table 34.  Within this series of compounds, m-CF3-pHP GABA (130) evinced the  
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Table 34. ClogP values for GABA derivatives (101, 122-131, 133-134), Glu 
derivatives (102, 143-145) and the conjugate bases of pHP GABA’s 122-131.    
 
Cmpd ClogP ClogP    
    (conjugate base)   
Parent 
(101) 1.19     
122 1.06 -2.71 R1 = F 
123 0.81 -3.15 R2 = F 
124 0.73 -2.82 R1, R2 = F 
125 0.8 -2.75 R1, R3 = F 
126 1.05 -2.3 R1, F4 = F 
127 0.55 -3.2 R2, R3 = F 
128 0.76 -2.44 R1, R2, R4 = F 
129 0.66 -2.52 R1, R2, R3, R4 = F 
130 2.02 -1.9 R1 = CF3 
131 1.93 -1.59 R1 = OCF3 
133 -3.81   R1, R4 = OCH3 
134 -3.38   R1 = OCH3 
    Glu   
Parent 
(102) -0.03     
143 -0.21   R2 = F 
144 0.04   R1 = F 
145 0.99   R1 = CF3 
 
 
highest ClogP value at 2.02 while the m,m’-di-OCH3-pHP GABA (133) the lowest at 
-3.81; the implications from these data are that 130 is the most lipophilic and 133 the 
least lipophilic in the series.  The extra carboxylic acid moiety that distinguishes l-Glu 
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from GABA was shown to impart drastic hydrophilic changes in the ClogP values; 
1.06 to 0.04 for m-F-pHP, 0.81 to -0.21 for o-F-pHP, and 2.02 to 0.99 for m-CF3-
pHP.  The conjugate bases, as anticipated from their charges, demonstrated sharp 
declines in ClogP values in reference to the protonated 122-131.   
 
B.  Energies and Geometries of Oxyallyl-Phenoxy Triplet Biradicals.  Previous 
studies by Givens and Wirz78 and Phillips82 revealed a significant role for hydroxylic 
component of water in the photo-Favorskii reaction. Specifically, water is thought to 
accept the phenolic proton from the triplet excited state of pHP, which helps drive the 
detachment of the hydrated nucleofuge, tantamount to a photosolvolysis process for 
the leaving group release and an extrusion process for the chromophore.  In order for 
these processes to obey the Wigner spin conservation rule, if it were an overall single 
step for a concerted process, these coupled steps generate at least one product that 
possesses unpaired spins, here the a phenoxy-oxyallyl triplet biradical (117) is the 
likely candidate.  A posited requirement for nucleofuge departure in this process is an 
out of plane (OOP) contortion of the acetate moiety relative to the planar, phenyoxy 
ring.  This generates an oxyallyl-phenoxy biradical as the extended triplet fragment.  
To investigate the energetics of the OOP contortions thus determine the associated 
relative stabilization energies of the variety of substituted triplet oxyallyl biradicals 
(117), Gaussian 03® MP2 calculations with 6-31G* basis set were performed for the 
biradical component 117 generated from 122-131.108 Additionally, the relative 
energies were determined for spirodienediones (100) that emerged after intersystem 
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crossing of the biradical triplet to a fleeting singlet followed by collapse to 100. The 
geometries of both the spirodienone 117 and the 100 are composed of nearly 
orthogonal oxyallyl and phenoxy constituents.  The results from these calculations are 
listed in Table 35. In all cases, the triplet biradical (117) was calculated to be 
substantially more stable than the corresponding spirodieneone by at least 78 
kcal/mol.  In addition, all precursors displayed an OOP contortion of at least 22o. The  
 
Table 35. The out of plane (OOP) contortion angles and relative energies of the 
oxyallyl-phenoxy triplet biradicals (117) of 122-131. 
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oxyallyl-phenoxy biradical associated with 2,3,5,6-tetrafluoro-pHP, tetraF 117, 
exhibited the greatest OOP contortion at 57.8o (Figure 48).  
Figure 48. Out of plane orientation of the biradicals of tetraF 117, fluorine (yellow), 
oxygen (red), carbon (gray), and white (hydrogen). 
 
 
C.  Spin and Charge Density Calculations.  The spin and charge densities of the 
oxyallyl-phenoxy transients were also obtained.  The spin density is the amount of 
unpaired electron density109 at specific atoms in the radical.9 The spin and charge 
densities were determined by from Gaussian 03® at the B3LYP level using the 6-
31G* basis set of the oxyallyl-phenoxy biradicals transients of the p-hydroxyphenacyl 
analogs of 122, 129-131, 134, and 154 and are represented by tetraF 117, the 
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oxyallyl-phenoxy triplet biradical from 129, in Table 36. The carbonyl carbon, C9, 
evinced the lowest spin density (-0.171987) i.e., the atom with the lowest probability 
on which one of the unpaired electrons would dwell.  In contrast, the alpha carbon to 
Table 36. Calculated spin and charge densities for tetraF 117.  
 
 
 
the carbonyl, C14, manifested the highest spin density (0.85803).  The oxygen atoms 
O10 (0.419314) and O7 (0.409811) conveyed nearly equivalent, significant 
probabilities for the location of an unpaired electron.  The most favored (lowest 
energy) biradical distribution would place one electron at C14 and the other electron 
at O10 or O7 or at C3 and O10 (Figure 49). 
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Figure 49. Predicted radical positions for the tetraF 117, from MP2 calculations at 
the B3LYP level using the 6-31G* basis set. 
 
 
 
 
 
IX. Laser Flash Photolysis Studies of pHP GABA derivatives (101, 122, 125, 128-
131), 5-acetylsalicylic acid GABA (153), and 5-acetyl-methylsalicylate GABA 
(154). 
 To obtain excited state parameters for 122, 125, 128-131, the unsubstituted 
parent 101, and 153, such as transient absorptions and rates of decay, laser flash 
photolysis (LFP) studies were conducted through a long standing collaboration with 
the Wirz group at the University of Basel.110  By pump-probe optical spectroscopy  
with a pump wavelength of 266 nm (see Experimental), bands at 320, 420, and 440 
nm were manifested for some derivatives and assigned to the appearance of the triplet 
oxyallyl phenoxy biradical (Table 37).  The rate constants for intersystem crossing for 
all derivatives were consistently ~1011s-1, and the triplet decay rate constants clustered 
around, ~108s-1.  The time to reach maximum absorption for the triplet state, however, 
was variable (5 ps for 2,3,5,6-tetraF-pHP GABA (129) to 174 ps for m-OCF3-pHP 
GABA (131) in water). Three dimensional, time dependent full spectral profiles for 
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excitation and decay from LFP m-F-pHP GABA (122) in aqueous CH3CN are 
illustrated in Figures 50 and 51. 
 
Table 37. Pump probe spectroscopy results from 101, 122, 125, 128-131, and 153 in 
water and mixed media. 
 
 
 
Following excitation, the initially formed singlet at 319 nm rapidly undergoes 
intersystem crossing to the triplet as observed by the decay of the singlet band at 319 
nm within 3 ps (the singlet maximum was observed at ~ 1 ps).  The rise of the triplet 
band at 394 nm, reaches its maximum at ~10 ps. The triplet decay occurs with a rate 
constant of 1.6 x 109 s-1.  In some instances a transient is detected at λ = 340 nm that 
  185 
Figure 50. Three dimensional, time resolved absorption contour of 122 in aqueous 
CH3CN.   
 
 
 
reaches a maximum at 20 ns and subsequently decays with a rate constant, 1.6 x 108 s-
1.  A part of this transient has tentatively also been assigned to the triplet oxyallyl-
phenoxy biradical, m-F 117.  Other absorptions of transients at 420 and 440 nm were 
revealed for several other precursors and were also assigned to the transient 117.  
Further elaboration of these findings can be found in the Discussion section. 
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Figure 51. Three dimensional triplet decay contour of 122 in aqueous CH3CN. 
 
 
 
A cross section of this diagram demonstrates the triplet of 122 at 394 nm (green), an 
unassigned band at 420 nm (red), and unknown transient at 340 nm (violet) (Figure 
52). 
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Figure 52. Cross section of the three dimensional, time resolved absorption contour 
of 122 in aqueous CH3CN.  
 
 
 
 
Triplet decay parameters for 101 were also obtained from LFP in aqueous CH3CN.  
The three dimensional contour is presented in Figure 53.  The triplet displayed two 
λmax at 400 nm and 500 nm, the former much stronger than the latter, which reached 
their maximum absorption maxima at 8 ps and decayed with rate constants of 2.6 x 
109s-1.   
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Figure 53. Three dimensional, time resolved triplet decay contour of 101 in aqueous 
CH3CN. 
 
 
 
 
Consistent with 122, the emergence of a band at 340 nm was observed, which 
decayed with a rate constant of 1.3 x 108 s-1. Corresponding one dimensional plots 
represent triplet decays at both wavelengths, 400 nm in Figure 54 and 500 nm in 
Figure 55.   The curve fit is represented by the green line, derived from data points 
that are in red. 
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Figure 54. Triplet decay profile of 101 at 400 nm in aqueous CH3CN. 
 
 
Figure 55. Triplet decay profile of 101 at 500 nm in aqueous CH3CN. 
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For comparison, the triplet decay profiles of 2,3,6-triflouro-pHP GABA (128) from 
LFP in aqueous CH3CN are included.  The three dimensional contour of 128 is shown 
in Figure 56.  Evidently, the band at 340 nm is significantly diminished compared to 
other pHP GABA derivatives.  
 
Figure 56. Three dimensional, time resolved triplet decay contour of 128 in aqueous 
CH3CN. 
 
 
 
 
Two triplet wavelengths were determined at 391 and 398 nm, the former much 
stronger in intensity than the latter, which reached their maximum absorbance at 80 
ps and decayed with a rate constant of 8 x 108 s-1.  A cross section of this triplet decay 
plot is exhibited in Figure 57.  In this representation, the unknown transient at with 
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λmax at 340 nm is readily apparent.  Both triplet bands at 391 and 398 nm are clearly 
depicted as well. The corresponding one dimensional triplet decay of the band at 391 
 
Figure 57. A cross section of the three dimensional absorption contour of 128 in 
aqueous CH3CN. 
 
 
 
nm is presented in Figure 58.  The green line represents the curve fit of the data 
points, which are in red. 
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Figure 58. Triplet decay plot of 128 in aqueous CH3CN. 
 
 
 
 
The triplet decay profiles for 5-acetylsalicylic acid GABA (153) in water were 
obtained by LFP.  A cross section of the three dimensional plot is represented in 
Figure 59. 
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Figure 59. Cross section of the three dimensional absorption profile of 153 in water.  
 
 
 
 
The triplet at 422 nm reaches it maximum absorption at 100 ps and decays with a rate 
constant of 6.0 x 108s-1.  Similar to the pHP GABA esters, a band emerges 340 nm 
that decays, however, with a markedly decelerated rate constant, 1.0 x 106s-1, versus 
unsubstituted pHP GABA, 1.3 x 108s-1, a 2 order of magnitude difference.  The 
corresponding one dimensional triplet decay profile for 153 in water is depicted in 
Figure 60. 
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Figure 60. Triplet decay profile of 153 in water. 
 
 
 
 
LFP studies were carried out with the 5-acetyl-methylsalicylate GABA (154) in 
aqueous CH3CN.  The absorption profile (Figure 61) revealed the singlet (red) at 326 
nm which was seen to decay to two triplet bands at 330 and 396 nm.  
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Figure 61.  Cross section of the three dimensional absorption contour of 154 in 
aqueous CH3CN. 
 
 
 
 
 
 
A short time later, a cross section (Figure 62) revealed the emergence of the 
commonly detected 340 nm band (violet), an unassigned band (red), and the triplet of 
154 at 416 nm, which reaches its maximum at 140 ps. 
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Figure 62. Cross section of the three dimensional absorption profile of 154 in 
aqueous CH3CN. 
 
 
 
 
 
 
 
Lastly, a one dimensional decay plot of the triplet at 416 nm (Figure 63) displayed the 
rate of decay as 1.3 x 109s-1. 
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Figure 63. Triplet decay profile of 154 at 416 nm in aqueous CH3CN. 
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Discussion 
 
 
 
A. Synthetic Strategies 
 The methodology used to synthesize pHP GABA esters 122-131 was outlined  
 
Scheme 38. (Introduction) The synthesis of m-fluoro pHP GABA (122). 
 
 
in Scheme 38 (Introduction) with m-F-pHP GABA 122. Briefly, the commercially 
available 4-bromo-2-fluorophenol (122a) was benzylated with benzyl bromide in an 
excess of potassium carbonate to afford 122b that then underwent a transmetallation 
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reaction with a slight excess of tributyl(1-ethyoxyvinyl)tin (1.1 equivalents), 
catalyzed by Pd(0), to afford the acetylated derivative (122c).   
It should be noted that heretofore, this Stille protocol for acetylation had not 
received any use with phenols. In our study, the Stille coupling is an essential step in 
the synthesis of ketones 122-131.  Several other acylation procedures were initially 
attempted, including Friedel Crafts acylation with acetyl chloride and aluminum 
trichloride, the Fries rearrangement with an acetyl-substituted phenol in the presence 
of aluminum trichloride, and lastly, transmetallation with n-butyl lithium followed by 
addition of acetyl chloride.  None of these methods provided yields of acetylated 
targets in excess of 20%.   
Several modifications of the Stille protocol were made to improve the 
acetylation.  Palladium (0) as the tetrakistriphenylphosphine complex, replaced the 
Pd(II) bischlorotriphenylphosphine complex (we thank Professor Helena Malinakova 
for this suggestion as well as advice on Stille protocols).  The former is air sensitive 
and oxidizes rapidly, whereas the latter is stable.  Presumably, when the latter is 
dissolved, prompt reduction to Pd (0) occurs from chloride departure, activating 
palladium for oxidative addition with the aryl bromide.  When employed for this 
purpose with 122, for example, the color turned from yellow to black within 15 
minutes, even after 30 minutes of solution degassing, and the yields of 122c never 
surpassed 10%.  Palladium black, as it is commonly known, is an inactive form of 
palladium.   
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Another modification involved the addition of saturated aqueous KF to the 
solution mixture after acetylation.  The byproduct of transmetallation, tributyltin 
bromide, is a liquid that proved difficult to separate from the target compound.  
Column chromatography with a broad range of eluents failed to completely remove 
this material.  However, in the presence of KF, fluoride exchange readily occurred 
with bromide to generate tributyltin fluoride, a white, insoluble precipitate that was 
easily removed by filtration and did not react with the target.  The use of Pd(0) as the 
catalyst for acetylation and fluoride for purification permitted the yields of 122-131c 
to routinely surpass 80%.    
 Once 122c (Scheme 38) was synthesized, supervening α-bromination was 
accomplished with dioxane-dibromide, DDB, in 1 h to afford 122d in high yield that 
subsequently underwent facile SN2 substitution with N-Boc protected GABA to 
generate 122e.  At this point, two divergent approaches were used.  Early synthetic 
strategies, including the preparation of the p-hydroxyphenacyl GABA’s, utilized 
distilled TFA over 24 h to eliminate both the benzyl and Boc protecting groups.  
Though this approach was effective in generating the fluorinated targets 122-131, 
oftentimes, wet, adhesive precipitates resulted that necessitated drying under reduced 
pressure for more than a week.  A later strategy was to first debenzylate with Pd/C 
and H2 in ethyl acetate, which was quick (2 to 4 h) and efficient (>95% without the 
need for further purification), followed by Boc deprotection with TFA:CH2Cl2 (1:1) 
for 10-15 minutes.  After lyophilization the products were generally flaky, white 
precipitates. 
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 The synthetic approach for pHP GABA esters (132-141), 4-fluorophenacyl 
GABA (142), pHP DOC (150), and α-alkyl-pHP diastereomers (166 and 167) were 
patterned after that for 122 but did not require the use of the Stille protocol, as the 
corresponding p-hydroxyacetophenones and 4-fluoroacetophenone (142) were 
commercially available.  In the cases where there were no protecting groups on the 
substrate, such as DOC for 150 and enantiomers for 166 and 167, the last step in the 
sequence involved Pd/C mediated hydrogenation. 
 The highlight for the synthesis of pHP diethyl phosphonate (151) entailed the 
Arbuzov reaction.  Here, the benzyl protected, α-brominated 146c was refluxed neat 
in triethylphosphite over 17 hours to afford the phosphonate that was easily reduced 
to the corresponding phenol 151 via Pd/C mediated hydrogenation.  
The key step in the synthesis of pHP F (152) consisted of a SN2 reaction 
between 146c and CsF in refluxing acetonitrile for 3 h to afford 152 after 
deprotection. 
 
B.  General photochemistry of pHP and 5-acetylsalicylic acid caged derivatives 
The general photochemistry of pHP caged compounds was summarized in 
Scheme 37 in the Introduction.   
 The results from photolysis of pHP GABA and Glu esters, the pHP caged 
amino acids, deoxycholic acid, and diastereomers at 300 nm in aqueous media were 
consistent with past studies; the only photo products observed were liberated 
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substrate and rearranged p-hydroxyphenylacetic acids as major products, along with 
minor p-hydroxybenzyl alcohols.   
 The p-hydroxybenzyl alcohols had been overlooked previously.  In current 
studies, however, a small, signature band at δ ~ 4.5 ppm was universally discerned in 
the 1H NMR spectra following photolysis and was verified in several cases by spiking 
the product mixture with an authentic sample of the corresponding p-hydroxybenzyl 
alcohol.  Certain derivatives were found to be unreactive, however.  These will be 
discussed later.  
The photochemistry of m-methoxy derivatives 133 and 134 were re-examined. 
The photoproducts from these, in addition to GABA, had been reported to be 
predominantly m-methoxy-pHP-acyloin and m-methoxy-p-hydroxyacetophenones.  
The rearranged p-hydroxyphenylacetic acid was said to be minor or non-existent.  
When re-evaluated, the primary photoproduct obtained for each was, in fact, the 
rearranged p-hydroxyphenylacetic acid; this was evidenced by the intense 1H NMR 
signal at δ ~ 3.7 ppm (see Figure 22 in Results).  The acyloin and acetophenone 
byproducts were also observed at δ = 4.99 and δ = 2.60 ppm, respectively, however 
only as minor photoproducts, along with the recently discovered p-hydroxybenzyl 
alcohol at δ = 4.60 ppm.  Nevertheless, the discrepancies in photoproduct 
distributions for 133, 134, and a few others were the first indicators of possible 
substituent-directed mechanistic changes in substrate photorelease from pHP.   
The photochemistry of 5-acetylsalicylic acid GABA (153), 5-acetyl-
methylsalicylate GABA (154), 5-acetylsalicylic acid alkanoyl acids (155 and 156), 
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and antennae compounds (157-165) produced primary photoproducts, besides the 
liberated substrate, that were consistent in chemical shift with the corresponding p-
hydroxyphenylacetic acid (δ = 3.64 ppm, Figure 35 in Results).  In addition, minor 
resonance signals were generally observed at δ ~ 4.50 ppm that approximated those 
for p-hydroxybenzyl alcohol.  
 
C. Preliminary Mechanistic Studies 
1)  Excited state assignments for pHP GABA esters.  Stern-Volmer quenching 
studies were conducted with 1-10 mM of pHP GABA esters (101, 122-131, and 137-
139) using 0-100 mM of potassium sorbate as a triplet quencher in water, in pH 7.3 
buffer and the reactions were analyzed by HPLC (see Table 33 and Figure 46 in 
Results).  Significant drops in the quantum efficiencies were observed with increasing 
sorbate concentration regardless of the medium, providing good empirical evidence 
for a reactive triplet excited state for all of these pHP derivatives.  The m-methoxy 
and m,m’-dimethoxy pHP GABA derivatives (134 and 133, respectively) had been 
analyzed previously97,111and manifested a prevalent reactive triplet state.  
 In addition to S-V quenching, LFP studies were conducted on the fluorinated 
pHP GABA esters in both aqueous CH3CN and water.  Absorbance profiles revealed 
rapid intersystem crossing from the singlet to triplet states (~1011s-1) with efficiencies 
near unity.  Degassing experiments failed to manifest any changes in the quantum 
efficiencies, due to the rapid decay rate (107-109 s-1) of the pHP triplet and the 
inherently low concentration of O2 in water (1.28 mM).112  
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 In accord with previous findings by Givens and Wirz,78,92 and Phillips,80-82,86-
88,99,91the reactive excited state for these pHP GABA esters is unequivocally the 
triplet.  In 2008, Givens and Wirz92 suggested the possibility of an adiabatic 
nucleofuge disjunction (Scheme 37) from the observation of a series of new bands  at 
330, 420 and 445 nm derived from LFP of pHP diethyl phosphate, mesylate, and 
tosylate, in aqueous CH3CN.  An oxyallyl-phenoxy triplet biradical was assigned to 
the transient intermediate based on these absorptions.  The same bands were 
consistently revealed for the other LFP probed pHP GABA esters, suggesting a 
common triplet oxyallyl-phenoxy biradical intermediate to the entire series. 
2)  Excited state assignments for 5-acetylsalicylic acid GABA and its esters.  The 
sole compound probed by S-V quenching analysis and LFP studies was 5-
acetylsalicylic acid GABA (153).  The carbomethoxy analog (154) was analyzed by 
LFP studies and was reported previously as exhibiting an operative triplet state.113 As 
shown in the Results section, 153 was readily quenched by potassium sorbate in 
water, manifesting a linear S-V correlation constant, KSV.  LFP studies in both water 
and aqueous CH3CN confirmed this and clearly showed the singlet rapidly crossing to 
the triplet, k = 2.1 x 1011s-1.  The triplet maximum occurred at λ = 422 nm within 100 
ps and decayed with a rate constant of 6.0 x 108s-1.  These findings confirm the triplet 
as the reactive state.  Additionally, short-lived absorption bands at 330, 420, and 445 
nm further substantiated an triplet oxyallyl-phenoxy biradical intermediate. The 
remaining 5-acetylsalicylic acid derivatives (155-165) were not probed by S-V 
quenching or LFP, but, nonetheless, are anticipated to react from the triplet state.   
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3)  A preliminary photo-Favorskii mechanism. Integrating the empirical data 
obtained from 1H NMR photochemical analyses in D2O, which revealed the 
rearranged p-hydroxyphenylacetic acid and released substrates as major products in 
near quantitative yields and a trace amount of p-hydroxybenzyl alcohol, with the S-V 
quenching and LFP established functional triplet state and a probable oxyallyl  
phenoxy triplet biradical that leads to the rearranged and decarbonylation product, a 
preliminary photo-Favorskii mechanism is posited (Scheme 52, with 153).   
 The process is as follows:  Initial excitation of 153 to the singlet excited state 
is followed by rapid (2.1 x 1011s-1) intersystem crossing to the triplet, (1533). 
Significant H-bonding interactions with water assist the complex in skewing the 
carbonyl OOP with respect to the ring, a necessary stereoelectronic arrangement for 
facile substrate release.  In this manner, the triplet undergoes solvent assisted 
deprotonation of the phenol with concomitant substrate departure (6.0 x 108 s-1), 
forming a triplet oxyallyl-phenoxy biradical that has an orthogonal OOP orientation.  
DFT calculations of 101, 122-131 (Table 35, Results) confirmed the OOP geometry 
of biradical and also predicted this to be much lower in energy than the corresponding 
ground state spirodieneone.  Once formed, the biradical then rapidly relaxes with 
intersystem crossing and collapses to the spirodiendione.  The completion of the route 
to the major, p-hydroxyphenylacetic acid product is through water-mediated 
fragmentation of the spirodienedione; the minor p-hydroxybenzyl alcohol is formed 
by an initial CO extrusion from the spirodienedione to form the p-quinone methide, 
which then undergoes conjugate addition of H2O.  
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4)  Alternative mechanisms and photoproducts  The m-methoxy and m,m’-
dimethoxy pHP GABA derivatives (134 and 133, respectively) were the only 
derivatives of pHP that manifested other exiguous photoproducts, such as p-
hydroxyacetophenone (115) and α-hydroxy acetophenone, an acyloin derivative (α-
OH-115) (Figure 64).  It is obvious that divergent mechanisms are operative in these.   
 
Figure 64. Photoproducts of 134 a) m,m’-diOCH3-115, b) m,m’-diOCH3-α-OH-115 
and 133 c) m-OCH3-115, d) m-OCH3-α-OH-115. 
 
 
 
Yousef111 previously explored the photochemistry of 134 in aqueous media and had 
noted the appearance of these photoproducts.  His mechanistic interpretations were 
congruent with results from disparate studies of Sheehan,51and Pincock114 (Scheme 
53 with 133).  The photoconversion course is proposed as follows:  Initial excitation 
of 133 to the singlet state is followed by rapid ISC, k = 2.7 x 1011s-1 to the triplet 
(1333), which undergoes homolytic scission to produce the geminate radical pair 
(133.).  The geminate radical pair can recombine to reproduce 133, or can diverge 
into two disparate mechanisms. 1) Electron transfer occurs between the radicals to 
generate a geminate ion pair (133I), which can regenerate 133 by recombination (not  
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shown) or solvent separate and hydrolyze to afford GABA and m,m’-diOCH3-α-OH-
(115).  Pincock114demonstrated this route was feasible from photolyses of a series of 
arylmethylacetates in methanol. 2)  A second possible mechanism manifests solvent 
incited separation of the geminate radical pair to engender a solvent separated radical 
pair, which H atom abstracts from the mixture, analogous to Sheehan’s51 suggested 
mechanism, from photolysis with p-methoxyphenacyl benzoates in EtOH, to furnish 
m,m’-diOCH3-115 and GABA.   
 
D.  Substituent effects on the photo-Favorskii rearrangement 
1)  Quantum Efficiencies of Fluoro-pHP GABA’s:  The role of the conjugate 
base.   The position and extent of fluoro substitution on the pHP chromophore was 
found to manifest stark changes in the quantum yields for GABA release, Φdis, in 
aqueous solutions.  The quantum yields, determined at 300 nm, for GABA and p-
hydroxyphenylacetic acid appearance were nearly identical to Φdis in all cases, thus 
Φdis will be principally considered.  In water (Table 22, Results), m-F-pHP GABA 
(123 (Φdis = 0.28)), 2,3-diF-pHP GABA (124 (Φdis = 0.24)), and  2,5-diF-pHP GABA 
(125 (Φdis = 0.22)) were the only derivatives that demonstrated improved yields 
relative to the unsubstituted parent (101 (Φdis = 0.20)), and o-F-pHP GABA (122 
(Φdis = 0.16)) and 2,6-diF-GABA (127 (Φdis = 0.16)) were nearly the same as 101.  
The common factor for these five was the λmax ~ 280 nm which indicated the 
protonated pHP dominated.  In contrast, 3,5-diF-GABA (126 (Φdis = 0.11)), 2,3,6-
triF-GABA (128 (Φdis = 0.08)), and 2,3,5,6-tetraF-GABA (129 (Φdis = 0.11)), evinced 
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the predominant conjugate base of the chromophore, which absorbs at λmax > 300 nm. 
In buffer pH 7.3 (Table 23, Results) all fluoro pHP derivatives manifested 
predominant conjugate bases, except 123, which exhibited both the conjugate base 
and protonated forms with absorptivities nearly the same.  Accordingly, Φdis at this 
pH were lower for all fluoro pHP GABA esters, e.g., 124 (Φdis = 0.11) and 125 (Φdis 
= 0.10), while that for 123 dipped only slightly, (Φdis = 0.21).   
 The unsubstituted parent, 101, which was predominantly protonated, evinced 
a constant Φdis = 0.21.  At pH 8.2, all fluoro pHP GABA’s were conjugate bases and 
all manifested low Φdis.  Conspicuously, the pH of the media impacts the efficiency 
of photoconversion 122-131 by controlling the equilibrium between the conjugate 
bases and protonated forms; thus, there exists a clear correlation between the pKa of 
the pHP and Φdis.  In water, pH = 6.5, those derivatives with pKa’s 5.5 and lower 
(Table 15 Results) 126, 128, 129, 130, conveyed the preponderant conjugate base, 
with accompanying lower Φdis.  Those with pKa’s between 5.5 and 6.7 showed both 
forms, i.e., 122, 124, 125, 131, while those with pKa’s 6.8 and higher, 123, and 127, 
predominantly the protonated form.   
 Two interesting trends are noticeable from comparisons of fluoro pHP 
GABA’s to the unsubstituted pHP GABA (101).  First, those with a single ortho 
fluorine, i.e., 123, 124, and 125 with pKa’s 7.2, 5.9, and 5.7 respectively, exhibited 
higher Φdis than unsubstituted 101 in water, with no control on the pH.  A sufficient 
explanation for this ortho-effect is not available.  Second, the Φdis for m-OCF3-pHP 
GABA (131 (0.09)) was double that of its proton counterpart m-OCH3-pHP GABA 
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(134 (0.04)).  A possible rationalization for this might be due to the reduced electron 
donating capacity of the -OCF3 vs. -OCH3, an influence that Givens, et. al., had 
previously reported.104  
 Attempts to discern linear correlations between pKa and Φdis in water (blue) 
and Φdis at pH 7.3 (pink) (Figure 65) showed little difference between the two sets of 
data.  However, the notion of discrete differences in the branching between decay of 
the excited state and progress towards release for the protonated versus conjugate 
  
Figure 65. Plot of pKa of fluoro pHP GABA’s vs. Φdis in water (blue diamonds) and 
buffer pH 7.3 (pink squares).  Unsubstituted pHP GABA (101) is included for 
comparison. 
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bases is consistent with our earlier conclusion.  The efficiency for photorelease is 
apparently independent of the pKa of the chromophore within the narrow range 
exhibited in this fluorinated pHP GABA series. 
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The singlet excited state of the conjugate base also rapidly intersystem crosses 
to the triplet state, kISC = 3.0 x 1011 s-1. A small fraction of the singlet also deactivates 
by fluorescence (Results, Table 20). The triplet deprotonation step, deemed to be 
crucial in initiating the photo-Favorskii rearrangement, is obviated from the singlet.  
These two distinctions separate the conjugate base pathways from the triplet reaction 
of the protonated pHP.  However, a rapid deprotonation of the singlet excited 
protonated pHP is precluded as there is no fluorescence observed from this species.  
The diminished Φdis for the conjugate bases must result from a more efficient decay 
pathway.  Since the products are the same, an operative photo-Favorskii 
rearrangement mechanism is the likely pathway. 
2)  Rate Constants of Fluoro pHP GABA esters.  The rates constants, kr, obtained 
from S-V quenching for GABA release, disclosed marginal differences in aqueous 
media.  From Table 33, kr spanned from 1.8 x 107s-1 for 2,3,6-trifluoro-pHP GABA 
(128) to 1.6 x 108s-1  for o-F-pHP GABA (123) in water and 1.1 x 107s-1 for 3,5-diF-
pHP GABA (127) to 8.9 x 107s-1 for 123 in pH 7.3 buffer.  These essentially identical 
rapid rates parallel the nearly constant quantum efficiencies.  The lack of change in 
the rate constants as might be anticipated in other linear free energy relationships 
such as Hammett σ-ρ correlation militates against an ionic charge buildup in the 
transition state for the release of the substrate.  At first pass, the result might appear 
implausible since the fragmentation step for covalent bond breaking results in the 
release of the carboxylate ion rather than a carbonyl radical.  The latter has been ruled  
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Figure 66. A. Plot of rate constants for release, kr, of pHP GABA’s vs. pKa’s in 
water.  B.  Plot of rate constants for release, kr, of pHP GABA’s vs. pKa’s in pH 7.3 
buffer. 
 
 
 
out due to the absence of radical decarboxylation processes in the photo-Favorskii 
reaction (see Introduction).  Attempts to correlate kr with corresponding pKa’s in 
water and pH 7.3 buffer demonstrated no association (Figure 66). 
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3)  Comparisons of the Stern-Volmer derived rate constants with the LFP 
values.  Rate constants obtained independently from LFP (Table 37) were, in general, 
higher by up to one order or magnitude relative to those obtained by S-V quenching 
studies.  The triplet lifetimes obtained by LFP are accordingly shorter than those 
obtained by S-V quenching with sorbate.  The origin of this effect may be due to the 
method, i.e., the nature of the quencher and estimated rate of diffusion used in 
calculation of the rate constants.  For example, Givens and Wirz,92 and Phillips81 
showed that added organic solvents greatly increase the lifetime of the pHP triplet.  
The diffusion rate constant may be an overestimate.  As sorbate is added in a S-V run, 
the “organic nature” of the solvent will increase, lengthening the lifetime of pHP 
triplets.  This renders them more susceptible to bimolecular quenching and gives the 
appearance of a slower competing rate for the reaction out of the triplet manifold. A 
second factor may be the relative protonation state of the pHP chromophore.  A 
slower quenching diffusion rate for the conjugate base will have a corresponding 
effect on the S-V constant, KSV, which will consequently result in a lower estimated 
lifetime of its triplet.   
4) The role of H2O.  As shown previously by Givens78 and Phillips,45 the triplet pHP 
ester is influenced by water, primarily assisting in the removal of the phenolic proton 
but also in assisting the concomitant loss of the leaving group, GABA, through  
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solvation.  Added organic quenchers will negatively influence the solvation and 
deprotonation processes causing a decrease in the triplet reactivity.   
5)  Other sources of variance.  An additional difference lies in the excitation source.  
For Stern-Volmer quenching, analyses were conducted with 300 nm, RPR phosphor 
coated lamps that span a range from 250 to 350 nm.  Both the phenol and its 
conjugate base, if present, will be excited at longer wavelengths near 300 nm.  In 
contrast, the pump probe spectroscopy studies were conducted with a monochromatic 
laser excitation of 266 nm having a dynamic range of ± 5 nm.  This wavelength 
would predominantly excite the protonated forms (the absorptivities are very low at 
266 nm for the conjugate bases). 
6)  Photochemistry of the conjugate bases.  Photolysis of 122-131 at 350 nm in 
0.01 M TRIS pH 9, where the conjugate bases predominate, evinced Φdis that were 
well below 0.01, ranging from 0.001 (124) to 0.008 (130).  These low values indicate 
that other deactivation pathways are  more efficient than GABA photorelease.  
7) Proposed mechanism for conjugate base.  An alternative mechanism is proposed 
for the conjugate bases of pHP (Scheme 54, vide supra with the conjugate base of 
pHP GABA (101)).  Red values highlighted in this mechanism are the result of this 
work and may differ from the mechanism for protonated pHP GABA. 
 
E.  Miscellaneous substituent effects on pHP GABA ester photochemistry  
Several other substituents were explored for their effects on the 
photochemistry.115  The nitro group is notorious for its deleterious effects on ketone 
  217 
photochemistry, frequently shutting down all photoluminescent and photochemical 
activity.  On the other hand, in an o-nitrobenzyl motif, the hydrogen abstraction 
photochemistry is the key step for this most popular photo-removable protecting 
group.104 For nitro substituted pHP, m-NO2-pHP GABA (132), the -NO2 moiety 
extended the π-π* absorption past 400 nm, but did not lead to GABA release when 
photolyzed between 254-350 nm in water. Here, the nitro group served as a 
deactivator.  
 Ortho and m-OH-pHP GABA’s (135 and 136, respectively) effectively 
quenched the photorelease of GABA as well.  Hydrogen bonding with the excited 
ketone carbonyl for the ortho OH, a stabilizing interaction, could hinder the 
stereoelectronic alignment to the necessary OOP rotation angle of the carbonyl for 
substrate release (Figure 67).   
 
Figure 67. Proposed H-bonding between the o-OH and ketone carbonyl of 135. 
 
 
 
The m-OH isomer also failed to effect GABA photorelease in water.  H-bonding with 
the p-OH moiety could interfere with the crucial proton transfer step of the substrate 
release (Figure 68).  
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Figure 68. H-bonding between meta and para-OH moieties of 136. 
 
 
 
The meta-methyl substituted pHP GABA’s manifested Φdis in water of 0.15.  
A small absorbance band shift to λmax = 304 nm for 138 (24 nm) vs. pHP GABA did 
not change the Φdis, 0.15 and 0.20 respectively.  At pH 8.2, Φdis drop to 0.08 and 0.11, 
respectively, congruent with declines previously seen with conjugate bases of all the 
derivatives. 
Interestingly, the o-CH3-pHP GABA (139) evinced a 45% decline in Φdis 
(0.11) compared to the unsubstituted analog (101) (0.20) and a 26% decline compared 
to meta isomer (0.15).  Although the origins of this were not examined, two effects, 
one steric effect and the other a reversible Norrish Type II hydrogen atom abstraction 
may interfere with GABA release.  The steric effect of CH3 may force the acetyl 
moiety to adopt a conformation that is less amenable to GABA release.  Low level 
MM2 calculations116 predicted the carbonyl of decaged 139 to adopt an OOP 
orientation with the ring (angle not specified), whereas the unsubstituted analog 115 
was planar (Figure 69). The reversible nature of o-arylmethyl ketone photochemistry 
has been well documented117 and has been pictured  
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Figure 69. Lowest energy conformations of decaged 139 and 115 by low level MM2 
calculations.  The OOP twist angle was not determined.  
  
 
 
 
 
as an “energy wasting” mechanism, much the same as the alkene cis-trans 
isomerization process (Equation 16). 
 
  Eq. 16 
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The α-methyl and ethyl substituted pHP GABA’s 140 and 141, respectively, showed 
 
 
 
low Φdis, 0.05 and 0.06, respectively.  These are secondary α-centers to the ketone, 
which may alter the stability of the initially formed radical intermediates.  The 
photoproducts included released GABA and the analogous, rearranged p-
hydroxyphenylacetic acid.   
 The impetus for the synthesis and subsequent probing of the photochemistry 
of 4-fluorophenacyl GABA (142) was based on the well documented p electron 
donation of fluorine to the π aromatic system of aromatic fluorine compounds.118 It 
was reasoned, then, that the p-fluoro moiety may be a surrogate for the p-OH group in 
inducing photorelease of GABA and rearranging to the corresponding 4-
fluorophenylacetic acid.  However, this compound proved to be inert at irradiation 
wavelengths of 254 and 300 nm. 
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F.  Substituent effects on 5-acetylsalicylic acid GABA derivatives (154, 157-165).   
 The quantum yield of methyl 5-acetyl-salicylate GABA (154) at 300 nm 
spanned from Φdis = 0.08 to 0.11 between pH 7 to 9, respectively, and the rate 
constants for GABA release, kr = 1.3 x 108s-1 were equable. These were consistent 
with 5-acetylsalicylic acid GABA (153).  Replacing the methyl with auxochromes 
(157-165) gave quantum yields between 0.01 and 0.12.  Though all of these 
compounds demonstrated strong absorbances at λ = 350 nm at 1 mM in water, when 
irradiated at 350 nm in water, they gave Φdis well below 0.01.  An energy threshold 
for efficient GABA release from the pHP and 5-acetylsalicylic acid phototriggers 
may have been reached when the triplet energy of the system drops from 70 kcal/mol 
(pHP) to that effectuated by the auxochrome.  
 
G. Nucleofuge effects on the photo-Favorskii rearrangement.  The primary 
research objectives were on comprehending substituent, pH and media effects on the 
photo-Favorskii rearrangement.  Another crucial aspect, however, concerns the nature 
of the nucleofuge.  Carboxylic acids were emphasized in studies presented in this 
thesis, i.e., γ-aminobutyric acid, l-glutamic acid, glycine, tyrosine, phenylalanine, 
valine, deoxycholic acid, and alkanoyl acids.   
1) l-Glutamate.  The l-glutamate nucleofuge exhibited the same behavior as GABA.   
2) Other amino acids.  The amino-acids glycine, valine, phenylalanine, and 
tryptophan manifested the same behavior as GABA.  
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3) Deoxycholic acid.  The quantum yield for the disappearance of pHP DOC (150) 
was determined to be 0.06 in 5% aq. CH3OH.  DOC is highly lipophilic, contrary to 
the hydrophilic GABA salt.  Solvent assistance, primarily through H-bonding with 
the nucleofuge, is considered to be central to nucleofuge departure. Though CH3OH 
can hydrogen bond, it is less much less efficient than water; less effective solvation 
could complicate nucleofuge departure, which would direct deactivation to other 
pathways.  However, the rearranged p-hydroxyphenylacetic acid was observed, 
suggesting that the operative mechanism is the “photo”-Favorskii pathway. 
4)  Alkanoyl acids. The nucleofuge capacities of dodecanoic and tetradecanoic acids 
were probed as substrates caged to the 5-acetylsalicylic acid chromophore (155 and 
156, respectively).  The motivation here involved the application of these as 
photocleavable surfactants.  Caprioli100and coworkers had synthesized structurally 
similar compounds to 155 and reported successful cell membrane protein extraction, 
improved ionization efficiencies and resolution of these proteins by MALDI analysis 
and facile surfactant removal by photolysis.  Only a handful of photocleavable 
surfactants have been reported in the literature.  The water solubility of 155 and 156 
was low.  The photolysis of 1 mM solutions of each in 5% aqueous CH3OH at 300 
nm evinced Φdis of 0.04 and 0.06, respectively.  However, 155 and 156 promptly 
dissolved in 0.01 M HEPES with 0.1 M LiClO4 at pH = 8.2, suggesting the 
carboxylic acid was deprotonated.  Irradiation of 1 mM of each in this buffer divulged 
Φdis that were 0.10 and 0.09, respectively, commensurate with the GABA derivative.  
The improved quantum yields in buffer, substantiate water-assisted substrate 
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disjunction, i.e., higher water content promotes substrate disjunction because of a 
higher degree of solvation.  This observation corroborates the hydrated triplet 
complex depicted in Scheme 52.  Though the photocleavable surfactant properties of 
155 and 156 seem favorable, i.e., each are soluble in pH 8.2 buffered media and 
exhibit efficient photodegradation, their biological assessments have not been 
determined.   
 
H.  Nucleofuge effects - linear free energy relationships.  Most nucleofuges studied 
for this thesis were carboxylic acids.  Dr. Cope, a recent graduate of the Givens 
group,119 explored the how the nature of nucleofuge impacts the photo-Favorskii 
rearrangement by synthesizing and probing the photochemistry of pHP mesylate 
(168), tosylate (169), benzoate (170a), p-OCH3-benzoate (170b), p-CF3-benzoate 
(170c) and formate (171). Through a combination of Stern-Volmer quenching and  
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LFP studies, a Brønsted βLG (nucleofuge), linear free energy relationship (LFER) was 
determined.   
 The nucleofuge capacity has also been determined to correlate with the log of 
the reaction rate constant (Equation 17), where βLG signifies the response of the rate 
constant to the nucleofuge acidity.  
 
log(k) = βLG(pKa) + log(C)   Eq. 17 
 
The nucleofuge capacity is enhanced by a decrease in pKa; thus a negative βLG would 
signify favorable nucleofuge properties.  Applied to a linear free energy setting, βLG 
indicates the degree of bond breaking (nucleofuge departure) in the rate determining 
step.120 The rate determining step in the photo-Favorskii is believed to be nucleofuge 
disjunction, so the acquisition of a βLG value is key to an improved comprehension of 
this step.  Parameters of other esters and sulfonates with those of pHP GABA, pHP p-
CN-phenolate121 and pHP-phenolate121 (for comparison), derived in aqueous CH3CN, 
are presented in Table 38. 
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Table 38. Parameters of 168-171 and other pHP derivatives. Adapted and modified 
from ref.119. 
 
 
pHP derivative LG pKa Φdis kτ3 decay (s-1) τ3 (ns) log (Φdis/τ3)a 
Mesylate 168 -1.54 0.932 8.5 x 109 0.118 9.70 
Tosylate 169 -0.43 1.04 9.6 x 109 0.104 10.0 
Diethyl Phosphate 
114 0.71 0.40 2.9 x 10
9 0.345 9.06 
pCF3 Benzoate170c 3.69 0.201 1.6 x 109 0.625 8.51 
Formate 171 3.75 0.94 1.5 x 109 0.667 9.15 
pOCH3 Benzoate 
170b 4.09 0.288 1.2 x 10
9 0.833 8.54 
Benzoate 170a 4.21 0.316 8.6 x 108 1.16 8.44 
GABA 101 4.00 0.21 2.9 x 109 0.345 8.78 
pCN Phenolate 7.17 0.11 6.9 x 108 1.45 7.88 
Phenolate 9.8 0.04 2.6 x 108 3.85 7.02 
alog kr = log(Φdis/τ3) 
 
The logs of the rates of disappearance, kr, were plotted against the pKa of the 
conjugate acid of the nucleofuge to obtain a slope (βLG) that was -0.2419121 (Figure 
70).  A good correlation between log of kr and nucleofuge pKa’s was observed, R2 = 
0.9061.  The moderate, negative value for βLG, indicates that some bond scission 
between pHP and the nucleofuge occurs in the transition state of the rate determining 
step.  The pKa of the nucloefuge, one direct measure of leaving group ability, is 
shown to be a significant factor on determining the rate of nucleofuge detachment. 
The data points in pink originate from the fluoro pHP GABA’s; these demonstrate 
that substituent effects are operative in modifying kr.   
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Figure 70. A plot of rates of disappearance, (Φdis/3τ) vs. the pKa of pHP esters, 
establishing a Brønsted linear free energy relationship.  The values in pink represent 
the fluoro pHP GABA series. 
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I.  Media effects on the photo-Favorskii rearrangement.   
1) Background. The media in which pHP cages are photolyzed is crucial to the 
efficiency of the photo-Favorskii rearrangement.  Wan and Corrie,73 Givens and 
Wirz,78,92 and Phillips86,88 conveyed the pertinence of water to induce the release of 
phosphate and acetate from the pHP chromophore.  Phillips,88accentuated the 
importance of both the hydrogen bond donor and acceptor nature of water in his 
modeling of the photo-Favorskii reaction.  For example, in 1:1 H2O:CH3CN, Φdis for 
pHP diethyl phosphate (114) was 0.40.  When measured in 1:1 DMSO:CF3CH2OH, a 
solvent mixture with a hydrogen bond acceptor (DMSO) and a hydrogen bond donor 
(CF3CH2OH), Φdis reduced to 0.17 but was still efficient.  However, when measured 
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in neat DMSO or CF3CH2OH, the reaction did not occur.  Phillips88 demonstrated a 
correlation between triplet lifetime, 3τ, of pHP diethyl phosphate (114) and the water 
content in CH3CN (Table 13); from neat CH3CN, where 3τ was 150 ns,80 the triplet 
lifetime progressively attenuated to less than 290 ps in 75% aq. CH3CN, a factor of 
517 decreases in 3τ.  Likewise, the 3τ of pHP acetate 110 dropped to a more modest 
extent, from 137 ns in neat CH3CN to 2.1 ns in 50% aq. CH3CN, a factor of 65.   
 The triplet lifetimes are directly related to the rates of substrate release by the 
equation kr = (Φdis/3τ). High Φdis have been communicated even at very low 
concentrations of H2O.78, 119 Wan and Corrie73 ascertained Φdis for pHP acetate (110) 
as 0.41 in 1:1 H2O:CH3CN pH 7 and revealed a correlation between media pH and 
Φdis (Figure 71).  At low pH (0-1), Φdis for 110 spanned from 0.12 to 0.32, 
respectively.  At pH 10.5 to 12.5, Φdis spanned from 0.30 to 0 (no acetate 
appearance), respectively.  Earlier, a media pH dependence on Φdis was underscored 
for fluoro pHP GABA’s 122-131, where the ratios of protonated vs. conjugate bases 
altered the Φdis.  Despite solvent modulated triplet lifetimes of pHP, Φdis appeared to 
remain steady.  For example, Givens and Wirz78 reported a Φdis for pHP diethyl 
phosphate (114) of  0.40 in 5% aq. CH3CN with a triplet lifetime of ~ 9 ns.88  
Phillips88 reported a Φdis of 0.40 for the same compound 1:1 H2O:CH3CN, though the 
triplet lifetime shortened to 0.350 ns.  From the equation, kr = (Φdis/3τ), the rate 
constants for nucleofuge disjunction change as a function of triplet lifetime. One 
plausible explanation is that though kr vary according to water content, they remain 
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fast enough to predominate as a major triplet deactivation pathway for pHP versus 
other deactivation pathways. 
 
Figure 71. Titration curves obtained from 1H NMR analysis depicting the 
dependence of quantum yields for acetate appearance, Φapp (Φp in plot) on pH for 
photolysis of pHP acetate (114) in 1:1 CH3CN (circles).  The circles represent p-
methoxyphenacyl acetate. Reproduced with permission from the ACS, ref. 73.  
 
 
     
2) Organic and mixed organic media. The quantum yields for disappearance, Φdis, 
of pHP GABA’s were assessed in 25% aq. CH3CN, DMSO, 10% aq. DMSO, 1-
pentanol, and 1-octanol at 300 nm (Table 24).  
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a) In 25% aq. CH3CN, the Φdis for 101, 122-125 and 127-131 were unchanged from 
those for 100% water, except the marked increase for 2,6-diF-pHP (126) (0.16 vs. 
0.11 in H2O).  UV-Vis analysis of 126 in this media revealed two absorbance bands, 
one at 277 nm and the other at 325 nm, reflecting the presence of both the protonated 
phenol and conjugate base.  Recall that 126 in H2O, only the conjugate base was 
manifested, at λmax = 331 nm.  The implication from these findings is that 25% H2O is 
sufficient to effectively solvate and consequently promote GABA release and pHP 
rearrangement as if in H2O.  Further, the CH3CN-H2O mixture forces the protonation 
equilibrium away from the conjugate base and toward the more reactive protonated 
pHP form. 
b) DMSO-H2O.  In accord with Phillips findings88 with pHP diethyl phosphate (114), 
the quantum yields, Φdis, for 101, 122-128, 130-131 were considerably lower than 
with those in 100% H2O.  However, 2,3,6-triF-GABA (128) expressed a Φdis of 0.12, 
an increase vs. H2O (0.08).  Congruent with 25% aq. CH3CN above, the Φdis for most 
pHP GABA derivatives in 10% aq. DMSO were similar to those in H2O. Marked 
increases, however, were observed for 2,3,6-trifluoro-pHP GABA (128 (0.15 vs. 0.08 
in H2O)) and 2,3,5,6-tetraF-GABA (129 (0.18 vs. 0.11 in H2O)).  All pHP GABA’s 
revealed absorbances in this medium at ~280 nm, the expected absorption for the 
predominantly protonated phenol; 128 and 129 have the lowest pKa’s (4.5 and 3.9, 
respectively) and therefore consist predominantly of the deprotonated form at higher 
H2O concentrations.  The results here represent Φdis for protonated 128 and 129. 
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c) 1-pentanol. 1-pentanol is a model solvent for pHP GABA esters, employed here to 
test the relevance of the calculated ClogP’s to their photorelease efficacy in lipophilic 
solvents. The calculated ClogP values for 101, 122-131, 133-134 revealed only m-
CF3-pHP GABA (130 (2.02)) and m-OCF3-pHP GABA (131 (1.93)) (Table 34 
Results) to be larger (more lipophilic) than pHP GABA (101 (1.19)). The ClogP’s of 
the remaining fluoro pHP GABA’s 122-129, though less than for 101, were, 
nonetheless, more positive.  In contrast, the m-methoxy pHP derivatives had ClogP 
values of -3.81 and -3.38, respectively. Nevertheless, 1 mM solutions of 133 and 134 
in 1-pentanol were prepared without difficulty. The Φdis values were reduced by 25-
50% compared to H2O.  The rest were unchanged within experimental error. 
d) 1-octanol.  The quantum yields in 1-octanol were consistent with 1-pentanol.  
Photolysis experiments of a 1mM sample of m-OCF3-pHP GABA (131) in 1-octanol 
with 19F NMR analysis revealed complete disappearance after 30 minutes at 300 nm, 
evidenced from the lack of signal at -59.68 ppm.  New bands were seen at -59.49 and 
-59.24 ppm, the former much larger than the latter.  Spiking with an authentic sample 
of p-hydroxy-m-OCF3-benzyl alcohol produced a new signal at-59.09 ppm, ruling this 
out as a photoproduct.  Spiking with an authentic sample of p-hydroxy-m-
trifluoromethoxy-acetophenone effected a substantial increase in the signal at -59.49 
ppm, identifying this as the major, reduced photoproduct and comparable to the 
results from photolysis of m-OCH3-pHP GABA (134) in H2O. A radical mechanism 
is imputed for the photorelease of GABA in 1-octanol, the same as shown in Scheme 
53. 
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J.  Salt and ionic strength effects.   
1) Background.  Phillips88 first broached the notion of contact ion pair recombination 
(Figure 9, Introduction) as a possible way to reestablish the pHP.  In this example, the 
intimate or contact spiroketone-diethyl phosphate ion pair, formed prior to 
deprotonation of the phenol, was posited to either recombine to pHP diethyl 
phosphate as one triplet decay mechanism or completely separate to allow 
intersystem crossing and solvolysis in forming the rearranged p-hydroxyphenylacetic  
 
Figure 9. Phillips’ proposed structure of unknown, M, as a solvation/contact ion pair 
complex. 
 
 
 
acid.  A direct result of ion-pair recombination is a lower Φdis, and hence this process 
represents one pathway for triplet deactivation.   
 A conceivable method to attenuate this ion recombination is to adjust the ionic 
strength of the solution by adding a photostable, non-nucleophilic salts, e.g., Li+, Na+, 
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or K+ ClO4-, which could intercede between the contact ion pair and hinder substrate 
return.   
 Winstein122 suggested that “salt effects” could enhance observed rates of 
solvolysis.123,124,125 The Winstein ion-pair mechanism (Scheme 55) is often applied to 
SN1 solvolysis reactions to demonstrate ion pair return.  Initial ionization of RX 
 
Scheme 55. Winstein’s ion-pair, solvolysis mechanism with added LiClO4. 
 
 
 
produces an intimate ion pair (IP) that can recombine (internal return) or further 
solvate through solvent insertion to form the solvent separated ion pairs (SSIP).  The 
SSIP can also recombine to IP or progress on to the solvolysis products.  Further 
stages of solvent separation to unpaired discrete ions (DI) may intervene and these 
can recombine to SSIP.  In the presence of added salts, the increased ionic strength 
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encourages the separation of the ions.  Normally, these added salts do not affect the 
intimate ion pair dissociation. However, LiClO4 is an exception.  It is particularly 
effective at dissociating SSIP by Li+ coordination with the nucleofuge through a salt 
scavenged pair (ScIP) that prevents external ion pair return from occurring, generally 
resulting in ameliorated rates of solvolysis.  Furthermore, in certain instances, it has 
been shown to intercept IP and is the origin of the “special salt effect”.   
 Tidwell126 and coworkers recently reported results from examinations of 
added LiClO4 on the rates of trifluoroacetolysis of 1,1,1-trifluoro-2-phenylpropan-2-
yl 4-methylbenzenesulfonate (172) (Equation 18).   
 
Eq. 18 
 
A positive linear correlation between the unimolecular rates of trifluoroacetolysis of 
172 (1) with NaO2CCF3 in CF3CO2H and [LiClO4] was observed (Figure 72), 
suggesting that LiClO4 effectively scavenges or further separates SSIP and thus 
hinders external ion pair return, resulting in augmented rates of trifluoroacetolysis. 
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Figure 72. Observed enhancements of kobsd of trifluoroacetolysis of 172 (R = CH3) as 
a function of [LiClO4].    Reproduced with permission from the ACS, ref. 126. 
 
 
 
2) Effects of added LiClO4 on the quantum yields.  Quantum yields at 300 nm 
were determined in the presence of [LiClO4] from 0 to 1.0 M.  It was reasoned that 
added salt would influence any pHP GABA ionization processes including any 
recombination events.  An increased  Φdis could be evidence for a contact ion-radical 
pair of the triplet biradical and the nucleofuge. Conversely, if GABA departure 
occurred prior to phenol deprotonation of pHP, a triplet ion pair intermediate would 
be obtained.  UV-Vis analysis of all pHP esters indicated the prevalence of protonated 
pHP in the ground states. Nearly all pHP GABA’s, excepting the m-methoxy pHP 
derivatives (133 and 134) evinced enhancements in Φdis with added LiClO4 (Table 
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24).  One example, pHP GABA (101), revealed a linear increase Φdis with an increase 
in  [LiClO4] between 0 to 1.0 M (Figure 73) and a slope of 0.0153 M-1 or 15.3 mM-1.  
 
Figure 73.  Plot of Φdis vs. [LiClO4] for pHP GABA (101). 
 
 
  
This was also obtained with 2,3-difluoro pHP GABA (123), which disclosed a linear 
relationship with a slope 0.0187 M-1 (18.7 mM-1) (Figure 74).  Note that units are not 
bimolecular rate constants because quantum yields are in mM/Ein and are not rates. 
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Figure 74. Plot of Φdis vs. [LiClO4] for o-F-pHP GABA (123). 
 
 
 
 In contrast to these findings, other derivatives showed an early rise in the 
increased efficiency dependence in LiClO4 concentration followed by a change in 
slope, such as 2,5-diF-pHP GABA (125) (Figure 75). Initially, a special salt effect 
was considered.  This is characterized by rapid changes induced at low concentrations 
of exclusively LiClO4 as the added salt, followed by a leveling off at higher 
concentrations.  However, a similar result with observed with NaClO4, which 
precluded the “special salt” effect associated with Li+.  The form of the quantum yield 
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dependence on the concentration of LiClO4 for 125 is similar to a saturation curve 
which would be expected for the ionic strength effect on quantum yields. 
 
Figure 75. Plot of Φdis vs. [LiClO4] for 2,5-diF-pHP GABA (125). 
 
 
 
No salt effects were observed for pHP Trp (149), which exhibited a Φdis of 0.12 in 1.0 
M LiClO4 vs. 0.10 in water.   
 Other perchlorate salts, as NaClO4 and Mg(ClO4)2, were probed for influences 
on Φdis for 2,3-diF-pHP GABA (124) and 2,5-diF-pHP GABA (125).  For 125,  
concentrations up to 1.0 M NaClO4 produced a correlation that differed with LiClO4. 
A logarithmic fit (R2 = 0.99) was revealed that possibly signifies saturation effect.  
Similarly, 124 manifested a logarithmic correlation (R2 = 0.95) between Φdis and 
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[NaClO4].  When assessed in KClO4, 125 manifested a logarithmic correlation (R2 = 
0.99) that paralleled that with LiClO4.  When assessed in Mg(ClO4)2, significant 
drops in Φdis were observed at low concentrations, but increased at 1.0 M Mg(ClO4)2.  
For example, 2,3-diF-pHP GABA (124) divulged a drop in Φdis from 0.24 in H2O to 
 
Figure 76. Plot of Φdis vs. [Mg(ClO4)2] for 2,3-diF-pHP GABA (124). 
 
 
0.12 at 0.01 M Mg(ClO4)2 that augmented to 0.31 at 0.1 M and remained constant  up 
to 1.0 M (Figure 76). The distinction that the doubly charged Mg2+ vs. singly charged 
Li+ or Na+ attenuates the Φdis could be through stabilizing interactions with GABA 
and the ketone compared to the ClO4- influence at low concentrations (Figure 77). 
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Figure 77. Proposed coordination between Mg2+ and 2,3-diF-pHP GABA (124).  
 
 
 
The rate constants and lifetimes measured by LFP for the triplet excited state 
prior to rearrangement were also examined to discern an effect of LiClO4 on pHP 
mesylate (168) in water and 0.66 M aqueous LiClO4.  This was accomplished  by LFP 
and found to cause no change in the rate for intersystem crossing, 3.4 x 1011s-1 vs. 3.9 
x 1011s-1, the rate for triplet decay, 1.6 x 1011s-1 and 1.1 x 1011s-1 or the rate for the 
decay of the triplet biradical (117), 1.4 x 109s-1 and 2.0 x 109s-1.  The results suggest 
that (1) either the ion radical recombination is occurring in those instances that show 
an increased Φdis with added LiClO4 or (2) a delicate balance or compensation 
between the increase in the rate of rearrangement relative to the rate of triplet pHP 
GABA decay that does not alter the sum of these two processes is occurring.  The 
yields of triplet (ISC vs. singlet decay) are not likely to be a factor here since ΦISC 
and kISC values are already maximal. 
3) Common ion effect.  As noted above, the recombination of the released GABA 
and either the protonated or unprotonated triplet biradical may serve as pathways for 
the decreased efficiencies in the absence of LiClO4. This suggests that a “common 
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ion-like effect”125 might also operate here.  In reference to Scheme 58, added X-, the 
common ion serves to enhance the recombination steps for SSIP and DI to regenerate 
RX, the consequence of which is a reduced apparent rate of solvolysis.  It was 
rationalized that added GABA would reduce Φdis by recombination of GABA with 
either the protonated or the conjugate base triplet pHP.  However, addition of 1 to 10 
equivalents of GABA (Table 26) made no significant changes on Φdis.  This 
observation could be due to the lack of intervention at the SSIP or IP stages.  It might 
also result from rather poor nucleophilicity of GABA.  A larger quantity of GABA or 
better nucleophilic trapping agent, such as azide N3-, may be needed to educe 
recombinations reflected in Φdis.   
 
K.  Rationalized mechanism of the photo-Favorskii rearrangement.  A summary 
of the findings from studies reported here; a) the singular formation of p-
hydroxyphenylacetic acid and p-hydroxybenzyl alcohol photoproducts from the pHP 
chromophore determined by 1H NMR and HPLC analysis; b) a discrete deactivation 
pathway for the protonated pHP (λmax ~ 280 nm, marginal fluorescence); c) a 
different, less efficient pathway for the pHP conjugate base (λmax ~ 330 nm, Φdis < 
0.10, fluorescence λem > 382 nm, kF 1010s-1); d) a narrow range for all GABA release 
efficiencies (Φdis) from 0.08 to 0.28, as well as for 5-acetylsalicyic acid caged 
carboxylic acids (GABA, l-Glu, Gly, etc.) at 300 nm; e) a narrow range for the Stern-
Volmer and LFP derived rate constants for intersystem crossing, (kISC ~ 1011s-1) and 
GABA release (kr ~ 107-108s-1); f) the confirmatory and diagnostic absorbance bands 
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for the transient intermediate, a triplet biradical (330, 420 and 445 nm); g) the DFT 
derived, out of plane (OOP) motion of the carbonyl during formation of the oxyallyl 
phenoxy triplet biradical to the ring; h) a reinforcement of the recently discovered 
Brǿnsted Kβ linear free energy relationship for the rate of nucleofuge release versus 
the pKa of the nucleofuge;  i) a measure of the change in the reactivity of the pHP 
photorelease process when solvents such as organic alcohols (1-pentanol and 1-
octanol) elicit GABA release at reasonable efficiencies and j) a dramatic salt effect 
from added LiClO4 and related salts that improve Φdis, possibly signifying intimate 
ion pairs.  These results are summarized by representative mechanisms for the photo-
Favorskii rearrangement in Scheme 56 for protonated pHP GABA and Scheme 57 for 
corresponding conjugate base. 
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L.  Biological studies.  
1)  Neuronal assays.  Neuronal studies were conducted by the Kandler Groups at the 
University of Pittsburgh. 127 To test the biological activity of pHP GABA esters, m-
CF3-pHP GABA (130) m-OCF3-pHP GABA (131) and were assessed in neurons of 
cortical sections of mice using patch clamp recordings.128 Confined photolysis with 
10-50 ms UV pulses through a narrow optical fiber generated whole cell inward 
currents.  Increasing concentrations of photolyzed 131 effectuated membrane currents 
of sizeable amplitudes and long durations (Figure 78). To compare the sensitivity of 
 
Figure 78. Amplified current as a function of photoreleased GABA from m-OCF3-
pHP GABA (131).  
 
 
 
photolyzed 130 and 131 with previously studied m-OCH3-pHP GABA (134),97 
concentration response curves for neurons subjected to 130, 131, and 134 were 
generated by fixing the responses to Hill’s equation128 with subsequent 
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determinations of half maximal effective concentration, EC50, values of 49 µM, 120 
µM and 93 µM, respectively, for 131, 134, and 130, respectively (Figure 79).  The 
 
Figure 79. Population data of peak currents normalized to the maximum peak 
response and fitted to Hill’s equation to derive EC50 values for 130, 131, and 134. 
 
 
 
data disclosed an enhanced GABA response for 131 (Φdis = 0.09) versus 134 (Φdis = 
0.04) and, surprisingly, showed 130 (Φdis = 0.17) as being the least effective. 
 The specific activation of the GABAA receptor antagonist SR 95531 
(Garbazine; Tocris, Ellisville, MI) was probed with m-OCF3-pHP GABA (131).  
Photolysis of 131 produced membrane currents that were completely blocked by 
Garbazine (Figure 80), signifying that the response is governed by activation of the 
GABAA receptor.  Additionally, the current-voltage relationships of the responses 
divulged a reverse potential of -14.2 ± 2.9 mV (Figure 81), which is near the  
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Figure 80. Membrane currents elicited from photolysis of 131 are completely 
obstructed by Garbazine, indicating the activation origin as the GABAA receptor. 
 
 
 
 
Figure 81.  Reverse potential educed from the photolysis of 131. 
 
 
  
theoretical potential of -20 mV, as determined from the Nernst equation for chloride 
concentration between the internal (60 mM) and external (133 mM) solution.  
Collectively, membrane currents evoked from photolysis of 130 and 131 are 
moderated by activating the GABAA chloride receptor channel. 
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 To determine whether caged GABA could function as an agonist for the 
GABAA receptor, 130 and 131 were examined for their effects on membrane input 
resistance by monitoring the current responses with short command steps from a 
holding potential of -70 mV to step potential of -65 mV during 100 ms in the 
presence and absence of GABA (100 µM) or 130 and 131 (100 µM).  Neither 130 nor 
131 altered the holding current (Figure 82) or reduced the membrane input resistance.  
 
 
Figure 82. Probing the effect of 131 on the holding currents or membrane input 
resistance.  No effect was noticed. 
 
 
 
 
 
However, the employ of GABA on the same neurons educed inward currents and 
decreased membrane resistance due to activation of GABAA chloride channels.  Thus, 
only photoreleased GABA and not caged GABA can activate the GABAA chloride 
channels. 
2)  FITC-DOC.   FITC-DOC  was synthesized and distributed to the Picking group129 
for use.  The crux of their research involves the Shigella flexneri organism, 
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specifically the induction mechanism to bacillary dysentery in humans. Bacillary 
dysentery is a debilitating and potentially fatal affliction educed by this organism and 
is common in the third world.  The type III secretion system (TTS) is a crucial 
apparatus for infection in this organism.  Among other constituents of TTS, a surface 
needle is protuberant.  The far terminus of the needle manifests a ‘tip complex’ that 
consists of an invasion plasmid antigen D (IpaD), a regulatory body for TTS and 
necessary for the engagement and organization of the translocator protein IpaB at the 
needle tip in the presence of deoxycholate (DOC) or other bile salts. Until recently, 
the role of DOC in IpaB recruitment to the TTSA needle tip was unknown. However, 
current studies revealed that IpaD specifically binds to FITC-DOC, specifically at the 
N-terminal-domain of IpaD at its central coiled-coil, a locus that also may be 
involved in needle-tip interactions.130    
  
M.  Future Studies.  Substituent and nucleofuge influences on the photo-Favorskii 
rearrangement have been probed. The pKa’s of substituted pHP’s and variation of the 
nucleofuge play key roles in the efficiencies and rates of nucleofuge release.  Time 
resolved resonance Raman, TR3, and laser flash photolysis, LFP, studies have 
provided a wealth of information concerning the structure and reactivity of excited 
state of pHP and the corresponding transient intermediates.  Assimilating these data 
into detailed mechanisms for the photo-Favorskii rearrangement of the pHP 
chromophore and its substituted derivatives are condensed into Schemes 56 and 57.  
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Nevertheless, there are several studies that are essential for further elucidation of 
these processes. 
1) Organic and mixed organic media.  The preliminary studies reported here 
conveyed nucleofuge release in 10% aq. DMSO, 1-pentanol and 1-octanol, but the 
minor the photoproducts in the latter two studies have not been identified.  The 
overall effects of organic or mixed organic media on the photo-Favorskii reaction 
would be useful information, especially with regard to future studies related to highly 
lipophilic, biologically relevant nucleofuges and media. 
2)  Salt effects.  Added perchlorate salts clearly manifested enhanced Φdis for nearly 
all pHP GABA’s.  The preliminary interpretation of these effects involve an influence 
of salts possibly on intimate ion-radical pairs, paralleling Winstein’s SN1 
solvolyses.125 However, further investigations are required to probe the origin of the 
effects, particularly focusing on rates of release.  Although LFP studies on pHP 
mesylate showed no changes in either the rates of ISC or triplet decay with 0.66 M 
LiClO4, this experiment was the only one tested and involved a superb nucleofuge, 
where return is expected to be minimal. Expanded LFP studies on other pHP 
derivatives are necessary.  
3)  Chiral nucleofuge.  A photochemical investigation of (R,R)-166 or (R,S)-167 
would have been useful for following the configurational changes at a stereocenter 
that is intimately involved in the cyclopropanone formation and collapse during the 
photo-Favorskii rearrangement. Measurements at partial conversion to photoproducts 
could test for ion-radical return as well.  This could be strong evidence for the 
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intermediacy of an intimate ion pair prior to the triplet biradical formation.  A 
suggested a stepwise nucleofuge departure and phenol deprotonation instead of the 
currently posited concomitant process may emerge.   
4)  Structurally similar entities to pHP.  Yousef111 reported low Φdis for a series of 
substituted 1,4 and 2,6 naphthols despite favorably lengthening the λmax.  Nitrogen 
analogs of pHP, such as 4-aminoacetophenone were briefly studied but gave radical 
products.131  Some structurally analogous entities to pHP should be investigated. 
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Conclusion 
 
The p-hydroxyphenacyl (pHP) chromophore is an efficacious phototrigger for the 
temporal, spatial and concentration control over substrate release.  The release 
mechanism is underscored by an intriguing rearrangement of pHP that resembles the 
well known Favorskii reaction.  Previous quenching and spectroscopic studies with 
various pHP cages were effective in providing an early mechanistic picture of the 
photo-Favorskii rearrangement, including a) the clean photoconversion, b) favorable 
quantum efficiencies for release (~0.2 and higher) at 300 nm, c) the triplet reactive 
excited state, d) the dependence of the triplet lifetime on the water content of the 
solvent, e) the pertinence of water in inducing substrate release and proton abstraction 
from pHP, f) the rapid rates (107-109 s-1) of substrate release and g) very limited 
structure-reactivity explorations.   
 However, the expanded studies reported here are essential for a more detailed, 
mechanistic comprehension.  These include 1) distinguishing nucleofuge influences, 
2) media effects (pH, buffer, mixed solvents and added salts), 3) structure-reactivity 
relationships (electron withdrawing and electron donating groups) and 4) modulating 
the pKa of the phenol to discern pH induced changes in, for example, the quantum 
yields for substrate release.  The pHP chromophore suffers from a low molar 
absorptivity at λ > 300 nm, which limit it’s usefulness in the biological arena because 
of possible secondary photodegradations and the paucity of inexpensive lasers that 
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utilize wavelengths between 300-320 nm.  Extending the λmax of pHP by substitution 
with auxochromes is a plausible motive to overcome these deficiencies. 
 Several pHP GABA derivatives were specifically designed and synthesized to 
probe structure-reactivity relationships, primarily between the nature of the 
substituent and quantum yield for GABA release, Φdis.  Electron donating groups, 
such as methoxy and hydroxy, appeared to attenuate Φdis (relative to the unsubstituted 
parent) or completely quench GABA photorelease. Electron withdrawing, m-
substituted carbonyl moieties also reduced Φdis by half.  The rate constants for GABA 
release, kr, did not vary significantly from the unsubstituted parent. 
 Several fluoro pHP GABA esters were designed and synthesized to explore 
how modulating the pKa of pHP would result in pH induced changes by the media on 
Φdis and kr.  The pH of the media was found to directly control the equilibrium 
between the protonated and conjugate bases of these fluoro pHP derivatives as 
evidenced by a) λmax values (<300 nm for protonated and >300 nm for conjugate 
bases) and b) the quantum yields for GABA release at 300 nm (Φdis > 0.15 for 
protonated, Φdis < 0.10 for conjugate bases).  Stern-Volmer and LFT studies 
determined rate constants for release that narrowly spanned from 107 to 108 s-1.  At 
350 nm, the conjugate bases revealed Φdis that were less than 0.01. The conjugate 
bases are fluorescent and the fluorescent lifetimes of 1-10 ns for these were obtained.  
A mechanism for GABA release from the conjugate bases of pHP was posited. 
 A series of 5-acetylsalicylate GABA’s with UV absorbing appendages 
(antennae compounds) were generated in efforts to lengthen the λmax of pHP.  Though 
  253 
this objective was accomplished, the Φdis were low at 300 nm (0.01 to 0.11) and very 
low (<0.01) at 350 nm. 
 The quantum efficiencies at 300 nm of several pHP GABA’s in aqueous 
DMSO and CH3CN were determined to be commensurate with those in water.  
However, GABA photorelease was quenched in neat DMSO.  Additionally, 
photolyses of these compounds were conducted in 1-pentanol and 1-octanol, which 
disclosed reasonable efficiencies (~0.1), though the primary photoproducts were the 
reduced p-hydroxyacetophenone, signifying an alternate mechanistic pathway than 
the photo-Favorskii rearrangement.  
 When perchlorate salts were added, significant increases in Φdis were 
observed for nearly all pHP GABA’s.  A corollary from this was a proposed transient, 
solvent separated, triplet pHP and GABA radical or ion pair. This phenomenon 
suggests a possible nucleofuge ionization step prior to proton abstraction from the 
pHP phenol, a pathway contrary to the currently accepted concerted process. 
 Laser flash photolysis on several pHP GABA’s revealed time resolved 
absorption bands at 330, 420, and 445 nm, which were ascribed to a triplet oxyallyl-
phenoxy biradical, a consequence of adiabatic nucleofuge disjunction.  DFT 
calculations of the triplet oxyallyl-phenoxy biradical determined the radicals to be 
contorted out of plane from 22o to 58o depending on the substituents and their 
position on the aryl ring.  Additionally, the triplet biradicals were calculated to be at 
least 78 kcal/mol lower in energy than their singlet spirodienedione counterparts.  
Time resolved FTIR spectroscopy was conducted with pHP diethyl phosphate and 
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disclosed a band at 1647 cm-1 that was consistent with a transient p-quinone-methide, 
a suitable precursor to the minor p-hydroxybenzyl alcohol.   
 Finally, studies on biological processes that are initiated by release of an 
active substrate such as the neurotransmitter GABA have shown the power of spatial 
and concentration control in neuronal preparations.  These studies were performed 
with three pHP GABA derivatives, which demonstrated the pHP chromophore as 
being an effective phototrigger for facile release of GABA in neuronal stimulation. 
 In summary, previous work and the studies reported here have provided a 
clearer understanding of the photochemical and photophysical processes of the p-
hydroxyphenacyl chromophore.  The photochemical details of the Favorskii 
rearrangement have been shown to include a transient oxyallyl-phenoxy triplet 
biradical, formed during the release of the conjugate base as substrate.  The role of 
H2O, solvents, pH and added salts on the photochemistry and photophysics as well as 
substituent effects on the chromophore have supported the general mechanistic 
schemes presented here. 
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Experimental 
 
Methods 
 
Melting points were conducted with open ended capillary tubes using a non-
calibrated Thomas-Hoover melting point apparatus. Lyophilization was performed 
using a Labconco FreezeZone device set at -52 °C and 0.04 mbar. Solution pH values 
were determined using a Fisher Science pH 510 meter calibrated with certified Fisher 
buffer solutions of pH 4, 7, and 10. Products of all reactions were assessed for purity 
using the following instrumental techniques: For 1H, 13C, and 19F NMR, Bruker DRX 
400 and DRX 500 MHz spectrometers were utilized with trifluoroacetic acid as an 
internal standard (δ = -76.55 ppm).  GC/MS analysis was done on an Agilent 6890N 
Network GC System equipped with a Quattro Micromass Triple Quadrupole Electron 
Impact mass spectrometer. Exact masses were performed on a Quattro Micromass 
Triple Quadrupole Electro Spray Ionization mass spectrometer. UV/Vis data was 
obtained on a Carey Bio100 instrument using 1.5 ml quartz cuvettes. Fluorescence 
data were acquired on a Carey Eclipse Fluorescence Spectrophotometer using a 10 
mm quartz cell. IR data were obtained using a Shimadzu FT-IR 8400 S instrument 
with pressed potassium bromide (KBr) pellets or a prefabricated sodium chloride 
(NaCl) chloroform cell for solid phase analysis, and NaCl prefabricated plates for oil 
analysis. Ground state pKa’s were determined through sample titration with increasing 
amounts of 0.0461 M NaOH (standardized with potassium hydrogen phthalate), 
correlating pH vs. [OH-], and ascertaining the half equivalence point as the pKa. 
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Product separation was achieved by flash chromatography using EM Science silica 
gel and gradient hexanes/ethyl acetate as eluting solvents. All reactions were run 
under ambient conditions unless otherwise stated. 1H NMR spectroscopy was utilized 
to monitor the progress of photolysis of all new pHP cages. In general, a 1-10 
millimolar sample of pHP-caged GABA was prepared in 2 ml D2O, approximately 2 
ml was placed in an NMR tube. This was positioned in a photoreactor equipped with 
two 15 W, 3000 Å Rayonet lamps and a merry-go-round. Irradiation for 30 min 
generally led to 100% conversion as judged by the absence of the ester proton signals. 
Photoproduct identification was achieved through spiking the samples of the 
irradiated mixture with authentic samples of the resolved GABA.  Quantitative 
photolysis conditions for determination of quantum yields and Stern-Volmer 
quenching constants (KSV) were as follows: The lamp light output (in 
mEinsteins/min) was established using the potassium ferrioxalate method.7 Milligram 
quantities of caged compounds and caffeine or acetamidophenol were weighed out on 
a Fisher brand Microbalance and dissolved in 4 ml of 18 MΩ ultrapure water, salt 
solutions of various concentrations, buffers with or without adjusted ionic strengths, 
or purified organic solvents were then added to a quartz tube and vortexed, resulting 
in a homogenous solution of the caged compound and internal standard. 
Concentrations of the caged compounds ranged from 1-9 mM. These tubes were then 
placed in a carousel within a Rayonet Photochemical Reactor equipped with two 3000 
Ǻ, 15 W Rayonet Photochemical Reactor RPR3000 Mercury Lamps as light sources. 
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100 µl samples were removed at 30 s intervals up to 5 minutes using a 250 µl 
Hamilton micro-syringe and diluted to 1 ml with water using 1 ml volumetric flasks. 
 
Picosecond Pump-probe Spectroscopy 
Picosecond transient absorption was measured with the pump–supercontinuum probe 
technique using a Ti/Sa laser system (Clark MXR CPA-2001; 775 nm, pulse energy 
0.9 mJ, full width at half maximum 150 fs, operating frequency 426 Hz). Part of the 
beam was fed into a Clark MXR NOPA. The output at 532 nm was frequency-
doubled by a β-barium borate (BBO) crystal to 266 nm and, after compression, 
provided pump pulses with an energy of 1 µJ and <150 fs pulse width. A probe beam 
continuum was produced by focusing the 775-nm beam in front of a CaF2 of 4 mm 
path length. The pump and probe beams were focused to a 0.04 mm2 spot on the 
sample that was flowing in an optical cell of 0.3 mm thickness. The absorbance was 
in the range of 0.3–1, depending on the solubility of the compound. The probe beam 
and a reference signal (passing the solution besides the pump beam) were spectrally 
dispersed and registered with two photodiode arrays (512 pixels). Transient 
absorption spectra were calculated from ratio of the two beams. Spectra recorded with 
time delays ranging from 0 to 1.8 ns (to observe the triplet decay) were typically 
recorded with 20 ps steps, those ranging from 0-8 ps (to observe ISC) with 80 fs 
steps. The shorter measurements were corrected for chirp using a program (SPAN) 
kindly provided by Prof. N. Ernsting, Berlin. To improve the signal-to-noise ratio, the 
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data were averaged over multiple pump-probe scans (3-6 scans with 400 shots per 
temporal point). 
 
Quantum Efficiency Determinations 
Quantitative analysis was achieved by HPLC/UV or HPLC/MS/MS. The LC/MS/MS 
instrument was a Waters 2695 Liquid Chromatographer equipped with a Quattro 
Micromass Triple Quadrupole Electro Spray Ionization Mass Spectrometer, outfitted 
with an autosampler. UV-Vis detection consisted of a Waters 2497 type with a dual 
wavelength detector set at 220 and 240 nm. The reservoirs used were as follows: A) 
99% water, 1% methanol, 10 mM ammonium formate and 0.06% formic acid. B) 
99% methanol, 1% water, 10 mM ammonium formate, and 0.06% formic acid. The 
column was a reverse-phase (C18), 4 µm mesh Altech Altima, 50 mm in length. 
Injections of 100 µl were made with an automated sampler for each run for a total of 
3 injections per vial. A mobile phase gradient was utilized to optimize compound 
separation. The flow rate was set at 300 µl/min. Data analysis was performed by 
Mass Lynx Ultima software and Microsoft Excel.  Smoothing functions were used for 
peak analysis of the chromatographic peaks. Calibration curves to obtain R values 
from linear least-squares regression were determined at concentrations of the 
reactants and products in photolyses by systematic increases of pHP-caged GABA, 
free GABA, and p-hydroxyphenylacetic acid concentrations to determine correlations 
with internal standards caffeine or 4-acetamidophenol.   The quantum efficiencies 
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were then calculated from the ratio of the reactant or product concentrations to the 
photons absorbed using the actinometer values obtains as indicated above.  
 
Lifetime and Rate Measurements 
The Stern–Volmer quenching method132 was employed to determine the triplet 
lifetimes of pHP derivatives. Potassium sorbate served as the quenching agent. 
Solutions of pHP-GABA, 0.001–0.01 M, were diluted with sorbate solutions of 
increasing concentration (0–0.1 M), and photolyzed under the aforementioned 
conditions to ascertain the change in quantum efficiencies of GABA release. Φ0/Φ vs. 
[Q], and the Stern–Volmer constant, KSV, were determined. To determine the triplet 
lifetime, τ3, the rate of quenching, kq, was assumed to be the rate of bimolecular 
diffusion, kdiff ~ 7.2 × 109 s-1 (water). The rates of photorelease, kr, were then 
computed as kr ~ Φrel*τ3. 
 
Calculations 
The atom coordinates for each molecule were introduced into SYBYL133 for 
molecular mechanics optimization using the Tripos Force Field.134 The ensuing 
structures withstood full geometric optimizations in Gaussian 03135 at the B3LYP136 
level using the 6-31G* basis set137, soliciting the lowest energy triplet state in each 
case. The triplet stabilization energy was determined by comparing the final energy of 
optimized structure of each compound to that of the lowest energy singlet state at the 
triplet-optimized geometry. In order to examine differences in the carbonyl out-of-
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plane angles generated by the B3LYP calculation (vs. the MP2-level models reported 
elsewhere), a subset of these triplet-state species were geometrically optimized at the 
MP3 level138 in Gaussian using the 6-31G* basis set. 
 
Time Correlated Single Photon Counting Fluorescence 
The experiments were conducted on a custom built instrument using a mode-locked, 
cavity-dumped Mira Optima 900f Ti:Sapphire system pumped by a 10W Verdi Laser 
from Coherent, Inc. (Santa Clara, CA) as the excitation source.  The pulses were 
frequency tripled using an Inrad harmonic separator.  The excitation wavelength was 
281 nm and the fluorescence emission was measured at the emission maximum 
determined with a fluorescence spectrophotometer.  The detection system was fitted 
with Oriel 27320 polarizers set to the magic angle (54.7) for fluorescent lifetime 
measurements, single-pass Sciencetech 9030 monochrometers, and Hamamatsu 
microchannel plate PMTs.  Sample temperature was regulated using a Peltier 
thermoelectric temperature controller from Quantum Northwest (Spokane, WA).  
Data collection was performed using an SPC-630 PCI card from Becker and Hickl 
GmbH (Berlin, Germany).  Data was collected to at least 60,000 peak counts for all of 
the decays.  The fluorescent lifetimes were fit using the maximum entropy method 
implemented in Pulse5T (Maximum Entropy Data Consultants, Inc.). The analysis 
used 200 logarithmically spaced exponentials with a maximum of 15 ns.  Discrete 
fitting was performed using standard iterative reconvolution techniques written in 
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Microsoft Excel.  Samples were prepared by dissolving requisite quantities of 
precursors in 25 ml of 0.1 M LiOH to furnish ~ 1 mM concentrations. 
 
Materials 
All starting materials were obtained from Aldrich or Matrix Scientific, unless 
otherwise indicated. Solvents were distilled prior to use, employing phosphorus 
pentoxide (P2O5) and stored in flame-dried, argon purged round-bottom flasks 
containing activated molecular sieves. Ultrapure (18 MΩ) water was used in all 
instances. 
 
Syntheses 
1-(benzyloxy)-4-bromo-2-fluorobenzene, 122b. The general method of Frechét, et 
al.139 was followed. A solution of 4-bromo-2-fluorophenol (122a, 3.83 g, 20.0 mmol), 
benzyl bromide (2.38 ml, 20.0 mmol) and potassium carbonate (6.91 g, 50.0 mmol) in 
CH3CN (30 ml) was stirred at room temperature for 15 h. The solution was diluted 
with 50 ml CH2Cl2, washed with water (3 × 30 ml), dried (magnesium sulfate), and 
concentrated to give 5.24 g (93%) of 1-(benzyloxy)-4-bromo-2-fluorobenzene, 122b, 
as a white precipitate: Mp: 65–67 oC; IR (CHCl3): 3020, 2987, 2684, 2304, 1498, 
1421, 1265, 1217, 1051, 896, 738, 695 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.41 (m, 
5H), 7.27 (dd, J = 6.36, J = 2.28, 1H), 7.26 (dt, J = 4.37, J = 2.00, 1H), 6.89 (t, J = 
8.76, 1H), 5.13 (s, 2H); 13C NMR (125 MHz, CDCl3) δ 154.23, 151.73, 146.06, 
136.02, 128.88, 127.73, 120.14, 117.23, 115.86, 113.02, 71.90; 19F NMR (376 MHz, 
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CDCl3 + drop CF3CO2H) δ -130.78; HRMS (EI): Calc’d for C13H10FBrO: 279.9899. 
Found: 279.9905. 
1-(benzyloxy)-3-fluorophenyl)ethanone, 122c.140 The general method of Kosugi, 
et al.141 was used.  The experimental procedure is described with 129 (vide infra). 
White ppt., 89%, Mp: 79–81 °C; IR (CHCl3): 3053, 2987, 1679, 1610, 1514, 1498, 
1421, 1265, 1217, 1052, 896, 738, 696 cm–1; 1H NMR (400 MHz, CDCl3) δ (ppm), 
7.74 (dd, J = 11.33, J = 2.38, 1H), 7.69 (dd, J = 9.04, J = 1.59, 1H) 7.44, (m, 5H), 
7.04 (t, J = 8.44, 1H), 5.23 (s, 2H), 2.55, (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
196.05, 153.66, 151.16, 135.82, 130.92, 128.95, 127.57, 125.76, 116.36, 114.22, 
71.25, 26.52; 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) -133.02; HRMS (M + 
H): Calc’d for C15H13FO2: 245.0978. Found: 245.0951. 
1-(4-(benzyloxy)-3-fluorophenyl)-2-bromoethanone, 122d. The general method of 
Paul, et al.142 was followed. A solution of 122c (700 mg, 2.86 mmol) in 20 ml CH2Cl2 
was cooled to 0 °C in an ice bath. Dioxane dibromide (773 mg, 3.15 mmol) was 
added and the resulting mixture stirred for 30 min. The ice bath was removed with 
continued stirring for another 60 min. GC/MS indicated the reaction to be complete. 
The solution was washed with water and CH2Cl2, the aqueous layer removed, and the 
residual layer dried with anhydrous MgSO4, filtered, and evaporated under reduced 
pressure to yield an orange precipitate, 900 mg (2.58 mmol). Purification was 
cumbersome and unnecessary for completion of the supervening step, and hence was 
not pursued. ~95%.  IR (CHCl3): 3055, 2988, 1679, 1615, 1511, 1498, 1417, 1267, 
1219, 1050, 891, 748, 696 cm–1; 1H NMR (400 MHz, CDCl3) δ (ppm), 7.77 (dd, J = 
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10.00, J = 2.38, 1H), 7.72 (dd, J = 7.05, J = 2.78, 1H), 7.42 (m, 5H), 7.07 (t, J = 8.43, 
1H), 5.24 (s, 2H), 4.37 (s, 2H); 19F NMR (376 MHz, CDCl3 + a drop CF3CO2H) δ 
(ppm),   -133.12. 
2-(4-(benzyloxy)-3-fluorophenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino)- 
butanoate, 122e. The general method of Hiyama, et al.143 was utilized. A solution of 
1-(4-(benzyloxy)-3-fluorophenyl)-2-bromoethanone, (122d, 900 mg, 2.78 mmol), 
potassium carbonate (1.15 mg, 8.35 mmol), 4-(tert-butoxycarbonylamino)butanoic 
acid (N-Boc-GABA, 678 mg, 3.33 mmol) in 50 ml of CH3CN was stirred for 24 h at 
room temperature. The solution was washed with EtOAc, water, the aqueous phase 
discarded, and the resulting phase evaporated under reduced pressure. Flash column 
chromatography (5:1 Hexanes/EtOAc) afforded a white precipitate, 1.10 g (89%). 
Mp: 97-99 °C; IR (KBr): 3300, 3100-2800, 1742, 1701, 1600, 1517, 1437, 1400 
1309, 1200, 1165, 953, 750, 700, 668 cm–1; 1H NMR (400 MHz, CD3CN) δ (ppm), 
7.80 (dd, J = 7.05, J = 2.47, 1H), 7.78 (dd, J = 7.05, J = 1.99, 1H), 7.47 (dd, J = 4.45, 
J = 1.78, 1H), 7.42 (m, 5H), 5.31 (s, 2H), 5.25 (s, 2H), 2.97 (t, J = 6.79), 2.45 (t, J = 
7.59 Hz, 2H), 1.76 (m, 2H), 1.40 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 
190.67, 172.51, 155.60, 152.30, 150.80, 135.82, 128.39, 128.14, 127.68, 126.93, 
125.60, 115.28, 114.82, 77.45, 70.36, 66.12, 39.64, 30.63, 28.22, 24.96; 19F NMR 
(376 MHz, CD3CN + drop CF3CO2H) δ (ppm), -133.44; HRMS (M + Na): Calc’d for 
C24H28FNO6Na: 468.1798. Found 468.1796. 
4-(2-(3-fluoro-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 122. The general method of Marsh, et al.144 was followed. In a 
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flame-dried, 50 ml round bottomed flask containing 2-(4-(benzyloxy)-3-
fluorophenyl)-2-oxoethyl-4-(tert-butoxy-carbonylamino)-butanoate, (122e, 850 mg, 
1.91 mmol) was added 20 ml of freshly distilled TFA. Stirring continued for 24 h at 
room under ambient conditions. The solution was evaporated under reduced pressure 
and washed with EtOAc/water. The water layer was then extracted, frozen, then 
lyophilized, affording an adhesive precipitate, 550 mg (78%). IR (KBr): 3434, 3269, 
3100-2800, 1741, 1693, 1610, 1553, 1420, 1201, 1050, 823, 759, 719 cm–1; 1H NMR 
(400 MHz, D2O) δ (ppm), 7.70 (d, J = 9.03, 2H), 7.12 (t, J = 9.94, 1H), 5.50 (s, 2H), 
3.09 (t, J = 7.59, 2H), 2.66 (t, J = 7.08, 2H), 2.05 (m, 2H); 13C NMR (125 MHz, 
MeOD) δ (ppm), 190.05, 172.06, 161.60, 152.27, 151.07, 150.33, 126.03, 125.33, 
117.30, 115.33, 65.95, 38.54, 30.02, 22.48; 19F NMR (376 MHz, D2O) δ (ppm), -
133.58; HRMS (M+): Calc’d for C12H15FNO4: 256.0985. Found 256.0977. 
The methodology for generating compounds 123–132 was analogous to that for 122 
unless otherwise indicated; the yields were consistent, as well, unless stated 
otherwise. Only spectroscopic data are included for each intermediate and the final 
caged derivatives. 
1-(4-benzyloxy)-2-fluorophenyl)ethanone, 123c.  123b is commercially available. 
White ppt., 90%, Mp: 97-99 °C; IR (CHCl3): 3056, 2992, 1701, 1616, 1510, 1487, 
1415, 1275, 1207, 1055, 881, 728, 683 cm–1; 1H NMR (400 MHz, CDCl3) δ (ppm), δ 
7.93 (t, J = 7.76, 1H), 7.40 (m, 5H), 6.85 (dd, J = 8.96, J = 2.49, 1H), 6.72 (dd, J = 
13.25, J = 2.39, 1H), 5.15 (d, J = 4.98, 2H), 2.70 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ (ppm), 198.76, 165.25, 159.13, 135.54, 132.70, 128.78, 127.75, 118.13, 
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115.45, 114.03, 103.11, 70.96, 31.08; 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) 
δ (ppm), -104.64; HRMS (M + H): Calc’d for C15H14FO2: 245.0978. Found: 
245.0962. 
1-(4-(benzyloxy)-2-fluorophenyl)-2-bromoethanone, 123d. Oil, ~92%; IR (NaCl): 
3058, 2990, 1711, 1621, 1510, 1486, 1413, 1265, 1227, 1063, 890, 725, 680 cm–1; 1H 
NMR (400 MHz, CDCl3) δ (ppm), δ 7.95 (t, J = 8.84, 1H), 7.40 (m, 5H), 6.89 (dd, J = 
8.84, J = 2.31, 1H), 6.73 (dd, J = 13.36, J = 2.50, 1H), 5.15 (s, 2H), 4.49 (d, J = 4.49, 
J = 2.50, 2H); 13C NMR (125 MHz, CDCl3) δ (ppm), 189.31, 165.37, 159.17, 135.51, 
132.68, 128.80, 127.75, 115.66, 115.45, 114.03, 102.99, 71.01, 35.73; 19F NMR (376 
MHz, CDCl3 + drop CF3CO2H) δ (ppm), -104.68; HRMS (M + H): Calc’d for 
C15H13FO2Br: 323.0083. Found: 323.0101. 
2-(4-(benzyloxy)-2-fluorophenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino)-
butanoate, 123e. White ppt., 86%, Mp: 105–107 °C; IR (KBr): 3303, 3100-2800, 
1742, 1701, 1614, 1437, 1408, 1309, 1203, 1167, 955, 747, 700, 668 cm–1; 1H NMR 
(400 MHz, d6-DMSO ) δ (ppm), δ 7.85 (t, J = 8.94, 1H), 7.40 (m, 5H), 7.10 (dd, J = 
13.59, J = 2.30, 1H), 7.01 (dd, J = 8.86, J = 2.42, 1H), 6.88 (t, J = 5.70, 1H), 5.24 (s, 
2H), 5.22 (d, J = 3.25, 2H), 2.98 (t, J = 6.81, 2H), 2.42 (t, J = 7.60, 2H), 1.70 (m, 2H), 
1.38 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 188.97, 172.17, 164.26, 
162.13, 155.60, 135.85, 131.75, 128.53, 127.96, 127.50, 115.05, 112.37, 102.82, 
77.45, 70.04, 68.32, 39.30, 30.78, 28.22, 24.93; 19F NMR (376 MHz, CD3CN + drop 
CF3CO2H) δ (ppm), -106.01; HRMS (M + Na): Calc’d for C24H28FNO6Na: 468.1798. 
Found: 468.1787. 
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4-(2-(2-fluoro-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoro-acetate, 123. Adhesive solid. IR (KBr): 3434, 3244, 3100-2800, 1741, 
1693, 1610, 1523, 1421, 1400, 1309, 1269, 1198, 1166, 1050, 824, 800, 760, 720. 
cm–1; 1H NMR (400 MHz, D2O) δ (ppm), δ 7.85 (t, J = 7.58, 2H), 6.73 (d, J = 9.09, 
1H), 5.40 (d, J = 3.03, 2H), 3.10 (t, J = 7.64, 2H), 2.64 (t, J = 7.12, 2H), 2.09 (m, 2H); 
13C NMR (125 MHz, D2O) δ (ppm), 189.35, 172.10, 165.34, 165.02, 163.13, 133.68, 
113.65, 113.39, 102.58, 68.71, 38.60, 30.06, 22.48; 19F NMR (376 MHz, D2O) δ 
(ppm), -106.45; HRMS (M+): Calc’d for C12H15FNO4: 256.0985. Found 256.0976. 
1-(benzyloxy)-4-bromo-2,3-difluorobenzene, 124b.145 Oil, 94%; IR (CHCl3): 3058, 
2982, 1600, 1510, 1465, 1250, 1202, 1050, 835, 740, 695 cm–1; 1H NMR (400 MHz, 
CDCl3) δ (ppm) 7.42 (m, 5H), 7.19 (dt, J = 8.05, J = 2.50, 1H), 6.90 (dt, J = 8.00, J = 
1.82, 1H), 5.16 (s, 2H); 13C NMR (125 MHz, CDCl3) δ (ppm) 161.58, 149.74, 
147.53, 135.60, 128.75, 127.50, 126.39, 117.38, 113.62, 101.35, 72.09; 19F NMR 
(376 MHz, CDCl3 + drop CF3CO2H) δ (ppm) -129.51, -154.65; HRMS (EI): Calc’d 
for C13H9F2OBr: 297.9805. Found: 297.9822. 
1-(4-(benzyloxy)-2,3-difluorophenyl)ethanone, 124c. White ppt., 88%, Mp: 96–98 
°C; IR (KBr): 3055, 2990, 1695, 1614, 1464, 1448, 1380, 1275, 1202, 1051, 880, 
725, 680 cm–1; 1H NMR (400 MHz, CDCl3) δ (ppm) 7.69 (dt, J = 9.39, J = 2.24, 1H), 
7.39 (m, 6H), 6.90 (dt, J = 8.00, J = 1.82, 1H), 5.26 (s, 2H), 2.71 (d, J = 5.38, 3H); 
13C NMR (125 MHz, CDCl3) δ (ppm) 198.21, 160.44, 141.88, 140.59, 134.96, 
128.75, 127.46, 118.93, 116.46, 113.62, 109.67, 71.67, 30.86; 19F NMR (376 MHz, 
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CDCl3 + drop CF3CO2H) δ (ppm) -132.74, -158.39; HRMS (M + H): Calc’d for 
C15H13F2O2: 263.0884. Found: 263.0887. 
1-(4-(benzyloxy)-2,3-difluorophenyl)-2-bromoethanone, 124d.  Oil, ~96%; 1H 
NMR (400 MHz, CDCl3) δ (ppm) 7.71 (dt, J = 8.44, J = 2.38, 1H), 7.41 (s, 5H), 6.92 
(dt, J = 7.80, J = 1.90, 1H), 5.27 (s, 2H), 4.46 (d, J = 2.48, 2H); 13C NMR (125 MHz, 
CDCl3) δ (ppm) 198.61, 160.37, 153.65, 140.38, 135.11, 128.93, 125.60, 117.97, 
113.44, 109.93, 71.96, 31.02; 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) δ (ppm),              
-132.93, -158.06. 
2-(4-(benzyloxy)-2,3-difluorophenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino)-
butanoate, 124e. White ppt., 84%, Mp: 115–117 °C; IR (KBr): 3300, 3100-2800, 
1742, 1701, 1664, 1619, 1436, 1406, 1200, 1169, 1136, 955, 749, 700, 670, cm–1; 1H 
NMR (400 MHz, d6-DMSO) δ (ppm) 7.71 (dt, J = 8.38, J = 2.22, 1H), 7.41 (m, 5H), 
7.29 (dt, J = 8.22, J = 1.57, 1H), 6.88, (t, J = 5.76, 1H), 5.34 (s, 2H), 5.25 (d, J = 2.82, 
2H), 2.96 (t, J = 6.85, 2H), 2.44 (t, J = 7.55, 2H), 1.67 (m, 2H), 1.37 (s, 9H); 13C 
NMR (125 MHz, d6-DMSO) δ (ppm) 188.76, 172.13, 155.60, 152.08, 149.66, 142.12, 
141.00, 139.04, 128.60, 128.02, 124.86, 116.21, 110.59, 72.91, 69.81, 69.72, 40.79, 
32.09, 29.01, 26.49; 19F NMR (376 MHz, CD3CN + drop CF3CO2H) δ (ppm) -
158.62, -133.05; HRMS (M + Na): Calc’d for C24H27F2NO6Na: 486.1704. Found: 
486.1689. 
4-(2-(2,3-difluoro-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium 2,2,2-
trifluoroacetate, 124. Adhesive ppt., 92%; IR (KBr): 3435, 3246, 3100–2800, 1739, 
1694, 1610, 1525, 1420, 1400, 1310, 1269, 1200, 1165, 1049, 825, 800, 759, 720. 
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cm–1; 1H NMR (400 MHz, D2O) δ (ppm) 7.43 (d, J = 6.57, 1H), 6.75 (d, J = 9.34, 
1H), 5.18 (d, J = 2.64, 2H), 3.04 (t, J = 6.81, 2H), 2.60 (t, J = 7.53, 2H), 1.97 (m, 2H); 
13C NMR (125 MHz, D2O) δ (ppm) 191.36, 173.96, 163.08, 151.57, 140.64, 138.70, 
128.71, 119.79, 117.47, 113.20, 68.83, 38.34, 30.09, 21.61; 19F NMR (376 MHz, 
D2O) δ (ppm) -133.71, -162.58; HRMS (M+): Calc’d for C12H14F2NO4: 274.0891. 
Found: 274.0884. 
1-(benzyloxy)-4-bromo-2,5-difluorobenzene, 125b. White ppt., 91%, Mp: 58–60 
°C; IR (CHCl3): 3002, 2943, 1618, 1508, 1419, 1406, 1375, 1334, 1188, 1170, 1039, 
840, 748, 702; 1H NMR (400 MHz, CDCl3) δ (ppm), 7.37 (m, 5H), 7.29 (dd, J = 6.64, 
J = 3.82, 1H), 6.82 (dd, J = 7.19, J = 2.68, 1H), 5.12 (s, 2H); 13C NMR (125 MHz, 
CDCl3) δ (ppm), 154.82, 150.45, 148.49, 147.28, 135.96, 129.35, 128.03, 120.47, 
104.54, 98.93, 72.22; 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) δ (ppm), -
111.53, -137.66; HRMS (EI): Calc’d for C13H9F2BrO: 297.9805. Found: 297.9833. 
1-(4-(benzyloxy)-2,5-difluorophenyl)ethanone, 125c. White ppt., 89%, Mp: 89–91 
°C; IR (CHCl3): 3060, 3002, 2943, 1681, 1625, 1508, 1411, 1398, 1375, 1334, 1186, 
1159, 1039, 744, 702; 1H NMR (400 MHz, CD3CN) δ (ppm), 7.60 (dd, J = 6.88, J = 
4.78, 1H), 7.43 (m, 5H), 7.00 (dd, J = 6.73, J = 5.93, 1H), 5.20 (s, 2H), 2.54 (d, J = 
5.18, 3H); 13C NMR (125 MHz, CD3CN) δ (ppm), 194.65, 159.45, 158.50, 148.92, 
136.38, 130.69, 129.43, 118.88, 117.28, 115.01, 104.46, 72.74, 31.59; 19F NMR (376 
MHz, CD3CN + drop CF3CO2H) δ (ppm), -110.97, -140.38; HRMS (EI): Calc’d for 
C15H12F2O2: 262.0805. Found: 262.0791. 
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1-(4-(benzyloxy)-2,5-difluorophenyl)-2-bromoethanone, 125d. Oil ~94%; IR 
(NaCl): 3055, 3008, 2942, 1691, 1624, 1511, 1406, 1395, 1357, 1332, 1181, 1150, 
1039, 790, 744, 702; 1H NMR (400 MHz, CDCl3) δ (ppm), 7.70 (dd, J = 6.69, J = 
4.59, 1H), 7.43 (m, 5H), 6.78 (dd, J = 6.50, J = 5.73, 1H), 5.22 (s, 2H), 4.46 (d, J = 
2.89, 3H). 
2-(4-(benzyloxy)-2,5-difluorophenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino) 
butanoate, 125e. White ppt., 92%, Mp: 118–120 °C; IR (KBr): 3303, 3100-2800, 
1741, 1701, 1657, 1623, 1512, 1437, 1407, 1203, 1165, 1144, 953, 897, 750, 699, 
667, cm–1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 7.69 (dd, J = 6.66, J = 4.91, 1H), 
7.43 (m, 6H), 6.89 (t, J = 5.62, 1H), 5.32 (d, 2H), 5.23 (d, J = 3.33, 2H), 2.97 (t, J = 
6.79, 2H), 2.44 (t, 2H), 1.68 (m, 2H), 1.38 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ 
(ppm), 188.50, 172.14, 159.73, 155.59, 151.91, 149.05, 147.12, 135.26, 128.48, 
128.10, 115.36, 114.11, 103.96, 77.46, 70.96, 68.25, 38.97, 30.61, 28.22, 24.92; 
HRMS (M + Na): Calc’d for C24H27F2NO6Na: 486.1704. Found: 486.1702. 
4-(2-(2,5-difluoro-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 125. Adhesive ppt., 75%; IR (KBr): 3440, 3246, 3100-2800, 1736, 
1695, 1610, 1525, 1422, 1398, 1310, 1269, 1200, 1167, 1049, 825, 800, 760, 718. 
cm–1; 1H NMR (400 MHz, MeOD) δ (ppm), 7.62 (dd, J = 6.40, J = 4.73, 1H), 6.81 (d, 
J = 6.75, 1H), 5.26 (d, J = 3.54, 2H), 3.10 (t, J = 7.59, 2H), 2.67 (t, J = 7.08, 2H), 
2.05 (m, 2H); 13C NMR (125 MHz, MeOD) δ (ppm), 188.62, 172.02, 160.69, 158.70, 
152.48, 149.40, 147.48, 115.53, 113.04, 104.71, 68.77, 38.55, 29.99, 22.48; 19F NMR 
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(376 MHz, MeOD) δ (ppm), -110.81, -141.90; HRMS (M+): Calc’d for 
C12H14NF2O4: 274.0891. Found: 274.0878. 
2-(benzyloxy)-5-bromo-1,3-difluorobenzene, 126b. Oil, 98%; IR (NaCl): 3091, 
2948, 1595, 1581, 1494, 1454, 1382, 1220, 1190, 1037, 840, 750, 696; 1H NMR (400 
MHz, CDCl3) δ (ppm), 7.41, (m, 5H), 7.08 (d, J = 7.70, 2H), 5.17 (s, 2H); 13C NMR 
(125 MHz, CDCl3) δ (ppm), 155.74, 136.37, 134.91, 129.60, 118.28, 116.52, 113.03, 
109.48, 66.85; 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) δ (ppm), -125.93; 
HRMS (EI): Calc’d for C13H9F2BrO: 297.9805. Found: 297.9815. 
1-(4-(benzyloxy)-3,5-difluorophenyl)ethanone, 126c. Oil, 91%; IR (NaCl): 3033, 
2927, 1689, 1616, 1577, 1508, 1454, 1433, 1360, 1197, 1041, 975, 750, 696; 1H 
NMR (400 MHz, CD3CN) δ (ppm), 7.49 (dd, J = 9.24, 2H), 7.41 (m, 5H), 7.36 (d, 
1H), 5.30 (s, 2H) 2.57 (s, 3H); 13C NMR (125 MHz, CD3CN) δ (ppm), 194.88, 
156.50, 154.11, 135.99, 131.77, 128.39, 128.18, 113.32, 111.00, 75.48, 25.49; 19F 
NMR (376 MHz, CD3CN + drop CF3CO2H) δ (ppm), -127.25; HRMS (EI): Calc’d 
for C15H12F2O2: 262.0805. Found: 262.0816. 
1-(4-(benzyloxy)-3,5-difluorophenyl)-2-bromoethanone, 126d. Oil, ~95%; IR 
(NaCl): 3035, 2922, 1692, 1621, 1577, 1516, 1446, 1425, 1369, 1205, 1041, 965, 
749, 696; 1H NMR (400 MHz, CDCl3) δ (ppm), 7.55 (d, J = 6.54, 2H), 7.43 (m, 5H), 
5.34 (s, 2H) 4.41 (s, 3H); 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) δ (ppm), -
127.88. 
2-(4-(benzyloxy)-3,5-difluorophenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino) 
butanoate, 126e. Adhesive ppt., 93%; IR (KBr) 3302, 3230, 3100-2800, 1742, 1700, 
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1660, 1621, 1518, 1426, 1407, 1202, 1152, 951, 748, 698, 672 cm–1; 1H NMR (400 
MHz, CD3CN) δ (ppm), 7.56 (d, J = 6.32, 2H), 7.43 (m, 5H), 5.32 (s, 2H), 5.08 (s, 
2H), 3.09 (t, J = 6.83, 2H), 2.45 (t, J = 7.58, 2H), 1.76 (m, 2H), 1.40 (s, 9H); 13C 
NMR (125 MHz, d6-DMSO) δ (ppm), 193.45, 172.21, 160.02, 156.10, 151.72, 
149.22, 146.32, 135.30, 128.76, 128.18, 115.54, 113.99, 105.01, 76.91, 69.95, 68.01, 
39.30, 30.61, 28.20, 24.85; 19F NMR (376 MHz, CD3CN) δ (ppm), -127.82; HRMS 
(M + Na): Calc’d for C24H27F2NO6Na: 486.1704. Found: 486.1700. 
4-(2-(3,5-difluoro-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium2,2,2-
trifluoroacetate, 126.  White ppt., 82%, Mp: 85–87 °C; IR (KBr): 3435, 3238, 3100-
2800, 1740, 1695, 1608, 1524, 1420, 1399, 1310, 1270, 1200, 1165, 1050, 823, 800, 
759, 720. cm–1; 1H NMR (400 MHz, MeOD) δ (ppm), 7.63 (d, J = 7.41, 2H), 5.39 (d, 
2H), 3.07 (t, J = 7.33, 2H), 2.64 (t, J = 7.09, 2H), 2.05 (m, 2H); 13C NMR (125 MHz, 
MeOD) δ (ppm), 194.16, 175.94, 157.12, 155.17, 155.12, 144.00, 132.59, 128.13, 
115.39, 69.88, 42.47, 33.93, 26.42; 19F NMR (376 MHz, MeOD) δ (ppm), -133.62; 
HRMS (M+): Calc’d for C12H14F2NO4: 274.0891. Found: 274.0884. 
1-(4-benzyloxy)-2,6-difluorophenyl)ethanone, 127c. 5-(benzyloxy)-2-bromo-1,3-
difluorobenzene, 127b, was generated by the same method as for 122b, determined to 
be pure by 1H NMR and GC/MS and utilized in the synthesis of 127c. Oil, 97%; IR 
(NaCl): 3035, 2930, 1696, 1610, 1571, 1500, 1451, 1433, 1360, 1199, 1043, 978, 
748, 695; 1H NMR (400 MHz, CDCl3) δ (ppm), 7.39 (m, 5H), 6.62 (dt, J = 8.07, J = 
5.08, 2H), 5.08 (s, 2H) 2.56 (dd, J = 1.85, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm), 
193.78, 163.12, 162.20, 161.02, 134.26, 128.74, 127.74, 111.05, 99.54; 19F NMR 
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(376 MHz, CD3CN + drop CF3CO2H) δ (ppm), -108.33; HRMS (EI): Calc’d for 
C15H12F2O2: 262.0805. Found: 262.0812. 
1-(4-benzyloxy)-2,6-difluorophenyl)-2-bromoethanone, 127d.  Oil, ~95%; 1H 
NMR (400 MHz, CDCl3) δ (ppm), 7.45 (m, 5H), 6.61 (dt, J = 10.47, J = 5.32, 2H), 
5.10 (s, 2H), 4.35 (s, 2H). 
2-(4-(benzyloxy)-2,6-difluorophenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino)-
butanoate, 127e. White ppt., 90%, Mp: 69–71°C; IR (KBr): 3304, 3100-2800, 1742, 
1703, 1652, 1630, 1437, 1407, 1201, 1153, 1133, 1049, 953, 750, 699, 667, cm–1; 1H 
NMR (400 MHz, d6-DMSO) δ (ppm), 7.43 (m, 5H), 6.97 (dd, J = 11.14, J = 4.46, 
1H), 6.89, (t, J = 5.95, 1H), 5.22 (s, 2H), 5.08 (s, 2H), 2.95 (t, J = 6.80, 2H), 2.41 (t, J 
= 7.59, 2H), 1.65 (m, 2H), 1.37 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 
188.75, 172.12, 163.10, 162.68, 160.75, 155.59, 135.51, 128.88, 128.33, 128.06, 
106.77, 106.49, 100.06, 76.33, 69.63, 67.69, 38.01, 29.40, 24.70; 19F NMR (376 
MHz, d6-DMSO) δ (ppm), -108.41; HRMS (M + Na): Calc’d for C24H27F2NO6Na: 
486.1704. Found: 486.1682. 
4-2-(2,6-difluoro-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium 2,2,2-
trifluoroacetate, 127.  White ppt., 86%, Mp: 85–87 °C; IR (KBr): 3438, 3245, 3100-
2800, 1741, 1694, 1610, 1525, 1420, 1400, 1310, 1268, 1200, 1165, 1050, 825, 800, 
758, 720. cm–1; 1H NMR (400 MHz, MeOD) δ (ppm) 7.41 (d, 1H), 6.54 (d, J = 13.06, 
2H), 5.10 (s, 2H), 3.09 (t, J = 7.59, 2H), 2.59 (t, J = 7.05, 2H), 2.00 (m, 2H); 13C 
NMR (125 MHz, D2O) δ (ppm) 188.59, 171.98, 163.70, 162.48, 161.56, 128.75, 
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117.38, 99.68, 68.98, 38.52, 30.07, 22.45; 19F NMR (376 MHz, D2O) δ (ppm) -
109.55; HRMS (M+): Calc’d for C12H14F2NO4: 274.0891. Found: 274.08879. 
2-(benzyloxy)-5-bromo-1,3,4-trifluorobenzene, 128b. Oil, 94%; IR (NaCl): 3033, 
2952, 1629, 1598, 1487, 1475, 1456, 1190, 1089, 1018, 821, 744, 696 cm–1; 1H NMR 
(400 MHz, CDCl3) δ 7.38 (m, 5H), 7.11-7.09 (qd, J = 2.54, 1H), 5.22 (s, 2H); 13C 
NMR (125 MHz, CDCl3) δ 152.73, 150.75, 135.53, 129.06, 128.65, 128.45, 115.38, 
114.56, 113.11, 102.41, 98.93, 66.31; 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) 
δ -131.82, -133.66, -147.45; HRMS (EI): Calc’d for C13H8F3BrO: 315.9711. Found: 
315.9712. 
1-(4-(benzyloxy)-2,3,5-trifluorophenyl)ethanone, 128c. White ppt., 84%, Mp: 45–
47 °C; IR (CHCl3): 3002, 2943, 1691, 1627, 1500, 1375, 1346, 1081, 1039, 918, 750, 
702 cm–1; 1H NMR (400 MHz, CDCl3) δ 7.45 (m, 6H), 5.37 (s, 2H), 2.68 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 194.74, 152.20, 150.23, 147.94, 143.62, 135.58, 128.77, 
119.68, 118.10, 115.83, 113.56, 66.45, 31.39; 19F NMR (376 MHz, CDCl3 + drop 
CF3CO2H) δ -131.10, -136.69, -149.56. HRMS (EI): Calc’d for C15H11F3O2: 
280.0711. Found: 280.0717. 
1-(4-(benzyloxy)-2,3,5-trifluorophenyl)-2-bromoethanone, 128d. Oil, ~94%; IR 
(CHCl3): 3000, 2945, 1698, 1624, 1502, 1369, 1352, 1081, 1045, 921, 750, 699. 1H 
NMR (400 MHz, CDCl3) δ (ppm) 7.53–7.51 (qd, J = 2.30, 1H), 7.40 (m, 5H), 5.25 (d, 
2H), 4.45 (s, 2H). 
2-(4-(benzyloxy)-2,3,5-trifluorophenyl)-2-oxoethyl-4-(tert-butoxy-carbonyl-
amino)butanoate, 128e. White ppt., 93%, Mp: 110–112 °C; IR (KBr) 3302, 3100-
  274 
2800, 1743, 1703, 1651, 1629, 1437, 1407, 1202, 1170, 1147, 950, 748, 698, 667 cm–
1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 7.62-7.60 (qd, J = 2.30, 1H), 7.41 (m, 
5H), 6.88, (t, J = 6.00, 1H), 5.40 (s, 2H), 5.26 (s, 2H), 2.96 (t, J = 6.82, 2H), 2.44 (t, J 
= 7.60, 2H), 1.67 (m, 2H), 1.38 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 
188.33, 172.09, 155.60, 151.48, 149.53, 148.47, 146.44, 144.63, 142.83, 140.05, 
128.55, 116.87, 110.58, 77.46, 75.71, 68.22, 30.53, 28.21, 24.89; HRMS (M + Na): 
Calc’d for C24H26F3NO6Na: 504.1610. Found: 504.1593. 
4-oxo-4-(2-oxo-2-(2,3,5-trifluoro-4-hydroxyphenyl) ethoxy) butan-1-aminium 
2,2,2-trifluoroacetate, 128.  White ppt., 90%, Mp: 131–133 °C; IR (KBr): 3434, 
3244, 3100-2800, 1738, 1695, 1610, 1523, 1420, 1400, 1309, 1267, 1199, 1166, 
1049, 824, 800, 759, 720 cm–1; 1H NMR (400 MHz, D2O) δ (ppm), 7.52-7.50 (qd, J = 
2.35, 1H), 5.37 (d, 2H), 3.14 (t, J = 7.06, 2H), 2.72 (t, J = 6.71, 2H), 2.07 (m, 2H); 
13C NMR (125 MHz, D2O) δ (ppm), 190.89, 174.05, 163.12, 149.21, 147.28, 141.03, 
139.81, 117.19, 115.16, 109.89, 69.88, 42.47, 33.93, 26.42; 19F NMR (376 MHz, 
D2O) δ (ppm), -136.48, -137.81, -156.79; HRMS (M+): Calc’d for C12H13F3NO4: 
292.0797. Found: 292.0794. 
1-(benzyloxy)-4-bromo-2,3,5,6-tetrafluorobenzene, 129b. White ppt., 96%, Mp: 
43–45 °C; IR (CHCl3): 3002, 2943, 1560, 1458, 1442, 1407, 1380, 1039, 918, 750; 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.39 (m, 5H), 5.28 (s, 2H); 13C NMR (125 
MHz, CDCl3) δ (ppm) 146.18, 144.22, 144.11, 140.70, 135.25, 129.04, 128.72, 93.26, 
76.51; 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) δ (ppm) -131.37, -155.12. 
HRMS (EI): Calc’d for C13H7F4BrO: 333.9616. Found: 333.9606. 
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1-(4-(benzyloxy)-2,3,5,6-tetrafluorophenyl)ethanone, 129c. A solution of 129b 
(1.00g 2.98 mmol), tributyl(1-ethoxyvinyl)stannane (1.44 ml, 4.27 mmol) and 25 ml 
toluene was degassed for 30 min while stirring. Tetrakistriphenylphosphine palladium 
(0) (205 mg, 0.178 mmol) was then added and the solution heated to 100 oC overnight 
with stirring. Fifty ml of 50% HCl (aq) were added and the solution stirred for 6 h, 
followed by filtration through Celite that effectively removed the palladium black. 
The resulting toluene filtrate was charged with 50 ml of saturated aqueous potassium 
fluoride and continuously stirred for 12 h. The insoluble tributylflourostannane was 
then filtered, the aqueous layer removed, and the organic layer concentrated. Flash 
column chromatography (6:1 Hex/Et2O) afforded 1-(4-(benzyloxy)-2,3,5,6-
tetrafluorophenyl)ethanone, 129c, in 85% yield (755 mg) as a faint yellow solid.  Mp: 
47–49 °C; IR (CDCl3): 2921, 2852, 1712, 1643, 1461, 1377, 1190, 1100, 742, 723, 
696 cm–1; 1H NMR (400 MHz, CDCl3) δ (ppm) 7.38 (m, 5H), 5.27 (s, 2H), 2.59 (t, J 
= 1.90, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm) 192.07, 146.39, 143.95, 142.52, 
139.89, 135.28, 129.27, 128.46, 66.07, 32.70; 19F NMR (376 MHz, CDCl3 + drop 
CF3CO2H) δ (ppm) -144.22, -161.88; HRMS (M + H): Calc’d for C15H11F4O2: 
299.0695. Found: 299.0702. 
1-(4-(benzyloxy)-2,3,5,6-tetrafluorophenyl)-2-bromoethanone, 129d. Oil, ~99%; 
IR (CHCl3): 2919, 2856, 1721, 1645, 1453, 1379, 1190, 1107, 745, 715, 696; 1H 
NMR (400 MHz, CDCl3) δ (ppm) 7.40 (m, 5H), 5.35 (s, 2H), 4.32 (t, J = 1.20, 2H). 
2-(4-(benzyloxy)-2,3,5,6-tetrafluorophenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-
amino)butanoate, 129e. White ppt., 87%, Mp: 106–108 °C; IR (KBr) 3301, 3100-
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2800, 1744, 1703, 1655, 1615, 1487, 1437, 1407, 1210, 1153, 1050, 749, 700, 667 
cm–1; 1H NMR (400 MHz, d6-DMSO) δ (ppm) 7.42 (m, 5H), 6.88, (t, J = 5.92, 1H), 
5.43 (s, 2H), 5.02 (t, J = 1.43, 2H), 2.93 (t, J = 6.74, 2H), 2.41 (t, J = 7.57, 2H), 1.65 
(m, 2H), 1.37 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 188.04, 172.14, 
155.59, 145.97, 143.96, 141.32, 139.47, 135.39, 128.64, 128.39, 109.10, 77.46, 76.14, 
68.81, 30.39, 28.82, 24.82; HRMS (M + Na): Calc’d for C24H25F4NO6Na: 522.1516. 
Found: 522.1493. 
4-oxo-4-(2-oxo-2-(2,3,5,6-tetrafluoro-4-hydroxyphenyl)ethoxy)butan-1-aminium-
2,2,2-trifluoroacetate, 129. White ppt., 83%, Mp: 107–109 °C; IR (KBr): 3440, 
3241, 3100-2800, 1735, 1690, 1610, 1525, 1420, 1400, 1310, 1265, 1200, 1166, 
1050, 824, 800, 759, 720. cm–1; 1H NMR (400 MHz, D2O) δ (ppm), 5.25 (t, J = 1.67, 
2H), 3.07 (t, J = 7.61, 2H), 2.66 (t, J = 7.06, 2H), 2.01 (m, 2H); 13C NMR (125 MHz, 
D2O) δ (ppm), 189.10, 173.25, 162.36, 147.43, 139.18, 129.31, 117.78, 113.12, 
104.46, 69.40, 38.59, 30.13, 22.22; 19F NMR (376 MHz, D2O) δ (ppm), -142.76, -
163.05; HRMS (M+): Calc’d for C12H12F4NO4: 310.0702. Found: 310.0701. 
1-benzyloxy-4-bromo-2-trifluoromethylbenzene, 130b. Oil, 93%; IR (NaCl):  
3033, 2935, 1602, 1490, 1454, 1139, 1053, 908, 811, 732 cm-1;   1H NMR (400 MHz, 
CDCl3) δ (ppm), 7.71 (d, J = 2.56, 1H), 7.56 (d, J = 2.56, 1H), 7.38 (m, 5H), 6.90 (d, 
J = 8.91, 1H), 5.19 (s, 2H); 13C NMR (125 MHz, CDCl3) δ (ppm), 155.66, 135.89, 
130.29, 129.19, 128.58, 127.02, 124.31, 121.59, 120.81, 115.22, 112.45;  19F NMR 
(376 MHz, CDCl3 + drop CF3CO2H) δ (ppm), -63.49; HRMS (EI):  Calc’d for 
C14H10F3BrO: 329.9867.  Found:  329.9850. 
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1-(4-benzyloxy-3-trifluoromethylphenyl)ethanone, 130c. White ppt., 84%, Mp: 
119-121 oC; IR (CHCl3):  3055, 2987, 2829, 1685, 1610, 1421, 1265, 1141, 896, 738, 
696 cm-1;   1H NMR (400 MHz, CDCl3) δ (ppm), 8.23 (d, J = 2.10, 1H), 8.11 (dd, J = 
8.78, J = 2.29, 1H), 7.44 (m, 5H), 7.09 (d, J = 8.80,  1H), 5.29 (s, 2H), 2.59 (s, 3H); 
13C NMR (125 MHz, CDCl3) δ (ppm), 201.19, 159.89, 135.05, 129.10, 128.5, 127.04, 
124.49, 121.78, 119.35, 116.09, 113.26, 110.42, 71.02, 26.11;  19F NMR (376 MHz, 
CDCl3 + drop CF3CO2H) δ (ppm), -63.77; HRMS (EI):  Calc’d for C16H14F3O2: 
295.0946.  Found:  295.0927.   
1-(4-benzyloxy-3-trifluoromethylphenyl)-2-bromoethanone, 130d. Oil, ~93%; IR 
(CHCl3):  3058, 2989, 2821, 1687, 1605, 1421, 1255, 1139, 892, 740, 690 cm-1;  1H 
NMR (400 MHz, CDCl3) δ (ppm), 7.90 (dd, J = 8.96, J = 2.15, 2H), 7.43 (m, 5H), 
7.06 (d, J = 8.90, 1H), 5.31 (s, 2H), 4.39 (s, 2H); 19F NMR (376 MHz, CDCl3 + drop 
CF3CO2H) δ (ppm), -63.81.  
2-(4-benzyloxy-3-trifluoromethylphenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-
amino)butanoate, 130e.  White ppt., 87%, Mp:  112-114oC; IR (KBr) 3304, 3100-
2800, 1741, 1701, 1659, 1612, 1508, 1437, 1407, 1218, 1167, 1137, 1053, 1008, 741, 
699, 667; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 8.26 (dd, J = 8.64, J = 2.20, 1H), 
8.15 (d, J = 1.50, 1H), 7.43 (m, 5H), 7.34 (t, J = 7.15, 1H), 6.88 (t, J = 7.25, 1H), 5.48 
(s, 2H), 5.41 (s, 2H), 2.98 (t, J = 6.74, 2H), 2.44 (t, J = 7.63, 2H), 1.70 (m, 2H), 1.38 
(s, 9H); 13C NMR (125 MHz, d6-DMSO) δ(ppm), 190.79, 172.18, 159.87, 155.60, 
135.73, 133.10, 132.00, 131.42, 128.69, 127.94, 126.44, 124.27, 122.10, 119.93, 
117.63, 114.27, 77.45, 70.21, 66.16, 38.97, 28.22, 26.47, 24.96;  19F NMR (376 MHz, 
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CD3CN + drop CF3CO2H) δ (ppm), -61.41; HRMS (M + Na):  Calc’d for 
C25H28F3NO6Na: 518.1766.  Found 518.1756. 
2-(4-hydroxy-3-(trifluoromethyl)phenyl)-2-oxoethyl4-(tert-butoxy-carbonyl)-
aminobutanoate, 130e’. The general method of Theodorakis146 was employed.  To a 
solution of 130e (1.10g, 2.22 mmol) in 25 ml EtOAc was added 220 mg of 10% Pd/C, 
and the heterogenous mixture stoppered with a septum.  While stirring, hydrogen (H2) 
was infused through a needle into the solution.  The reaction was completed ~ 2h as 
indicated by TLC. The residual Pd/C was filtered off through Celite and the organic 
phase concentrated under reduced pressure to yield 875 mg of 130e’ as an adhesive 
precipitate (97%);  1H NMR (400 MHz, d6-DMSO) δ (ppm), 11.60 (s, 1H), 8.10 (dd, 
J = 8.80, J = 2.10, 1H), 7.25 (t, J = 8.00, 1H), 7.15 (d, J = 7.70, 1H), 6.90 (t, J = 7.20, 
1H), 5.48 (s, 2H) 2.96 (t, J = 6.90, 2H), 2.42 (t, J = 7.50, 2H), 1.66 (m, 2H), 1.38 (s, 
9H). 
4-(2-(4-hydroxy-3-trifluoromethylphenyl)-2-oxoethoxy)-4-oxobutan-1-amonium 
2,2,2-trifluoroacetate, 130. A modified preparation of Marsh’s13 technique was 
utilized.  To a round bottomed flask containing 130e’ (800 mg, 1.97 mmol) was 
added 20 ml of 1:1 TFA/CH2Cl2.  The reaction persisted for 15 min while stirring and 
at room temperature.  At this time, excess solvent was removed under reduced 
pressure, washed with 50 ml of 1:1 CH2Cl2/H2O and the water layer retained and 
lyophilized to afford 130 as a white solid, (72%);  Mp: 129-131 oC;  IR (KBr):  3439, 
3271, 3100-2800, 1742, 1692, 1605, 1516, 1431, 1380, 1311, 1253, 1222, 1200, 
1166, 1057, 822, 760 cm-1; 1H NMR (400 MHz, D2O) δ (ppm), 8.25 (d, J = 2.10, 1H), 
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8.12 (d, J = 9.29, 1H), 7.20 (d, J = 8.98, 1H), 5.55 (s, 2H), 3.15 (t, J = 8.05, 2H), 2.73 
(t, J = 9.29, 2H), 2.06, (m, 2H); 13C NMR (125 MHz, MeOD) δ (ppm), 191.05, 
172.35, 161.92, 161.05, 133.82, 128.25, 125.01, 122.32, 120.16, 117.42, 115.71, 
65.97, 38.51, 30.09, 22.38; HRMS (M+):  Calc’d for C13H15F3NO4: 306.0953.  Found 
306.0953. 
The same steps were utilized to make 131 and 132. 
1-(benzyloxy)-4-bromo-2-(trifluoromethoxy)benzene, 131b. Oil, 93%; IR (NaCl):  
3033, 2916, 1595, 1500, 1454, 1382, 1190, 1135, 1024, 804, 736, 696.   1H NMR 
(400 MHz, CDCl3) δ 7.36 (m, 8H), 6.88 (d, J = 8.9, 1H), 5.15 (s, 2H); 13C NMR (125 
MHz, CDCl3) δ 150.33, 138.80, 135.79, 129.06, 127.13, 121.61, 119.55, 117.49, 
115.45, 112.36, 110.92, 71.13; 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) δ -
59.08; HRMS (EI):  Calc’d for C14H10F3BrO2: 345.9816.  Found:  345.9812. 
1-(4-(benzyloxy)-3-(trifluoromethoxy)phenyl)ethanone, 131c. Oil, 92%; IR 
(NaCl):  3035, 2929, 1681, 1606, 1581, 1514, 1454, 1427, 1380, 1205, 1170, 1135, 
813, 738, 696;   1H NMR (400 MHz, CDCl3) δ 7.87 (dd, J = 8.88, J = 2.01, 2H), 7.43 
(m, 5H), 7.26 (d, J = 8.57, 1H), 5.25 (s, 2H) 2.56 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 195.65, 154.73, 137.40, 135.84, 129.34, 127.44, 122.68, 119.53, 117.49, 
115.74, 113.85, 111.20, 70.64, 25.56; 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) 
δ -58.69; HRMS (EI):  Calc’d for C16H13F3O3: 310.0817.  Found:  310.0828. 
1-(4-benzyloxy-3-trifluoromethoxyphenyl)-2-bromoethanone, 131d. Oil, ~93%;  
IR (CDCl3):  3035, 2928, 1680, 1606, 1580, 1516, 1444, 1423, 1371, 1215, 1150, 
1125, 827, 730, 692;   1H NMR (400 MHz, CDCl3) δ (ppm), 8.26 (d, J = 2.00, 1H), 
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8.14 (dd, J = 8.74, J = 2.20, 1H), 7.41 (m, 5H), 7.12 (d, J = 8.58, 1H), 5.26 (s, 2H) 
4.37 (s, 2H); 19F NMR (376 MHz, CDCl3 + drop CF3CO2H) δ (ppm), -58.73. 
2-(4-benzyloxy-3-trifluoromethoxy)phenyl-2-oxoethyl-4-(tert-butyoxycarbonyl-
amino)butanoate, 131e.  White ppt., 85%, Mp:  112-114oC; IR (KBr):  3307, 3100-
2800, 1742, 1701, 1659, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667; 1H NMR 
(400 MHz, d6-DMSO ) δ (ppm), 8.03 (dd, J = 8.98, J = 2.20, 1H), 7.89 (t, J = 2.63, 
1H), 7.42 (m, 5H), 6.88 (t, J = 6.30, 1H), 5.44 (s, 2H) 5.35 (s, 2H) 2.98 (t, J = 6.79, 
2H), 2.44 (t, J = 7.59, 2H), 1.68 (m, 2H), 1.38 (s, 9H); 13C NMR (125 MHz, d6-
DMSO) δ (ppm), 190.79, 172.18, 159.87, 155.60, 134.40, 133.10, 132.00, 128.91, 
127.23, 126.44, 124.27, 122.10, 119.93, 117.38, 114.27, 77.45, 70.32, 66.16, 39.47, 
30.62, 28.22, 24.96; 19F NMR (376 MHz, CD3CN + drop CF3CO2H) δ (ppm), -61.14; 
HRMS (M + Na):  Calc’d for C25H28F3NO7Na: 534.1716.  Found 534.1712. 
2-(4-hydroxy-3-(trifluoromethoxy)phenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-
amino)butanoate, 131e’. Adhesive ppt., 97%; 1H NMR (400 MHz, d6-DMSO ) δ 
(ppm), 7.87 (dd, J = 8.60, J = 2.20, 1H), 7.81 (s, 1H), 7.11 (d, J = 8.62, 1H), 6.89 (t, J 
= 5.50, 1H), 5.38 (s, 2H), 2.97 (t, J = 6.80, 2H), 2.42 (t, J = 7.65, 2H), 1.70 (m, 2H), 
1.38 (s, 9H).    
4-(2-(4-hydroxy-3-trifluoromethoxyphenyl-2-oxoethoxy)-4-oxobutan-1-
ammonium-2,2,2-trifluoroacetate, 131. White ppt., 96%,  Mp:  121-123 oC.  IR 
(KBr):  3439, 3271, 3100-2800, 1742, 1692, 1605, 1516, 1431, 1380, 1311, 1253, 
1222, 1200, 1166, 1057, 822, 760 cm-1;  1H NMR (400 MHz, D2O) δ (ppm),  7.90 (t, 
J = 1.50, 1H), 7.85 (dd, J = 8.82, J = 2.13, 1H), 7.14 (d, J = 8.80, 1H), 5.47 (s, 2H), 
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3.08 (t, J = 7.65, 2H), 2.68 (t, J = 7.08, 2H), 2.02 (m, 2H); 13C NMR (125 MHz, D2O) 
δ (ppm),  193.76, 174.15, 163.12, 154.43, 136.51, 132.19,  129.16, 125.96, 123.47, 
121.99, 119.37, 117.73, 66.67, 38.53, 30.23, 21.96;  HRMS (M+):  Calc’d for 
C13H15F3NO5: 322.0902.  Found:  322.0905. 
1-(4-(benzyloxy)-3-nitrophenyl)ethanone, 132c.  3-nitro-4-hydroxyacetophenone is 
commercially available.  96%.  This compound is known.  1H NMR (400 MHz, 
CDCl3) δ (ppm), 8.45 (dd, J = 9.22, J = 2.38,1H), 8.14 (dd, J = 9.15, J = 1.69, 1H), 
7.42 (m, 6H), 5.34 (s, 2H), 2.60 (s, 2H). 
1-(4-(benzyloxy)-3-nitrophenyl)-2-bromoethanone, 132d. Oil, ~97%; 1H NMR 
(400 MHz, CDCl3) δ (ppm), 8.34 (s,1H), 8.00 (d, 1H), 7.28 (m, 6H), 5.20 (s, 2H), 
4.23 (s, 2H). 
2-(4-(benzyloxy)-3-nitrophenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino) 
butanoate, 132e.  White ppt., 67%, Mp: 144-146oC.  IR (KBr):  3310, 3100-2800, 
1740, 1700, 1655, 1603, 1433, 1400, 1204, 1170, 955, 745, 697, 665;  1H NMR (400 
MHz, CD3CN) δ (ppm),  8.37 (dd, J = 7.12, J = 2.57, 1H), 8.12 (d, J = 1.50, 1H), 7.43 
(m, 6H), 6.85 (t, J = 7.21, 1H), 5.34 (s, 2H), 3.09 (t, J = 6.79, 2H), 2.46 (t, J = 7.60, 
2H), 1.77 (m, 2H), 1.40 (s, 9H);  13C NMR (125 MHz, CD3CN) δ (ppm), 195.22, 
173.42, 160.65, 158.77, 139.23, 136.54, 135.40, 133.98, 131.78, 128.36, 125.89, 
119.24, 116.82, 66.72, 38.44, 30.51, 29.11, 21.88; HRMS (M + Na):  Calc’d for 
C24H28N2O8Na:  495.1743.  Found: 495.1755 
4-(2-(4-hydroxy-3-nitrophenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 132.  White ppt., 78%, Mp: 76-78oC;  IR (KBr):  3441, 3265, 3100-
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2800, 1740, 1690, 1605, 1520, 1430, 1377, 1309, 1252, 1225, 1199, 1166, 1055, 820, 
760. cm-1; 1H NMR (400 MHz, D2O) δ (ppm), 8.72 (d, J = 2.16, 1H), 8.20 (d, J = 
9.29, 1H), 7.32 (d, J = 8.85, 1H), 5.56 (s, 2H), 3.14 (t, J = 7.80, 2H), 2.72 (t, J = 9.18, 
2H), 2.08 (m, 2H); 13C NMR (125 MHz, D2O) δ (ppm), 193.16, 174.10, 163.13, 
157.81, 135.75, 134.33, 126.61, 120.50, 117.44, 115.12, 66.69, 38.54, 30.23, 21.96;  
HRMS (M +):  Calc’d for C12H15N2O6:  283.0925.  Found: 283.0914. 
4-(2-(4-hydroxy-3,5-dimethoxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium 
2,2,2-trifluoroacetate, 133.  The synthesis of 133 was accomplished from use of the 
procedure by Conrad, et. al.97 
4-(2-(4-hydroxy-3-methoxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 134.  The synthesis of 134 was accomplished from use of the 
procedure by Conrad, et. al.97 
1-(2,4-bis(benzyloxy)phenyl)ethanone, 135b. 2,4-dihydroxyacetophenone is 
commercially available.  Benzylation of this utilized the same procedure as in the 
synthesis of 122b. White ppt., 97%.  This compound is known.  1H NMR (400 MHz, 
CDCl3) δ (ppm), 7.86 (t, J = 7.63, 1H), 7.39 (m, 11H), 6.64 (dd, J = 8.71, J = 2.33, 
1H), 5.12 (s, 2H), 5.10 (s, 2H), 2.57 (s, 3H).   
1-(2,4-bis(benzyloxy)phenyl)-2-bromoethanone, 135c. An identical procedure was 
used as to construct 122d. ~ 94%.  1H NMR (400 MHz, CDCl3) δ (ppm), 7.78 (s,1H), 
7.35 (m, 10H), 6.60 (d, 2H), 5.12 (s, 2H), 5.09 (s, 2H), 4.51 (s, 1H), 4.46 (1H). 
2-(2,4-bis(benzyloxy)phenyl)-2-oxoethyl 4-(tert-butoxycarbonylamino)butanoate, 
135d.  The same procedure was utilized as to synthesize 122e. Adhesive ppt, 48%; IR 
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(KBr):  3310, 3100-2800, 1743, 1700, 1658, 1601, 1436, 1400, 1200, 1165, 955, 745, 
742, 700, 697, 665, 651;  1H NMR (400 MHz, d6-DMSO) δ (ppm),  7.93 (t, J = 8.79, 
1H), 7.43 (m, 10H), 7.14 (dd, J = 8.74, J = 2.15, 1H), 6.88 (t, J = 5.70, 1H), 6.62 (d, J 
= 4.66, 1H), 5.37 (s, 2H),  5.29 (s, 1H), 5.21 (s, 1H), 5.10 (s, 2H), 2.94 (t, J = 6.63, 
2H), 2.37 (t, J = 7.51, 2H), 1.76 (m, 2H), 1.37 (s, 9H);  13C NMR (125 MHz, d6-
DMSO) δ (ppm),  190.50, 172.15, 164.65, 159.78, 155.58, 135.99, 132.04, 128.35, 
127.51, 118.10, 107.59, 103.90, 100.33, 77.43, 70.72, 69.19, 39.95, 30.68, 28.22, 
24.88;  HRMS (M + H):  Calc’d for C31H36NO7:  534.2492.  Found: 534.2504. 
2-(2,4-dihydroxyphenyl)-2-oxoethyl-4-(tert-butoxycarbonylamino)butanoate, 
135e.  An identical procedure was used as to engender 130’e. Adhesive ppt., 97%;  
1H NMR (400 MHz, d6-DMSO) δ (ppm),  11.43, (s, 1H), 11.34 (s, 1H), 7.88 (s,1H), 
7.70 (d, 1H), 6.87 (t, 1H), 6.38 (d, 1H), 5.28 (s, 1H),  2.96 (t, 2H), 2.40 (t, 2H), 1.67 
(m, 2H), 1.38 (s, 9H). 
4-(2-(2,4-dihydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 135.  An identical procedure was used as to produce 130.  White 
ppt., 85%, Mp: 136-138 oC;  IR (KBr):  3432, 3274, 3100-2800, 1739, 1691, 1602, 
1520, 1421, 1377, 1309, 1298, 1201, 1178, 1128, 1055, 1027, 1008, 823, 762, 717, 
613 cm-1; 1H NMR (400 MHz, D2O) δ (ppm), 7.97 (d, J = 6.81, 1H), 7.72 (d, J = 
8.84, 1H), 6.53 (d, J = 7.63, 1H), 5.48 (s, 1H), 5.43 (s, 1H), 3.14 (t, J = 7.64, 2H), 
2.72 (t, J = 7.05, 2H), 2.08 (m, 2H); 13C NMR (125 MHz, D2O) δ (ppm), 193.77, 
174.15, 162.75, 151.02, 144.22, 125.92, 122.70, 119.65, 117.37, 115.58, 66.60, 38.51, 
30.28, 22.00; HRMS (M +):  Calc’d for C12H16NO5:  254.1028.  Found: 254.1038. 
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The same methodology was utilized to assemble 136-141. 
1-(3,4-bis(benzyloxy)phenyl)ethanone, 136b. 3,4-dihydroxyacetophenone is 
commercially available.  Benzylation of this utilized the same procedure as in the 
synthesis of 127b. 98%.  This compound is known.  1H NMR (400 MHz, CDCl3) δ 
(ppm), 7.63 (dd, J = 8.77, J = 2.32, 1H), 7.40 (m, 11H), 6.94 (dd, J = 9.10, J = 1.90, 
1H), 5.25 (s, 2H), 5.22 (s, 2H), 2.52 (s, 3H).   
1-(3,4-bis(benzyloxy)phenyl)-2-bromoethanone, 136c. Oil ~96%; 1H NMR (400 
MHz, CDCl3) δ (ppm), 7.68 (s,1H), 7.41 (m, 11H), 6.96 (d, 1H), 5.24 (s, 2H), 5.22 (s, 
2H), 4.46 (s, 2H). 
2-(3,4-bis(benzyloxy)phenyl)-2-oxoethyl-4-(tert-butoxy-carbonyl-amino)-
butanoate, 136d.   White ppt., 90%, Mp: 112-114oC; IR (KBr):  3310, 3100-2800, 
1743, 1700, 1658, 1601, 1436, 1400, 1200, 1165, 955, 745, 742, 700, 697, 665, 651;  
1H NMR (400 MHz, d6-DMSO) δ (ppm),  7.62 (dd, J = 7.25, J = 2.38, 1H), 7.56 (d, J 
= 1.72, 1H), 7.38 (m, 10H), 7.19 (d, J = 8.13, 1H), 6.92 (t, J = 7.21, 1H), 5.40 (s, 2H),  
5.27 (s, 2H), 5.21 (s, 2H), 2.97 (t, J = 6.78, 2H), 2.40 (t, J = 7.70, 2H), 1.70 (m, 2H), 
1.38 (s, 9H);  13C NMR (125 MHz, d6-DMSO) δ (ppm),  197.09, 171.80, 155.60, 
152.85, 147.98, 136.85, 128.41, 127.94, 127.58, 126.84, 122.64, 113.04, 112.51, 
77.47, 70.00, 66.07, 39.61, 30.67, 28.22, 24.54;  HRMS (M + H):  Calc’d for 
C31H36NO7:  534.2492.  Found: 534.2484. 
2-(2,4-dihydroxyphenyl)-2-oxoethyl-4-(tert-butoxycarbonylamino)butanoate, 
136e. Adhesive ppt., 98%; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 7.32 (d, 2H), 
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6.93 (s, 1H), 6.89 (t, 1H), 5.39 (s, 2H), 2.98 (t, 2H), 2.38 (t, 2H), 1.68 (m, 2H), 1.40 
(s, 9H). 
4-(2-(3,4-dihydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 136.  White ppt., 92%, Mp: 56-58oC; IR (KBr):  3432, 3274, 3100-
2800, 1739, 1691, 1602, 1520, 1421, 1377, 1309, 1298, 1201, 1178, 1128, 1055, 
1027, 1008, 823, 762, 717, 613 cm-1; 1H NMR (400 MHz, D2O) δ (ppm), 7.35 (s, 
1H), 7.33 (s, 1H), 6.91 (d, J = 7.10, 1H), 5.36 (s, 2H), 3.07 (t, J = 6.80, 2H), 2.65 (t, J 
= 7.76, 2H), 2.00 (m, 2H); 13C NMR (125 MHz, D2O) δ (ppm), 194.29, 174.13, 
163.06, 150.88, 144.11, 125.88, 122.69, 119.74, 117.42, 115.10, 66.56, 38.30, 30.23, 
21.95; HRMS (M +):  Calc’d for C12H16NO5:  254.1028.  Found: 254.1032. 
1-(4-(benzyloxy)-3-methyl-phenyl)ethanone, 137b. 3-methyl-4-dihydroxy-
acetophenone is commercially available.  Benzylation of this comprised the same 
procedure as in the synthesis of 122b. white ppt., 95%.  This compound is known.  1H 
NMR (400 MHz, CDCl3) δ (ppm), 7.82 (s 1H), 7.80 (s, 1H), 7.40 (m, 5H), 6.90 (d, J= 
8.75, 1H), 5.17 (s, 2H), 2.56 (s, 3H), 2.33 (s, 3H). 
1-(4-(benzyloxy)-3-methylphenyl)-2-bromoethanone, 137c.  Oil, ~97%; 1H NMR 
(400 MHz, CDCl3) δ (ppm), 7.82 (d, 2H), 7.40 (m, 5H), 6.88 (d, J = 8.80,1H), 5.19 (s, 
2H), 4.33 (s, 2H), 2.33 (s, 3H). 
2-(4-(benzyloxy)-3-methylphenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino) 
butanoate, 137d.  White ppt., 94%, Mp:  105-106 oC; IR (KBr):  3307, 3100-2800, 
1742, 1701, 1659, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667; 1H NMR (400 
MHz, d6-DMSO) δ (ppm), 7.82 (d, J = 9.14, 2H), 7.40 (m, 5H), 7.14 (d, J = 8.10, 
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1H), 6.87 (t, J = 7.40, 1H), 5.39 (s, 2H), 5.25 (s, 2H), 2.96 (t, J = 6.81, 2H), 2.42 (t, J 
= 7.62, 2H), 2.24 (s, 3H), 1.70 (m, 2H), 1.38 (s, 9H); 13C NMR (125 MHz, d6-
DMSO) δ (ppm), 191.14, 172.20, 161.40, 155.60, 136.67, 131.00, 130.10, 129.26, 
128.50, 127.34, 126.45, 125.07, 111.62, 77.45, 69.55, 66.03, 39.33, 30.68, 28.18, 
24.98, 16.04; HRMS (M + Na):  Calc’d for C25H31NO6Na: 464.2049.  Found: 
464.2017. 
2-(4-hydroxy-3-methylphenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino)-
butanoate, 137e.  Adhesive ppt., 98%; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 
10.76 (s, 1H), 7.86 (d, J = 9.26, 2H), 7.66 (d, J = 8.04, 1H), 6.89 (t, 1H), 5.38 (s, 2H) 
2.96 (t, J = 6.94, 2H), 2.42 (t, J = 7.88, 2H), 2.24 (s, 3H), 1.70 (m, 2H), 1.38 (s, 9H). 
4-(2-(4-hydroxy-3-methylphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 137.  White ppt., 89%, Mp: 118-120oC. IR (KBr):  3432, 3274, 
3100-2800, 1739, 1691, 1602, 1520, 1421, 1377, 1309, 1298, 1201, 1178, 1128, 
1055, 1027, 1008, 823, 762, 717, 613. cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 
7.86 (s, 3H), 7.72 (d, J = 6.22, 1H), 7.67 (dd, J = 9.03, J = 1.79, 1H), 5.39 (s, 1H), 
2.88 (t, J = 6.97, 2H), 2.56 (t, J = 7.55, 2H), 2.16 (s, 3H), 1.87 (m, 2H); 13C NMR 
(125 MHz, d6-DMSO) δ (ppm), 190.67, 171.72, 160.98, 158.27, 130.76, 127.76, 
125.10, 120.30, 117.94, 114.76, 66.11, 38.09, 30.15, 22.10, 15.80; HRMS (M+):  
Calc’d for C13H18NO4:  252.1230.  Found: 252.1212. 
1-(4-(benzyloxy)-3,5-dimethylphenyl)ethanone, 138b. 4-hydroxy-3,3-dimethyl-
acetophenone is commercially available.  Benzylation of this involve the same 
procedure as in the synthesis of 135b.  Oil, 95%.  This compound is known.  GC/MS 
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(EI):  One peak, retention time, 8.38 min (initial temp 50oC, ramp 25oC/min until 
300oC), MS; 254.0 m/z. 
1-(4-(benzyloxy)-3,5-dimethylphenyl)-2-bromoethanone, 138c.  White ppt., ~95%. 
This compound is known.  GC/MS (EI):  One peak, retention time, 9.87 min (initial 
temp 50oC, ramp 25oC/min until 300oC), MS; 331.9, 333.9 m/z. 
2-(4-(benzyloxy)-3,5-dimethylphenyl)-2-oxoethyl-4-(tert-butoxycarbony-lamino)-
butanoate, 138d. Adhesive ppt., 96%; IR (KBr):  3307, 3100-2800, 1742, 1701, 
1659, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667; 1H NMR (400 MHz, d6-
DMSO) δ (ppm), 7.70 (d, J = 8.60, 1H), 7.50-7.40 (m, 5H), 6.89 (t, J = 7.20, 1H), 
5.42 (s, 2H), 4.88 (s, 2H), 2.97 (t, J = 6.90, 2H), 2.43 (t, J = 7.80, 2H), 2.29 (s, 6H), 
1.68 (m, 2H), 1.36 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 191.84, 172.19, 
160.04, 155.60, 137.06, 131.49, 129.59, 128.68, 128.36, 128.13, 127.85, 77.45, 73.52, 
66.20, 38.97, 30.50, 28.18, 24.97, 16.20; HRMS (M + Na):  Calc’d for C26H33NO6Na: 
478.2206;  Found: 478.2191. (M + H):  Calc’d for C26H34NO6: 456.2386.  Found: 
456.2388.  
2-(4-hydroxy-3,5-dimethylphenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino)-
butanoate, 138e.  Adhesive ppt., 99%; IR (KBr):  3548, 3301, 3100-2800, 1739, 
1702, 1661, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667; 1H NMR (400 MHz, 
d6-DMSO) δ (ppm), 9.40 (s, 1H), 7.59 (d, J = 8.60, 2H), 6.89 (t, J = 7.15, 1H), 5.36 
(s, 2H), 2.98 (t, J = 7.00, 2H), 2.55 (t, J = 7.50, 2H), 2.20 (s, 6H), 1.92 (m, 2H); 13C 
NMR (125 MHz, d6-DMSO) δ (ppm), 190.91, 172.20, 159.67, 155.59, 128.60, 
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125.25, 123.74, 77.44, 65.91, 38.96, 30.90, 28.18, 24.98, 16.52; HRMS (M + Na):  
Calc’d for C19H27NO6Na: 388.1736.  Found: 388.1735. 
4-(2-(4-hydroxy-3,5-dimethylphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 138.  White ppt., 92%, Mp: 125-127oC; IR (KBr): 3550, 3301, 
3100-2800, 1739, 1702, 1661, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667; 1H 
NMR (400 MHz, d6-DMSO) δ (ppm), 9.36 (s, 1H), 7.86 (s, 3H), 7.62 (d, J = 8.60, 
2H), 5.36 (s, 2H), 2.98 (t, J = 7.00, 2H), 2.43 (m, 5H), 2.22 (s, 6H), 1.69 (m, 2H), 
1.37 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 189.74, 170.61, 157.71, 
156.71, 127.72, 124.97, 123.15, 116.95, 65.02, 37.10, 28.88, 21.48, 15.55; HRMS 
(M+):  Calc’d for C14H20NO4: 266.1392.  Found: 266.1389. 
1-(4-(benzyloxy)2-methylphenyl)ethanone, 139b. 4-hydroxy-2-methylacetophenone 
is commercially available.  Benzylation of this entailed the same procedure as in the 
synthesis of 135b.  White ppt., 93%,  This compound is known.  GC/MS (EI):  One 
peak, retention time, 8.24 min (initial temp 50oC, ramp 25oC/min until 300oC), MS; 
240.0 m/z. 
1-(4-(benzyloxy)-2-methylphenyl)-2-bromoethanone, 139c.  White ppt., ~92%. 
This compound is known.  GC/MS (EI):  One peak, retention time, 9.77 min (initial 
temp 50oC, ramp 25oC/min until 300oC), MS; 317.9, 319.9 m/z. 
2-(4-(benzyloxy)-2-methylphenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino)-
butanoate, 139d.  Adhesive ppt., 91%; IR (KBr):  3307, 3100-2800, 1742, 1701, 
1659, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667; 1H NMR (400 MHz, d6-
DMSO) δ (ppm), 7.86 (d, J = 9.10, 1H), 7.47-7.40 (m, 5H), 6.97 (t, J = 6.50, 2H), 
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6.87 (t, J = 7.35, 1H), 5.28 (s, 2H), 5.19 (s, 2H), 2.97 (t, J = 6.70, 2H), 2.42 (m, 5H), 
1.68 (m, 2H), 1.37 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 193.63, 172.21, 
161.05, 155.60, 141.48, 136.40, 132.04, 128.47, 127.42, 125.06, 118.30, 111.85, 
107.74, 77.45, 69.30, 67.05, 38.83, 30.68, 28.22, 24.54, 21.11; HRMS (M + Na):  
Calc’d for C25H31NO6Na: 464.2049.  Found: 464.2040. 
2-(4-hydroxy-2-methylphenyl)-2-oxoethyl-4-(tert-butoxycarbonyl-amino)-
butanoate, 139e.  Adhesive ppt., 98%; IR (KBr):  3460, 3300, 3100-2800, 1740, 
1699, 1662, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667; 1H NMR (400 MHz, 
d6-DMSO) δ (ppm), 10.30 (d, 1H), 7.78 (d, J = 9.10, 1H), 6.89 (t, J = 7.50, 1H), 6.71 
(t, J = 6.30, 1H), 5.26 (s, 2H), 2.98 (t, J = 6.70, 2H), 2.41 (m, 5H), 1.69 (m, 2H), 1.39 
(s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 192.91, 172.21, 160.96, 155.60, 
141.83, 131.87, 125.29, 118.74, 112.51, 77.45, 66.86, 38.97, 30.46, 28.22, 24.95, 
21.68; HRMS (M + Na):  Calc’d for C18H25NO6Na: 374.1580.  Found: 374.1577. 
4-(2-(4-hydroxy-2-methylphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 139.  White ppt., 95%, Mp: 110-112oC; IR (KBr):  3460, 3300, 
3100-2800, 1740, 1699, 1662, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667; 1H 
NMR (400 MHz, d6-DMSO) δ (ppm), 7.86 (s, 3H), 7.80 (d, J = 9.00, 1H), 6.74 (t, J = 
6.20, 1H), 5.28 (s, 2H), 2.96 (t, J = 6.70, 2H), 2.54 (t, J = 7.60, 2H), 2.40 (s, 3H), 1.87 
(m, 2H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 192.71, 171.72, 161.19, 158.64, 
141.88, 131.90, 124.55, 118.81, 117.56, 112.58, 67.02, 37.84, 30.14, 22.54, 20.34; 
HRMS (M +):  Calc’d for C13H18NO4: 252.1236.  Found: 252.1227. 
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2-(4-(benzyloxy)phenyl)-2-oxoethyl propionate, 140b.  2-(4-(benzyloxy)phenyl)-2-
oxoethyl propionate is commercially available.  Benzylation of this involved the same 
procedure as in the synthesis of 135b.  This compound in known.  97%, GC/MS (EI):  
One peak, retention time, 7.63 min (initial temp 50oC, ramp 25oC/min until 300oC), 
MS; 262.0 m/z. 
2-(4-(benzyloxy)phenyl)-2-oxoethyl 2-bromopropanoate, 140c (racemic).  ~94%. 
GC/MS (EI):  One peak, retention time, 8.10 min (initial temp 50oC, ramp 25oC/min 
until 300oC), MS; 317.0, 319.0, m/z. 
(S)-tert-butyl 5-(4-(benzyloxy)phenyl)-4-methyl-5-oxopentylcarbamate and (R)-
tert-butyl-5-(4-(benzyloxy)phenyl)-4-methyl-5-oxopentylcarbamate, (R,S)-140d.  
Adhesive ppt., 95%; IR (KBr):  3307, 3100-2800, 1742, 1701, 1659, 1606, 1437, 
1407, 1209, 1167, 955, 743, 700, 667; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 7.98 
(d, J = 8.89, 2H), 7.40 (m, 5H), 7.14 (d, J = 9.03, 2H), 6.87 (t, J = 7.35, 1H), 5.95 (m, 
1H), 5.21 (s, 2H), 2.93 (t, J = 7.00, 2H), 2.37 (t, J = 7.51, 2H), 1.63 (m, 2H), 1.39 (s, 
9H), 1.17 (d, J = 7.20, 3H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 194.93, 172.10, 
162.61, 155.61, 136.31, 130.67, 128.48, 128.03, 127.53, 126.38, 114.93, 77.47, 69.89, 
63.47, 36.16, 30.12, 28.18, 20.70, 17.08; HRMS (M + Na):  Calc’d for C25H31NO6Na: 
464.2049.  Found: 464.2049. 
(S)-tert-butyl-5-(4-hydroxyphenyl)-4-methyl-5-oxopentylcarbamate and (R)-tert-
butyl-5-(4-hydroxyphenyl)-4-methyl-5-oxopentylcarbamate, (R,S)-140e.  
Adhesive ppt., 92%; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 7.87 (d, J = 9.05, 2H), 
6.88 (m, 3H), 5.90 (m, 1H), 2.94 (t, J = 6.86, 2H), 2.34 (t, J = 7.72, 2H), 2.24 (s, 3H), 
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1.63 (m, 2H), 1.39 (s, 9H), 1.18 (d, J = 6.88, 3H); 13C NMR (125 MHz, d6-DMSO) δ 
(ppm), 195.55, 173.02, 163.50, 157.24, 132.90, 128.93, 115.54, 78.43, 71.95, 40.00, 
31.57, 29.14, 25.82, 16.81; HRMS (M + Na):  Calc’d for C18H25NO6Na: 374.1567.  
Found: 374.1567. 
(R)-4-(1-(4-hydroxyphenyl)-1-oxopropan-2-yloxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate and (S)-4-(1-(4-hydroxyphenyl)-1-oxopropan-2-yloxy)-4-
oxobutan-1-aminium-2,2,2-trifluoroacetate, (R,S)-140. Adhesive ppt., 83%; IR 
(KBr):  3448, 3274, 3100-2800, 1739, 1691, 1602, 1520, 1421, 1377, 1309, 1298, 
1201, 1178, 1128, 1055, 1027, 1008, 823, 762, 717, 613 cm-1; 1H NMR (400 MHz, 
D2O) δ (ppm), 7.99 (J = 8.69, 2H), 7.00 (d, J = 8.10, 2H), 6.06 (m, 1H), 3.06 (J = 
7.10, 2H), 2.64 (t, J = 7.70, 2H), 2.00 (m, 2H), 1.54 (d, J = 7.05, 3H); 13C NMR (125 
MHz, d6-DMSO) δ (ppm), 190.67, 171.72, 160.98, 158.27, 130.76, 127.76, 125.10, 
120.30, 117.94, 114.76, 66.11, 38.09, 30.15, 22.10, 15.80; HRMS (M +):  Calc’d for 
C13H18NO4:  252.1230.  Found: 252.1236. 
1-(4-(benzyloxy)phenyl)butan-1-one, 141b.  1-(4-(benzyloxy)phenyl)butan-1-one is 
commercially available.  Benzylation of this involved the same procedure as in the 
synthesis of 122b.  This compound is known. White ppt., 97%. 1H NMR (400 MHz, 
CDCl3) δ (ppm), 7.96 (d, J = 8.64, 2H), 7.40 (m, 5H), 7.02 (d, J = 8.50, 2H), 5.14 (s, 
2H), 2.90 (t, J = 7.43, 2H), 1.76 (m, 2H), 1.01 (t, J = 6.73, 3H). 
1-(4-(benzyloxy)phenyl)-3-bromobutan-1-one, 141c. Racemic, 88%; GC/MS (EI):  
One peak, retention time, 9.58 min (initial temp 50oC, ramp 25oC/min until 300oC), 
MS; 331.8, 333.9 m/z.  
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(R)-tert-butyl 4-(4-(benzyloxy)benzoyl)hexylcarbamate and (S)-tert-butyl 4-(4-
(benzyloxy)benzoyl)hexylcarbamate (R,S)-141d.  Adhesive ppt., 89%; IR (KBr):  
3307, 3100-2800, 1742, 1701, 1659, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 
667; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 7.99 (d, J = 8.62, 2H), 7.39 (m, 5H), 
7.13 (d, J = 8.88, 2H), 6.87 (t, J = 7.21, 1H), 5.88 (m, 1H), 5.22 (s, 2H), 2.94 (t, J = 
6.88, 2H), 2.39 (t, J = 7.51, 2H), 1.70-1.60 (m, 4H), 1.37 (s, 9H), 0.94 (t, J = 7.05, 
3H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 194.42, 172.51, 162.60, 155.58, 
136.23, 130.63, 128.49, 128.03, 127.85, 127.10, 115.45, 77.77, 75.64, 70.45, 39.14, 
30.77, 28.21, 24.91, 20.73, 9.49; HRMS (M + Na):  Calc’d for C26H33NO6Na: 
478.2206.  Found: 464.2189. 
(R)-tert-butyl 4-(4-hydroxybenzoyl)hexylcarbamate and (S)-tert-butyl 4-(4-
hydroxybenzoyl)hexylcarbamate, (R,S)-141e.  Adhesive ppt., 98%;  1H NMR (400 
MHz, d6-DMSO) δ (ppm), 10.66 (s, 1H), 7.89 (d, J = 8.75, 2H), 6.88 (m, 3H), 5.80 
(m, 1H), 2.94 (t, J = 6.95, 2H), 2.37 (t, J = 7.33, 2H), 1.70-1.60 (m, 4H), 1.38 (s, 9H), 
0.94 (t, J = 6.85, 3H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 194.04, 172.26, 
162.52, 155.58, 130.86, 125.29, 115.45, 77.59, 75.59, 39.13, 30.95, 28.35, 24.92, 
21.02, 9.54; HRMS (M + Na):  Calc’d for C17H27NO6Na: 388.1736.  Found: 
388.1721. 
(R)-4-(1-(4-hydroxyphenyl)-1-oxopropan-2-yloxy)-4-oxobutan-1-aminium 2,2,2-
trifluoroacetate and (S)-4-(1-(4-hydroxyphenyl)-1-oxopropan-2-yloxy)-4-
oxobutan-1-aminium 2,2,2-trifluoroacetate, (R,S)-141.  Adhesive ppt., 80%; IR 
(KBr):  3450, 3274, 3100-2800, 1739, 1691, 1602, 1520, 1421, 1377, 1309, 1298, 
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1201, 1178, 1128, 1055, 1027, 1008, 823, 762, 717, 613. cm-1; 1H NMR (400 MHz, 
d6-DMSO) δ (ppm), 7.88 (J = 8.23, 2H), 6.88 (d, J = 7.75, 2H), 5.83 (m, 1H), 2.85 (J 
= 7.01, 2H), 2.40 (t, J = 7.62, 2H), 1.82-1.68 (m, 4H), 0.91 (d, J = 6.82, 3H); 13C 
NMR (125 MHz, d6-DMSO) δ (ppm), 193.38, 171.76, 162.69, 158.41, 130.87, 
125.42, 117.47, 115.50, 75.82, 38.08, 30.17, 24.57, 22.55, 9.48; HRMS (M+):  Calc’d 
for C14H20NO4:  266.1392.  Found: 266.1389. 
2-bromo-1-(4-fluorophenyl)ethanone, 142b.  4-fluoroacetophenone is commercially 
available.  The same conditions were used as in the synthesis of 141c.  This 
compound is known.  Oil, ~95% yield by GC/MS (EI):  One peak, retention time, 
4.79 min (initial temp 50oC, ramp 25oC/min until 300oC), MS; 215.9, 217.9 m/z. 
2-(4-fluorophenyl)-2-oxoethyl 4-(tert-butoxycarbonylamino)butanoate, 142c.  
The same general procedure to make 122e was followed. White ppt., 82%, Mp:  85-
87oC; IR (KBr):  3307, 3100-2800, 1742, 1701, 1659, 1606, 1437, 1407, 1209, 1167, 
955, 743, 700, 667; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 8.04 (m, 2H), 7.39 (t, J 
= 8.80, 2H), 6.87 (t, J = 7.40, 1H), 5.46 (s, 2H), 2.96 (dd, J = 6.82, J = 6.65,  2H), 
2.42 (t, J = 7.94, 2H), 1.68 (m, 2H), 1.38 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ 
(ppm), 191.51, 172.19, 166.35, 164.34, 155.60, 130.63, 116.09, 77.46, 66.26, 39.14, 
30.62, 28.22, 24.95; HRMS (M + Na):  Calc’d for C17H22FNO5Na: 362.1380.  Found: 
362.1377 
 4-(2-(4-fluorophenyl)-2-oxoethoxy)-4-oxobutan-1-aminium 2,2,2-trifluoroacetate 
142.  The same general method to make 130 was followed.  Adhesive ppt., 93%;  IR 
(KBr):  3460, 3307, 3100-2800, 1742, 1701, 1659, 1606, 1437, 1407, 1209, 1167, 
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955, 743, 700, 667. 1H NMR (400 MHz, D2O) δ (ppm), 8.06 (m, 2H), 7.32 (t, J = 
8.80, 2H), 5.56 (s, 2H), 3.12 (dd, J = 6.82, J = 6.65, 2H), 2.72 (t, J = 7.94, 2H), 2.06 
(m, 2H); 19F NMR (376 MHz, D2O) δ (ppm), -104.12.  13C NMR (125 MHz, d6-
DMSO) δ (ppm), 191.46, 171.72, 166.40, 164.39, 158.67, 130.91, 116.12; HRMS 
(M+): Calc’d for C12H15FNO3: 240.1030.  Found: 240.0998. 
5-(2-(4-(benzyloxy)-2-fluorophenyl)-2-oxoethyl)-1-tert-butyl-2-(tert-butoxy-
carbonylamino)pentanedioate, 143e.  The series to construct 143e paralleled those 
for 122e.  Adhesive ppt., 91%; IR (KBr):  3307, 3100-2800, 1742, 1701, 1659, 1606, 
1437, 1407, 1209, 1167, 955, 743, 700, 667;  1H NMR (400 MHz, d6-DMSO) δ 
(ppm), 7.85 (t, J = 8.88, 1H), 7.40 (m, 5H), 7.22 (d, J = 7.64, 1H), 7.10 (d, J = 10.50, 
1H), 7.01 (d, J = 6.61, 1H), 5.24 (s, 2H), 5.22 (s, 2H), 3.89 (m, 1H), 2.45 (t, J = 6.69, 
2H), 1.99 (m, 1H), 1.89 (m, 1H), 1.39 (s, 18H);  13C NMR (125 MHz, d6-DMSO) δ 
(ppm), 198.83, 171.32, 170.32, 164.28, 162.14, 154.64, 135.99, 131.42, 128.63, 
127.95, 115.84, 112.37, 111.80, 102.83, 80.42, 78.11, 70.18, 68.41, 59.74, 30.73, 
29.76, 28.15, 25.91; HRMS (M + Na):  Calc’d for C29H36FNO8Na: 568.2323.  Found: 
568.2296. 
1-tert-butyl-5-(2-(2-fluoro-4-hydroxyphenyl)-2-oxoethyl)-2-(tert-butoxycarbonyl-
amino)pentanedioate, 143e’.  An identical procedure was followed to compose 
130e’.  Adhesive ppt., 94%; IR (KBr):  3460, 3100-2800, 1742, 1701, 1659, 1606, 
1437, 1407, 1209, 1167, 955, 743, 700, 667;  1H NMR (400 MHz, MeOD) δ (ppm), δ 
7.86 (t, J = 8.24, 1H), 6.90 (t, J = 6.55, 1H), 6.73 (d, J = 7.70, 1H), 6.64 (d, J = 9.10, 
1H), 5.24 (s, 2H), 3.99 (m, 1H), 2.56 (t, J = 7.05, 2H), 2.10 (m, 1H), 1.97 (m, 1H), 
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1.51 (s, 18H);  13C NMR (125 MHz, MeOD) δ (ppm), 189.27, 172.44, 171.59, 
165.31, 163.29, 158.70, 131.71, 115.88, 113.74, 102.51, 81.28, 79.14, 68.50, 54.80, 
47.10, 29.73, 27.33, 26.47; HRMS (M + Na):  Calc’d for C22H31FNO8: 456.2034.  
Found: 456.2034.  Calc’d for C22H30FNO8Na: 478.1853.  Found: 478.1866. 
1-carboxy-4-(2-(2-fluoro-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium 
2,2,2-trifluoroacetate, 143.  The same procedure was used as in the synthesis of 130.  
Adhesive ppt., 68%; IR (KBr):  3460, 3274, 3100-2800, 1739, 1691, 1602, 1520, 
1421, 1377, 1309, 1298, 1201, 1178, 1128, 1055, 1027, 1008, 823, 762, 717, 613 cm-
1; 1H NMR (400 MHz, MeOD) δ (ppm), δ 7.84 (t, J = 8.20, 1H), 6.75 (d, J = 7.52, 
1H), 6.62 (d, J = 9.22, 1H), 5.22 (s, 2H), 3.96 (m, 1H), 2.53 (t, J = 6.92, 2H), 2.09 (m, 
1H), 1.97 (m, 1H);  13C NMR (125 MHz, MeOD) δ (ppm), 189.55, 172.46, 169.99, 
163.47, 161.33, 130.12, 117.24, 115.37, 114.10, 112.03, 103.37, 68.81, 54.27, 29.33, 
26.48; HRMS (M+):  Calc’d for C13H15FNO6: 300.0878. Found 300.0859. 
The same sequence of steps was followed to generate 144 and 145. 
5-(2-(4-(benzyloxy)-3-fluorophenyl)-2-oxoethyl)-1-tert-butyl-2-(tert-butoxy-
carbonylamino)pentanedioate, 144e.    Adhesive ppt., 82%; IR (KBr):  3307, 3100-
2800, 1742, 1701, 1659, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667;  1H NMR 
(400 MHz, CD3OD) δ (ppm), δ 7.82 (t, J = 8.85, 1H), 7.44 (m, 6H), 7.21 (d, J = 
12.02, 1H), 5.43 (s, 2H), 5.31 (d, 2H), 3.89 (m, 1H), 2.49 (t, J = 6.88, 2H), 1.99 (m, 
1H), 1.89 (m, 1H), 1.39 (s, 18H);  13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.58, 
171.74, 170.32, 155.53, 152.29, 150.89, 150.34, 135.82, 128.56, 127.93, 126.91, 
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125.61, 115.29, 114.83, 80.42, 78.11, 70.36, 66.23, 53.45, 29.75, 27.90, 27.60, 25.92; 
HRMS (M + Na):  Calc’d for C29H36FNO8Na: 568.2323.  Found: 568.2275. 
1-tert-butyl-5-(2-(3-fluoro-4-hydroxyphenyl)-2-oxoethyl)-2-(tert-butoxy-
carbonylamino)pentanedioate, 144e’. Adhesive ppt., 94%; IR (KBr):  3460, 3100-
2800, 1742, 1701, 1659, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667;  1H NMR 
(400 MHz, d6-DMSO) δ (ppm), δ 7.72 (t, J = 8.52, 1H), 7.67 (d, J = 8.63, 1H), 7.22 
(d, J = 7.64, 1H), 7.05 (t, J = 8.14, 1H), 5.39 (s, 2H), 3.82 (m, 1H), 2.48 (t, J = 6.88, 
2H), 1.95 (m, 1H), 1.82 (m, 1H), 1.40 (s, 18H);  13C NMR (125 MHz, d6-DMSO) δ 
(ppm), 190.30, 171.74, 171.33, 155.53, 151.56, 150.50, 148.63, 125.62, 117.23, 
115.70, 80.41, 78.10, 66.11, 54.37, 29.70, 28.15, 27.90, 25.79; HRMS (M + Na):  
Calc’d for C22H31FNO8: 456.2034.  Found: 456.2034.  Calc’d for C22H30FNO8Na: 
478.1853.  Found: 478.1815. 
1-carboxy-4-(2-(3-fluoro-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium 
2,2,2-trifluoroacetate, 144.  Adhesive ppt., 84%;  IR (KBr): 3455, 3269, 3100-2800, 
1741, 1693, 1610, 1553, 1420, 1201, 1050, 823, 759, 719 cm–1; 1H NMR (400 MHz, 
D2O) δ (ppm), 7.72 (d, J = 8.98, 2H), 7.08 (t, J = 9.52, 1H), 5.41 (s, 2H), 4.57 (t, J = 
7.42, 1H), 2.65 (t, J = 7.14, 2H), 2.34 (m, 1H), 2.12 (m, 1H); 13C NMR (125 MHz, 
D2O) δ (ppm), 190.12, 172.06, 170.06, 161.44, 152.57, 150.54, 131.17, 126.14, 
119.58, 117.22, 115.40, 67.74, 53.99, 30.02, 23.51; HRMS (M+): Calc’d for 
C13H15FNO6: 300.0878. Found 300.0892. 
5-(2-(4-(benzyloxy)-3-(trifluoromethyl)phenyl)-2-oxoethyl)-1-tert-butyl-2-(tert-
butoxycarbonylamino)pentanedioate, 145e.  This was synthesized in the same 
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manner as 143e by a laboratory associate.  However, no characterization was done 
preceding the next synthetic step. 
1-tert-butyl-5-(2-(4-hydroxy-3-(trifluoromethyl)phenyl)-2-oxoethyl)-2-(tert-
butoxycarbonylamino)pentanedioate, 145e’.  Adhesive ppt., 91%; 1H NMR (400 
MHz, d6-DMSO) δ (ppm), 11.73 (s, 1H), 8.08 (s, 1H), 8.06 (s, 1H), 7.21 (d, J = 7.52, 
1H), 7.13 (d, J = 9.50), 5.55 (s, 2H), 3.91 (dd, J = 8.40, J = 5.80, 1H), 2.49 (t, J = 
9.05, 2H), 1.94, (m, 2H), 1.82 (m, 1H), 1.40 (s, 9H), 1.36 (s, 9H). 
1-carboxy-4-(2-(4-hydroxy-3-(trifluoromethyl)phenyl)-2-oxoethoxy)-4-oxobutan-
1-aminium 2,2,2-trifluoroacetate, 145.  White ppt., 55%, Mp: 59-61oC;  IR (KBr):  
3405, 3310, 3100-2800, 1735, 1710, 1690, 1595, 1520, 1430, 1370, 1248, 1200, 
1165, 1050, 818, 760, 710 cm-1; 1H NMR (400 MHz, MeOD) δ (ppm), 8.13 (d, J = 
1.50, 1H), 8.06 (dd, J = 8.70, J = 2.10, 1H), 7.06 (d, J = 8.50, 1H), 5.41 (s, 2H), 4.55 
(d, J = 9.10, 1H), 2.61 (t, J = 7.70, 2H), 2.36, (m, 1H), 2.12 (m, 1H); 13C NMR (125 
MHz, MeOD) δ (ppm), 192.31, 173.69, 162.42, 159.48, 159.19, 134.81, 128.68, 
126.79, 123.89, 118.70, 118.07, 116.42, 67.78, 53.46, 31.21, 27.19; HRMS (M+):  
Calc’d for C14H15F3NO6: 350.0851.  Found 350.0863. 
1-(4-(benzyloxy)phenyl)ethanone, 146b.  The same procedure to construct 135b 
was utilized but only one equivalent of benzyl bromide was required.  White ppt, 
96%.  This compound is known. GC/MS (EI):  One peak, retention time, 7.43 min 
(initial temp 50oC, ramp 25oC/min until 300oC), MS; 226.09 m/z. 
1-(4-(benzyloxy)phenyl)-2-bromoethanone, 146c.  The same method to generate 
135c was used.  Oil, ~94%.  This compound is known. GC/MS (EI):  One peak, 
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retention time, 8.22 min (initial temp 50oC, ramp 25oC/min until 300oC), MS; 304.01, 
306.01 m/z. 
2-(4-(benzyloxy)phenyl)-2-oxoethyl-2-(tert-butoxycarbonylamino)acetate, 146d. 
The same general method to produce 135d was used but with N-Boc-Gly. White ppt., 
95%, Mp: 100-102oC; IR (KBr):  3307, 3100-2800, 1742, 1701, 1659, 1606, 1437, 
1407, 1209, 1167, 955, 743, 700, 667; 1H NMR (400 MHz, CDCl3) δ (ppm), 7.90 (d, 
J = 8.49, 2H), 7.41 (m, 5H), 7.05 (d, J = 8.82, 2H), 5.37 (s, 2H), 5.15 (s, 2H), 5.04 (s, 
1H), 4.12 (d, J = 7.02, 2H), 1.45 (s, 9H); 13C NMR (125 MHz, CDCl3) δ (ppm), 
189.94, 170.09, 163.32, 155.72, 135.92, 132.28, 130.12, 128.77, 128.04, 127.15, 
114.99, 80.10, 70.25, 66.30, 42.31, 28.33; HRMS (M + Na):  Calc’d for 
C22H25NO6Na: 422.1580.  Found: 422.1559. 
2-(4-hydroxyphenyl)-2-oxoethyl 2-(tert-butoxycarbonylamino)acetate, 146e. The 
same general method to produce 135e was used. White ppt., 94%, Mp: 125-127 oC;  
1H NMR (400 MHz, d6-DMSO) δ (ppm), 10.48 (s, 1H), 7.85 (d, J = 8.66, 2H), 7.27 
(t, J = 5.63, 1H), 6.88 (d, J = 8.23, 2H), 5.42 (s, 2H), 3.82 (d, J = 6.95, 2H), 1.38 (s, 
9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.36, 170.15, 162.87, 155.75, 
130.55, 125.32, 115.41, 78.48, 66.25, 41.58, 28.04; HRMS (M + Na):  Calc’d for 
C15H19NO6Na: 332.1110.  Found: 332.1101. 
2-(2-(4-hydroxyphenyl)-2-oxoethoxy)-2-oxoethanaminium-2,2,2-trifluoroacetate, 
146.  The same general method to produce 135 was followed.  Adhesive ppt, 79%; IR 
(KBr):  3405, 3310, 3100-2800, 1735, 1710, 1690, 1595, 1520, 1430, 1370, 1248, 
1200, 1165, 1050, 818, 760, 710 cm-1; 1H NMR (400 MHz, MeOD) δ (ppm), 7.88 (d, 
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J = 8.42, 2H), 6.88 (d, J = 8.06, 2H), 5.57 (s,1H), 5.47 (s, 1H), 4.24 (s, 1H), 4.04 (s, 
1H); 13C NMR (125 MHz, MeOD) δ (ppm), 191.21, 168.34, 167.11, 163.54, 130.40, 
125.88, 117.38, 115.41, 66.63, 40.52; HRMS (M+):  Calc’d for C10H12NO4: 
210.0766.  Found: 210.0764. 
The same succession of steps was followed to produce 147-149.  The amino acids all 
were N-Boc protected. 
2-(4-(benzyloxy)phenyl)-2-oxoethyl-2-(tert-butoxycarbonylamino)-3-methyl-
butanoate, 147d.  White ppt., 95%, Mp: 119-120oC; IR (KBr):  3307, 3100-2800, 
1742, 1701, 1659, 1606, 1437, 1407, 1209, 1167, 955, 743, 700, 667; 1H NMR (400 
MHz, d6- DMSO) δ (ppm), 7.96 (d, J = 8.60, 2H), 7.40 (m, 5H), 7.13 (m, 3H), 5.49 
(d, J = 8.24, 1H), 5.42 (d, J =8.20, 1H),  5.15 (s, 2H), 4.05 (t, J = 6.75, 1H), 2.14 (m, 
1H), 1.39 (s, 9H), 0.97 (d, J = 7.05, 6H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 
190.88, 171.51, 162.60, 155.73, 136.37, 130.15, 128.89, 128.03, 127.79, 126.89, 
114.97, 78.19, 69.53, 66.34, 59.07, 29.78, 27.91, 19.03; HRMS (M + Na):  Calc’d for 
C25H31NO6Na: 464.2049.  Found: 464.2061. 
2-(4-hydroxyphenyl)-2-oxoethyl-2-(tert-butoxycarbonylamino)-3-methyl-
butanoate, 147e.  Adhesive ppt., 75%;  1H NMR (400 MHz, MeOD) δ (ppm), 7.90 
(d, J = 8.75, 2H), 6.88 (m, 3H), 5.50 (d, J = 8.22, 1H), 5.46 (d, J = 8.15, 1H), 4.22 (t, 
J = 6.85, 1H), 2.25 (m, 1H), 1.48 (s, 9H), 1.05 (d, J = 7.10, 6H); 13C NMR (125 MHz, 
MeOD) δ (ppm), 191.03, 171.84, 163.00, 156.88, 130.73, 125.81, 114.80, 79.19, 
66.02, 59.08, 30.58, 27.17, 18.26; HRMS (M + Na):  Calc’d for C18H25NO6Na: 
374.1580.  Found: 374.1592. 
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1-(2-(4-hydroxyphenyl)-2-oxoethoxy)-3-methyl-1-oxobutan-2-aminium-2,2,2-
trifluoroacetate, 147.  Adhesive ppt, 72%; IR (KBr):  3405, 3310, 3100-2800, 1735, 
1710, 1690, 1595, 1520, 1430, 1370, 1248, 1200, 1165, 1050, 818, 760, 710 cm-1; 1H 
NMR (400 MHz, MeOD) δ (ppm), 7.86 (d, J = 8.29, 2H), 6.88 (d, J = 8.02, 2H), 5.59 
(d, J = 8.22, 1H), 5.42 (d, J = 8.15, 1H), 4.09 (t, J = 6.72, 1H), 2.49 (m, 1H), 1.06 (d, 
J = 7.15, 6H); 13C NMR (125 MHz, MeOD) δ (ppm), 188.64, 167.78, 161.50, 158.73, 
129.15, 123.81, 115.85, 113.58, 65.78, 61.36, 27.84, 16.29; HRMS (M+):  Calc’d for 
C13H18NO4: 252.1230.  Found: 252.1222. 
1-(2-(4-hydroxyphenyl)-2-oxoethoxy)-3-(1H-indol-3-yl)-1-oxopropan-2-aminium 
2,2,2-trifluoroacetate, 148.  The precursor, 148e, was obtained from an associate, 
without characterization.  White ppt., 92%, Mp:  75-77oC;  IR (KBr):  3405, 3310, 
3100-2800, 1735, 1710, 1690, 1595, 1520, 1430, 1370, 1248, 1200, 1165, 1050, 818, 
760, 710 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 11.11 (s, 1H), 10.70, (s, 1H), 
8.46, (s, 3H), 7.87 (d, J = 12.1, 2H), 7.60 (d, J = 8.10, 1H), 7.41, (d, J = 8.04, 1H), 
7.33 (d, J = 4.23, 1H), 7.10 (t, J = 7.95,  J = 1H), 7.05 (t, J = 7.85, 1H), 6.92 (d, J = 
8.20, 2H), 5.61 (dd, J = 16.30, J = 12.20, 2H), 4.45 (t, J = 7.05, 1H), 3.32 (m, 2H); 
13C NMR (125 MHz, d6-DMSO) δ (ppm), 189.81, 169.06, 162.96, 158.82, 136.25, 
130.50, 128.10, 126.90, 125.12, 125.01, 121.20, 118.89, 117.96, 115.52, 111.57, 
106.37, 67.29, 52.53, 26.36; HRMS (M+):  Calc’d for C19H19N2O4: 339.1345.  
Found: 339.1345. 
1-(2-(4-hydroxyphenyl)-2-oxoethoxy)-1-oxo-3-phenylpropan-2-aminium-2,2,2-
trifluoroacetate, 149.  The precursor, 149e, was obtained from an associate, without 
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characterization. White ppt., 74%, Mp: 64-66oC;  IR (KBr):  3405, 3310, 3100-2800, 
1735, 1710, 1690, 1595, 1520, 1430, 1370, 1248, 1200, 1165, 1050, 818, 760, 710 
cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 10.86, (s, 1H), 8.58, (s, 3H), 7.87 (d, J 
= 8.04, 2H), 7.31 (m, 5H), 6.92 (d, J = 8.15, 2H), 5.61 (dd, J = 16.15, J = 4.00, 2H), 
4.45 (t, J = 4.20, 1H), 3.30 (dd, J = 15.88, J = 8.03, 1H), 3.18 (dd, J = 12.10, J = 4.05, 
1H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 189.73, 168.75, 163.00, 158.66, 
134.66, 130.50, 129.55, 128.60, 127.26, 124.95, 117.95, 115.51, 67.27, 53.01, 36.03; 
HRMS (M+):  Calc’d for C17H18NO4: 300.1230.  Found: 300.1244. 
 (4R)-2-(4-(benzyloxy)phenyl)-2-oxoethyl-4-((3R,5R,8R,10S,12S,13R,17R)-3,12-
dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-
yl)pentanoate, 150d.  The reaction was patterned after the one to synthesize 146d but 
used DMF instead of CH3CN as the solvent.  White ppt., 84%, Mp: 77-79oC; 1H 
NMR (400 MHz, CDCl3) δ (ppm), 7.90 (d, J = 8.47, 2H), 7.40 (m, 5H), 7.01 (d, J = 
9.00, 2H), 5.28 (s, 2H), 5.14 (s, 2H),  3.99 (s, 1H), 3.67 (s, 1H),  2.56 (m, 1H), 2.46 
(m, 1H), 2.00-1.00 (m, 26 H), 1.01 (s, 3H), 0.91 (s, 3H), 067 (s, 3H); 13C NMR (125 
MHz, d6-DMSO) δ (ppm), 197.78, 173.72, 163.16, 135.98, 130.11, 128.75, 128.34, 
127.51, 127.48, 114.89, 73.18, 71.88, 70.21, 65.89, 65.62, 53.46, 48.28, 47.37, 46.54, 
42.10, 36.46, 36.31, 36.06, 35.23, 35.05, 34.14, 33.69, 30.92, 30.82, 30.54, 28.66, 
27.44, 26.14, 23.66, 23.19, 17.39, 17.29, 15.30, 12.79. 
(4R)-2-(4-hydroxyphenyl)-2-oxoethyl-4-((3R,5R,8R,10S,12S,13R,17R)-3,12-
dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-
yl)pentanoate, 150. The same method to produce 130e’ was used. White ppt., 93%, 
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Mp: 97-99oC;  1H NMR (400 MHz, d6-DMSO) δ (ppm), 7.84 (d, J = 8.42, 2H), 6.88 
(d, J = 8.95, 2H), 5.35 (s, 2H),  4.21, (s, 1H), 3.81, (s, 1H), 2.52 (m, 1H), 2.40 (m, 
1H), 2.00-1.00 (m, 26 H), 0.96 (s, 3H), 0.85 (s, 3H), 0.62 (s, 3H); 13C NMR (125 
MHz, d6-DMSO) δ (ppm), 190.91, 173.97, 160.98, 130.46, 127.41, 115.72, 73.29, 
71.98, 65.90, 65.65, 60.46, 53.45, 48.29, 47.10, 42.08, 36.37, 36.02, 35.20, 34.13, 
33.70, 30.73, 30.43, 28.61, 27.45, 26.12, 23.65, 23.17, 21.10, 17.37, 15.29, 14.22, 
12.75;  HRMS (M + H):  Calc’d for C32H47O6: 527.3373.  Found: 527.3397. (M + 
Na):  Calc’d for C32H46O6Na: 549.3192.  Found: 549.3191. (M + NH4):  Calc’d for 
C32H50O6N: 544.3639.  Found: 544.3634.   
diethyl 2-(4-(benzyloxy)phenyl)-2-oxoethylphosphonate, 151d.  The general 
method of De Borggraeve147 was utilized.  An Argon purged solution of 1-(4-
(benzyloxy)phenyl)-2-bromoethanone (146d, 2.44 g (7.99 mmol)) in 10 ml of neat 
triethylphosphite was heated to 100oC, where it was maintained with stirring and 
under Argon for 17h.  After cooling to room temperature, most of the surfeit 
CH3CN/Triethylphosphite was removed under reduced pressure.  The mixture was 
then flash chromatographed on silica with gradients of ethyl acetate/hexanes 
mixtures, until 151d eluted at 100% ethyl acetate.  After 1 day of vacuum, viscous oil 
was observed, 2.48 g (86%).  This compound is known.  1H NMR (400 MHz, d6- 
DMSO) δ (ppm), 8.00 (d, J = 9.25, 2H), 7.40 (m, 5H), 7.13 (d, J = 9.56, 2H), 5.22 (s, 
2H), 4.00 (m, 4H), 1.24 (t, J = 8.33, 6H). 
diethyl 2-(4-hydroxyphenyl)-2-oxoethylphosphonate, 151.  The same general 
method to produce 130e’ was used.  White ppt., 96%, Mp: 108-110oC; IR (KBr):  
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3460, 3310, 3100-2800, 1735, 1710, 1690, 1595, 1520, 1430, 1370, 1248, 1200, 
1165, 1050, 818, 760, 710 cm-1; 1H NMR (400 MHz, d6- DMSO) δ (ppm), 10.45 (s, 
1H), 7.89 (d, J = 9.31, 2H), 6.85 (d, J = 9.40, 2H), 5.09 (s, 2H), 4.00 (m, 4H), 1.24 (t, 
J = 8.47, 6H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.28, 162.46, 131.89, 
127.80, 115.07, 60.88, 37.66, 16.10; HRMS (M + Na):  Calc’d for C12H17PO5Na: 
295.0711;  Found: 295.0698; (M + H): Calc’d for C12H18PO5: 273.0892.  Found: 
273.0877. 
1-(4-(benzyloxy)phenyl)-2-fluoroethanone, 152d.  To a solution of 1-(4-
(benzyloxy)phenyl)-2-bromoethanone (analog of 146d, 820 mg (2.69 mmol)) in 100 
ml CH3CN was added cesium fluoride (1.63 g, 10.7 mmol).  The heterogenous 
mixture was refluxed for 1.5 h at which time the reaction was deemed complete as 
indicated by GC/MS.  Excess CH3CN was removed under reduced pressure, equal 
volumes of EtOAc/H2O added (50 ml), the organic phase retained and flash 
chromatographed on silica gel (1:1 Et2O, Hex), affording 590 mg of 152d as a white 
ppt,  90%,  Mp:  106-108oC; IR (KBr):  3460, 3310, 3100-2800, 1735, 1710, 1690, 
1595, 1520, 1430, 1370, 1248, 1200, 1165, 1050, 818, 760, 710 cm-1;  1H NMR (400 
MHz, CDCl3) δ (ppm), 7.98 (d, J = 8.67, 2H), 7.40 (m, 5H), 7.06 (d, J = 9.10, 2H), 
5.54 (s, 1H), 5.43 (s, 1H), 5.16 (s, 2H);  13C NMR (125 MHz, CDCl3) δ (ppm), 
192.01, 163.37, 135.91, 131.58, 130.30, 128.77, 127.50, 126.45, 114.80, 84.22, 
70.24; HRMS (FAB +):  Calc’d for C15H13FO2: 245.0978.  Found: 245.0978. 
2-fluoro-1-(4-hydroxyphenyl)ethanone, 152.  White ppt., 92%.  This compound is 
known.  1H NMR (400 MHz, MeOD) δ (ppm), 7.91 (d, J = 8.50, 2H), 6.91 (d, J = 
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9.15, 2H), 5.72 (s, 1H), 5.61 (s, 1H); HRMS (M - H):  Calc’d for C8H6FO2: 153.0352.  
Found: 153.0326.  (M + Na): Calc’d for C8H7FO2Na: 177.0328.  Found: 177.0327. 
benzyl 5-acetyl-2-(benzyloxy)benzoate, 153b.  The reaction conditions to produce 
153c were amenable to those to create 135b.  White ppt., 93%, Mp: 98-100 oC; IR 
(KBr):  3325, 3100-2800, 1726, 1697, 1676, 1598, 1500, 1452, 1370, 1269, 1230, 
1176, 1060, 1030, 1008, 821, 757, 721, 698 cm-1; 1H NMR (400 MHz, CDCl3) δ 
(ppm), 8.46 (d, J = 2.10, 1H), 8.08 (dd, J = 9.00, J = 2.34, 1H), 7.44-7.33 (m, 10H), 
7.09 (d, J = 8.85, 2H), 5.38 (s, 2H), 5.25 (s, 2H), 2.58 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ (ppm), 195.42, 165.04, 160.91, 135.11, 134.24, 133.04, 130.28, 129.16, 
128.22, 127.81, 119.35, 117.36, 112.49, 70.08, 68.86, 25.74; HRMS (M + Na):  
Calc’d for C23H20O4Na: 383.1259.  Found:  383.1262. 
benzyl 2-(benzyloxy)-5-(2-bromoacetyl)benzoate, 153c.  The synthetic method to 
generate 122d was followed.  Oil, 95%; IR (KBr):  3325, 3100-2800, 1726, 1697, 
1676, 1598, 1500, 1452, 1370, 1269, 1230, 1176, 1060, 1030, 1008, 821, 757, 721, 
698 cm-1; 1H NMR (400 MHz, CDCl3) δ (ppm), 8.50 (d, J = 2.15, 1H), 8.10 (dd, J = 
9.00, J = 2.40, 1H), 7.44-7.33 (m, 10H), 7.10 (d, J = 8.90, 2H), 5.38 (s, 2H), 5.25 (s, 
2H), 4.41 (s, 2H); 13C NMR (125 MHz, CDCl3) δ (ppm), 189.39, 165.32, 162.18, 
135.68, 135.48, 134.52, 133.49, 128.74, 128.26, 127.11, 126.47, 120.87, 113.44, 
70.86, 67.21, 30.48; HRMS (M + Na):  Calc’d for C23H19BrO4Na: 461.0365.  Found:  
461.0372. 
benzyl-2-(benzyloxy)-5-(2-(4-(tert-butoxycarbonyl-amino)-butanoyloxy)-acetyl)-
benzoate, 153d.  The synthetic mode to engender 122e was utilized.  White ppt., 
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75%, Mp: 75-77oC;  IR (KBr):  3271, 3100-2800, 1733, 1701, 1697, 1600, 1577, 
1500, 1454, 1415, 1365, 1269, 1251, 1215, 1166, 1056, 1028, 1008, 919, 875, 821, 
758, 700 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 8.26 (d, J = 2.44, 1H), 8.12 
(dd, J = 9.00, J = 2.33, 1H), 7.44-7.33 (m, 11H), 6.89 (t, J = 5.51, 2H), 5.45 (s, 2H), 
5.33 (s, 2H), 2.97 (t, J = 7.20, 2H), 2.42 (t, J = 7.00, 2H), 1.68 (m, 2H), 1.38 (s, 9H); 
13C NMR (125 MHz, CDCl3) δ (ppm), 190.85, 172.13, 165.28, 161.01, 155.90, 
135.82, 133.51, 130.81, 128.42, 128.04, 127.89, 127.33, 126.27, 113.95, 77.78, 70.10, 
64.96, 59.73, 39.30, 30.64, 28.22, 25.24; HRMS (M + Na):  Calc’d for C32H35NO8Na: 
584.2260.  Found:  584.2239. 
5-(2-(4-(tert-butoxycarbonylamino)butanoyloxy)acetyl)-2-hydroxybenzoic acid, 
153e.  The reaction conditions to produce 130e’ were abided. Adhesive ppt., 96%;  1H 
NMR (400 MHz, d6-DMSO) δ (ppm), 8.37 (d, J = 2.35, 1H), 8.08 (dd, J = 9.15, J = 
2.30, 1H), 7.10 (d, J = 8.90, 2H) 6.90 (t, J = 5.51, 2H), 5.43 (s, 2H), 2.98 (t, J = 7.15, 
2H), 2.44 (t, J = 7.05, 2H), 1.68 (m, 2H), 1.36 (s, 9H). 
4-(2-(3-carboxy-4-hydroxyphenyl)-2-oxoethoxy)-4-oxobutan-1-aminium-2,2,2-
trifluoroacetate, 153.  The method used to produce 130 was followed.  Adhesive 
ppt., 94%; IR (KBr):  3440, 3274, 3100-2800, 1733, 1741, 1692, 1649, 1631, 1596, 
1500, 1450, 1416, 1299, 1201, 1184, 1124, 1053, 1006, 823, 800, 760, 707, 680 cm-1; 
1H NMR (400 MHz, D2O) δ (ppm), 8.36 (s, 1H), 8.00 (d, J = 8.93, 1H), 7.08 (d, J = 
8.10), 5.46 (s, 2H), 3.12 (t, J = 7.20, 2H), 2.68 (t, J = 7.00, 2H), 2.06 (m, 2H);  13C 
NMR (125 MHz, D2O) δ (ppm), 193.77, 174.11, 171.62, 165.14, 163.06, 134.87, 
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131.89, 119.72, 117.89, 115.09, 113.41, 66.60, 38.55, 30.45, 21.97; HRMS (M+):  
Calc’d for C13H16NO6: 282.0978.  Found:  282.0967. 
4-(2-(4-hydroxy-3-(methoxycarbonyl)phenyl)-2-oxoethoxy)-4-oxobutan-1-
aminium 2,2,2-trifluoroacetate, 154. The precursor, methyl-5-(2-(4-(tert-
butoxycarbonylamino)butanoyloxy)acetyl)-2-hydroxybenzoate, was received from an 
associate.  Adhesive ppt., 79%; IR (KBr):  3440, 3274, 3100-2800, 1733, 1741, 1692, 
1649, 1631, 1596, 1500, 1450, 1416, 1299, 1201, 1184, 1124, 1053, 1006, 823, 800, 
760, 707, 680 cm-1;  1H NMR (400 MHz, D2O) δ (ppm), 8.40 (s, 1H), 8.03 (d, J = 
9.05, 1H), 7.05 (d, J = 8.00, 1H), 5.48 (s, 2H), 3.96 (s, 3H), 3.10 (t, J = 7.15, 2H), 
2.70 (t, J = 7.00, 2H), 2.05 (m, 2H);  13C NMR (125 MHz, D2O) δ (ppm), 193.33, 
174.36, 169.84, 165.22, 162.84, 133.99, 132.18, 121.01, 117.44, 115.87, 113.73, 
66.88, 51.10, 39.02, 29.97; HRMS (M+):  Calc’d for C14H18NO6: 298.1134.  Found:  
298.1123. 
benzyl 2-(benzyloxy)-5-(2-(dodecanoyloxy)acetyl)benzoate, 155d.  The same 
method to produce 153d was used but with dodecanoic acid.  Oil, 79%; IR (KBr):  
3271, 3100-2800, 1733, 1701, 1697, 1600, 1577, 1500, 1454, 1415, 1365, 1269, 
1251, 1215, 1166, 1056, 1028, 1008, 919, 875, 821, 758, 700 cm-1; 1H NMR (400 
MHz, d6-DMSO) δ (ppm), 8.26 (d, J = 2.30, 1H), 8.14 (dd, J = 8.85, J = 2.25, 1H), 
7.44-7.33 (m, 11H), 5.42 (s, 2H), 5.32 (s, 4H), 2.42 (t, J = 7.15, 2H), 1.55 (m, 2H), 
1.26-1.15 (m, 16), 0.84 (t, J = 5.95, 3H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 
190.35, 173.29, 165.34, 162.09, 135.67, 133.62, 132.43, 130.80, 128.33, 127.10, 
126.76, 120.77, 113.49, 70.82, 67.20, 65.60, 33.94, 31.80, 30.51, 29.64, 29.37, 29.29, 
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29.13, 24.93, 22.72, 21.09, 14.23; HRMS (M + Na):  Calc’d for C35H42O6Na: 
581.2879.  Found:  581.2850.  (M + H):  Calc’d for C35H43O6: 559.3060.  Found:  
559.3055. (M + NH4):  Calc’d for C35H46O6N: 576.3325.  Found:  576.3337.   
5-(2-(dodecanoyloxy)acetyl)-2-hydroxybenzoic acid, 155.  The same method to 
generate 153e was followed.  White ppt., 92%, Mp: 58-60oC;  IR (KBr):  3271, 3100-
2800, 1733, 1701, 1697, 1600, 1577, 1500, 1454, 1415, 1365, 1269, 1251, 1215, 
1166, 1056, 1028, 1008, 919, 875, 821, 758, 700 cm-1;  1H NMR (400 MHz, CDCl3) δ 
(ppm), 11.02, (s, 1H), 8.51 (d, J = 2.05, 1H), 8.11 (dd, J = 4.80, J = 4.10, 1H), 7.10 
(d, J = 7.95, 1H), 5.32 (s, 2H), 2.25 (t, J = 7.20, 2H), 1.70 (m, 2H), 1.39-1.27 (m, 
16H), 0.88 (t, J = 6.00, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm), 190.34, 173.82, 
172.53, 166.28, 135.87, 128.91, 126.16, 118.74, 111.25, 65.67, 35.44, 33.99, 31.93, 
31.00, 29.63, 29.36, 29.12, 24.93, 22.71, 14.15; HRMS (M - H):  Calc’d for 
C21H29O6: 377.1964.  Found:  377.1959. 
The same procedures were utilized to synthesize 156. 
benzyl 2-(benzyloxy)-5-(2-(tetradecanoyloxy)acetyl)benzoate, 156d. White ppt., 
71%, Mp: 55-57oC; IR (KBr):  3271, 3100-2800, 1733, 1701, 1697, 1600, 1577, 
1500, 1454, 1415, 1365, 1269, 1251, 1215, 1166, 1056, 1028, 1008, 919, 875, 821, 
758, 700 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 8.26 (d, J = 2.30, 1H), 8.14 
(dd, J = 8.85, J = 2.25, 1H), 7.44-7.33 (m, 11H), 5.42 (s, 2H), 5.33 (s, 4H), 2.40 (t, J 
= 7.10, 2H), 1.56 (m, 2H), 1.26-1.22 (m, 20H), 0.84 (t, J = 6.00, 3H); 13C NMR (125 
MHz, CDCl3) δ (ppm), 190.955, 174.49, 165.34, 162.09, 135.67, 133.62, 132.43, 
130.80, 128.33, 127.10, 126.76, 120.77, 113.49, 70.82, 67.20, 65.60, 33.94, 31.80, 
  308 
30.51, 29.64, 29.37, 29.29, 29.13, 28.66, 28.31, 24.93, 22.72, 21.09, 14.23; HRMS 
(M + Na):  Calc’d for C37H46O6Na: 609.3192.  Found:  609.3201. 
2-hydroxy-5-(2-(tetradecanoyloxy)acetyl)benzoic acid, 156.  White ppt., 94%, Mp: 
60-62oC; IR (KBr):  3271, 3100-2800, 1733, 1701, 1697, 1600, 1577, 1500, 1454, 
1415, 1365, 1269, 1251, 1215, 1166, 1056, 1028, 1008, 919, 875, 821, 758, 700 cm-1; 
1H NMR (400 MHz, d6-DMSO) δ (ppm), 8.30 (d, J = 2.30, 1H), 7.92 (dd, J = 8.80, J 
= 2.20, 1H), 6.88 (d,  J = 8.60, 1H), 5.36 (s, 2H), 2.40 (t, J = 7.05, 2H), 1.56 (m, 2H), 
1.26-1.22 (m, 20H), 0.85 (t, J = 6.00, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm), 
190.40, 174.49, 172.42, 170.63, 133.28, 130.85, 123.29, 117.31, 116.06, 65.78, 33.62, 
31.27, 29.04, 28.99, 28.95, 28.86, 28.69, 28.51, 28.33, 26.23, 24.47, 22.08, 13.94; 
HRMS (M + Na):  Calc’d for C23H34O6Na: 429.2253.  Found:  429.2250. 
5-acetyl-2-(benzyloxy)benzoic acid, 157b.  The general benzylation method as 122b 
was followed.  To a solution of methyl-5-acetyl-2-hydroxybenzoate (157a, 3.06 g, 
15.7 mmol) in 50 ml of DMF was added potassium carbonate (6.53 g, 47.3 mmol) 
and benzyl bromide (4.68 ml, 39.4 mmol).  The reaction was stirred at room 
temperature for 2 days.  At this time, the mixture was diluted with 200 ml of 1:1 
EtOAc/H2O, the organic phase retained, concentrated, and flash chromatographed on 
silica gel (4:1 Hex/EtOAc) to obtain an oil, 4.40 g (98%) that was then dissolved in 
100 ml of CH3OH with 25 ml of aqueous 6 M KOH.  The mixture was stirred for 3 h, 
at which time, conc. HCl was added slowly until an acidic solution was manifest by 
pH paper.  The profuse solid material (KCl) was filtered off, 150 ml of CHCl3 added, 
the organic phase extracted, dried with MgSO4, and inspissated in vacuo to produce 
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157b as a white precipitate, 3.50 g (92%).  This compound is known.  1H NMR (400 
MHz, CDCl3) δ (ppm), 8.77 (d, J = 2.00, 1H), 8.23 (dd, J = 8.68, J = 2.20, 1H), 7.45 
(m, 5H), 7.22 (d, J = 8.75, 1H), 5.38 (s, 2H), 2.63 (s, 3H). 
5-acetyl-N-(4-benzoylphenyl)-2-(benzyloxy)benzamide, 157c.  The general 
approach utilized by Fairbanks, et. al.148 was applied.  To a solution comprised of 
157b (614 mg, 2.27 mmol) in 25 ml of dry CH2Cl2 was added DCC (469 mg, 2.27 
mmol) and DMAP (69 mg, 0.568 mmol).  This admixture was immured in an 
ice/saturated NaCl solution (~ 0oC). While stirring, a solution of 4-aminophenyl-
(phenyl)methanone (448 mg, 2.27 mmol) in 10 ml of CH2Cl2 was slowly added 
dropwise.  Once added, the reaction mixture was removed from the ice bath and 
persisted at room temperature overnight.  At this time, the excess DCU was filtered 
off and remaining solution flash chromatographed (CH2Cl2/EtOAc) to afford 157c as 
a white precipitate, 58%.  Mp: 185-187 oC; IR (KBr):  3271, 3100-2800, 1685, 1670, 
1649, 1593, 1535, 1500, 1323, 1311, 1200, 1054, 1028, 1008, 927, 823, 760 cm-1; 1H 
NMR (400 MHz, CDCl3) δ (ppm), 10.10 (s, 1H), 8.94, (d, J = 2.32, 1H), 8.24 (dd, J = 
8.94, J = 2.32, 1H), 7.77-7.46 (m, 14H), 6.69 (d, J = 8.28, 1H), 5.33 (s, 2H), 2.68 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ (ppm), 196.50, 195.64, 162.29, 159.96, 150.90, 
142.07, 138.86, 135.49, 134.25, 133.63, 132.88, 132.19, 131.30, 129.78, 129.55, 
128.98, 128.29, 127.20, 120.98, 118.92, 113.65, 72.48, 26.62; HRMS (M + H):  
Calc’d for C29H24NO4: 450.1705.  Found:  450.1700. 
N-(4-benzoylphenyl)-2-(benzyloxy)-5-(2-bromoacetyl)benzamide, 157d.  The 
synthetic method paralleled that for 122d.  Oil, ~92%; 1H NMR (400 MHz, CDCl3) δ 
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(ppm), 10.10 (s, 1H), 8.95, (d, J = 2.32, 1H), 8.24 (dd, J = 8.94, J = 2.32, 1H), 7.77-
7.46 (m, 15H), 5.35 (s, 2H), 4.53 (s, 2H). 
2-(3-(4-benzoylphenylcarbamoyl)-4-(benzyloxy)phenyl)-2-oxoethyl-4-(tert-
butoxycarbonylamino)butanoate, 157e.  The same reaction conditions were utilized 
as those to produce 122e.  White ppt., 48%, Mp: 199-201oC;   IR (KBr):  3271, 3100-
2800, 1685, 1670, 1649, 1593, 1535, 1500, 1323, 1311, 1200, 1054, 1028, 1008, 927, 
823, 760 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 10.69 (s, 1H), 8.20, (d, J = 
2.10, 1H), 8.14 (dd, J = 9.00, J = 2.40, 1H), 7.77-7.46 (m, 14H), 6.89 (t, J = 5.95, 
1H), 5.48 (s, 2H), 5.35 (s, 2H), 2.97 (t, J = 6.80, 2H), 2.40 (t, J = 7.80, 2H), 1.70 (m, 
2H), 1.38 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 194.56, 191.01, 172.23, 
164.29, 159.60, 155.61, 142.90, 137.45, 136.00, 132.32, 132.08, 131.12, 131.73, 
131.12, 129.48, 129.41, 128.50, 128.15, 127.71, 126.59, 125.80, 118.68, 113.41, 
77.47, 70.35, 66.17, 30.65, 28.22, 24.95; HRMS (M + Na):  Calc’d for 
C38H38N2O8Na: 673.2526.  Found:  673.2534. 
2-(3-(4-benzoylphenylcarbamoyl)-4-hydroxyphenyl)-2-oxoethyl-4-(tert-butoxy-
carbonylamino)butanoate, 157f.   The same reaction conditions were utilized as 
those to produce 130'.  Adhesive ppt., 86%; 1H NMR (400 MHz, CD3CN) δ (ppm), 
9.21 (s, 1H), 8.45, (d, J = 2.20, 1H), 8.03 (dd, J = 9.00, J = 2.40, 1H), 7.56 (d, J = 
8.65, 2H), 7.31-7.24 (m, 7H), 7.05 (d, J = 7.20, 1H), 5.48 (s, 2H), 5.35 (s, 2H), 3.09 
(t, J = 7.00, 2H), 2.45 (t, J = 7.80, 2H), 1.78 (m, 2H), 1.40 (s, 9H). 
4-(2-(3-(4-benzoylphenylcarbamoyl)-4-hydroxyphenyl)-2-oxoethoxy)-4-
oxobutan-1-aminium 2,2,2-trifluoroacetate, 157.  The same reaction conditions 
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were utilized as those to generate 130. Adhesive ppt., 74%;  IR (KBr):  3271, 3100-
2800, 1685, 1670, 1649, 1593, 1535, 1500, 1323, 1311, 1200, 1054, 1028, 1008, 927, 
823, 760 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 12.75 (s, 1H), 10.57 (s, 1H), 
8.56 (d, J = 2.00, 1H), 8.08 (dd, J = 8.80, J = 2.10, 1H), 7.87 (s, 3H), 7.69 (d, J = 
8.20, 2H), 7.35 (t, J = 7.68, 2H), 7.30 (m, 4H), 7.25 (t, J = 7.30, 1H), 7.18 (d, J = 
8.69, 1H), 5.56 (s, 2H), 2.96 (t, J = 6.80, 2H), 2.65 (t, J = 7.80, 2H), 1.96 (m, 2H);  
13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.68, 171.77, 165.31, 162.69, 157.90, 
157.65, 141.35, 137.96, 135.97, 132.78, 130.02, 129.00, 128.61, 128.41, 125.94, 
125.12, 121.06, 118.60, 117.61, 116.05, 66.28, 38.11, 30.12, 22.59; HRMS (M+):  
Calc’d for C26H25N2O6: 461.1707.  Found:  461.1715. 
The same reaction conditions were utilized to produce 159-165. 
3,5-difluorophenyl-5-acetyl-2-(benzyloxy)benzoate, 158c.  White ppt., 82%, Mp: 
115-117 oC; IR (KBr):  3275, 3100-2800, 1751, 1731, 1677, 1606, 1502, 1465, 1363, 
1271, 1208, 1122, 1056, 1028, 1008, 822, 760 cm-1; 1H NMR (400 MHz, CDCl3) δ 
(ppm), 8.60, (d, J = 2.20, 1H), 8.19 (dd, J = 9.00, J = 2.20, 1H), 7.50 (d, J = 8.10, 
2H), 7.38 (m, 3H), 7.18 (d, J = 8.2, 2H), 6.77 (m, 3H), 5.30 (s, 2H), 2.63 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ (ppm), 195.82, 164.05, 162.93, 161.95, 152.16, 135.34, 
134.81, 133.67, 132.84, 128.91, 128.19, 127.09, 118.69, 113.33, 106.19, 101.78, 
70.63, 26.42; HRMS (M + H):  Calc’d for C22H24F2O4Na: 405.0914.  Found:  
405.0918.   
3,5-difluorophenyl-2-(benzyloxy)-5-(2-bromoacetyl)benzoate, 158d. Oil, ~93%; 
1H NMR (400 MHz, CDCl3) δ (ppm), 8.63, (d, J = 2.20, 1H), 8.20 (dd, J = 9.00, J = 
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2.20, 1H), 7.50 (d, J = 8.10, 2H), 7.38 (m, 3H), 7.18 (d, J = 8.2, 2H), 6.77 (m, 3H), 
5.32 (s, 2H), 4.44 (s, 2H). 
3,5-difluorophenyl-2-(benzyloxy)-5-(2-(4-(tert-butoxycarbonylamino)-butanoy-
loxy)acetyl)benzoate, 158e.  Oil, 44%; IR (KBr): 3271, 3100-2800, 1685, 1670, 
1649, 1593, 1535, 1500, 1323, 1311, 1200, 1054, 1028, 1008, 927, 823, 760 cm-1; 1H 
NMR (400 MHz, d6-DMSO) δ (ppm), 8.50, (d, J = 2.10, 1H), 8.24 (dd, J = 9.00, J = 
2.40, 1H), 7.53-7.49 (m 6H), 7.39 (d, J = 5.60, 1H), 7.13 (dd, J = 8.20, J = 2.10, 2H), 
6.89 (t, J = 5.95, 1H), 5.49 (s, 2H), 5.40 (s, 2H), 2.98 (t, J = 6.80, 2H), 2.42 (t, J = 
7.80, 2H), 1.70 (m, 2H), 1.37 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 
190.88, 172.44, 170.36, 164.36, 162.80, 161.74, 155.55, 151.39, 135.99, 134.59, 
131.77, 128.44, 127.65, 126.97, 118.45, 114.22, 106.30, 102.18, 77.44, 70.32, 66.16, 
59.75, 39.50, 30.42, 28.71, 24.33; HRMS (M + Na):  Calc’d for C31H31F2NO8Na: 
606.1916.  Found:  606.1899. (M + H):  Calc’d for C31H32F2NO8: 584.2096.  Found:  
584.2078. 
3,5-difluorophenyl-5-(2-(4-(tert-butoxycarbonylamino)butanoyloxy)acetyl)-2-
hydroxybenzoate, 158f.  Adhesive ppt., 86%; 1H NMR (400 MHz, d6-DMSO) δ 
(ppm), 8.56, (d, J = 2.10, 1H), 8.22 (dd, J = 9.00, J = 2.40, 1H), 7.22 (d, J = 9.60, 
1H), 7.39 (d, J = 5.60, 1H), 7.08 (dd, J = 8.20, J = 1.90, 1H), 7.02 (m, 2H), 5.49 (s, 
2H), 2.97 (t, J = 6.80, 2H), 2.42 (t, J = 7.80, 2H), 1.69 (m, 2H), 1.39 (s, 9H). 
4-(2-(3-((3,5-difluorophenoxy)carbonyl)-4-hydroxyphenyl)-2-oxoethoxy)-4-
oxobutan-1-aminium 2,2,2-trifluoroacetate, 158.  Adhesive ppt., 82%; IR (KBr):  
3271, 3100-2800, 1685, 1670, 1649, 1593, 1535, 1500, 1323, 1311, 1200, 1054, 
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1028, 1008, 927, 823, 760 cm-1; 1H NMR (400 MHz, MeOD) δ (ppm), 8.68, (d, J = 
2.10, 1H), 8.22 (dd, J = 9.10, J = 2.40, 1H), 7.19 (d, J = 9.10, 1H), 7.07 (d, J = 5.42, 
1H), 7.00 (m, 2H), 5.51 (s, 2H), 3.08 (t, J = 6.80, 2H), 2.66 (t, J = 7.80, 2H), 2.04 (m, 
2H). 19F NMR (376 MHz, MeOD) δ (ppm), -109.79; 13C NMR (125 MHz, MeOD) δ 
(ppm), 190.89, 172.05, 166.59, 165.62, 164.08, 162.23, 161.54, 151.63, 135.33, 
131.31, 126.05, 118.20, 112.15, 106.07, 101.66, 66.00, 38.80, 28.69, 22.50; HRMS 
(M+):  Calc’d for C19H18F2NO6: 394.1102.  Found:  394.1101. 
2-(trifluoromethyl)phenyl-5-acetyl-2-(benzyloxy)benzoate, 159c.  White ppt., 
51%. Mp: 83-85 oC; IR (KBr): 3271, 3100-2800, 1755, 1681, 1598, 1502, 1494, 
1456, 1409, 1361, 1323, 1197, 1168, 1132, 1112, 1056, 1028, 1009, 822, 760, 698 
cm-1; 1H NMR (400 MHz, CDCl3) δ (ppm), 8.72, (d, J = 2.20, 1H), 8.20 (dd, J = 9.00, 
J = 2.20, 1H), 7.75 (d, J = 8.20, 1H), 7.65 (dd, J = 12.05, J = 8.00, 1H), 7.52 (d, J = 
8.20, 2H), 7.43-7.32 (m, 5H), 7.17 (dd, J = 8.50, J = 2.20, 1H), 5.35 (s, 2H), 2.63 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ (ppm), 195.95, 162.59, 162.39, 148.22, 135.63, 
134.63, 133.14, 129.88, 128.72, 128.13, 127.04, 126.37, 124.61, 124.20, 123.36, 
122.03, 119.86, 118.21, 113.36, 70.76, 26.31; HRMS (M + Na):  Calc’d for 
C23H17F3O4Na: 437.0977.  Found:  437.0966.   
2-(trifluoromethyl)phenyl-2-(benzyloxy)-5-(2-bromoacetyl)benzoate, 159d.  Oil, 
~93%. 1H NMR (400 MHz, CDCl3) δ (ppm), 8.72, (d, J = 2.20, 1H), 8.20 (dd, J = 
9.00, J = 2.20, 1H), 7.75 (d, J = 8.20, 1H), 7.65 (dd, J = 12.05, J = 8.00, 1H), 7.51 (d, 
J = 8.20, 2H), 7.43-7.32 (m, 5H), 7.17 (dd, J = 8.50, J = 2.20, 1H), 5.35 (s, 2H), 4.45 
(s, 2H).   
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2-(trifluoromethyl)phenyl-2-(benzyloxy)-5-(2-(4-(tert-butoxycarbonyl-amino)-
butanoyloxy)acetyl)benzoate, 159e. White ppt., 44%, Mp: 117-119 oC; IR (KBr): 
3271, 3100-2800, 1753, 1697, 1666, 1600, 1529, 1494, 1456, 1415, 1380, 1367, 
1321, 1272, 1195, 1166, 1143, 1112, 1055, 1028, 1009, 821, 760 cm-1; 1H NMR (400 
MHz, d6-DMSO) δ (ppm), 8.52, (d, J = 2.20, 1H), 8.37 (dd, J = 9.00, J = 2.20, 1H), 
7.85 (m, 2H), 7.58-7.50 (m, 5H), 7.37 (t, J = 9.00, 2H), 7.31 (d, J = 8.10, 1H), 6.89 (t, 
J = 5.80, 1H), 5.48 (s, 2H), 5.42 (s, 2H), 2.98 (t, J = 6.80, 2H), 2.42 (t, J = 7.80, 2H), 
1.68 (m, 2H), 1.37 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.80, 172.23, 
162.09, 155.61, 147.63, 135.99, 134.90, 134.22, 131.55, 128.41, 127.88, 127.06, 
126.84, 126.34, 125.10, 124.11, 121.95, 121.20, 119.78, 117.98, 114.35, 77.46, 70.19, 
66.09, 39.43, 30.62, 28.20, 20.73; HRMS (M + Na):  Calc’d for C32H32F3O8Na: 
638.1978.  Found:  638.1960.   
2-(trifluoromethyl)phenyl-5-(2-(4-(tert-butoxycarbonyl-amino)-butanoyloxy)-
acetyl)-2-hydroxybenzoate, 159f.  Adhesive ppt., 90%; 1H NMR (400 MHz, d6-
DMSO) δ (ppm), 11.43, (s, 1H), 8.51, (d, J = 2.20, 1H), 8.17 (dd, J = 9.00, J = 2.20, 
1H), 7.62 (d, J = 8.40, 2H), 7.56 (m, 2H), 7.19 (d, J = 8.10, 1H), 6.89 (t, J = 5.80, 
1H), 5.44 (s, 2H), 2.98 (t, J = 6.80, 2H), 2.43 (t, J = 7.80, 2H), 1.68 (m, 2H), 1.37 (s, 
9H). 
4-(2-(4-hydroxy-3-((2-(trifluoromethyl)phenoxy)carbonyl)phenyl)-2-oxoethoxy)-
4-oxobutan-1-aminium 2,2,2-trifluoroacetate, 159. Adhesive ppt., 81%; IR (KBr): 
3442, 3271, 3100-2800, 1741, 1691, 1645, 1600, 1494, 1454, 1417, 1380, 1323, 
1269, 1199, 1172, 1130, 1053, 1026, 821, 800, 760, 717 cm-1; 1H NMR (400 MHz, 
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d6-DMSO) δ (ppm), 11.43 (s, 1H), 8.51, (d, J = 2.20, 1H), 8.17 (dd, J = 9.00, J = 
2.20, 1H), 7.88-7.83 (m, 5H), 7.62-7.58 (m, 2H), 7.19 (d, J = 8.20, 1H), 5.49 (s, 2H), 
2.90 (t, J = 6.80, 2H), 2.42 (t, J = 7.80, 2H), 1.86 (m, 2H); 19F NMR (376 MHz, d6-
DMSO) δ (ppm), -63.07; 13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.46, 171.74, 
165.18, 163.73, 159.43, 158.27, 147.48, 134.97, 134.20, 131.86, 128.46, 126.94, 
125.21, 124.13, 121.61, 118.11, 115.73, 114.45, 66.16, 38.10, 30.15, 22.32; HRMS 
(M+):  Calc’d for C20H19NF3O6: 426.1165.  Found:  426.1140.   
2-fluorophenyl 5-acetyl-2-(benzyloxy)benzoate, 160c. White ppt., 57%, Mp: 91-
93oC; IR (KBr): 3271, 3100-2800, 1755, 1681, 1598, 1502, 1494, 1456, 1409, 1361, 
1323, 1197, 1168, 1132, 1112, 1056, 1028, 1009, 822, 760, 698 cm-1; 1H NMR (400 
MHz, CDCl3) δ (ppm), 8.73, (d, J = 2.20, 1H), 8.23 (dd, J = 9.00, J = 2.20, 1H), 7.40 
(t, J = 7.50, 2H), 7.38-7.33 (m, 3H), 7.28-7.20 (m, 5H), 5.34 (s, 2H), 2.71 (s, 3H); 19F 
NMR (376 MHz, CDCl3) δ (ppm), -128.93; 13C NMR (125 MHz, CDCl3) δ (ppm), 
190.82, 172.10, 169.24, 161.98, 155.77, 154.92, 151.67, 138.03, 136.08, 134.43, 
131.67, 128.55, 127.00, 124.36, 124.87, 118.09, 116.78, 115.42, 77.01, 26.87; HRMS 
(M + Na):  Calc’d for C22H17FO4Na: 387.1009.  Found:  387.1015.   
2-fluorophenyl-2-(benzyloxy)-5-(2-bromoacetyl)benzoate, 160d.  Oil, ~ 84%; 1H 
NMR (400 MHz, CDCl3) δ (ppm), 8.78, (d, J = 2.20, 1H), 8.22 (dd, J = 9.00, J = 
2.20, 1H), 7.40 (t, J = 7.50, 2H), 7.38-7.33 (m, 3H), 7.28-7.20 (m, 5H), 5.36 (s, 2H), 
4.44 (s, 2H). 
3-fluorophenyl-2-(benzyloxy)-5-(2-(4-(tert-butoxycarbonyl-amino)-butanoyloxy)-
acetyl)benzoate, 160e. White ppt., 74%, Mp: 114-116 oC; IR (KBr): 3271, 3100-
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2800, 1755, 1681, 1598, 1502, 1494, 1456, 1409, 1361, 1323, 1197, 1168, 1132, 
1112, 1056, 1028, 1009, 822, 760, 698 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 
8.51, (d, J = 2.20, 1H), 7.51 (m, 3H), 7.38-7.33 (m, 3H), 7.28-7.20 (m, 5H), 6.88 (t, J 
= 6.90, 1H), 5.49 (s, 2H), 5.41 (s, 2H), 2.98 (t, J = 6.80, 2H), 2.42 (t, J = 7.80, 2H), 
1.68 (m, 2H), 1.37 (s, 9H); 19F NMR (376 MHz, CDCl3) δ (ppm), -128.98; 13C NMR 
(125 MHz, d6-DMSO) δ (ppm), 190.91, 172.24, 170.37, 161.92, 155.62, 154.57, 
152.61, 137.66, 136.01, 134.74, 131.67, 128.41, 127.65, 127.06, 126.39, 125.21, 
124.23, 118.09, 116.79, 114.37, 77.49, 70.23, 66.18, 59.75, 30.64, 28.21, 24.96; 
HRMS (M + Na):  Calc’d for C31H32FNO8Na: 588.2010.  Found:  588.2021.  
2-fluorophenyl-5-(2-(4-(tert-butoxycarbonylamino)butanoyloxy)acetyl)-2-
hydroxybenzoate, 160f. White ppt., 74%, Mp: 114-116 oC; IR (KBr): 3271, 3100-
2800, 1755, 1681, 1598, 1502, 1494, 1456, 1409, 1361, 1323, 1197, 1168, 1132, 
1112, 1056, 1028, 1009, 822, 760, 698 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 
8.52, (d, J = 2.20, 1H), 8.13 (dd, J = 9.00, J = 2.20, 1H), 7.45-7.29 (m, 5H), 7.19 (d, J 
= 8.10, 1H), 5H), 5.44 (s, 2H), 2.96 (t, J = 6.80, 2H), 2.42 (t, J = 7.80, 2H), 1.68 (m, 
2H), 1.37 (s, 9H); 19F NMR (376 MHz, d6-DMSO) δ (ppm), -130.36; 13C NMR (125 
MHz, d6-DMSO) δ (ppm), 190.67, 172.24, 163.53, 163.22, 155.62, 154.56, 152.59, 
137.42, 134.88, 132.08, 127.91, 125.37, 124.35, 118.15, 116.76, 114.20, 77.49, 66.06, 
59.75, 30.64, 28.21, 24.96; HRMS (M + Na):  Calc’d for C24H26FNO8Na: 498.1540.  
Found:  498.1533. 
4-(2-(3-((2-fluorophenoxy)carbonyl)-4-hydroxyphenyl)-2-oxoethoxy)-4-
oxobutan-1-aminium 2,2,2-trifluoroacetate, 160.  Adhesive ppt., 92%; IR (KBr): 
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3271, 3100-2800, 1755, 1681, 1598, 1502, 1494, 1456, 1409, 1361, 1323, 1197, 
1168, 1132, 1112, 1056, 1028, 1009, 822, 760, 698 cm-1; 1H NMR (400 MHz, d6-
DMSO) δ (ppm), 11.55 (s, 1H), 8.55, (d, J = 2.20, 1H), 8.14 (dd, J = 9.00, J = 2.20, 
1H), 7.86 (s, 3H), 7.47-7.39 (m, 4H), 7.21 (d, J = 8.10, 1H), 5.51 (s, 2H), 2.89 (t, J = 
6.80, 2H), 2.59 (t, J = 7.80, 2H), 1.86 (m, 2H), 1.37 (s, 9H); 19F NMR (376 MHz, d6-
DMSO) δ (ppm), -130.75; 13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.58, 171.73, 
163.63, 163.14, 158.23, 154.56, 152.60, 137.45, 134.83, 132.11, 127.88, 125.22, 
124.35, 118.17, 116.76, 115.64, 114.34, 66.26, 38.08, 30.10, 22.57; HRMS (M+):  
Calc’d for C19H19FNO6: 376.1191.  Found:  376.1197. 
3-nitrophenyl 5-acetyl-2-(benzyloxy)benzoate, 161c.  White ppt., 46%, Mp: 106-
108oC; IR (KBr): 3271, 3100-2800, 1728, 1712, 1677, 1604, 1502, 1454, 1392, 1353, 
1321, 1284, 1209, 1168, 1051, 1024, 1004, 902, 823, 761, 725 cm-1; 1H NMR (400 
MHz, CDCl3) δ (ppm), 8.69, (d, J = 2.20, 1H), 8.17-8.15 (m, 2H), 8.10 (d, J = 8.20, 
1H), 7.59-7.49 (m, 4H), 7.41-7.35 (m, 3H), 7.20 (d, J = 8.60, 1H), 5.31 (s, 2H), 2.64 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm), 196.02, 163.13, 162.36, 151.09, 
148.85, 135.49, 133.36, 131.40, 130.10, 128.35, 127.20, 121.97, 120.93, 118.48, 
117.64, 115.45, 113.39, 112.19, 71.02, 26.63; HRMS (M + Na):  Calc’d for 
C22H17NO6Na: 414.0954.  Found:  414.0966.   
3-nitrophenyl 2-(benzyloxy)-5-(2-bromoacetyl)benzoate, 161d.  Oil, ~65%;  1H 
NMR (400 MHz, CDCl3) δ (ppm), 8.71, (d, J = 2.20, 1H), 8.17-8.15 (m, 2H), 8.10 (d, 
J = 8.20, 1H), 7.59-7.49 (m, 4H), 7.41-7.35 (m, 3H), 7.22 (d, J = 8.60, 1H), 5.35 (s, 
2H), 4.46 (s, 2H). 
  318 
3-nitrophenyl-2-(benzyloxy)-5-(2-(4-(tert-butoxycarbonyl-amino)butanoyloxy)-
acetyl)benzoate, 161e.  Adhesive ppt., 39%; IR (KBr): 3271, 3100-2800, 1728, 1712, 
1677, 1604, 1502, 1454, 1392, 1353, 1321, 1284, 1209, 1168, 1051, 1024, 1004, 902, 
823, 761, 725 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 8.56, (d, J = 2.30, 1H), 
8.20 (m, 3H), 7.75 (d, J = 8.00, 2H), 7.52-7.48 (m, 3H), 7.37-7.34 (m, 3H), 6.89 (t, J 
= 7.10, 1H), 5.49 (s, 2H), 5.40 (s, 2H), 2.96 (t, J = 6.90, 2H), 2.43 (t, J = 7.70, 2H), 
1.67 (m, 2H), 1.36 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.67, 172.34, 
164.67, 161.54, 155.80, 150.84, 148.34, 136.36, 134.51, 131.82, 129.85, 128.84, 
128.13, 127.96, 127.66, 126.94, 121.11, 118.24, 117.48, 114.27, 78.77, 70.42, 66.13, 
39.72, 30.34, 28.14, 24.27; HRMS (M + Na):  Calc’d for C31H32N2O10Na:  615.1955.  
Found:  615.1971.   
3-nitrophenyl-5-(2-(4-(tert-butoxycarbonylamino)butanoyloxy)acetyl)-2-
hydroxybenzoate, 161f.  Adhesive ppt., 87%;  1H NMR (400 MHz, d6-DMSO) δ 
(ppm), 8.52, (d, J = 2.30, 1H), 8.13 (dd, J = 8.40, J = 2.30, 1H), 7.70 (d, J = 8.00, 
1H), 7.59-7.51 (m, 2H), 7.19 (dd, J = 7.90, J = 1.90, 2H), 6.88 (t, J = 7.10, 1H), 5.49 
(s, 2H), 2.97 (t, J = 6.90, 2H), 2.44 (t, J = 7.70, 2H), 1.67 (m, 2H), 1.36 (s, 9H). 
4-(2-(4-hydroxy-3-((3-nitrophenoxy)carbonyl)phenyl)-2-oxoethoxy)-4-oxobutan-
1-aminium 2,2,2-trifluoroacetate, 161. White ppt., 80%, Mp:  58-60oC; IR (KBr): 
3271, 3100-2800, 1728, 1712, 1677, 1604, 1502, 1454, 1392, 1353, 1321, 1284, 
1209, 1168, 1051, 1024, 1004, 902, 823, 761, 725 cm-1; 1H NMR (400 MHz, d6-
DMSO) δ (ppm), 8.51, (d, J = 2.30, 1H), 8.13 (dd, J = 8.40, J = 2.30, 1H), 7.84 (s, 
3H), 7.71 (d, J = 8.00, 1H), 7.59-7.51 (m, 2H), 7.19 (dd, J = 7.90, J = 1.90, 2H), 5.52 
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(s, 2H), 2.91 (t, J = 6.90, 2H), 2.60 (t, J = 7.70, 2H), 1.86 (m, 2H); 13C NMR (125 
MHz, d6-DMSO) δ (ppm), 190.60, 171.74, 164.55, 158.22, 157.77, 154.78, 150.11, 
137.46, 134.55, 131.87, 130.01, 125.16, 122.46, 120.44, 118.68, 116.79, 115.89, 
114.49, 66.29, 38.09, 30.08, 22.57; HRMS (M+):  Calc’d for C19H19N2O8:  403.1136.  
Found:  403.1145. 
4-nitrophenyl 5-acetyl-2-(benzyloxy)benzoate, 162c.  White ppt., 91%. Mp: 93-
95oC; IR (KBr): 3250, 3100-2800, 1751, 1728, 1677, 1649, 1598, 1523, 1411, 1348, 
1269, 1195, 1165, 1055, 1026, 1007, 905, 860, 823, 760 cm-1; 1H NMR (400 MHz, 
CDCl3) δ (ppm), 8.64, (d, J = 2.20, 1H), 8.30 (d, J = 9.20, 2H), 8.21 (d, J = 8.40, 1H), 
7.50 (dd, J = 8.40, J = 2.10, 2H), 7.41-7.35 (m, 5H), 7.20 (d, J = 8.65, 1H), 5.31 (s, 
2H), 2.63 (s, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm), 196.07, 171.26, 162.79, 
155.58, 145.43, 135.47, 133.55, 131.44, 130.17, 128.79, 127.57, 126.76, 125.53, 
122.70, 118.48, 115.67, 71.02, 26.44; HRMS (M + Na):  Calc’d for C22H17NO6Na: 
414.0954.  Found:  414.0969.   
4-nitrophenyl-2-(benzyloxy)-5-(2-bromoacetyl)benzoate, 162d. Oil, ~84%;  1H 
NMR (400 MHz, CDCl3) δ (ppm), 8.70, (d, J = 2.20, 1H), 8.33 (d, J = 9.20, 2H), 8.23 
(d, J = 8.40, 1H), 7.51 (dd, J = 8.40, J = 2.10, 2H), 7.41-7.35 (m, 5H), 7.24 (d, J = 
8.65, 1H), 5.35 (s, 2H), 4.46 (s, 2H). 
4-nitrophenyl2-(benzyloxy)-5-(2-(4-(tert-butoxycarbonyl-amino)butanoyl-
oxy)acetyl)benzoate, 162e.  White ppt., 57%, Mp: 105-107 oC; IR (KBr): 3275, 
3100-2800, 1745, 1697, 1658, 1602, 1523, 1413, 1348, 1271, 1195, 1165, 1051, 
1026, 1007, 860, 823, 761 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 8.55, (d, J 
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= 2.20, 1H), 8.36 (d, J = 9.20, 2H), 8.26 (d, J = 8.40, 1H), 7.58 (dd, J = 8.40, J = 
2.10, 2H), 7.53-7.50 (m, 3H), 7.41-7.37 (m, 2H), 7.33 (d, J = 8.65, 1H), 6.89 (t, J = 
7.10, 1H), 5.50 (s, 2H), 5.42 (s, 2H), 2.97 (t, J = 6.90, 2H), 2.44 (t, J = 7.70, 2H), 1.70 
(m, 2H), 1.38 (s, 9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.88, 172.22, 
162.33, 161.89, 156.56, 155.31, 145.18, 136.02, 134.64, 131.89, 128.46, 127.66, 
127.18, 126.35, 125.34, 123.32, 118.44, 114.28, 77.46, 70.30, 66.19, 40.06, 30.64, 
28.22, 24.44; HRMS (M + Na):  Calc’d for C31H32N2O10Na: 615.1955.  Found:  
615.1937. 
4-nitrophenyl-5-(2-(4-(tert-butoxycarbonylamino)butanoyloxy)acetyl)-2-
hydroxybenzoate, 162f.  White ppt., 87%, Mp: 144-146oC; IR (KBr): 3275, 3100-
2800, 1745, 1697, 1658, 1602, 1523, 1413, 1348, 1271, 1195, 1165, 1051, 1026, 
1007, 860, 823, 761 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 11.30 (s, 1H), 
8.54, (d, J = 2.20, 2H), 8.38 (d, J = 9.20, 2H), 8.18 (d, J = 8.40, 1H), 7.65 (dd, J = 
8.40, J = 2.10, 2H), 7.20 (d, J = 8.65, 1H), 6.89 (t, J = 7.10, 1H), 5.47 (s, 2H), 2.98 (t, 
J = 6.90, 2H), 2.43 (t, J = 7.70, 2H), 1.68 (m, 2H), 1.38 (s, 9H); 13C NMR (125 MHz, 
d6-DMSO) δ (ppm), 190.63, 172.00, 165.08, 156.94, 145.21, 142.34, 134.78, 132.13, 
130.99, 126.12, 125.31, 123.44, 118.08, 114.64, 77.45, 66.08, 39.96, 30.64, 28.21, 
24.95; HRMS (M + Na):  Calc’d for C24H26N2O10Na: 525.1485.  Found:  525.1487.  
4-(2-(4-hydroxy-3-((4-nitrophenoxy)carbonyl)phenyl)-2-oxoethoxy)-4-oxobutan-
1-aminium 2,2,2-trifluoroacetate, 162.  White ppt., 91%, Mp: 88-90oC; IR (KBr): 
3275, 3100-2800, 1745, 1697, 1658, 1602, 1523, 1413, 1348, 1271, 1195, 1165, 
1051, 1026, 1007, 860, 823, 761 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 11.48 
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(s, 1H), 8.54, (d, J = 2.20, 2H), 8.38 (d, J = 9.20, 2H), 8.15 (d, J = 8.40, 1H), 7.80 (s, 
3H), 7.63 (dd, J = 8.40, J = 2.10, 2H), 7.19 (d, J = 8.65, 1H), 5.51 (s, 2H), 2.89 (t, J = 
6.90, 2H), 2.59 (t, J = 7.70, 2H), 1.86 (m, 2H); 13C NMR (125 MHz, d6-DMSO) δ 
(ppm), 190.59, 171.78, 163.55, 157.99, 157.75, 155.18, 145.23, 134.76, 132.19, 
125.34, 125.19, 123.44, 118.38, 115.99, 114.76; HRMS (M+):  Calc’d for 
C19H19N2O8Na: 403.1141.  Found:  403.1131.  
3,5-bis(trifluoromethyl)phenyl 5-acetyl-2-(benzyloxy)benzoate, 163c.  White ppt., 
90%, Mp: 73-75oC; IR (KBr): 3270, 3100-2800, 1753, 1731, 1679, 1629, 1598, 1500, 
1413, 1371, 1282, 1205, 1180, 1137, 1056, 1029, 1008, 844, 821, 760, 700 cm-1; 1H 
NMR (400 MHz, CDCl3) δ (ppm), 8.65, (d, J = 2.20, 1H), 8.23 (dd, J = 8.80, J = 
2.40, 1H), 7.80 (d, J = 2.20, 1H), 7.67 (d, J = 8.80, 2H), 7.50 (dd, J = 8.40, J = 2.10, 
2H), 7.42-7.36 (m, 3H), 7.20 (d, J = 8.65, 1H), 5.31 (s, 2H), 2.64 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ (ppm), 195.71, 171.20, 162.94, 162.40, 151.27, 135.28, 133.45, 
132.55, 130.01, 128.81, 127.35, 126.03, 123.86, 121.69, 119.84, 118.15, 113.41, 
71.13, 26.42; HRMS (M + Na):  Calc’d for C24H16F6O4Na: 505.0850.  Found:  
505.0866.   
3,5-bis(trifluoromethyl)phenyl-2-(benzyloxy)-5-propionylbenzoate, 163d. Oil, 
~92%. 1H NMR (400 MHz, CDCl3) δ (ppm), 8.69, (d, J = 2.20, 1H), 8.25 (dd, J = 
8.80, J = 2.40, 1H), 7.81 (d, J = 2.20, 1H), 7.68 (d, J = 8.80, 2H), 7.51 (dd, J = 8.40, J 
= 2.10, 2H), 7.43-7.37 (m, 3H), 7.23 (d, J = 8.65, 1H), 5.33 (s, 2H), 4.45 (s, 2H). 
3,5-bis(trifluoromethyl)phenyl-2-(benzyloxy)-5-(2-(4-(tert-butoxycarbonyl-
amino)butanoyloxy)acetyl)benzoate, 163e.  Adhesive ppt., 58%; IR (KBr): 3270, 
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3100-2800, 1745, 1697, 1602, 1529, 1500, 1460, 1371, 1282, 1253, 1174, 1139, 
1054, 1029, 1008, 823, 760, 680 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 8.60, 
(d, J = 2.20, 1H), 8.29 (dd, J = 8.80, J = 2.40, 1H), 8.11 (m, 3H), 7.54-7.50 (m, 3H), 
7.39-7.34 (m, 3H), 7.20 (d, J = 8.65, 1H), 6.89 (t, J = 7.10, 1H), 5.50 (s, 2H), 5.41 (s, 
2H), 2.97 (t, J = 6.90, 2H), 2.44 (t, J = 7.70, 2H), 1.70 (m, 2H), 1.38 (s, 9H);13C NMR 
(125 MHz, d6-DMSO) δ (ppm), 190.86, 172.24, 162.38, 161.99, 155.60, 151.32, 
135.98, 134.72, 132.09, 131.66, 128.40, 128.00, 127.32, 126.30, 123.91, 121.72, 
119.98, 118.22, 114.19, 77.46, 70.40, 66.17, 39.63, 30.64, 28.21, 24.97; HRMS (M + 
Na):  Calc’d for C33H31F6NO8Na: 706.1852.  Found:  706.1844; (M + H):  Calc’d for 
C33H32F6NO8: 684.2032.  Found:  684.2028.  
3,5-bis(trifluoromethyl)phenyl-5-(2-(4-(tert-butoxycarbonyl-amino)butanoyl-
oxy)acetyl)-2-hydroxybenzoate, 163f.  Adhesive ppt., 35%; 1H NMR (400 MHz, 
CD3CN) δ (ppm), 8.70, (d, J = 2.20, 1H), 8.16 (dd, J = 8.80, J = 2.40, 1H), 8.01 (m, 
3H), 7.15 (d, J = 8.65, 1H), 5.36 (s, 2H), 3.08 (t, J = 6.90, 2H), 2.44 (t, J = 7.70, 2H), 
1.79 (m, 2H), 1.39 (s, 9H).     
4-(2-(3-((3,5-bis(trifluoromethyl)phenoxy)carbonyl)-4-hydroxyphenyl)-2-
oxoethoxy)-4-oxobutan-1-aminium-2,2,2-trifluoroacetate, 163.  White ppt., 93%, 
Mp: 77-79oC; IR (KBr): 3438, 3270, 3100-2800, 1741, 1691, 1600, 1460, 1413, 
1373, 1282, 1201, 1176, 1130, 1054, 1029, 1008, 823, 761, 717, 680 cm-1; 1H NMR 
(400 MHz, d6-DMSO) δ (ppm), 11.49, (s, 1H), 8.58, (d, J = 2.20, 1H), 8.21 (d, J = 
8.80, 2H), 8.14 (d, J = 6.10, 2H), 7.85 (s, 3H), 7.20 (d, J = 8.65, 1H), 5.51 (s, 2H), 
2.88 (t, J = 6.90, 2H), 2.59 (t, J = 7.70, 2H), 1.88 (m, 2H); 13C NMR (125 MHz, d6-
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DMSO) δ (ppm), 190.55, 171.76, 163.68, 157.97, 157.48, 151.23, 134.81, 132.35, 
131.34, 125.14, 124.07, 121.75, 119.97, 118.24, 115.88, 114.51, 66.26, 38.08, 30.10, 
22.57; HRMS (M+):  Calc’d for C21H18F6NO6: 494.1038.  Found:  494.1021. 
quinolin-8-yl 5-acetyl-2-(benzyloxy)benzoate, 164c.  White ppt., 86%, Mp: 179-
181oC; IR (KBr): 3275, 3100-2800, 1745, 1670, 1598, 1581, 1496, 1467, 1448, 1382, 
1276, 1238, 1199, 1163, 1056, 1028, 1007, 873, 821, 760, 692, 680 cm-1; 1H NMR 
(400 MHz, CDCl3) δ (ppm), 8.92, (m, 2H), 8.23 (m, 2H), 7.78 (dd, J = 7.20, J = 2.47, 
1H), 7.59-7.52 (m, 4H), 7.46 (dd, J = 8.28, J = 4.25, 1H), 7.32-7.28 (m, 3H), 7.18 (d, 
J = 8.70, 1H), 5.34 (s, 2H), 2.65 (s, 3H); 13C NMR (125 MHz, CDCl3) δ (ppm), 
196.24, 163.86, 162.41, 156.72, 150.62, 147.60, 136.00, 135.87, 134.29, 134.06, 
129.92, 129.63, 128.59, 128.42, 128.10, 127.07, 126.82, 126.29, 121.79, 119.54, 
113.41, 70.71, 24.96;  HRMS (M + H):  Calc’d for C25H20NO4: 398.1392.  Found:  
398.1389. 
quinolin-8-yl 2-(benzyloxy)-5-(2-bromoacetyl)benzoate, 164d.  Oil, ~84%.  1H 
NMR (400 MHz, CDCl3) δ (ppm), 8.96, (m, 2H), 8.23 (m, 2H), 7.80 (dd, J = 7.20, J 
= 2.47, 1H), 7.63-7.58 (m, 4H), 7.55 (dd, J = 8.28, J = 4.25, 2H), 7.49-7.30 (m, 3H), 
7.21 (d, J = 8.70, 1H), 5.37 (s, 2H), 4.52 (s, 2H).   
quinolin-8-yl-2-(benzyloxy)-5-(2-(4-(tert-butoxycarbonyl-amino)-butanoyloxy)-
acetyl)benzoate, 164e.  Adhesive ppt., 48%; IR (KBr): 3275, 3100-2800, 1745, 1670, 
1598, 1581, 1496, 1467, 1448, 1382, 1276, 1238, 1199, 1163, 1056, 1028, 1007, 873, 
821, 760, 692, 680 cm-1; 1H NMR (400 MHz, d6-DMSO) δ (ppm), 8.91, (d, J = 8.05, 
1H), 8.89 (d, J = 7.60, 1H), 8.70 (d, J = 9.40, 1H), 8.50 (d, J = 8.75, 1H), 7.97 (dd, J 
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= 7.50, J = 2.10, 1H), 7.69 (d, J = 8.20, 2H), 7.64 (dd, J = 8.28, J = 4.25, 1H), 7.53 
(m, 3H),  7.33 (m, 3H), 6.89 (d, J = 7.10, 1H), 5.52 (s, 2H), 5.43 (s, 2H), 2.98 (t, J = 
6.90, 2H), 2.44 (t, J = 7.70, 2H), 1.68 (m, 2H), 1.37 (s, 9H); 13C NMR (125 MHz, d6-
DMSO) δ (ppm), 190.98, 172.24, 170.32, 162.74, 162.04, 155.59, 150.76, 146.93, 
140.45, 136.27, 135.06, 134.55, 131.92, 129.17, 128.34, 127.76, 127.06, 126.47, 
126.20, 122.30, 121.71, 119.02, 114.27, 77.49, 70.09, 66.19, 39.14, 33.32, 30.65, 
28.21, 24.44;  HRMS (M + H):  Calc’d for C34H35N2O8: 592.2393.  Found:  
599.2347. (M + Na):  Calc’d for C34H34N2O8Na: 621.2213.  Found:  621.2204. 
quinolin-8-yl-5-(2-(4-(tert-butoxycarbonylamino)butanoyloxy)acetyl)-2-
hydroxybenzoate, 164f.  White ppt., 92%, Mp:  137-139oC; IR (KBr): 3469, 3298, 
3274, 3100-2800, 1743, 1697, 1664, 1631, 1604, 1500, 1421, 1365, 1299, 1249, 
1232, 1199, 1166, 1056, 1027, 1009, 875, 821, 760 cm-1; 1H NMR (400 MHz, d6-
DMSO) δ (ppm), 11.34 (s, 1H), 8.92, (d, J = 8.05, 1H), 8.67 (d, J = 7.60, 1H), 8.52 
(d, J = 9.40, 1H), 8.21 (d, J = 8.75, 1H), 8.01 (dd, J = 7.50, J = 2.10, 1H), 7.76 (d, J = 
8.20, 2H), 7.71 (dd, J = 8.28, J = 4.25, 1H), 7.21 (d, J = 8.40, 1H), 6.89 (d, J = 7.10, 
1H), 5.48 (s, 2H), 2.96 (t, J = 6.90, 2H), 2.43 (t, J = 7.70, 2H), 1.68 (m, 2H), 1.37 (s, 
9H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.76, 172.24, 164.92, 163.64, 
155.59, 150.85, 146.45, 140.05, 136.53, 134.94, 131.91, 129.14, 128.34, 126.98, 
125.60, 122.34, 121.88, 118.31, 114.49, 77.45, 66.10, 39.47, 30.65, 28.21, 24.95;  
HRMS (M + H):  Calc’d for C27H29N2O8: 509.1924.  Found: 509.1910. (M + Na):  
Calc’d for C27H28N2O8Na: 531.1743.  Found:  531.1739. 
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4-(2-(4-hydroxy-3-((quinolin-8-yloxy)carbonyl)phenyl)-2-oxoethoxy)-4-
oxobutan-1-aminium 2,2,2-trifluoroacetate, 164.  Adhesive ppt., 92%; IR (KBr): 
3469, 3298, 3274, 3100-2800, 1743, 1697, 1664, 1631, 1604, 1500, 1421, 1365, 
1299, 1249, 1232, 1199, 1166, 1056, 1027, 1009, 875, 821, 760 cm-1; 1H NMR (400 
MHz, d6-DMSO) δ (ppm), 11.34 (s, 1H), 8.91, (d, J = 8.05, 1H), 8.67 (d, J = 7.60, 
1H), 8.52 (d, J = 9.40, 1H), 8.21 (d, J = 8.75, 1H), 8.01 (dd, J = 7.50, J = 2.10, 1H), 
7.80 (s, 3H), 7.76 (d, J = 8.20, 2H), 7.71 (dd, J = 8.28, J = 4.25, 1H), 7.21 (d, J = 
8.40, 1H), 5.53 (s, 2H), 2.89 (t, J = 6.90, 2H), 2.60 (t, J = 7.70, 2H), 1.87 (m, 2H);  
13C NMR (125 MHz, d6-DMSO) δ (ppm), 190.70, 171.76, 164.82, 163.69, 158.09, 
157.84, 150.83, 146.43, 140.03, 136.57, 134.91, 131.96, 129.14, 126.56, 125.44, 
122.35, 121.90, 118.33, 117.98, 115.55, 66.30, 38.09, 30.09, 22.55;  HRMS (M+):  
Calc’d for C22H21N2O6: 409.1400.  Found: 409.1394. 
Naphthalen-1-yl 5-acetyl-2-(benzyloxy)benzoate, 165c. White ppt., 39%, Mp: 134-
136oC; IR (KBr): 3275, 3100-2800, 1745, 1670, 1598, 1581, 1496, 1467, 1448, 1382, 
1276, 1238, 1199, 1163, 1056, 1028, 1007, 873, 821, 760, 692, 680 cm-1; 1H NMR 
(400 MHz, CDCl3) δ (ppm), 8.75, (d, J = 2.36, 1H), 8.22 (dd, J = 8.79, J = 2.36, 1H), 
7.97 (d, J = 8.66, 1H), 7.91 (d, J = 8.73, 1H), 7.81 (d J = 8.53, 1H), 7.54-7.49 (m, 
4H), 7.41-7.34 (m, 5H),  7.23 (d, J = 8.93, 1H), 5.36 (s, 2H), 2.65 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ (ppm), 196.03, 164.30, 162.08, 146.86, 135.52, 134.72, 134.39, 
134.15, 133.30, 130.03, 128.74, 128.59, 128.24, 127.99, 127.22, 126.48, 126.23, 
125.46, 121.57, 119.77, 118.28, 113.37, 70.97, 26.48;  HRMS (M + H):  Calc’d for 
C26H20O4Na: 419.1259.  Found:  419.1268.  
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Naphthalen-1-yl 2-(benzyloxy)-5-(2-bromoacetyl)benzoate, 165d.  Oil, ~88%;  1H 
NMR (400 MHz, CDCl3) δ (ppm), 8.77, (d, J = 2.36, 1H), 8.25 (dd, J = 8.79, J = 
2.36, 1H), 8.01 (d, J = 8.66, 1H), 7.93 (d, J = 8.73, 1H), 7.82 (d J = 8.53, 1H), 7.56-
7.50 (m, 4H), 7.41-7.34 (m, 5H),  7.27 (d, J = 8.93, 1H), 5.36 (s, 2H), 4.45 (s, 2H). 
Naphthalen-1-yl-2-(benzyloxy)-5-(2-(4-(tert-butoxycarbonyl-amino)-
butanoyloxy)acetyl)benzoate, 165e.  This compound was manufactured by an 
associate and was not characterized prior to further reactivity. 
Naphthalen-1-yl-5-(2-(4-(tert-butoxycarbonylamino)butanoyloxy)acetyl)-2-
hydroxybenzoate, 165f.  Yellow, adhesive ppt, 96%; IR (KBr): 3450, 3275, 3100-
2800, 1745, 1670, 1598, 1581, 1496, 1467, 1448, 1382, 1276, 1238, 1199, 1163, 
1056, 1028, 1007, 873, 821, 760, 692, 680 cm-1; 1H NMR (400 MHz, d6-DMSO) δ 
(ppm), 11.54 (s, 1H), 8.62, (d, J = 2.36, 1H), 8.14 (dd, J = 8.79, J = 2.36, 1H), 8.02 
(m, 2H), 7.93 (d, J = 8.73, 1H), 7.62-7.58 (m, 3H), 7.49 (d, J = 8.10, 1H),  7.16 (d, J 
= 8.93, 1H), 6.89 (t, J = 5.90, 1H), 5.36 (s, 2H), 2.98 (t, J = 6.90, 2H), 2.43 (t, J = 
7.70, 2H), 1.70 (m, 2H), 1.37 (s, 9H);13C NMR (125 MHz, CDCl3) δ (ppm), 190.50, 
172.24, 165.18, 164.27, 155.60, 146.19, 134.52, 134.17, 132.18, 129.71, 128.48, 
127.99, 126.85, 126.36, 125.75, 124.80, 121.22, 119.75, 118.70, 115.02, 77.45, 66.07 
39.47, 30.67, 28.22, 24.97;  HRMS (M + Na):  Calc’d for C28H29NO8Na: 530.1791.  
Found:  530.1794.  
4-(2-(4-hydroxy-3-((naphthalen-1-yloxy)carbonyl)phenyl)-2-oxoethoxy)-4-
oxobutan-1-aminium 2,2,2-trifluoroacetate, 165.  White ppt., 91%, Mp: 63-65oC; 
IR (KBr): 3450, 3275, 3100-2800, 1745, 1670, 1598, 1581, 1496, 1467, 1448, 1382, 
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1276, 1238, 1199, 1163, 1056, 1028, 1007, 873, 821, 760, 692, 680 cm-1; 1H NMR 
(400 MHz, d6-DMSO) δ (ppm), 11.55, (s, 1H), 8.65, (d, J = 2.36, 1H), 8.17 (d, J = 
7.60, 2H), 8.05 (d, J = 8.20, 1H), 7.95 (s, 3H), 7.84 (d, J = 8.55, 1H), 7.63 (m, 3H), 
7.51 (d, J = 8.10, 1H), 7.27 (d, J = 8.93, 1H), 6.89 (t, J = 5.90, 1H), 5.56 (s, 2H), 2.90 
(t, J = 6.90, 2H), 2.60 (t, J = 7.70, 2H), 1.88 (m, 2H); 13C NMR (125 MHz, d6-
DMSO) δ (ppm), 190.64, 171.75, 165.04, 163.52, 158.02, 157.54, 146.12, 134.63, 
132.21, 129.73, 128.65, 127.67, 126.88, 125.76, 122.10, 121.15, 119.74, 118.59, 
118.11, 116.03, 115.17, 66.32, 38.09, 30.11, 22.58; HRMS (M+):  Calc’d for 
C23H22NO6Na: 408.1447.  Found:  408.1447. 
(R)-((R)-1-(4-(benzyloxy)phenyl)-1-oxopropan-2-yl)-2-acetoxy-2-phenylacetate + 
(R)-((S)-1-(4-(benzyloxy)phenyl)-1-oxopropan-2-yl)-2-acetoxy-2-phenylacetate 
166a, 167a.  A parallel process as described for the synthesis of 122e was utilized.  
Viscous oil, 94%; IR (KBr): 3275, 3100-2800, 1745, 1697, 1658, 1602, 1523, 1413, 
1348, 1271, 1195, 1165, 1051, 1026, 1007, 860, 823, 761 cm-1; 1H NMR (400 MHz, 
d6-DMSO) δ (ppm), 7.96 (d, J = 8.17, 2H), 7.88 (d, J = 8.95, 2H), 7.48-7.35 (m, 
20H), 7.11 (d, J = 8.17, 2H), 7.07 (d, J = 8.20, 2H), 6.07, (d, J  = 3.00, 2H), 6.04 (d, J 
= 2.90, 2H), 5.22 (s, 2H), 5.21, (s, 2H), 2.13 (s, 3H), 2.10 (s, 3H), 1.39 (d, J = 7.00, 
3H), 1.33 (d, J = 6.75, 3H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 193.85, 
193.83, 170.33, 169.79, 169.70, 167.77, 167.74, 162.69, 162.58, 161.99, 136.49, 
136.34, 133.59, 133.11, 130.91, 130.81, 130.70, 130.05, 129.67, 129.26, 129.19, 
128.71, 128.58, 128.50, 128.37, 128.11, 128.04, 127.97, 127.80, 127.78, 127.58, 
127.43, 127.41, 126.43, 126.38,  115.08, 114.92, 114.84, 114.61, 73.82, 73.68, 72.43, 
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72.16, 69.54, 69.52, 20.74, 20.32, 16.95, 16.89;  HRMS (M + Na):  Calc’d for 
C26H24O6Na: 455.1471.  Found:  455.1474.  (M + H):  Calc’d for C26H25O6: 
433.1651.  Found:  433.1670. 
(R)-((R)-1-(4-hydroxyphenyl)-1-oxopropan-2-yl)-2-acetoxy-2-phenylacetate + 
(R)-((S)-1-(4-hydroxyphenyl)-1-oxopropan-2-yl)-2-acetoxy-2-phenylacetate, 166, 
167.  A parallel process as described for the synthesis of 130e’ was utilized.  Viscous 
oil, 99%; IR (KBr): 3455, 3100-2800, 1745, 1697, 1658, 1602, 1523, 1413, 1348, 
1271, 1195, 1165, 1051, 1026, 1007, 860, 823, 761 cm-1; 1H NMR (400 MHz, d6-
DMSO) δ (ppm), 10.53 (s, 2H), 7.84 (d, J = 8.17, 2H), 7.80 (d, J = 8.95, 2H), 7.53-
7.42 (m, 10H), 6.85 (d, J = 8.17, 2H), 6.82 (d, J = 8.20, 2H), 6.07, (d, J  = 3.00, 2H), 
6.04 (d, J = 2.90, 2H), 2.12 (s, 3H), 2.10 (s, 3H), 1.38 (d, J = 7.00, 3H), 1.32 (d, J = 
6.75, 3H); 13C NMR (125 MHz, d6-DMSO) δ (ppm), 193.49, 193.46, 169.78, 169.69, 
167.76, 167.73, 162.68, 162.57, 133.64, 133.57, 131.07, 130.96, 130.28, 129.26, 
129.19, 129.07, 128.88, 128.70, 128.62, 128.57, 128.13, 127.99, 127.83, 127.74, 
124.88, 124.83, 115.62, 115.47, 114.91, 114.43, 74.83, 74.18, 72.34, 72.03, 20.38, 
20.32, 17.08, 17.00;  HRMS (M + Na):  Calc’d for C19H18O6Na: 365.1001.  Found:  
365.0996. 
 6-((R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-
hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentan-amido)hexan-1-
aminium, 168c.  A solution of deoxycholic acid 168a, (DOC, 503 mg, 1.28 mmol), 
N-hydroxybenzotriazole (HOBT, 173 mg, 1.28 mmol), and 1-ethyl-3-(3-dimethyl 
aminopropyl) carbodiimide hydrochloride (EDCI, 368 mg, 1.92 mmol) in 10 ml of 
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DMF was stirred for 30 min to ensure complete dissolution.  While stirring, tert-butyl 
6-aminohexylcarbamate (277 mg, 1.28 mmol) in 5 ml DMF was slowly added over 5 
minutes.  The reaction proceeded for 22 h under ambient conditions.  After this time, 
the solution was diluted with ethyl acetate and 100 ml of water was added.  An 
extraction of the organic layer then was performed, followed by addition of 
anhydrous magnesium sulfate.  After concentration, 15 ml of 4 M HCl in 1,4-dioxane 
was added.  Stirring of this solution, under ambient conditions, occurred for 1 h.  
Excess solution was removed under reduced pressure for 2 days to afford 168c as a 
white, adhesive precipitate, 456 mg (75%). IR (KBr):  3584, 3226, 2950, 2846, 1657, 
1569, 1448, 1419, 1390, 1340, 1157, 1100, 1062, 1016; 1H NMR (400 MHz, MeOD) 
δ 7.98 (s, 1H), 3.61 (m, 2H), 3.19 (t, 2H), 2.94 (t, 2H), 2.31 (m, 4H), 1.61-1.33 (m, 
31H), 1.23 (s, 3H), 0.99 (s, 3H), 0.88 (s, 3H); 13C NMR (125 MHz, MeOD), d 
177.97, 74.17, 72.68, 48.83, 48.15, 47.72, 43.75, 40.89, 40.80, 37.61, 37.44, 37.34, 
37.13, 36.57, 35.46, 34.98, 33.66, 32.08, 31.22, 30.96, 30.09, 30.01, 28.87, 28.63, 
27.49, 27.15, 25.02, 23.86, 17.74, 13.33; HRMS (M+):  Calc'd for C30H55N2O3:  
491.4213.  Found:  491.4209. 
(R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-
hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-N-(6-(3-(3',6'-dihydroxy-3-
oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-yl)thioureido)hexyl)pentanamide, 
168.  A solution of 168c (238 mg, 0.484 mmol) and fluorescein-4-isothiocyanate 
(FITC, 226 mg, 0.581 mmol) in 20 ml of MeOH was stirred for 30 min.  While 
stirring at 0o C, triethylamine (TEA, 67 mL (0.484 mmol) was added over a period of 
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5 minutes.  The reaction proceeded under ambient conditions for 16 h.  Inspissation 
under reduced pressure followed to yield a dark red/brown precipitate.  Flash column 
chromatography (100% Ethyl acetate, then 1:1 Ethyl acetate/Acetone, then 1:1 
Acetone/Methanol furnished 227 mg of 168 (53%) as a yellowish, waxy precipitate. 
IR (KBr):  3580, 3278, 2933, 2856, 1757, 1712, 1614, 1587, 1504, 1452, 1365, 1334, 
1220, 1180, 1118, 1081, 871, 850, 786, 711, 673;   1H NMR (400 MHz, MeOD) δ 
8.22 (s, 1H), 7.76 (m, 2H), 7.16 (d, 1H), 6.68 (m, 3H), 6.55 (m, 3H),  3.61 (m, 2H), 
3.19 (t, 2H), 2.94 (t, 2H), 2.31 (m, 4H), 1.61-1.33 (m, 31H), 1.23 (s, 3H), 0.99 (s, 
3H), 0.88 (s, 3H); 13C NMR (125 MHz, MeOD), δ 182.84, 176.96, 171.68, 154.70, 
142.76, 131.75, 130.66, 126.28, 126.11, 126.02, 120.22, 118.83, 114.35, 112.29, 
112.04, 74.17, 72.68, 48.83, 48.15, 47.72, 43.75, 40.89, 40.80, 37.58, 37.34, 36.96, 
36.58, 35.45, 34.96, 34.38, 33.60, 31.22, 30.49, 30.05, 30.00, 29.69, 28.88, 28.55, 
27.75, 27.62, 25.03, 23.91,17.83, 13.43. 9.38. HRMS (M + H):  Calc'd for 
C51H65N3O8S:  880.4571.  Found:  880.4578. 
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